Chart Industries, Inc. 424B4
Filed Pursuant to Rule 424(B)(4)
Registration No. 333-141730
PROSPECTUS
12,612,513 Shares
Chart Industries,
Inc.
Common Stock
The selling stockholders, consisting of FR X Chart Holdings LLC
and certain of our executive officers, including our Chief
Executive Officer, and other employees are selling
12,612,513 shares of our common stock. We will grant the
underwriters an option to purchase up to
1,891,876 additional shares of newly issued common stock to
cover over-allotments. We will not receive any proceeds from the
sale of shares by the selling stockholders. We intend to use the
proceeds we receive from any shares sold pursuant to the
underwriters over-allotment option for general corporate
purposes, including reduction of our indebtedness.
Our common stock is listed on the Nasdaq Global Market under the
symbol GTLS. On June 6, 2007, the last reported
sale price of our common stock was $21.25 per share.
Investing in the common stock involves risks. See Risk
Factors beginning on page 11.
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds, Before
|
|
|
Public
|
|
Underwriting
|
|
Expenses, to the
|
|
|
Offering Price
|
|
Discount
|
|
Selling Stockholders
|
|
Per Share
|
|
$21.25
|
|
$1.0094
|
|
$20.2406
|
Total
|
|
$268,015,901.25
|
|
$12,731,070.62
|
|
$255,284,830.63
|
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
The underwriters expect to deliver the shares to purchasers on
or about June 12, 2007.
|
|
|
Morgan
Stanley |
Lehman
Brothers |
Goldman,
Sachs & Co. |
|
|
Natexis
Bleichroeder Inc. |
Simmons &
Company |
June 6, 2007
Darwin LNG liquefaction facility in Northern Territory,
Australia,
including Chart vacuum-insulated pipe and
vacuum-insulated pipe riser modules for large storage
tanks
Chart brazed aluminum heat exchanger core
for use in an air separation cold box
Atlantic LNG Company plant, Point Fortin, Trinidad &
Tobago, including Chart liquefaction
cold boxes and vacuum-insulated pipe for jetty cool-down
lines
(Photo courtesy Atlantic LNG Company, Point Fortin,
Trinidad & Tobago)
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
11
|
|
|
|
|
24
|
|
|
|
|
26
|
|
|
|
|
27
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
30
|
|
|
|
|
34
|
|
|
|
|
62
|
|
|
|
|
65
|
|
|
|
|
76
|
|
|
|
|
102
|
|
|
|
|
105
|
|
|
|
|
107
|
|
|
|
|
112
|
|
|
|
|
116
|
|
|
|
|
118
|
|
|
|
|
121
|
|
|
|
|
125
|
|
|
|
|
125
|
|
|
|
|
125
|
|
|
|
|
F-1
|
|
You should rely only on the information contained in this
prospectus. We have not authorized anyone to provide you with
information different from that contained in this prospectus. We
are offering to sell shares of common stock and seeking offers
to buy shares of common stock only in jurisdictions where offers
and sales are permitted. The information contained in this
prospectus is accurate only as of the date of this prospectus,
regardless of the time of delivery of this prospectus or of any
sale of the shares of common stock.
PROSPECTUS
SUMMARY
This summary highlights information contained elsewhere in
this prospectus, but it may not contain all of the information
that is important to you. We urge you to read this entire
prospectus including the section entitled Risk
Factors and the financial statements and related notes,
before investing in our common stock.
Unless the context otherwise requires, as used in this
prospectus, (i) the terms we, our,
us, the Company, Chart
Industries and similar terms refer to Chart Industries,
Inc. and its consolidated subsidiaries, (ii) the term
issuer refers to Chart Industries, Inc. and not any
of its subsidiaries and (iii) the term initial public
offering refers to our initial public offering of common
stock which was completed on July 31, 2006.
Chart
Industries, Inc.
Our
Company
We are a leading independent global manufacturer of highly
engineered equipment used in the production, storage and end-use
of hydrocarbon and industrial gases, based on our sales and the
estimated sales of our competitors. We supply engineered
equipment used throughout the global liquid gas supply chain.
The largest portion of end-use applications for our products is
energy-related, accounting for 56% of sales and 58% of orders in
2006, and 79% of backlog at December 31, 2006. We are a
leading manufacturer of standard and engineered equipment
primarily used for low-temperature and cryogenic, or very low
temperature, applications. We have developed an expertise in
cryogenic systems and equipment, which operate at low
temperatures sometimes approaching absolute zero (0 kelvin;
−273o
Centigrade;
−459o
Fahrenheit). The majority of our products, including
vacuum-insulated containment vessels, heat exchangers, cold
boxes and other cryogenic components, are used throughout the
liquid gas supply chain for the purification, liquefaction,
distribution, storage and end-use of hydrocarbon and industrial
gases.
We have attained this position by capitalizing on our low-cost
global manufacturing footprint, technical expertise and
know-how, broad product offering, reputation for quality, and by
focusing on attractive, growing markets. We have an established
sales and customer support presence across the globe and
low-cost manufacturing operations in the United States, Central
Europe and China. We believe we are the number one or two
equipment supplier in all of our primary end-use markets. For
the three months ended March 31, 2007 and 2006, we
generated sales of $152.5 million and $120.8 million,
respectively. For the year ended December 31, 2006, the
combined year ended December 31, 2005 and the year ended
December 31, 2004, we generated sales of
$537.5 million, $403.1 million and
$305.6 million, respectively.
We believe that we are well-positioned to benefit from a variety
of long-term trends driving demand in our industry, including:
|
|
|
|
|
increasing demand for natural gas and the geographic dislocation
of supply and consumption, which is resulting in the need for a
global network for liquefied natural gas, or LNG;
|
|
|
|
increasing demand for natural gas processing, particularly in
the Middle East, as crude oil producers look to utilize the gas
portions of their reserves; and
|
|
|
|
increased demand for natural and industrial gases resulting from
rapid economic growth in developing areas, particularly Central
and Eastern Europe and China.
|
We operate in three segments: (i) Energy and Chemicals, or
E&C, (ii) Distribution and Storage, or D&S, and
(iii) BioMedical. While each segment manufactures and
markets different cryogenic equipment and systems to distinct
end-users, they all share a reliance on our heat transfer and
low temperature storage know-how and expertise. The E&C and
D&S segments manufacture products used in energy-related
and other applications, such as the separation, liquefaction,
distribution and storage of hydrocarbon and industrial gases.
Through our BioMedical segment, we supply cryogenic equipment
used in the storage and distribution of biological materials and
oxygen, used primarily in the medical, biological research and
animal breeding industries.
1
Competitive
Strengths
We believe that the following competitive strengths position us
to enhance our growth and profitability:
Focus on Attractive Growing End Markets. We
anticipate growing demand in the end markets we serve, with
particularly strong growth in LNG, natural gas processing,
specific international markets across all segments, and
biomedical equipment. Rapid economic development in developing
areas, particularly Central and Eastern Europe and China, has
caused a significant increase in the demand for natural and
industrial gases.
Substantial Revenue Visibility. We have a
large and growing backlog, which provides us with a high degree
of visibility in our forecasted revenue. Our backlog as of
March 31, 2007, December 31, 2006, December 31,
2005 and December 31, 2004 was $342.2 million,
$319.2 million, $233.6 million and
$129.3 million, respectively. Projects for
energy-related
applications totaled approximately $251.0 million in
backlog as of December 31, 2006.
Leading Market Positions. We believe we are
the #1 or #2 equipment supplier in each of our primary
end markets both domestically and internationally. We believe
that our strong industry positioning makes us typically one of
only two or three suppliers qualified to provide certain
products to key customers.
Diverse, Long-Standing Customer Base. We
currently serve over 2,000 customers worldwide. Our primary
customers are large, multinational producers and distributors of
hydrocarbon and industrial gases that provide us with revenue
stability. Customers and end-users also include high growth LNG
processors, petrochemical processors and biomedical companies.
We have developed strong, long-standing relationships with these
customers.
Highly Flexible and Low-Cost Manufacturing
Base. Given our long-term investment in global
manufacturing facilities and specialized equipment, we have
developed a substantial comparative scale and geographic
advantage within the markets for the cryogenic products that we
manufacture with more than 1.9 million square feet of
manufacturing space across 12 primary facilities and three
continents. This scale and the related substantial operational
flexibility enable us to be a low-cost producer for our products.
Product Expertise, Quality, Reliability and
Know-How. Within our end markets, we have
established a reputation for quality, reliability and technical
innovation. We believe that the main drivers of our target
customers purchasing decisions are a suppliers
product expertise, quality, reliability and know-how rather than
pricing and terms, giving us an advantage based on our
reputation and consequent brand recognition. We believe it would
be difficult for a new entrant to duplicate our capabilities.
Experienced Management Team. We have assembled
a strong senior management team with over 250 combined
years of related experience and complementary skills. This team
is largely responsible for our strong performance since 2003.
Business
Strategy
We believe that we are well-positioned to maintain our
leadership in providing highly engineered equipment for use in
low-temperature and cryogenic applications and to meet the
worlds growing demand for hydrocarbon and industrial gases
with more economical, reliable and environmentally friendly
systems. The principal elements of our strategy are as follows:
Continue to develop innovative, high-growth, energy-specific
products. We plan to continue to focus on
extending our cryogenic technological leadership, both to
capitalize on increasing demand for energy and to create new
applications.
Leverage our global platform to capitalize on growing
international demand. We expect growth in
hydrocarbon and industrial gas demand and investment over the
next five years in the Middle East, Central and Eastern Europe,
Russia and China. We believe that our investment in
manufacturing, sales and marketing capabilities positions us to
increase our market share in these growing international markets.
Capitalize on our position as a market
leader. We plan to continue to grow our
long-standing relationships with the leading users of cryogenic
equipment and expand our customer base.
2
Maintain our position as a low-cost producer while continuing
to improve operating performance. We believe we
are the lowest cost manufacturer for most of our products and we
intend to continue to leverage our scale, scope, technical
expertise and know-how to deliver to our customers higher
quality and more reliable products and services at lower cost.
Our disciplined approach to capital expenditures is intended to
enhance capacity where we expect to realize significant and
timely returns.
Recent
Developments
On March 19, 2007, Mr. Ben A. Guill announced his
resignation from our board of directors effective March 19,
2007. Mr. Guills resignation from the board of
directors, where he served as our Chairman, did not involve any
disagreement with us on any matter relating to our operations,
policies or practices. Mr. Guill resigned from the board of
directors in connection with his resignation from First Reserve
Corporation, or First Reserve, to explore new challenges which
may include deal sourcing
and/or
another affiliation with First Reserve while allowing him more
time with his family and to pursue other personal interests. On
March 27, 2007, the board of directors designated
Mr. Samuel F. Thomas, our Chief Executive Officer and
President, to serve as Chairman.
In the first quarter of 2007, Mr. John T. Romain resigned
as President of our E&C segment and left our company in the
second quarter of 2007. On May 14, 2007, Michael T. Bright
joined our company as President of our E&C segment.
Primarily as a result of the vesting of the performance-based
options based on First Reserve achieving a specified investment
return upon completion of this offering, we estimate that we
will incur a pre-tax, non-cash stock-based compensation expense
of approximately $7.0 million in the period in which this
offering is consummated. Upon completion of this offering, 82%
of such performance-based options will vest.
Mr. Thomas established a
Rule 10b5-1
stock sale plan in late 2006. Under the plan, Mr. Thomas
sold 60,000 shares of our common stock between
March 22, 2007 and March 28, 2007 at prices ranging
from $17.11 to $18.61 per share in accordance with the plan.
Risk
Factors
Investing in our common stock involves substantial risk. You
should carefully consider all the information in this prospectus
prior to investing in our common stock. Our ability to execute
our strategy is subject to the risks that are generally
associated with the production, storage and end-use of
hydrocarbon and industrial gases. We are also subject to a
number of risks related to our competitive position, operations
and business strategies. For example, our strategy relating to
potential acquisitions exposes us to the risks involved in
consummating and integrating acquisitions, including the risk
that in a future acquisition we could incur additional debt and
contingent liabilities which could adversely affect our
operating results. For additional risks relating to our business
and the offering, see Risk Factors beginning on
page 11 of this prospectus.
Company
Information
Chart Industries, Inc. is a Delaware corporation incorporated in
1992. Our principal executive offices are located at One
Infinity Corporate Centre Drive, Suite 300, Garfield
Heights, Ohio, 44125 and our telephone number is
(440) 753-1490.
On July 8, 2003, we and all of our then majority-owned
U.S. subsidiaries filed voluntary petitions for
reorganization relief under Chapter 11 of the
U.S. Bankruptcy Code. On September 15, 2003, we and
those subsidiaries emerged from Chapter 11 proceedings. On
August 2, 2005, we entered into an agreement and plan of
merger with certain of our stockholders, First Reserve, and CI
Acquisition, Inc., which provided for the sale of shares of
common stock of Chart Industries, Inc. by certain of its
stockholders to CI Acquisition and the merger of CI Acquisition
with and into Chart Industries, with Chart Industries surviving
the merger as an indirect,
wholly-owned
subsidiary of First Reserve. We refer to the stock purchase, the
merger and the related financing thereof collectively as the
Acquisition.
Before the closing of the Acquisition by First Reserve on
October 17, 2005, we filed periodic and other reports with
the Securities and Exchange Commission. We ceased filing those
reports upon the closing of the Acquisition
3
when our pre-Acquisition securities were cancelled and ceased to
be outstanding. Since the completion of our initial public
offering on July 31, 2006, we have filed periodic and other
reports with the Securities and Exchange Commission. The
financial statements and other financial data presented in this
prospectus are of Chart Industries, Inc. and its direct and
indirect subsidiaries.
Equity
Sponsor
First Reserve is the oldest and largest private equity firm
specializing in the energy industry. Founded in 1983, First
Reserve was the first private equity investment firm to actively
pursue building a broadly diversified global investment
portfolio of companies involved in the various sectors of the
energy industry. Since 1992, First Reserve has raised over
$12.7 billion for its buyout-focused funds and made more
than 65 principal transactions. In addition, First Reserve
portfolio companies have completed 230 add-on transactions. Past
and present public First Reserve portfolio companies include
Chicago Bridge and Iron N.V., Weatherford International,
Dresser-Rand Group Inc., Pride International, Inc., Alpha
Natural Resources, Foundation Coal, China Coal Energy Company
Limited, T-3 Energy Services Inc. and Quintana Maritime Limited.
Upon completion of this offering, affiliates of First Reserve
will no longer own any shares in our company.
4
The
Offering
|
|
|
Selling Stockholders |
|
FR X Chart Holdings LLC, certain of our executive officers,
including Messrs. Thomas and Biehl, and other employees.
Our executive officers and other employees are selling
236,299 shares in the aggregate. |
|
Shares of common stock offered by the selling stockholders |
|
12,612,513 shares. |
|
Shares of common stock outstanding after this offering |
|
25,647,656 shares (including shares currently subject to
options that are expected to be exercised in connection with
this offering). |
|
Over-allotment option |
|
1,891,876 shares. |
|
Use of proceeds |
|
We will not receive any of the proceeds from the sale of shares
by the selling stockholders. The selling stockholders will
receive all the net proceeds from the sale of shares of common
stock offered by this prospectus. |
|
|
|
In the event the underwriters exercise any part of their
over-allotment option, we intend to use the proceeds for general
corporate purposes, including reduction of our indebtedness. See
Use of Proceeds. |
|
Nasdaq Global Market |
|
GTLS |
Unless we specifically state otherwise, all information in this
prospectus:
|
|
|
|
|
assumes no exercise by the underwriters of their option to
purchase additional shares; and
|
|
|
|
excludes 2,391,995 shares of common stock reserved for
issuance under stock options granted before the date of this
prospectus that we expect to continue to be outstanding under
our plans after this offering, which options would be
exercisable at a weighted average exercise price of $7.43.
|
5
Summary
Historical Financial Information
The financial statements referred to as the Predecessor Company
financial statements include the consolidated audited financial
statements of Chart Industries, Inc. and its subsidiaries prior
to the Acquisition. The financial statements referred to as the
Company financial statements include the consolidated audited
financial statements of Chart Industries, Inc. and its
subsidiaries after the Acquisition.
The following table sets forth our summary historical
consolidated financial and other data as of the dates and for
the periods indicated. The Predecessor Company summary
historical financial statements and other data for the year
ended December 31, 2004 and the period from January 1,
2005 to October 16, 2005 are derived from our audited
financial statements for such periods included elsewhere in this
prospectus, which have been audited by Ernst & Young
LLP. The Company summary historical financial statements and
other data as of and for the period from October 17, 2005
to December 31, 2005 and the year ended December 31,
2006 are derived from our audited financial statements for such
periods included elsewhere in this prospectus, which have been
audited by Ernst & Young LLP. The Company unaudited
summary historical financial information and other data for the
three months ended March 31, 2006 and as of and for the
three months ended March 31, 2007, respectively, have been
derived from the unaudited condensed consolidated financial
statements and related notes which are included elsewhere in
this prospectus, and reflect all adjustments, consisting of
normal, recurring adjustments which are, in the opinion of
management, necessary for a fair presentation of the
Companys financial position, results of operation and cash
flows for the three months ended March 31, 2006 and as of
and for the three months ended March 31, 2007 and are not
necessarily indicative of our results of operations for the full
year. The data should be read in conjunction with the
consolidated financial statements, related notes and other
financial information included herein.
The historical consolidated financial data presented below is
not necessarily indicative of our future performance. This
information is only a summary and should be read in conjunction
with Selected Historical Consolidated Financial
Data, Managements Discussion and Analysis of
Financial Condition and Results of Operations and our
audited consolidated financial statements and related notes
included elsewhere in this prospectus.
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars and shares in thousands, except per share data)
|
|
|
(Unaudited)
|
|
Statement of Operations
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
$
|
305,576
|
|
|
$
|
305,497
|
|
|
|
$
|
97,652
|
|
|
$
|
537,454
|
|
|
$
|
120,840
|
|
|
$
|
152,463
|
|
Cost of sales(1)
|
|
|
211,770
|
|
|
|
217,284
|
|
|
|
|
75,733
|
|
|
|
382,535
|
|
|
|
83,853
|
|
|
|
112,604
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
93,806
|
|
|
|
88,213
|
|
|
|
|
21,919
|
|
|
|
154,919
|
|
|
|
36,987
|
|
|
|
39,859
|
|
Selling, general and administrative
expenses(2)
|
|
|
53,374
|
|
|
|
59,826
|
|
|
|
|
16,632
|
|
|
|
87,652
|
|
|
|
21,039
|
|
|
|
22,473
|
|
Restructuring and other operating
expenses, net(3)
|
|
|
3,353
|
|
|
|
7,528
|
|
|
|
|
217
|
|
|
|
396
|
|
|
|
162
|
|
|
|
99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,727
|
|
|
|
67,354
|
|
|
|
|
16,849
|
|
|
|
88,048
|
|
|
|
21,201
|
|
|
|
22,572
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
37,079
|
|
|
|
20,859
|
|
|
|
|
5,070
|
|
|
|
66,871
|
|
|
|
15,786
|
|
|
|
17,287
|
|
Interest expense, net(4)
|
|
|
4,712
|
|
|
|
4,164
|
|
|
|
|
5,556
|
|
|
|
25,461
|
|
|
|
6,545
|
|
|
|
6,346
|
|
Other expense (income)
|
|
|
(465
|
)
|
|
|
659
|
|
|
|
|
409
|
|
|
|
1,003
|
|
|
|
222
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,247
|
|
|
|
4,823
|
|
|
|
|
5,965
|
|
|
|
26,464
|
|
|
|
6,767
|
|
|
|
6,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
before income taxes and minority interest
|
|
|
32,832
|
|
|
|
16,036
|
|
|
|
|
(895
|
)
|
|
|
40,407
|
|
|
|
9,019
|
|
|
|
10,891
|
|
Income tax expense (benefit)
|
|
|
10,134
|
|
|
|
7,159
|
|
|
|
|
(441
|
)
|
|
|
13,044
|
|
|
|
2,980
|
|
|
|
3,713
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations
before minority interest
|
|
|
22,698
|
|
|
|
8,877
|
|
|
|
|
(454
|
)
|
|
|
27,363
|
|
|
|
6,039
|
|
|
|
7,178
|
|
Minority interest, net of taxes and
other
|
|
|
(98
|
)
|
|
|
(19
|
)
|
|
|
|
(52
|
)
|
|
|
(468
|
)
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
22,600
|
|
|
$
|
8,858
|
|
|
|
$
|
(506
|
)
|
|
$
|
26,895
|
|
|
$
|
6,045
|
|
|
$
|
7,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share
data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share
|
|
$
|
4.22
|
|
|
$
|
1.65
|
|
|
|
$
|
(0.06
|
)
|
|
$
|
1.70
|
|
|
$
|
0.76
|
|
|
$
|
0.28
|
|
Diluted earnings (loss) per
share(5)(6)
|
|
$
|
4.10
|
|
|
$
|
1.57
|
|
|
|
$
|
(0.06
|
)
|
|
$
|
1.65
|
|
|
$
|
0.73
|
|
|
$
|
0.28
|
|
Weighted average shares
basic
|
|
|
5,351
|
|
|
|
5,366
|
|
|
|
|
7,952
|
|
|
|
15,835
|
|
|
|
7,952
|
|
|
|
25,604
|
|
Weighted average shares
diluted
|
|
|
5,516
|
|
|
|
5,649
|
|
|
|
|
7,952
|
|
|
|
16,269
|
|
|
|
8,285
|
|
|
|
25,810
|
|
Cash flow data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
$
|
35,059
|
|
|
$
|
15,641
|
|
|
|
$
|
14,635
|
|
|
$
|
36,398
|
|
|
$
|
11,895
|
|
|
$
|
1,037
|
|
Net cash (used in) investing
activities
|
|
$
|
(3,317
|
)
|
|
$
|
(20,799
|
)
|
|
|
$
|
(362,250
|
)
|
|
$
|
(38,664
|
)
|
|
$
|
(2,566
|
)
|
|
$
|
(6,646
|
)
|
Net cash (used in) provided by
financing activities
|
|
$
|
(35,744
|
)
|
|
$
|
1,708
|
|
|
|
$
|
348,489
|
|
|
$
|
9,235
|
|
|
$
|
(5,839
|
)
|
|
$
|
(928
|
)
|
Other financial data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization(7)
|
|
$
|
8,490
|
|
|
$
|
6,808
|
|
|
|
$
|
4,396
|
|
|
$
|
22,449
|
|
|
$
|
5,194
|
|
|
$
|
4,991
|
|
EBITDA(8)
|
|
$
|
45,936
|
|
|
$
|
26,989
|
|
|
|
$
|
9,005
|
|
|
$
|
87,849
|
|
|
$
|
20,764
|
|
|
$
|
22,228
|
|
Capital expenditures
|
|
$
|
9,379
|
|
|
$
|
11,038
|
|
|
|
$
|
5,601
|
|
|
$
|
22,253
|
|
|
$
|
2,566
|
|
|
$
|
5,024
|
|
Backlog
|
|
$
|
129,278
|
|
|
$
|
206,215
|
|
|
|
$
|
233,639
|
|
|
$
|
319,153
|
|
|
$
|
237,033
|
|
|
$
|
342,182
|
|
7
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
As of March 31,
|
|
|
|
2006
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
(Unaudited)
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
18,854
|
|
|
$
|
12,359
|
|
Working capital(9)
|
|
$
|
73,290
|
|
|
$
|
84,286
|
|
Total assets(10)
|
|
$
|
724,875
|
|
|
$
|
736,316
|
|
Debt:
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
$
|
750
|
|
|
$
|
|
|
Long-term debt
|
|
$
|
290,000
|
|
|
|
|
|
Total debt
|
|
$
|
290,750
|
|
|
$
|
290,000
|
|
Shareholders equity
|
|
$
|
219,734
|
|
|
$
|
226,963
|
|
|
|
|
(1) |
|
The period from October 17, 2005 to December 31, 2005
includes non-cash inventory valuation charges of
$8.9 million related to purchase accounting. |
|
|
|
(2) |
|
Includes amortization expense related to intangible assets for
the year ended December 31, 2004, the period from
January 1, 2005 to October 16, 2005, the period from
October 17, 2005 to December 31, 2005, the year ended
December 31, 2006, the three months ended
March 31, 2006 and the three months ended March 31,
2007 of $2.8 million, $2.7 million, $3.0 million,
$15.4 million, $3.6 million and $3.0 million,
respectively. Includes charges (income), net of insurance
recoveries, related to Hurricane Rita of $1.1 million,
$0.4 million and ($2.3 million) for the period from
January 1, 2005 to October 16, 2005, the period from
October 17, 2005 to December 31, 2005 and the year
ended December 31, 2006, respectively. |
|
|
|
(3) |
|
Includes gain or loss on sale of assets. |
|
(4) |
|
Includes derivative contract valuation income or expense for
interest rate collars to manage interest exposure relative to
term debt. |
|
(5) |
|
The basic and diluted loss or earnings per share for the period
from October 17, 2005 to December 31, 2005 are the
same because incremental shares issuable upon conversion are
anti-dilutive. |
|
|
|
(6) |
|
Diluted earnings (loss) per share for the three months ended
March 31, 2007 are not comparable to diluted earnings
(loss) per share for the three months ended March 31, 2006
due to the change in our capital structure upon completion of
our initial public offering in July 2006. |
|
|
|
(7) |
|
The period from October 17, 2005 to December 31, 2005,
the year ended December 31, 2006, the three months
ended March 31, 2006 and the three months ended
March 31, 2007 include financing costs amortization of
$0.3 million, $1.5 million, $0.4 million and
$0.4 million, respectively |
|
|
|
(8) |
|
EBITDA is calculated as net income (loss) before
income tax expense and interest expense plus depreciation and
amortization. Adjusted EBITDA is defined as EBITDA adjusted as
indicated below. EBITDA and Adjusted EBITDA are not intended to
represent cash flow from operations as defined by U.S. GAAP
and should not be used as an alternative to net income as an
indicator of operating performance or to cash flow as a measure
of liquidity. EBITDA and Adjusted EBITDA are included in this
prospectus because they are a basis upon which our management
assesses financial performance. The senior secured credit
facility also includes the definition of pro forma EBITDA which
is used in the calculation of certain covenants. Pro forma
EBITDA is calculated based on EBITDA and is adjusted in a manner
similar to that described herein. While EBITDA and Adjusted
EBITDA are frequently used as a measure of operations and the
ability to meet debt service requirements, they are not
necessarily comparable to other similarly titled captions of
other companies due to potential inconsistencies in the method
of calculation. The following table reconciles EBITDA to net
income (loss): |
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
Statement of Operations
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
22,600
|
|
|
$
|
8,858
|
|
|
|
$
|
(506
|
)
|
|
$
|
26,895
|
|
|
$
|
6,045
|
|
|
$
|
7,178
|
|
Income tax expense (benefit)
|
|
|
10,134
|
|
|
|
7,159
|
|
|
|
|
(441
|
)
|
|
|
13,044
|
|
|
|
2,980
|
|
|
|
3,713
|
|
Interest expense net(a)
|
|
|
4,712
|
|
|
|
4,164
|
|
|
|
|
5,556
|
|
|
|
25,461
|
|
|
|
6,545
|
|
|
|
6,346
|
|
Depreciation and amortization(b)
|
|
|
8,490
|
|
|
|
6,808
|
|
|
|
|
4,396
|
|
|
|
22,449
|
|
|
|
5,194
|
|
|
|
4,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
45,936
|
|
|
$
|
26,989
|
|
|
|
$
|
9,005
|
|
|
$
|
87,849
|
|
|
$
|
20,764
|
|
|
$
|
22,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Includes derivative contract valuation income or expense for
interest rate collars to manage interest exposure relative to
term debt. |
|
|
|
(b) |
|
The period from October 17, 2005 to December 31, 2005,
the year ended December 31, 2006, the three months ended
March 31, 2006 and the three months ended March 31,
2007 include financing costs amortization of $0.3 million,
$1.5 million, $0.4 million and $0.4 million,
respectively. |
The following table reconciles EBITDA to Adjusted EBITDA as such
terms are defined in our senior secured credit facility and the
indenture governing the notes. Certain covenants under the
senior secured credit facility are also tied to ratios based on
Adjusted EBITDA and our ability to engage in activities such as
incurring additional debt, making investments and paying
dividends under both our indenture and senior secured credit
facility are also tied to ratios based on Adjusted EBITDA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(In thousands)
|
|
EBITDA
|
|
$
|
45,936
|
|
|
$
|
26,989
|
|
|
|
$
|
9,005
|
|
|
$
|
87,849
|
|
|
$
|
20,764
|
|
|
$
|
22,228
|
|
Stock-based compensation expense(a)
|
|
|
2,433
|
|
|
|
9,508
|
|
|
|
|
437
|
|
|
|
1,907
|
|
|
|
321
|
|
|
|
361
|
|
Inventory valuation charge(b)
|
|
|
|
|
|
|
|
|
|
|
|
8,903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition expenses(c)
|
|
|
|
|
|
|
6,602
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-process research and development
charge(d)
|
|
|
|
|
|
|
2,768
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hurricane & storm costs
(recoveries)(e)
|
|
|
|
|
|
|
1,057
|
|
|
|
|
406
|
|
|
|
(1,593
|
)
|
|
|
182
|
|
|
|
|
|
Offering expenses(f)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
260
|
|
Employee separation and plant
closure costs(g)
|
|
|
3,346
|
|
|
|
1,700
|
|
|
|
|
255
|
|
|
|
396
|
|
|
|
162
|
|
|
|
99
|
|
Reorganization expenses(h)
|
|
|
706
|
|
|
|
1,470
|
|
|
|
|
88
|
|
|
|
162
|
|
|
|
45
|
|
|
|
|
|
Appraisal rights settlement(i)
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management fees(j)
|
|
|
380
|
|
|
|
306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of assets(k)
|
|
|
133
|
|
|
|
(131
|
)
|
|
|
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
$
|
52,934
|
|
|
$
|
50,269
|
|
|
|
$
|
19,672
|
|
|
$
|
88,721
|
|
|
$
|
21,474
|
|
|
$
|
22,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Represents stock-based compensation charges for stock and stock
options issued to key employees and directors, and an additional
charge for the cash-out of stock options in the period from
January 1, 2005 to October 16, 2005 as a result of the
Acquisition. Although it may be of limited relevance to holders
of our debt instruments, it may be of more relevance to our
equity holders, since such equity holders ultimately bear such
expenses |
9
|
|
|
(b) |
|
Represents a non-cash inventory valuation charge recorded in
cost of sales for the adjustment of inventory to fair value as a
result of purchase accounting as of October 17, 2005, the
closing date of the Acquisition. Under purchase accounting,
inventory was adjusted to the fair value as of the date
indicated above, and a corresponding charge was taken in the
subsequent period from October 17, 2005 to
December 31, 2005 cost of sales as the inventory was sold. |
|
(c) |
|
Represents acquisition expenses, primarily professional fees,
incurred by us as a result of the Acquisition. |
|
(d) |
|
Represents a non-cash charge for purchased in-process research
and development in conjunction with the acquisition of Changzhou
CEM Cryo Equipment Co., Ltd., or CEM, in 2005. |
|
(e) |
|
Represents losses and costs incurred related to Hurricane Rita
at our New Iberia, Louisiana facilities, net of insurance
recoveries. |
|
|
|
(f) |
|
Represents offering expenses, primarily professional fees,
incurred by us as a result of this offering. |
|
|
|
(g) |
|
Includes inventory valuation charges recorded in cost of sales,
and severance expenses, facility exit costs and non-operating
expenses related to the execution of our operational
restructuring plan, which primarily included moving the
Burnsville, Minnesota manufacturing operations to Canton,
Georgia and closing the Plaistow, New Hampshire manufacturing
facility. See Managements Discussion and Analysis of
Financial Condition and Results of Operations for
additional information. |
|
|
|
(h) |
|
Represents pre-bankruptcy debt restructuring-related fees,
professional fees and expenses, and a claim settlement related
to our 2003 bankruptcy reorganization. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations for additional
information. |
|
|
|
(i) |
|
Represents a charge for the settlement of former Predecessor
Company stockholders appraisal rights claims as a result
of the Acquisition. |
|
|
|
(j) |
|
Represents non-recurring management fees charged by our
Predecessor Company majority stockholders, which are not charged
by First Reserve. |
|
|
|
(k) |
|
Includes non-recurring gains and losses and charges on the sale,
disposal or impairment of assets. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations for additional information. |
|
|
|
(9) |
|
Working capital is defined as current assets, excluding cash,
less current liabilities, excluding short-term debt. |
|
|
|
(10) |
|
Includes $247.1 million of goodwill and
$146.6 million of finite-lived and
indefinite-lived
intangible assets as of December 31, 2006. Includes
$246.8 million of goodwill and $143.6 million of
finite-lived and indefinite-lived intangible assets as of
March 31, 2007. |
10
RISK
FACTORS
Investing in our common stock involves substantial risk. You
should carefully consider the risks described below as well as
the other information contained in this prospectus, prior to
investing in our common stock. Any of the following risks could
materially adversely affect our business, financial condition
and results of operations. In such case, you may lose all or
part of your original investment.
Risks
Related to our Business
The
markets we serve are subject to cyclical demand, which could
harm our business and make it difficult to project long-term
performance.
Demand for our products depends in large part upon the level of
capital and maintenance expenditures by many of our customers
and end users, in particular those customers in the global
hydrocarbon and industrial gas markets. These customers
expenditures historically have been cyclical in nature and
vulnerable to economic downturns. Decreased capital and
maintenance spending by these customers could have a material
adverse effect on the demand for our products and our business,
financial condition and results of operations. In addition, this
historically cyclical demand limits our ability to make accurate
long-term predictions about the performance of our company.
For example, certain of our core businesses underperformed in
the years prior to 2004 due to a general downturn in capital
spending in the global and domestic industrial gas markets.
While we have experienced demand growth since late 2003 in the
global hydrocarbon and industrial gas markets, this growth may
not continue and our businesses performance may not be
markedly better or may be worse in the future. For example,
while we have recently experienced increased order activity for
smaller LNG projects and industrial gas plants, we have
experienced delay in the receipt of some large
LNG liquefier and GTL projects resulting from
industry cost growth, constrained resources and local political
uncertainty. In addition, changing world economic and political
conditions may reduce the willingness of our customers and
prospective customers to commit funds to purchase our products
and services. Further, in 2005, the U.S. government
announced the reduction of the amount of dollars it offered as
reimbursement to our customers for purchasing our medical oxygen
therapy products, which has adversely affected demand for these
products.
The
loss of, or significant reduction or delay in, purchases by our
largest customers could reduce our revenues and
profitability.
Although no single customer accounted for more than 10% of our
total sales for the year ended December 31, 2006, a small
number of customers has accounted for a substantial portion of
our historical net sales, and we expect that a limited number of
customers will continue to represent a substantial portion of
our sales for the foreseeable future. Approximately 35%, 33% and
39% of our sales for the years ended December 31, 2006,
2005 and 2004, respectively, were made to Praxair, Air Liquide,
Air Products, Bechtel, Airgas, Linde and JGC, which management
believes are the largest producers and distributors of
hydrocarbon and industrial gases, and their suppliers. The loss
of any of our major customers or a decrease or delay in orders
or anticipated spending by such customers could materially
reduce our revenues and profitability. Our largest customers,
could also engage in business combinations which could increase
their size, reduce their demand for our products as they
recognize synergies or rationalize assets and increase or
decrease the portion of our total sales concentration to any
single customer. For example, Linde and BOC, or combined known
as The Linde Group, engaged in a business combination in 2006.
Additionally, we currently sell all of our magnetic resonance
imaging, or MRI, components to GE, a leading worldwide
manufacturer of MRI equipment, which accounted for
$8.8 million in sales for the year ended December 31,
2006. The loss of, or significant reduction in, purchases of our
MRI components by GE could reduce revenues and profitability in
our BioMedical segment.
We may
be unable to compete successfully in the highly competitive
markets in which we operate.
Although many of our products serve niche markets, a number of
our direct and indirect competitors in these markets are major
corporations, some of which have substantially greater
technical, financial and marketing resources than we, and other
competitors may enter these markets. Any increase in competition
may cause us to lose market share or compel us to reduce prices
to remain competitive, which could result in reduced sales and
earnings.
11
Companies that operate in our industry are Air Products, Kobe,
The Linde Group, Nordon, Puritan-Bennett, a division of Tyco
International, Ltd., Sumitomo and Taylor-Wharton, a Harsco
Company. Additionally, we compete with several suppliers owned
by global industrial gas producers and many smaller
fabrication-only facilities around the world. Increased
competition with these companies could prevent the institution
of price increases or could require price reductions or
increased spending on research and development and marketing and
sales, any of which could materially reduce our revenues,
profitability or both. In the event of an industry downturn,
customers who typically outsource their need for cryogenic
systems to us may use their excess capacity to produce such
systems themselves. We also compete in the sale of a limited
number of products with certain of our major customers.
We
will soon be required to evaluate our internal controls under
Section 404 of the Sarbanes-Oxley Act of 2002 and any
adverse results from such evaluation could result in a loss of
investor confidence in our financial reports and have an adverse
effect on our stock price.
The initial public offering resulted in our becoming subject to
reporting and other obligations under the Securities Exchange
Act of 1934, as amended, or the Exchange Act.
Beginning with the year ending December 31, 2007, pursuant
to Section 404 of the Sarbanes-Oxley Act of 2002, we will
be required to furnish a report by our management on our
internal control over financial reporting, and our auditors will
be required to deliver an attestation report on
managements assessment of and operating effectiveness of
internal controls. The report by our management must contain,
among other matters, an assessment of the effectiveness of our
internal control over financial reporting and audited
consolidated financial statements as of the end of our fiscal
year. This assessment must include disclosure of any material
weaknesses in our internal control over financial reporting
identified by management.
Unlike many companies whose shares are publicly traded, we are
not presently required to be in compliance with
Section 404s internal control requirements. We have
substantial effort ahead of us to complete documentation of our
internal control system and financial processes, information
systems, assessment of their design, remediation of control
deficiencies identified in these efforts and management testing
of the designs and operation of internal controls. We may not be
able to complete the required management assessment by our
reporting deadline or may not meet applicable standards in
following years. An inability to complete and document this
assessment or to comply in following years could result in our
receiving less than an unqualified report from our auditors with
respect to our internal controls. This could cause investors to
lose confidence in the accuracy and completeness of our
financial reports, which could decrease the price of our stock.
As a
global business, we are exposed to economic, political and other
risks in different countries which could materially reduce our
revenues, profitability or cash flows, or materially increase
our liabilities.
Since we manufacture and sell our products worldwide, our
business is subject to risks associated with doing business
internationally. In 2006, 52% of our sales were made in
international markets. Our future results could be harmed by a
variety of factors, including:
|
|
|
|
|
changes in foreign currency exchange rates;
|
|
|
|
exchange controls and currency restrictions;
|
|
|
|
changes in a specific countrys or regions political,
social or economic conditions, particularly in emerging markets;
|
|
|
|
civil unrest, turmoil or outbreak of disease in any of the
countries in which we operate;
|
|
|
|
tariffs, other trade protection measures and import or export
licensing requirements;
|
|
|
|
potentially negative consequences from changes in U.S. and
international tax laws;
|
|
|
|
difficulty in staffing and managing geographically widespread
operations;
|
|
|
|
differing labor regulations;
|
|
|
|
requirements relating to withholding taxes on remittances and
other payments by subsidiaries;
|
12
|
|
|
|
|
different regulatory regimes controlling the protection of our
intellectual property;
|
|
|
|
restrictions on our ability to own or operate subsidiaries, make
investments or acquire new businesses in these jurisdictions;
|
|
|
|
restrictions on our ability to repatriate dividends from our
foreign subsidiaries;
|
|
|
|
difficulty in collecting international accounts receivable;
|
|
|
|
difficulty in enforcement of contractual obligations under
non-U.S. law;
|
|
|
|
transportation delays or interruptions;
|
|
|
|
changes in regulatory requirements; and
|
|
|
|
the burden of complying with multiple and potentially
conflicting laws.
|
Our international operations also expose us to different local
political and business risks and challenges. For example, we are
faced with potential difficulties in staffing and managing local
operations and we have to design local solutions to manage
credit and legal risks of local customers and distributors. In
addition, because some of our international sales are to
suppliers that perform work for foreign governments, we are
subject to the political risks associated with foreign
government projects. For example, certain foreign governments
may require suppliers for a project to obtain products solely
from local manufacturers or may prohibit the use of products
manufactured in certain countries.
International growth and expansion into emerging markets, such
as China, Central and Eastern Europe, and the Middle East, may
cause us difficulty due to greater regulatory barriers than in
the United States, the necessity of adapting to new regulatory
systems, problems related to entering new markets with different
economic, social and political systems, and significant
competition from the primary participants in these markets, some
of which may have substantially greater resources than us.
Our overall success as a global business depends, in part, upon
our ability to succeed in differing economic, social and
political conditions. We may not succeed in developing and
implementing policies and strategies to counter the foregoing
factors effectively in each location where we do business and
the foregoing factors may cause a reduction in our revenues,
profitability or cash flows, or cause an increase in our
liabilities.
If we
are unable to successfully manage our growth, it may place a
significant strain on our management and administrative
resources and lead to increased costs and reduced
profitability.
We expect to continue to expand our operations in the United
States and abroad, particularly in China and the Czech Republic.
Our ability to operate our business successfully and implement
our strategies depends, in part, on our ability to allocate our
resources optimally in each of our facilities in order to
maintain efficient operations as we expand. Ineffective
management of our growth could cause manufacturing
inefficiencies, increase our operating costs, place significant
strain on our management and administrative resources and
prevent us from implementing our business plan.
For example, we have invested or plan to invest up to
$30 million in new capital expenditures in the United
States and China in 2006 and 2007 related to the expected growth
of our E&C and D&S segments. If we fail to implement
these capital projects in a timely and effective manner, we may
lose the opportunity to obtain some customer orders. Even if we
effectively implement these projects, the orders needed to
support the capital expenditure may not be obtained, may be
delayed or may be less than expected, which may result in sales
or profitability at lower levels than anticipated. We have
experienced some delay in orders related to our E&C segment
expansion from the timing initially anticipated in connection
with that expansion, which has resulted in the underutilization
of some of our capacity, and we cannot provide assurance when
those orders will be obtained, if ever. In addition, potential
cost overruns, delays or unanticipated problems in any capital
expansion could make the expansion more costly than originally
predicted.
13
If we
lose our senior management or other key employees, our business
may be adversely affected.
Our ability to successfully operate and grow our business and
implement our strategies is largely dependent on the efforts,
abilities and services of our senior management and other key
employees. Our future success will also depend on, among other
factors, our ability to attract and retain qualified personnel,
such as engineers and other skilled labor, either through direct
hiring or the acquisition of other businesses employing such
professionals. Our products, many of which are highly
engineered, represent specialized applications of cryogenic or
low temperature technologies and know-how, and many of the
markets we serve represent niche markets for these specialized
applications. Accordingly, we rely heavily on engineers,
salespersons, business unit leaders, senior management and other
key employees who have experience in these specialized
applications and are knowledgeable about these niche markets,
our products, and our company. Additionally, we may modify our
management structure from time to time. We recently named a new
president to lead our E&C segment, and the change of
leadership in that segment may create marketing, operational and
other business risks. The loss of the services of these senior
managers or other key employees, any modification of our
management structure or the failure to attract or retain other
qualified personnel could reduce the competitiveness of our
business or otherwise impair our business prospects.
Fluctuations
in the prices and availability of raw materials and our exposure
to fixed-price contracts, including exposure to fixed pricing on
long-term customer contracts, could negatively impact our
financial results.
The pricing and availability of raw materials for use in our
businesses can be volatile due to numerous factors beyond our
control, including general, domestic and international economic
conditions, labor costs, production levels, competition,
consumer demand, import duties and tariffs and currency exchange
rates. This volatility can significantly affect the availability
and cost of raw materials for us, and may, therefore, increase
the short-term or long-term costs of raw materials.
The commodity metals we use, including aluminum and stainless
steel, have experienced significant upward fluctuations in
price. On average, over half of our cost of sales is represented
by the cost of commodities metals. We have generally been able
to recover the cost increases through price increases to our
customers; however, during periods of rising prices of raw
materials, such as in 2004, 2005, 2006 and 2007, we may be
unable to pass a portion of such increases on to our customers.
Conversely, when raw material prices decline, customer demands
for lower prices could result in lower sale prices and, to the
extent we have existing inventory, lower margins. As a result,
fluctuations in raw material prices could result in lower
revenues and profitability.
In addition, a substantial portion of our sales is derived from
fixed-price contracts for large system projects, which may
involve long-term fixed price commitments to customers. Among
our long-term fixed-price contracts, we presently are executing
two large projects each involving over $20 million of
revenue on which our margins have deteriorated significantly, as
previously disclosed. On one of these projects, we have
experienced significant cost overruns, and the other was
disrupted by a storm and related damage. The customer for one of
these projects made the decision in the first quarter of 2007 to
repair the damage through costly purchases of new replacement
materials and has asserted we are responsible for other repairs.
We may be required to pay for some of these or other repair
costs in the future to the extent the customer successfully
asserts that we are responsible for the damage occurring, which
we would contest vigorously. To the extent that any of our
fixed-price contracts are delayed, contract counterparties
successfully assert claims against us, the original cost
estimates in these or other contracts prove to be inaccurate or
the contracts do not permit us to pass increased costs on to our
customers, profitability from a particular contract may
decrease, which, in turn, could decrease our revenues and
overall profitability. The uncertainties associated with our
fixed-price contracts make it more difficult to predict our
future results and exacerbate the risk that our results will not
match expectations, which has happened in the past.
We may
fail to successfully acquire or integrate companies that provide
complementary products or technologies.
A component of our business strategy is the acquisition of
businesses that complement our existing products and services.
Such a strategy involves the potential risks inherent in
assessing the value, strengths, weaknesses, contingent or other
liabilities and potential profitability of acquisition
candidates and in integrating the operations
14
of acquired companies. In addition, any acquisition of a foreign
business may increase our exposure to certain risks inherent in
doing business outside the United States.
From time to time, we may have acquisition discussions with
potential target companies. If a large acquisition opportunity
arises and we proceed, a substantial portion of our surplus
borrowing capacity could be used for the acquisition or we may
seek additional debt or equity financing.
We are not presently engaged in any negotiations concerning any
acquisition which may be material in size and scope to our
business. We anticipate, however, that one or more potential
acquisition opportunities could become available in the future.
If and when appropriate acquisition opportunities become
available, we may pursue them actively. Any acquisition may or
may not occur and, if an acquisition does occur, it may not be
successful in enhancing our business for one or more of the
following reasons:
|
|
|
|
|
Any business acquired may not be integrated successfully and may
not prove profitable;
|
|
|
|
The price we pay for any business acquired may overstate the
value of that business or otherwise be too high;
|
|
|
|
We may fail to achieve acquisition synergies; or
|
|
|
|
The focus on the integration of operations of acquired entities
may divert managements attention from the
day-to-day
operation of our businesses.
|
Inherent in any future acquisition is the risk of transitioning
company cultures and facilities. The failure to efficiently and
effectively achieve such transitions could increase our costs
and decrease our profitability.
If we
are unable to continue our technological innovation in our
business and successful introduction of new commercial products,
our profitability could be adversely affected.
The industries we serve, particularly the energy and biomedical
industries, experience periodic technological change and product
improvement. Manufacturers periodically introduce new
generations of products or require new technological capacity to
develop customized products or respond to industry developments
or needs. Our future growth will depend on our ability to gauge
the direction of the commercial and technological progress in
our markets, as well as our ability to acquire new product
technology or fund and successfully develop, manufacture and
market products in this constantly changing environment. We must
continue to identify, develop, manufacture and market innovative
products on a timely basis to replace existing products in order
to maintain our profit margins and competitive position. We may
not be successful in acquiring and developing new products or
technology and any of our new products may not be accepted by
our customers. If we fail to keep pace with evolving
technological innovations in the markets we serve, our
profitability may decrease.
We
carry significant goodwill and indefinite-lived intangible
assets on our balance sheet, which are subject to impairment
testing and could subject us to significant charges to earnings
in the future if impairment occurs.
As of March 31, 2007, we had goodwill and indefinite-lived
intangible assets of $281.3 million, which represented
approximately 38% of our total assets. Goodwill and
indefinite-lived intangible assets are not amortized but are
tested for impairment annually or more often if events or
changes in circumstances indicate a potential impairment may
exist. Factors that could indicate that our goodwill or
indefinite-lived intangible assets are impaired include a
decline in stock price and market capitalization, lower than
projected operating results and cash flows, and slower growth
rates in our industry. To test for impairment, a model to
estimate the fair market value of our reporting segments has
been developed. This fair market value model incorporates our
estimates of future operating results and cash flows, estimates
of allocations of certain assets and cash flows among reporting
segments, estimates of future growth rates and our judgment
regarding the applicable discount rates to use to discount those
estimated operating results and cash flows. If an impairment is
determined to exist, we are required to record a charge to
earnings in our financial statements, which may be significant,
as in 2002 when we recorded a non-cash impairment charge of
$92.4 million to write off non-deductible goodwill of the
D&S segment. While we do not presently anticipate that any
of our goodwill or indefinite-lived intangible assets will be
impaired in the
15
foreseeable future, if an impairment is determined to exist and
we are required to record a charge to earnings, it may result in
significantly decreased profitability and shareholders
equity.
We may
be required to make material expenditures in order to comply
with environmental, health and safety laws, or incur additional
liabilities under these laws.
We are subject to numerous environmental, health and safety laws
and regulations that impose various environmental controls on us
or otherwise relate to environmental protection and various
health and safety matters, including the discharge of pollutants
in the air and water, the handling, use, treatment, storage and
clean-up of
solid and hazardous materials and wastes, the investigation and
remediation of soil and groundwater affected by hazardous
substances, and the requirement to obtain and maintain permits
and licenses. These laws and regulations often impose strict,
retroactive and joint and several liability for the costs of,
and damages resulting from, cleaning up our, or our
predecessors, past or present facilities and third party
disposal sites. Compliance with these laws generally increases
the costs of transportation and storage of raw materials and
finished products, as well as the costs of storing and disposing
waste, and could decrease our liquidity and profitability and
increase our liabilities. Health and safety and other laws in
the jurisdictions in which we operate, impose various
requirements on us including state licensing requirements that
may benefit our customers. If we are found to have violated any
of these laws, we may become subject to corrective action orders
and fines or penalties, and incur substantial costs, including
substantial remediation costs and commercial liability to our
customers. For example, in a project involving over
$20 million in total revenue, we were subject to an
investigation that commenced in the fourth quarter of 2006 by
state regulators concerning whether one of our subsidiaries is
required to have a license to install our manufactured
equipment. Although we do not believe we are required to be
licensed, if we were formally found to be in violation of the
licensing requirement, we could owe substantial penalties to the
state or be required to return job revenues to the customer.
Further, we also could be subject to future liability resulting
from conditions that are currently unknown to us that could be
discovered in the future.
We are currently remediating or developing work plans for
remediation of environmental conditions involving certain
current or former facilities. For example, the discovery of
contamination arising from historical industrial operations at
our Clarksville, Arkansas property has exposed us, and in the
future may continue to expose us, to remediation obligations. To
date, our environmental remediation expenditures and costs for
otherwise complying with environmental laws and regulations have
not been material, but the uncertainties associated with the
investigation and remediation of contamination and the fact that
such laws or regulations change frequently makes predicting the
cost or impact of such laws and regulations on our future
operations uncertain. Stricter environmental, safety and health
laws, regulations or enforcement policies could result in
substantial costs and liabilities to us and could subject us to
more rigorous scrutiny. Consequently, compliance with these laws
could result in significant expenditures as well as other costs
and liabilities that could decrease our liquidity and
profitability and increase our liabilities.
The
insolvency of our formerly consolidated subsidiary, Chart Heat
Exchangers Limited, could have a material adverse impact on our
liquidity and financial position.
On March 28, 2003, our U.K. subsidiary, Chart Heat
Exchangers Limited, or CHEL, which previously operated the
closed Wolverhampton, United Kingdom manufacturing facility,
filed for a voluntary administration under the U.K. Insolvency
Act of 1986. CHELs application for voluntary
administration was approved on April 1, 2003 and an
administrator was appointed. Additionally, we received
information that indicated that CHELs net pension plan
obligations had increased significantly, primarily due to a
decline in plan asset values and interest rates, as well as
increased plan liabilities, resulting in an estimated plan
deficit of approximately $12 million as of March 2003.
Based on our financial condition in March 2003, we determined
not to advance funds to CHEL in amounts necessary to
fund CHELs obligations. Since CHEL was unable to fund
its net pension deficit, the trustees of the CHEL pension plan
requested a decision to
wind-up the
plan from a U.K. pension regulatory board. That board approved
the wind-up
as of March 28, 2003. While no claims related to the CHEL
insolvency presently are pending against us, persons impacted by
the insolvency or others could bring pension
and/or
benefit related claims against us. Claims may be asserted
against us for pension or other obligations of CHEL related to
these matters. To
16
the extent we are found to have significant liability with
respect to CHELs obligations, such liability could have a
material adverse impact on our liquidity, profitability and
financial condition as a result of CHELs insolvency.
Due to
the nature of our business and products, we may be liable for
damages based on product liability and warranty
claims.
Due to the high pressures and low temperatures at which many of
our products are used and the fact that some of our products are
relied upon by our customers or end users in their facilities or
operations, or are manufactured for relatively broad consumer
use, we face an inherent risk of exposure to claims in the event
that the failure, use or misuse of our products results, or is
alleged to result, in bodily injury, property damage or economic
loss. We believe that we meet or exceed existing professional
specification standards recognized or required in the industries
in which we operate. We have been subject to claims in the past,
none of which have had a material adverse effect on our
financial condition or results of operations, and we may be
subject to claims in the future. Although we currently maintain
product liability coverage, which we believe is adequate for the
continued operation of our business, such insurance may become
difficult to obtain or unobtainable in the future on terms
acceptable to us and may not cover warranty claims. A successful
product liability claim or series of claims against us,
including one or more consumer claims purporting to constitute
class actions, in excess of our insurance coverage or a
significant warranty claim or series of claims against us could
materially decrease our liquidity and impair our financial
condition.
Increases
in labor costs, potential labor disputes and work stoppages at
our facilities could materially decrease our revenues and
profitability.
Our financial performance is affected by the availability of
qualified personnel and the cost of labor. As of March 31,
2007, we had 2,686 employees, including 906 salaried, 324
bargaining unit hourly and 1,456 non-bargaining unit hourly
employees. Employees represented by a union were subject to one
collective bargaining agreement in the United States that
expired in February 2007. A new three-year agreement was entered
into in February 2007, and expires in February 2010. In
connection with negotiating this new collective bargaining
agreement, we experienced a work stoppage from the time that the
previous agreement expired on February 3, 2007 until the
terms of the new agreement were reached on February 7,
2007. If we are unable to enter into new, satisfactory labor
agreements with our unionized employees when necessary in the
future or other labor controversies or union organizing efforts
arise, we could experience a significant disruption to our
operations, lose business or experience an increase in our
operating expenses, which could reduce our profit margins.
We may
have to make significant cash payments to our defined benefit
pension plans, reducing the cash available for our
business.
We have four defined benefit pension plans covering certain
U.S. hourly and salaried employees. All of these plans have
been frozen. Our current funding policy is to contribute at
least the minimum funding amounts required by law. Based on
current actuarial estimates, we contributed $1.3 million to
our U.S. defined benefit pension plans during 2006 and
expect to contribute $0.7 million during 2007. If the
performance of our assets in our pension plans does not meet our
expectations or if other actuarial assumptions are modified, our
contributions could be higher than we expect, thus reducing the
available cash for our business.
Fluctuations
in exchange and interest rates may affect our operating
results.
Fluctuations in the value of the U.S. dollar may decrease
our sales or earnings. Because our consolidated financial
results are reported in U.S. dollars, if we generate sales
or earnings in other currencies, the translation of those
results into U.S. dollars can result in a significant
increase or decrease in the amount of those sales or earnings.
We also bid for certain foreign projects in U.S. dollars.
If the U.S. dollar strengthens relative to the value of the
local currency, we may be less competitive on those projects. In
addition, our debt service requirements are primarily in
U.S. dollars and a portion of our cash flow is generated in
euros or other foreign currencies. Significant changes in the
value of the foreign currencies relative to the U.S. dollar
could limit our ability to meet interest and principal payments
on our debt and impair our financial condition.
17
In addition, fluctuations in currencies relative to the
U.S. dollar may make it more difficult to perform
period-to-period
comparisons of our reported results of operations. For purposes
of accounting, the assets and liabilities of our foreign
operations, where the local currency is the functional currency,
are translated using period-end exchange rates, and the revenues
and expenses of our foreign operations are translated using
average exchange rates during each period.
In addition to currency translation risks, we incur currency
transaction risk whenever we or one of our subsidiaries enters
into either a purchase or a sales transaction using a currency
other than the local currency of the transacting entity. Given
the volatility of exchange rates, we may not be able to
effectively manage our currency
and/or
translation risks. Volatility in currency exchange rates may
decrease our revenues and profitability and impair our financial
condition. We have purchased and may continue to purchase
foreign currency forward purchase and sales contracts to manage
the risk of adverse currency fluctuations.
Our
operations could be impacted by the effects of hurricanes, which
could be more severe than the damage and impact that our New
Iberia, Louisiana operations encountered from hurricanes in
2005.
Some of our operations, including our operations in New Iberia,
Louisiana and Houston, Texas, are located in geographic regions
and physical locations that are susceptible to physical damage
and longer-term economic disruption from hurricanes. We also
could make significant capital expenditures in
hurricane-susceptible locations from time to time. These weather
events can disrupt our operations, result in damage to our
properties and negatively affect the local economy in which
these facilities operate. In 2005, for example, our New Iberia,
Louisiana operations encountered some damage from the storm
surge and flooding caused by Hurricane Rita. Future hurricanes
may cause production or delivery delays as a result of the
physical damage to the facilities, the unavailability of
employees and temporary workers, the shortage of or delay in
receiving certain raw materials or manufacturing supplies and
the diminished availability or delay of transportation for
customer shipments, any of which may have an adverse affect on
our revenues and profitability. Although we maintain insurance
subject to certain deductibles, which may cover some of our
losses, that insurance may become unavailable or prove to be
inadequate.
Failure
to protect our intellectual property and know-how could reduce
or eliminate any competitive advantage and reduce our sales and
profitability.
We rely on a combination of internal procedures, nondisclosure
agreements, intellectual property rights assignment agreements,
licenses, patents, trademarks and copyright law to protect our
intellectual property and know-how. Our intellectual property
rights may not be successfully asserted in the future or may be
invalidated, circumvented or challenged. For example, we
frequently explore and evaluate potential relationships and
projects with other parties, which often requires that we
provide the potential partner with confidential technical
information. While confidentiality agreements are typically put
in place, there is a risk the potential partner could violate
the confidentiality agreement and use our technical information
for its own benefit or the benefit of others or compromise the
confidentiality. In addition, the laws of certain foreign
countries in which our products may be sold or manufactured do
not protect our intellectual property rights to the same extent
as the laws of the United States. For example, we are increasing
our manufacturing capabilities and sales in China, where laws
may not protect our intellectual property rights to the same
extent as in the United States. Failure or inability to protect
our proprietary information could result in a decrease in our
sales or profitability.
We have obtained and applied for some U.S. and foreign trademark
and patent registrations and will continue to evaluate the
registration of additional trademarks and patents, as
appropriate. We cannot guarantee that any of our pending
applications will be approved. Moreover, even if the
applications are approved, third parties may seek to oppose or
otherwise challenge them. A failure to obtain registrations in
the United States or elsewhere could limit our ability to
protect our trademarks and technologies and could impede our
business. The patents in our patent portfolio are scheduled to
expire between 2007 and 2024.
In addition, we may be unable to prevent third parties from
using our intellectual property rights and know-how without our
authorization or from independently developing intellectual
property that is the same as or similar to ours, particularly in
those countries where the laws do not protect our intellectual
property rights as fully as in the United States. We compete in
a number of industries (for example, heat exchangers and
cryogenic storage) that are
18
small or specialized, which makes it easier for a competitor to
monitor our activities and increases the risk that ideas will be
stolen. The unauthorized use of our know-how by third parties
could reduce or eliminate any competitive advantage we have
developed, cause us to lose sales or otherwise harm our business
or increase our expenses as we attempt to enforce our rights.
We may
be subject to claims that our products or processes infringe the
intellectual property rights of others, which may cause us to
pay unexpected litigation costs or damages, modify our products
or processes or prevent us from selling our
products.
Although it is our intention to avoid infringing or otherwise
violating the intellectual property rights of others, third
parties may nevertheless claim (and have in the past claimed)
that our processes and products infringe their intellectual
property and other rights. For example, a third party has
claimed that we may infringe certain patents related to
cryogenic pipe technology and may have breached an undertaking
relating to same, although we believe that these claims are
without merit. In addition, our BioMedical business manufactures
products for relatively broad consumer use, is actively
marketing these products in multiple jurisdictions
internationally and risks infringing technologies that may be
protected in one or more of these international jurisdictions as
the scope of our international marketing efforts expands. Our
strategies of capitalizing on growing international demand as
well as developing new innovative products across multiple
business lines present similar infringement claim risks both
internationally and in the United States as we expand the scope
of our product offerings and markets. We compete with other
companies for contracts in some small or specialized industries,
which increases the risk that the other companies will develop
overlapping technologies leading to an increased possibility
that infringement claims will arise. Whether or not these claims
have merit, we may be subject to costly and time-consuming legal
proceedings, and this could divert our managements
attention from operating our businesses. In order to resolve
such proceedings, we may need to obtain licenses from these
third parties or substantially re-engineer or rename our
products in order to avoid infringement. In addition, we might
not be able to obtain the necessary licenses on acceptable
terms, or at all, or be able to reengineer or rename our
products successfully.
We are
subject to regulations governing the export of our
products.
Due to our significant foreign sales, our export activities are
subject to regulation, including the U.S. Treasury
Departments Office of Foreign Assets Controls
regulations. While we believe we are in compliance with these
regulations, we may currently or may in the future be in
violation of these regulations. Any violations may subject us to
government scrutiny, investigation and civil and criminal
penalties and may limit our ability to export our products.
Additional
liabilities related to taxes could adversely impact our
financial results, financial condition and cash
flow.
We are subject to tax and related obligations in the
jurisdictions in which we operate or do business, including
state, local, federal and foreign taxes. The taxing rules of the
various jurisdictions in which we operate or do business often
are complex and subject to varying interpretations, and tax
authorities may challenge tax positions that we take or
historically have taken, and may assess taxes where we have not
made tax filings or may audit the tax filings we have made and
assess additional taxes. Some of these assessments may be
substantial, and also may involve the imposition of substantial
penalties and interest. For example, a state in which we operate
has asserted that we may be liable for substantial state income
taxes, penalties and interest related to our operations in the
state from 1993 to 2000. The taxes asserted by the state
pre-date the Acquisition, and we believe that if the state
issued a formal assessment and was successful in pursuing that
assessment against us, the amounts owed, except for penalties
and interest for periods after the Acquisition, would increase
our goodwill instead of being charged against our earnings, but
the negative cash flow impact could be significant and there
could be a negative impact on our earnings related to
post-Acquisition penalties and interest. We would vigorously
contest any such assessment, if issued, including through
administrative and court proceedings, but we may be unsuccessful
and ultimately required to pay additional taxes, penalties and
interest. Also, our federal income tax returns for 2004 and 2005
are currently under routine audit by the Internal Revenue
Service. These audits could possibly result in additional taxes,
penalties and interest. The payment of substantial additional
taxes, penalties or interest resulting from these assessments
could materially and adversely impact our financial results,
financial condition and cash flow.
19
As a
provider of products to the U.S. government, we are subject
to federal rules, regulations, audits and investigations, the
violation or failure of which could adversely affect our
business.
We sell certain of our products to the U.S. government and,
therefore, we must comply with and are affected by laws and
regulations governing purchases by the U.S. government.
Government contract laws and regulations affect how we do
business with our government customers and, in some instances,
impose added costs on our business. For example, a violation of
specific laws and regulations could result in the imposition of
fines and penalties or the termination of our contracts or
debarment from bidding on contracts. In some instances, these
laws and regulations impose terms or rights that are more
favorable to the government than those typically available to
commercial parties in negotiated transactions.
Risks
Related to our Leverage
Our
substantial leverage and significant debt service obligations
could adversely affect our financial condition, limit our
ability to raise additional capital to fund our operations,
limit our ability to react to changes in the economy or our
industry, impact the way we operate our business, expose us to
interest rate risk to the extent of our variable rate debt and
prevent us from fulfilling our debt service
obligations.
We are highly leveraged and have significant debt service
obligations. Our financial performance could be affected by our
substantial leverage. As of March 31, 2007, our total
indebtedness was $290.0 million. In addition, at that date,
we had approximately $22.6 million of letters of credit and
bank guarantees outstanding and borrowing capacity of
approximately $92.4 million under the revolving portion of
our senior secured credit facility, after giving effect to the
letters of credit and bank guarantees outstanding. We may also
incur additional indebtedness in the future. This high level of
indebtedness could have important negative consequences to us
and you, including:
|
|
|
|
|
we may have difficulty generating sufficient cash flow to pay
interest and satisfy our debt obligations;
|
|
|
|
we may have difficulty obtaining financing in the future for
working capital, capital expenditures, acquisitions or other
purposes;
|
|
|
|
we will need to use a substantial portion of our available cash
flow to pay interest and principal on our debt, which will
reduce the amount of money available to finance our operations
and other business activities;
|
|
|
|
some of our debt, including our borrowings under our senior
secured credit facility, has variable rates of interest, which
exposes us to the risk of increased interest rates;
|
|
|
|
our debt level increases our vulnerability to general economic
downturns and adverse industry conditions;
|
|
|
|
our debt level could limit our flexibility in planning for, or
reacting to, changes in our business and in our industry in
general;
|
|
|
|
our substantial amount of debt and the amount we must pay to
service our debt obligations could place us at a competitive
disadvantage compared to our competitors that have less debt;
|
|
|
|
our customers may react adversely to our significant debt level
and seek or develop alternative suppliers; and
|
|
|
|
our failure to comply with the financial and other restrictive
covenants in our debt instruments which, among other things,
require us to maintain specified financial ratios and limit our
ability to incur debt and sell assets, could result in an event
of default that, if not cured or waived, could have a material
adverse effect on our business or prospects.
|
Our net cash flow generated from operating activities was
$1.0 million, $36.4 million, $30.3 million (on a
combined basis) and $35.1 million for the three months
ended March 31, 2007 and the years 2006, 2005 and 2004,
respectively. Our high level of indebtedness requires that we
use a substantial portion of our cash flow from operations to
pay principal of, and interest on, our indebtedness, which will
reduce the availability of cash to fund working capital
requirements, capital expenditures, research and development or
other general corporate or business activities, including future
acquisitions.
In addition, a substantial portion of our indebtedness bears
interest at variable rates. If market interest rates increase,
debt service on our variable-rate debt will rise, which would
adversely affect our cash flow. Although our senior secured
credit facility requires us to employ hedging strategies such
that not less than 50% of our total debt carries a fixed rate of
interest for a period of three years following consummation of
the Acquisition, any hedging
20
arrangement put in place may not offer complete protection from
this risk. Additionally, the remaining portion of the senior
secured credit facility may not be hedged and, accordingly, the
portion that is not hedged will be subject to changes in
interest rates.
Our business may not generate sufficient cash flow from
operations and future borrowings may not be available to us
under our senior secured credit facility or otherwise in an
amount sufficient to permit us to pay the principal and interest
on our indebtedness or fund our other liquidity needs. We may be
unable to refinance any of our debt, including our senior
secured credit facility or the notes, on commercially reasonable
terms. See Managements Discussion and Analysis of
Financial Condition and Results of Operations
Liquidity and Capital Resources.
If our cash flows and capital resources are insufficient to fund
our debt service obligations, we may be forced to sell assets,
seek additional capital or seek to restructure or refinance our
indebtedness. These alternative measures may not be successful
and may not permit us to meet our scheduled debt service
obligations. Our senior secured credit facility and the
indenture under which the notes were issued restrict our ability
to use the proceeds from asset sales. We may be unable to
consummate those asset sales to raise capital or sell assets at
prices that we believe are fair and proceeds that we do receive
may be inadequate to meet any debt service obligations then due.
See Description of Indebtedness.
Despite
our current leverage, we may still be able to incur
substantially more debt. This could further exacerbate the risks
that we face.
We may be able to incur substantial additional indebtedness in
the future. The terms of our debt instruments do not fully
prohibit us from doing so. The revolving credit portion of our
senior secured credit facility provides commitments of up to
$115.0 million, approximately $92.4 million of which
would have been available for future borrowings (after giving
effect to letters of credit and bank guarantees outstanding) as
of March 31, 2007. We may also further increase the size of
our senior secured credit facility. See Description of
Indebtedness Senior Secured Credit Facility.
If new debt is added to our current debt levels, the related
risks that we now face could intensify.
The
senior secured credit facility and the indenture governing the
notes contain a number of restrictive covenants which limit our
ability to finance future operations or capital needs or engage
in other business activities that may be in our
interest.
The senior secured credit facility and the indenture governing
the notes impose, and the terms of any future indebtedness may
impose, operating and other restrictions on us and our
subsidiaries. Such restrictions affect or will affect, and in
many respects limit or prohibit, among other things, our ability
and the ability of our restricted subsidiaries to:
|
|
|
|
|
incur additional indebtedness;
|
|
|
|
create liens;
|
|
|
|
pay dividends and make other distributions in respect of our
capital stock;
|
|
|
|
redeem our capital stock;
|
|
|
|
make certain investments or certain other restricted payments;
|
|
|
|
sell certain kinds of assets;
|
|
|
|
enter into certain types of transactions with
affiliates; and
|
|
|
|
effect mergers or consolidations.
|
The senior secured credit facility also requires us to achieve
certain financial and operating results and maintain compliance
with specified financial ratios. Our ability to comply with
these ratios may be affected by events beyond our control.
21
The restrictions contained in the senior secured credit facility
and the indenture governing the notes could:
|
|
|
|
|
limit our ability to plan for or react to market or economic
conditions or meet capital needs or otherwise restrict our
activities or business plans; and
|
|
|
|
adversely affect our ability to finance our operations,
acquisitions, investments or strategic alliances or other
capital needs or to engage in other business activities that
would be in our interest.
|
A breach of any of these covenants or our inability to comply
with the required financial ratios could result in a default
under our senior secured credit facility
and/or the
indenture governing the notes. If an event of default occurs
under our senior secured credit facility, which includes an
event of default under the indenture governing the notes the
lenders could elect to:
|
|
|
|
|
declare all borrowings outstanding, together with accrued and
unpaid interest, to be immediately due and payable;
|
|
|
|
require us to apply all of our available cash to repay the
borrowings; or
|
|
|
|
prevent us from making debt service payments on the notes;
|
any of which would result in an event of default under the
notes. The lenders will also have the right in these
circumstances to terminate any commitments they have to provide
further financing.
If we were unable to repay or otherwise refinance these
borrowings when due, our lenders could sell the collateral
securing the senior secured credit facility, which constitutes
substantially all of our and our domestic wholly-owned
subsidiaries assets.
We are
a holding company and we depend upon cash from our subsidiaries
to service our debt. If we do not receive cash distributions,
dividends or other payments from our subsidiaries, we may be
unable to meet our obligations.
We are a holding company and all of our operations are conducted
through our subsidiaries. Accordingly, we are dependent upon the
earnings and cash flows of, and cash distributions, dividends
and other payments from, our subsidiaries to provide the funds
necessary to meet our debt service obligations. If we do not
receive such cash distributions, dividends or other payments
from our subsidiaries, we may be unable to pay the principal or
interest on our debt. In addition, certain of our subsidiaries
are holding companies that rely on subsidiaries of their own as
a source of funds to meet any obligations that might arise.
Generally, the ability of a subsidiary to make cash available to
its parent is affected by its own operating results and is
subject to applicable laws and contractual restrictions
contained in its debt instruments and other agreements.
Moreover, there may be restrictions on payments by our
subsidiaries to us under applicable laws, including laws that
require companies to maintain minimum amounts of capital and to
make payments to shareholders only from profits. As a result,
although our subsidiaries may have cash, we may be unable to
obtain that cash to satisfy our obligations and make payments to
our stockholders, if any.
Risks
Related to this Offering
Future
sales of our shares could depress the market price of our common
stock.
The market price of our common stock could decline as a result
of sales of a large number of shares of common stock in the
market after the offering or the perception that such sales
could occur. These sales, or the possibility that these sales
may occur, also might make it more difficult for us to sell
equity securities in the future at a time and at a price that we
deem appropriate.
We, the selling stockholders (except FR X Chart Holdings LLC)
and each of our executive officers and directors have agreed
with the underwriters not to sell, dispose of or hedge any
shares of our common stock or securities convertible into or
exchangeable for shares of our common stock, subject to
specified exceptions, during the period from the date of this
prospectus continuing through the date that is 90 days
after the date of this prospectus, except with the prior written
consent of the representatives of the underwriters. See
Underwriting.
22
After this offering, we will have 25,647,656 shares of
common stock outstanding (including shares currently subject to
options that are expected to be exercised in connection with
this offering). Of those shares, the 12,500,000 shares of
common stock sold in our initial public offering, the
12,612,513 shares being offered hereby and the
approximately 120,000 shares previously sold under
applicable securities law resale exemptions will be freely
tradable. The approximately 410,000 shares that were not
sold in our initial public offering, under the resale exemption
provided by Rule 701 under the Securities Act or this
offering will be eligible for resale from time to time after the
expiration of the
90-day
lock-up
period, subject to contractual and Securities Act restrictions,
including those relating to volume, manner of sale and other
conditions of Rule 144. None of those shares may currently
be resold under Rule 144(k).
The
market price of our common stock may be volatile, which could
cause the value of your investment to decline.
Securities markets worldwide experience significant price and
volume fluctuations. This market volatility, as well as general
economic, market or political conditions, could reduce the
market price of our common stock in spite of our operating
performance. In addition, our operating results could be below
the expectations of securities analysts and investors, and in
response, the market price of our common stock could decrease
significantly. Further, the trading price of our common stock
might also decline in reaction to events that affect other
companies in our industry even if these events do not directly
affect us. You may be unable to resell your shares of our common
stock at or above the offering price. Factors affecting the
trading price of our common stock may include:
|
|
|
|
|
actual or anticipated variations in our operating results;
|
|
|
|
changes in financial estimates by research analysts, or any
failure by us to meet or exceed any such estimates, or changes
in the recommendations of any research analysts that elect to
follow our common stock or the common stock of our competitors;
|
|
|
|
actual or anticipated changes in economic, political or market
conditions, such as recessions or international currency
fluctuations;
|
|
|
|
actual or anticipated changes in the regulatory environment
affecting our industry;
|
|
|
|
changes in the market valuations of our industry peers; and
|
|
|
|
announcements by us or our competitors of significant
acquisitions, strategic partnerships, divestitures, joint
ventures or other strategic initiatives.
|
In the past, following periods of volatility in the market price
of a companys securities, stockholders have often
instituted class action securities litigation against those
companies. Such litigation, if instituted, could result in
substantial costs and a diversion of management attention and
resources, which could significantly harm our profitability and
reputation.
Provisions
in our amended and restated certificate of incorporation and
amended and restated bylaws and Delaware law may discourage a
takeover attempt.
Provisions contained in our amended and restated certificate of
incorporation and amended and restated bylaws and Delaware law
could make it more difficult for a third party to acquire us.
Provisions of our amended and restated certificate of
incorporation and amended and restated bylaws and Delaware law
impose various procedural and other requirements, which could
make it more difficult for stockholders to effect certain
corporate actions. For example, our amended and restated
certificate of incorporation authorizes our board of directors
to determine the rights, preferences, privileges and
restrictions of unissued series of preferred stock, without any
vote or action by our stockholders. Therefore, our board of
directors can authorize and issue shares of preferred stock with
voting or conversion rights that could adversely affect the
voting or other rights of holders of our common stock. These
rights may have the effect of delaying or deterring a change of
control of our company. These provisions could limit the price
that certain investors might be willing to pay in the future for
shares of our common stock. See Description of Capital
Stock.
23
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus includes forward-looking statements.
These forward-looking statements include statements relating to
our business. In some cases, forward-looking statements may be
identified by terminology such as may,
should, expects,
anticipates, believes,
projects, forecasts,
continue or the negative of such terms or comparable
terminology. Forward-looking statements contained herein
(including future cash contractual obligations) or in other
statements made by us are made based on managements
expectations and beliefs concerning future events impacting us
and are subject to uncertainties and factors relating to our
operations and business environment, all of which are difficult
to predict and many of which are beyond our control, that could
cause our actual results to differ materially from those matters
expressed or implied by forward-looking statements. We believe
that the following factors, among others (including those
described in Risk Factors), could affect our future
performance and the liquidity and value of our securities and
cause our actual results to differ materially from those
expressed or implied by forward-looking statements made by us or
on our behalf:
|
|
|
|
|
the cyclicality of the markets which we serve;
|
|
|
|
the loss of, or a significant reduction or delay in purchases
by, our largest customers;
|
|
|
|
competition in our markets;
|
|
|
|
our compliance obligations with the Sarbanes-Oxley Act of 2002;
|
|
|
|
general economic, political, business and market risks
associated with our
non-U.S. operations;
|
|
|
|
our ability to successfully manage our growth;
|
|
|
|
the loss of key employees;
|
|
|
|
the pricing and availability of raw materials and our ability to
manage our fixed-price contract exposure, including exposure to
fixed pricing on long-term customer contracts;
|
|
|
|
our ability to successfully acquire or integrate companies that
provide complementary products or technologies;
|
|
|
|
our ability to continue our technical innovation in our product
lines;
|
|
|
|
the impairment of our goodwill and other indefinite-lived
intangible assets;
|
|
|
|
the costs of compliance with environmental, health and safety
laws and responding to potential liabilities under these laws;
|
|
|
|
the insolvency of our formerly consolidated subsidiary, Chart
Heat Exchangers Limited, or CHEL, and CHELs administration
proceedings in the United Kingdom, including claims that may be
asserted against us with respect to CHELs obligations;
|
|
|
|
litigation and disputes involving us, including the extent of
product liability, warranty, pension and severance claims
asserted against us;
|
|
|
|
labor costs and disputes;
|
|
|
|
our relations with our employees;
|
|
|
|
our funding requirements in connection with our defined benefit
pension plans;
|
|
|
|
fluctuations in foreign currency exchange and interest rates;
|
|
|
|
disruptions in our operations due to hurricanes;
|
|
|
|
our ability to protect our intellectual property and know-how;
|
|
|
|
regulations governing the export of our products;
|
|
|
|
additional liabilities related to taxes;
|
|
|
|
risks associated with our substantial indebtedness, leverage,
debt service and liquidity;
|
24
|
|
|
|
|
risks related to this offering; and
|
|
|
|
other factors described in this prospectus.
|
There may be other factors that may cause our actual results to
differ materially from the forward-looking statements.
All forward-looking statements attributable to us or persons
acting on our behalf apply only as of the date of this
prospectus and are expressly qualified in their entirety by the
cautionary statements included in this prospectus. We undertake
no obligation to update or revise forward-looking statements
which may be made to reflect events or circumstances that arise
after the date made or to reflect the occurrence of
unanticipated events.
25
MARKET
AND INDUSTRY DATA
This prospectus includes industry data and forecasts that we
have prepared based, in part, upon industry data and forecasts
obtained from industry publications and surveys. These sources
include publications by Energy Ventures Analysis, the Energy
Information Administration, the International Energy Agency and
Spiritus Consulting. Third-party industry publications, surveys
and forecasts generally state that the information contained
therein has been obtained from sources believed to be reliable,
but there can be no assurance as to the accuracy or completeness
of included information or whether this information reflects
current market data. We have not independently verified any of
the data from third-party sources nor have we ascertained the
underlying economic assumptions relied upon therein. Forecasts
are particularly likely to be inaccurate, especially over long
periods of time. As an example of the unpredictable nature of
these forecasts, in 1983, the U.S. Department of Energy
forecast that oil would cost $74 per barrel in 1995;
however, the price of oil was actually $17 per barrel. In
addition, we do not know what assumptions regarding general
economic growth were used in preparing the forecasts we cite.
Statements made herein as to our leading positions in our
industry and segments are based on our sales volumes measured
against managements estimates of our competitors
sales volumes, coupled with managements knowledge and
experience in the markets that we serve.
26
USE OF
PROCEEDS
The selling stockholders, including FR X Chart Holdings LLC,
will receive all the net proceeds from the sale of our common
stock in this offering. The net proceeds received by FR X Chart
Holdings LLC will be distributed to affiliates of First Reserve.
In addition, certain of our executive officers, including our
Chief Executive Officer, are selling an aggregate of
140,000 shares in this offering as follows: Mr. Thomas
(120,000 shares); and Mr. Biehl (20,000 shares).
The proceeds to be received by certain of our executive officers
(before payment of underwriting discounts) will be:
Mr. Thomas ($2,550,000); and Mr. Biehl ($425,000).
Other employees are selling an aggregate of 96,299 shares
in this offering.
We will not receive any of the proceeds from the sale of common
stock by the selling stockholders in this offering. In
connection with this offering, selling stockholders who are
employees will pay us approximately $0.3 million to
purchase shares of our common stock underlying stock options for
sale in this offering. In the event the underwriters fully
exercise their over-allotment option, we will issue new shares
to cover the over-allotment and we will use the approximately
$38.3 million of net proceeds for general corporate
purposes, including reduction of our indebtedness with interest
rates ranging from an average of 6.93% to 9.125% at
March 31, 2007 and maturities of October 2012 and October
2015, respectively.
27
DIVIDEND
POLICY
In connection with our initial public offering, we distributed
approximately $150.3 million of the net proceeds to pay a
dividend to our stockholders existing immediately prior to the
initial public offering, consisting of affiliates of First
Reserve and certain members of management. FR X Chart Holdings
LLC, an affiliate of First Reserve, received approximately
$142.1 million, approximately $8.2 million in the
aggregate was received by certain of our executive officers and
other members of our management, consisting of Mr. Thomas
($5,866,697) and Mr. Biehl ($328,493), and $1,979,953 was
received by seven other employees in the aggregate. In addition,
upon the expiration of the underwriters over-allotment
option, we issued 1,733,022 shares to FR X Chart Holdings
LLC, 101,978 shares to certain of our executive officers
and other members of our management, consisting of
Mr. Thomas (73,181 shares) and Mr. Biehl
(4,097 shares), and 24,700 shares to seven other
employees in the aggregate as a stock dividend.
We do not currently intend to pay any cash dividends on our
common stock, and instead intend to retain earnings, if any, for
future operations and debt reduction. The amounts available to
us to pay cash dividends will be restricted by our senior
secured credit facility. The indenture governing the notes also
limits our ability to pay dividends. Any decision to declare and
pay dividends in the future will be made at the discretion of
our board of directors and will depend on, among other things,
our results of operations, financial condition, cash
requirements, contractual restrictions and other factors that
our board of directors may deem relevant.
PRICE
RANGE OF OUR COMMON STOCK
Trading in our common stock commenced on the Nasdaq Global
Market on July 26, 2006 under the symbol GTLS.
Prior to that time, there was no public market for our common
stock. The following table sets forth, for the periods
indicated, the high and low sales prices per share of our common
stock as reported on the Nasdaq Global Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2006
|
|
|
|
|
|
|
|
|
Quarter ended September 30,
2006
|
|
$
|
16.60
|
|
|
$
|
11.43
|
|
Quarter ended December 31,
2006
|
|
$
|
16.33
|
|
|
$
|
11.16
|
|
2007
|
|
|
|
|
|
|
|
|
Quarter ended March 31, 2007
|
|
$
|
18.89
|
|
|
$
|
14.94
|
|
Quarter ended June 30, 2007
(through June 6, 2007)
|
|
$
|
24.27
|
|
|
$
|
17.00
|
|
28
CAPITALIZATION
The information in this table should be read in conjunction with
Selected Historical Consolidated Financial Data,
Managements Discussion and Analysis of Financial
Condition and Results of Operations, Description of
Indebtedness and our consolidated financial statements and
related notes included elsewhere in this prospectus. The table
excludes cash and cash equivalents as of March 31, 2007 of
$12.4 million.
|
|
|
|
|
|
|
As of
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
|
(In millions)
|
|
|
Debt:
|
|
|
|
|
Senior secured credit facility:
|
|
|
|
|
Revolving credit facility(1)
|
|
$
|
|
|
Term loan facility
|
|
|
120.0
|
|
91/8% senior
subordinated notes due 2015
|
|
|
170.0
|
|
|
|
|
|
|
Total debt
|
|
$
|
290.0
|
|
|
|
|
|
|
Shareholders
equity:
|
|
|
|
|
Common stock, par value
$0.01 per share, 150,000,000 shares authorized,
25,588,835 shares issued and outstanding
|
|
|
0.3
|
|
Additional paid-in capital
|
|
|
185.9
|
|
Retained earnings
|
|
|
33.6
|
|
Accumulated other comprehensive
income
|
|
|
7.2
|
|
|
|
|
|
|
Total shareholders equity
|
|
$
|
227.0
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
517.0
|
|
|
|
|
|
|
|
|
|
(1) |
|
As of March 31, 2007, we had approximately
$92.4 million available for borrowing under the revolving
portion of the senior secured credit facility, subject to
certain conditions, after giving effect to approximately
$22.6 million of letters of credit and bank guarantees
outstanding thereunder. See Description of
Indebtedness. |
29
SELECTED
HISTORICAL CONSOLIDATED FINANCIAL DATA
The financial statements referred to as the Pre-Predecessor
Company financial statements include the consolidated audited
financial statements of Chart Industries, Inc. and its
subsidiaries prior to our Chapter 11 bankruptcy
proceedings. Our emergence from Chapter 11 bankruptcy
proceedings resulted in a new reporting entity and the adoption
of Fresh-Start accounting in accordance with the American
Institute of Certified Public Accountants Statement of Position
90-7,
Financial Reporting by Entities in Reorganization Under
the Bankruptcy Code. The financial statements referred to
as the Predecessor Company financial statements include the
consolidated audited financial statements of Chart Industries,
Inc. and its subsidiaries after our emergence from
Chapter 11 bankruptcy proceedings and prior to the
Acquisition and related financing thereof. The financial
statements referred to as the Company financial statements
include the consolidated audited financial statements of Chart
Industries, Inc. and its subsidiaries after the Acquisition and
the related financing thereof.
The following table sets forth the selected historical
consolidated financial information as of the dates and for each
of the periods indicated. The Pre-Predecessor Company selected
historical consolidated financial data as of and for the year
ended December 31, 2002 and as of and for the nine months
ended September 30, 2003 is derived from our audited
financial statements for such period, which have been audited by
Ernst & Young LLP and which are not included in this
prospectus. The Predecessor Company selected historical
consolidated financial data as of and for the three months ended
December 31, 2003, as of December 31, 2004 and
October 16, 2005 are derived from our audited financial
statements for such periods which have been audited by
Ernst & Young LLP, and which are not included in this
prospectus. The Predecessor Company selected historical
consolidated financial data for the year ended December 31,
2004 and for the period from January 1, 2005 to
October 16, 2005 is derived from our audited financial
statements for such periods included elsewhere in this
prospectus, which have been audited by Ernst & Young
LLP. The Company selected historical consolidated financial
statements and other data as of December 31, 2005 and
December 31, 2006 and for the period from October 17,
2005 to December 31, 2005 and for the year ended
December 31, 2006 is derived from our audited financial
statements for such periods included elsewhere in this
prospectus, which have been audited by Ernst & Young
LLP. The Company selected historical consolidated financial data
for the three months ended March 31, 2006, and as of and
for the three months ended March 31, 2007, respectively,
have been derived from the unaudited condensed consolidated
financial statements and related notes which are included
elsewhere in this prospectus, and reflect all adjustments,
consisting of normal, recurring adjustments which are, in the
opinion of management, necessary for a fair presentation of the
Companys financial position, results of operations and
cash flows for the three months ended March 31, 2006 and as
of and for the three months ended March 31, 2007 and are
not necessarily indicative of our results of operations for the
full year.
You should read the following table together with
Managements Discussion and Analysis of Financial
Condition and Results of Operations and our consolidated
financial statements and related notes, included elsewhere in
this prospectus.
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
|
Pre-Predecessor Company
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
|
Three
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
|
|
|
|
Months
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
Ended
|
|
|
|
Ended
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
2002
|
|
|
2003
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(In thousands, except per share data)
|
|
|
(Unaudited)
|
|
Statement of Operations
Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
$
|
276,353
|
|
|
$
|
197,017
|
|
|
|
$
|
68,570
|
|
|
$
|
305,576
|
|
|
$
|
305,497
|
|
|
|
$
|
97,652
|
|
|
$
|
537,454
|
|
|
$
|
120,840
|
|
|
$
|
152,463
|
|
Cost of sales(1)
|
|
|
205,595
|
|
|
|
141,240
|
|
|
|
|
52,509
|
|
|
|
211,770
|
|
|
|
217,284
|
|
|
|
|
75,733
|
|
|
|
382,535
|
|
|
|
83,853
|
|
|
|
112,604
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
70,758
|
|
|
|
55,777
|
|
|
|
|
16,061
|
|
|
|
93,806
|
|
|
|
88,213
|
|
|
|
|
21,919
|
|
|
|
154,919
|
|
|
|
36,987
|
|
|
|
39,859
|
|
Selling, general and administrative
expenses(2)(3)
|
|
|
65,679
|
|
|
|
44,211
|
|
|
|
|
14,147
|
|
|
|
53,374
|
|
|
|
59,826
|
|
|
|
|
16,632
|
|
|
|
87,652
|
|
|
|
21,039
|
|
|
|
22,473
|
|
Restructuring and other operating
expenses, net(4)(5)(6)
|
|
|
104,477
|
|
|
|
13,503
|
|
|
|
|
994
|
|
|
|
3,353
|
|
|
|
7,528
|
|
|
|
|
217
|
|
|
|
396
|
|
|
|
162
|
|
|
|
99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
170,156
|
|
|
|
57,714
|
|
|
|
|
15,141
|
|
|
|
56,727
|
|
|
|
67,354
|
|
|
|
|
16,849
|
|
|
|
88,048
|
|
|
|
21,201
|
|
|
|
22,572
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
(99,398
|
)
|
|
|
(1,937
|
)
|
|
|
|
920
|
|
|
|
37,079
|
|
|
|
20,859
|
|
|
|
|
5,070
|
|
|
|
66,871
|
|
|
|
15,786
|
|
|
|
17,287
|
|
Interest expense, net(7)
|
|
|
19,176
|
|
|
|
10,300
|
|
|
|
|
1,344
|
|
|
|
4,712
|
|
|
|
4,164
|
|
|
|
|
5,556
|
|
|
|
25,461
|
|
|
|
6,545
|
|
|
|
6,346
|
|
Other expense (income)
|
|
|
4,240
|
|
|
|
(3,737
|
)
|
|
|
|
(350
|
)
|
|
|
(465
|
)
|
|
|
659
|
|
|
|
|
409
|
|
|
|
1,003
|
|
|
|
222
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,416
|
|
|
|
6,563
|
|
|
|
|
994
|
|
|
|
4,247
|
|
|
|
4,823
|
|
|
|
|
5,965
|
|
|
|
26,464
|
|
|
|
6,767
|
|
|
|
6,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing
operations before income taxes and minority interest
|
|
|
(122,814
|
)
|
|
|
(8,500
|
)
|
|
|
|
(74
|
)
|
|
|
32,832
|
|
|
|
16,036
|
|
|
|
|
(895
|
)
|
|
|
40,407
|
|
|
|
9,019
|
|
|
|
10,891
|
|
Income tax expense (benefit)
|
|
|
11,136
|
|
|
|
1,755
|
|
|
|
|
(125
|
)
|
|
|
10,134
|
|
|
|
7,159
|
|
|
|
|
(441
|
)
|
|
|
13,044
|
|
|
|
2,980
|
|
|
|
3,713
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing
operations before minority interest
|
|
|
(133,950
|
)
|
|
|
(10,255
|
)
|
|
|
|
51
|
|
|
|
22,698
|
|
|
|
8,877
|
|
|
|
|
(454
|
)
|
|
|
27,363
|
|
|
|
6,039
|
|
|
|
7,178
|
|
Minority interest, net of taxes and
other
|
|
|
(52
|
)
|
|
|
(63
|
)
|
|
|
|
(20
|
)
|
|
|
(98
|
)
|
|
|
(19
|
)
|
|
|
|
(52
|
)
|
|
|
(468
|
)
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing
operations
|
|
|
(134,002
|
)
|
|
|
(10,318
|
)
|
|
|
|
31
|
|
|
|
22,600
|
|
|
|
8,858
|
|
|
|
|
(506
|
)
|
|
|
26,895
|
|
|
|
6,045
|
|
|
|
7,178
|
|
Income from discontinued operation,
including gain on sale, net of tax(8)
|
|
|
3,217
|
|
|
|
3,233
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
(130,785
|
)
|
|
$
|
(7,085
|
)
|
|
|
$
|
31
|
|
|
$
|
22,600
|
|
|
$
|
8,858
|
|
|
|
$
|
(506
|
)
|
|
$
|
26,895
|
|
|
$
|
6,045
|
|
|
$
|
7,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) Earnings per share
data(9):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic (loss) earnings per share
|
|
$
|
(5.22
|
)
|
|
$
|
(0.27
|
)
|
|
|
$
|
0.01
|
|
|
$
|
4.22
|
|
|
$
|
1.65
|
|
|
|
$
|
(0.06
|
)
|
|
$
|
1.70
|
|
|
$
|
0.76
|
|
|
$
|
0.28
|
|
Diluted (loss) earnings per share
|
|
$
|
(5.22
|
)
|
|
$
|
(0.27
|
)
|
|
|
$
|
0.01
|
|
|
$
|
4.10
|
|
|
$
|
1.57
|
|
|
|
$
|
(0.06
|
)
|
|
$
|
1.65
|
|
|
$
|
0.73
|
|
|
$
|
0.28
|
|
Weighted average shares
basic
|
|
|
25,073
|
|
|
|
26,336
|
|
|
|
|
5,325
|
|
|
|
5,351
|
|
|
|
5,366
|
|
|
|
|
7,952
|
|
|
|
15,835
|
|
|
|
7,952
|
|
|
|
25,604
|
|
Weighted average shares
diluted
|
|
|
25,073
|
|
|
|
26,336
|
|
|
|
|
5,325
|
|
|
|
5,516
|
|
|
|
5,649
|
|
|
|
|
7,952
|
|
|
|
16,269
|
|
|
|
8,285
|
|
|
|
25,810
|
|
Cash Flow Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
$
|
5,249
|
|
|
$
|
19,466
|
|
|
|
$
|
4,988
|
|
|
$
|
35,059
|
|
|
$
|
15,641
|
|
|
|
$
|
14,635
|
|
|
$
|
36,398
|
|
|
$
|
11,895
|
|
|
$
|
1,037
|
|
Net cash provided by (used in)
investing activities
|
|
|
1,288
|
|
|
|
15,101
|
|
|
|
|
154
|
|
|
|
(3,317
|
)
|
|
|
(20,799
|
)
|
|
|
|
(362,250
|
)
|
|
|
(38,664
|
)
|
|
|
(2,566
|
)
|
|
|
(6,646
|
)
|
Net cash (used in) provided by
financing activities
|
|
|
(17,614
|
)
|
|
|
(15,907
|
)
|
|
|
|
(13,976
|
)
|
|
|
(35,744
|
)
|
|
|
1,708
|
|
|
|
|
348,489
|
|
|
|
9,235
|
|
|
|
(5,839
|
)
|
|
|
(928
|
)
|
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization(10)
|
|
$
|
14,531
|
|
|
$
|
9,260
|
|
|
|
$
|
2,225
|
|
|
$
|
8,490
|
|
|
$
|
6,808
|
|
|
|
$
|
4,396
|
|
|
$
|
22,449
|
|
|
$
|
5,194
|
|
|
$
|
4,991
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-Predecessor Company
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
As of
|
|
|
As of
|
|
|
|
As of
|
|
|
As of
|
|
|
As of
|
|
|
|
As of
|
|
|
As of
|
|
|
As of
|
|
|
|
December 31,
|
|
|
September 30,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2002
|
|
|
2003
|
|
|
|
2003
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
7,225
|
|
|
$
|
27,815
|
|
|
|
$
|
18,600
|
|
|
$
|
14,814
|
|
|
$
|
11,470
|
|
|
|
$
|
11,326
|
|
|
|
18,854
|
|
|
|
12,359
|
|
Working capital(11)
|
|
|
48,563
|
|
|
|
35,826
|
|
|
|
|
47,161
|
|
|
|
51,292
|
|
|
|
43,486
|
|
|
|
|
59,561
|
|
|
|
73,290
|
|
|
|
84,286
|
|
Total assets
|
|
|
279,294
|
|
|
|
299,745
|
|
|
|
|
299,637
|
|
|
|
307,080
|
|
|
|
343,107
|
|
|
|
|
635,641
|
(13)
|
|
|
724,875
|
(13)
|
|
|
736,316
|
(13)
|
Long-term debt
|
|
|
1,161
|
(12)
|
|
|
122,537
|
|
|
|
|
109,081
|
|
|
|
76,406
|
|
|
|
74,480
|
|
|
|
|
345,000
|
|
|
|
290,000
|
|
|
|
290,000
|
|
Total debt
|
|
|
263,900
|
(12)
|
|
|
126,012
|
|
|
|
|
112,561
|
|
|
|
79,411
|
|
|
|
80,943
|
|
|
|
|
347,304
|
|
|
|
290,750
|
|
|
|
290,000
|
|
Shareholders equity (deficit)
|
|
|
(81,617
|
)
|
|
|
89,865
|
|
|
|
|
90,807
|
|
|
|
115,640
|
|
|
|
121,321
|
|
|
|
|
116,330
|
|
|
|
219,734
|
|
|
|
226,963
|
|
|
|
|
(1) |
|
The three months ended December 31, 2003 and the period
from October 17, 2005 to December 31, 2005 include
non-cash inventory valuation charges of $5.4 million and
$8.9 million, respectively, related to Fresh-Start and
purchase accounting. |
|
(2) |
|
Includes amortization expense related to intangible assets for
the year ended December 31, 2002, the nine months ended
September 30, 2003, the three months ended
December 31, 2003, the year ended December 31, 2004,
the period from January 1, 2005 to October 16, 2005,
the period from October 17, 2005 to December 31, 2005,
the year ended December 31, 2006, the three months ended
March 31, 2006 and the three months ended March 31,
2007 of $1.7 million, $1.2 million, $0.7 million,
$2.8 million, $2.7 million $3.0 million,
$15.4 million, $3.6 million and $3.0 million,
respectively. |
|
(3) |
|
Includes charges (income), net of insurance recoveries, related
to Hurricane Rita of $1.1 million, $0.4 million and
($2.3 million) for the period from January 1, 2005 to
October 16, 2005, the period from October 17, 2005 to
December 31, 2005 and the year ended December 31,
2006, respectively. |
|
(4) |
|
In March 2003, we completed the closure of our Wolverhampton,
United Kingdom manufacturing facility, operated by CHEL. On
March 28, 2003, CHEL filed for voluntary administration
under the U.K. Insolvency Act of 1986. CHELs application
for voluntary administration was approved on April 1, 2003
and an administrator was appointed. In accordance with
SFAS No. 94, Consolidation of All Majority-Owned
Subsidiaries, we are not consolidating the accounts or
financial results of CHEL subsequent to March 28, 2003 due
to the assumption of control of CHEL by the insolvency
administrator. Effective March 28, 2003, we recorded a
non-cash impairment charge of $13.7 million to write off
our net investment in CHEL. |
|
(5) |
|
In 2002, we recorded a non-cash impairment charge of
$92.4 million to write off non-deductible goodwill of the
D&S segment. |
|
(6) |
|
In September 2003, in accordance with Fresh-Start accounting,
all assets and liabilities were adjusted to their fair values.
The adjustment to record the assets and liabilities at fair
value resulted in net other income of $5.7 million for the
nine months ended September 30, 2003. |
|
(7) |
|
Includes derivative contracts valuation income or expense for
interest rate collars to manage interest exposure relative to
term debt. |
|
(8) |
|
This discontinued operation relates to the sale of our former
Greenville Tube, LLC business in July 2003. |
|
(9) |
|
The basic and diluted loss and earnings per share for the year
ended December 31, 2002, the nine months ended
September 30, 2003, the three months ended
December 31, 2003 and the period from October 17, 2005
to December 31, 2005 are the same because incremental
shares issuable upon conversion are anti-dilutive. Diluted
earnings (loss) per share for the three months ended
March 31, 2007 are not comparable to diluted earnings
(loss) per share for the three months ended March 31, 2006
due to the change in our capital structure upon completion of
our initial public offering in July 2006. |
|
(10) |
|
Includes financing costs amortization for the year ended
December 31, 2002, the nine months ended September 30,
2003, the period from October 17, 2005 to December 31,
2005, the year ended December 31, 2006, the three months
ended March 31, 2006 and the three months ended
March 31, 2007 of $3.2 million, $1.7 million,
$0.3 million, $1.5 million, $0.4 million and
$0.4 million, respectively. |
|
(11) |
|
Working capital is defined as current assets, excluding cash
minus current liabilities, excluding short-term debt. |
32
|
|
|
(12) |
|
As of December 31, 2002, we were in default on our senior
debt due to violation of financial covenants. In April 2003, the
lenders under our then-existing credit facility waived all
defaults existing at December 31, 2002 and through
April 30, 2003. Since the waiver of defaults did not extend
until January 1, 2004, this debt was classified as a
current liability on our consolidated balance sheet as of
December 31, 2002. |
|
(13) |
|
Includes $236.7 million of goodwill and $154.1 million
of finite-lived and indefinite-lived intangible assets as of
December 31, 2005. Includes $247.1 million of goodwill
and $146.6 million of finite-lived and indefinite-lived
intangible assets as of December 31, 2006. Includes
$246.8 million of goodwill and $143.6 million of
finite-lived and indefinite-lived intangible assets as of
March 31, 2007. |
33
MANAGEMENTS
DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our results of
operations includes periods prior to the consummation of the
Acquisition and periods after the consummation of the
Acquisition. Accordingly, the discussion and analysis of
historical periods does not reflect fully the significant impact
that the Acquisition will have on us, including significantly
increased leverage and liquidity requirements. You should read
the following discussion of our results of operations and
financial condition in conjunction with the Selected
Historical Consolidated Financial Data section and our
consolidated financial statements and related notes appearing
elsewhere in this prospectus. Actual results may differ
materially from those discussed below. This discussion contains
forward-looking statements. See Special
Note Regarding Forward-Looking Statements and
Risk Factors for a discussion of certain of the
uncertainties, risks and assumptions associated with these
statements.
Overview
We are a leading independent global manufacturer of highly
engineered equipment used in the production, storage and end-use
of hydrocarbon and industrial gases. We supply engineered
equipment used throughout the global liquid gas supply chain.
The largest portion of end-use applications for our products is
energy-related. We are a leading manufacturer of standard and
engineered equipment primarily used for low-temperature and
cryogenic applications. We have developed an expertise in
cryogenic systems and equipment, which operate at low
temperatures sometimes approaching absolute zero (0 kelvin;
−273o
Centigrade;
−459o
Fahrenheit). The majority of our products, including
vacuum-insulated containment vessels, heat exchangers, cold
boxes and other cryogenic components, are used throughout the
liquid gas supply chain for the purification, liquefaction,
distribution, storage and end-use of hydrocarbon and industrial
gases.
For the three months ended March 31, 2007, orders remained
strong at $174.8 million and backlog increased to
$342.2 million compared to $319.2 million at
December 31, 2006. This increase was primarily due to
increased demand in the hydrocarbon processing and industrial
gas markets served by our Energy and Chemicals
(E&C) and Distribution and Storage
(D&S) segments and continued penetration of the
international markets served by our BioMedical segment. Also, we
experienced growth in our sales, gross profit and operating
income for the three months ended March 31, 2007 compared
to the same period in 2006, which was primarily attributable to
higher volume across all of our business segments, and the
timing of product price increases, particularly in our D&S
segment. Sales for the three months ended March 31, 2007
were $152.5 million compared to sales of
$120.8 million for the three months ended March 31,
2006, reflecting an increase of $31.7 million, or 26.2%.
Our gross profit for the three months ended March 31, 2007
was $39.9 million, or 26.1% of sales, as compared to
$37.0 million, or 30.6% of sales, for the same period in
2006. In addition, our operating income for the three months
ended March 31, 2007 was $17.3 million compared to
$15.8 million for the same period in 2006. Our gross profit
margin decline was attributed to our E&C segment as margins
in our D&S and BioMedical segments improved.
For the year ended December 31, 2006, we experienced
significant increases in our backlog, orders, sales, gross
profit and operating income compared to the combined year ended
December 31, 2005. These increases were primarily due to
continued growth in the global hydrocarbon processing and
industrial gas markets served by our E&C and D&S
segments and the acquisition of an air cooled heat exchanger
business that is included in our E&C segment. Backlog as of
December 31, 2006 was $319.2 million compared to
$233.6 million as of December 31, 2005, representing
an increase of $85.6 million or 36.6%. Orders for the year
ended December 31, 2006 were $605.8 million compared
to $511.2 for the combined year ended December 31, 2005,
representing an increase of $94.6 million or 18.5%. Sales
for 2006 were $537.5 million compared to sales of
$403.1 million for the combined year 2005, reflecting an
increase of $134.3 million, or 33.3%. Gross profit for the
year ended December 31, 2006 was $155.0 million, or
28.8% of sales, as compared to $110.1 million, or 27.3% of
sales, for the combined year ended December 31, 2005. In
addition, operating income for the year ended December 31,
2006 was $66.9 million compared to $25.9 million for
combined year 2005. Increased sales volume in all three of our
operating segments, manufacturing productivity improvements in
our D&S and BioMedical segments, and the timing of product
price increases in our D&S segment, were contributing
factors to the growth in our gross profit in 2006. Our gross
profit and operating income for the combined year ended
December 31, 2005 was negatively impacted by
$8.9 million, or
34
2.2% of sales and $26.5 million or 6.6% of sales,
respectively, of non-recurring charges primarily as a result of
the Acquisition.
On May 26, 2006, we acquired Cooler Service Company, Inc.,
an air-cooled heat exchanger business (CSC), which
was included in our E&C segment. Our results of operations
for the last seven months of 2006 include the results from CSC.
As a result of the continued growth in many of the markets we
serve, our present and anticipated customer order trends, our
backlog level of $342.2 million as of March 31, 2007,
and our focus on energy-related industries, we presently expect
to experience continued sales and operating income growth for
the remainder of 2007 as compared to the same period in 2006.
While overall growth is expected in the global industrial gas
market during the remainder of 2007, more of this growth is
forecasted from international markets, particularly Central
Europe and Asia, as the U.S. market is experiencing signs
of moderating growth. We also believe that our cash flow from
operations, available cash and available borrowings under the
senior secured credit facility should be adequate to meet our
working capital, capital expenditure, debt service and other
funding requirements for the remainder of 2007.
Stock-Based
Compensation Expense
We granted options to purchase an aggregate of
266,390 shares of our common stock (93,179 time-based
options and 173,221 performance-based options) in 2006 under the
Amended and Restated 2005 Stock Incentive Plan to certain
members of management. In connection with these time-based
options, we will record pre-tax
stock-based
compensation expense of approximately $1.3 million in the
aggregate. This expense will be amortized over the five-year
vesting period of the 93,179 time-based options, including
approximately $0.4 million in 2006. Further, we may also
record additional stock-based compensation expense, which may be
substantial, in future periods related to the 1,580,607
performance-based options granted in 2005 and 2006 under the
Amended and Restated 2005 Stock Incentive Plan to certain
members of management if it becomes probable that any of the
future performance criteria will be achieved. We presently
believe that the maximum share-based compensation expense
relating to the performance-based options is approximately
$7.7 million, which will be recognized if and to the extent
it becomes probable that the specified actual returns on First
Reserve Fund X, L.P.s investment will be achieved.
Primarily as a result of the vesting of the performance-based
options based on First Reserve Fund X, L.P. achieving a
specified investment return upon completion of this offering, we
estimate that we will incur a pre-tax, non-cash stock-based
compensation expense of approximately $7.0 million in the
period in which this offering is consummated.
Operating
Results
The following table sets forth the percentage relationship that
each line item in our consolidated statements of operations
represents to sales for the year ended December 31, 2004,
the period from January 1, 2005 to October 16, 2005,
the period from October 17, 2005 to December 31, 2005,
the year ended December 31, 2006, the three months ended
March 31, 2006 and the three months ended March 31,
2007. The Predecessor Company and the Company
35
are further described in our audited financial statements and
related notes thereto included elsewhere in this prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
Three Months
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
Sales
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of sales(1)
|
|
|
69.3
|
|
|
|
71.1
|
|
|
|
|
77.6
|
|
|
|
71.2
|
|
|
|
69.4
|
|
|
|
73.9
|
|
Gross profit
|
|
|
30.7
|
|
|
|
28.9
|
|
|
|
|
22.4
|
|
|
|
28.8
|
|
|
|
30.6
|
|
|
|
26.1
|
|
Selling, general and
administrative expenses(2)(3)(4)(5)(6)
|
|
|
16.6
|
|
|
|
18.7
|
|
|
|
|
13.9
|
|
|
|
13.4
|
|
|
|
14.5
|
|
|
|
12.8
|
|
Amortization expense
|
|
|
0.9
|
|
|
|
0.9
|
|
|
|
|
3.1
|
|
|
|
2.9
|
|
|
|
3.0
|
|
|
|
2.0
|
|
Acquisition expense(7)
|
|
|
|
|
|
|
2.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
1.0
|
|
|
|
0.3
|
|
|
|
|
0.1
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
(Loss) on sale of assets
|
|
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity expense in joint venture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
12.2
|
|
|
|
6.8
|
|
|
|
|
5.2
|
|
|
|
12.4
|
|
|
|
13.1
|
|
|
|
11.3
|
|
Interest expense, net
|
|
|
(1.6
|
)
|
|
|
(1.4
|
)
|
|
|
|
(5.7
|
)
|
|
|
(4.7
|
)
|
|
|
(5.4
|
)
|
|
|
(4.1
|
)
|
Financing costs amortization
|
|
|
|
|
|
|
|
|
|
|
|
(0.3
|
)
|
|
|
(0.3
|
)
|
|
|
(0.3
|
)
|
|
|
(0.3
|
)
|
Derivative contracts valuation
income (expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency income (loss)
|
|
|
0.1
|
|
|
|
(0.2
|
)
|
|
|
|
(0.1
|
)
|
|
|
0.1
|
|
|
|
0.1
|
|
|
|
0.2
|
|
Income (loss) before income taxes
and minority interest
|
|
|
10.7
|
|
|
|
5.2
|
|
|
|
|
(0.9
|
)
|
|
|
7.5
|
|
|
|
7.5
|
|
|
|
7.1
|
|
Income tax (benefit) expense
|
|
|
3.3
|
|
|
|
2.3
|
|
|
|
|
(0.5
|
)
|
|
|
2.4
|
|
|
|
2.5
|
|
|
|
2.4
|
|
Income (loss) before minority
interest
|
|
|
7.4
|
|
|
|
2.9
|
|
|
|
|
(0.4
|
)
|
|
|
5.1
|
|
|
|
5.0
|
|
|
|
4.7
|
|
Minority interest, net of taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
7.4
|
|
|
|
2.9
|
|
|
|
|
(0.4
|
)
|
|
|
5.0
|
|
|
|
5.0
|
|
|
|
4.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes non-cash inventory valuation charges of
$8.9 million, $0.6 million and $0.2 million,
representing, 9.2%, 0.2%, and 0.1% of sales, for the period from
October 17, 2005 to December 31, 2005, the period from
January 1, 2005 to October 16, 2005 and the year ended
December 31, 2004, respectively. |
|
(2) |
|
Includes $1.5 million and $0.7 million, representing
0.5% and 0.2% of sales, for claim settlements, professional fees
incurred by us related to our debt restructuring and bankruptcy
reorganization activities for the period from January 1,
2005 to October 16, 2005 and the year ended
December 31, 2004, respectively. |
|
(3) |
|
Includes stock-based compensation expense of $0.4 million,
$1.9 million, $0.3 million, $0.4 million,
$9.5 million, and $2.4 million, representing 0.2%,
0.4%, 0.3%, 0.4%, 3.1%, and 0.8% of sales, for the three months
ended March 31, 2007, the year ended December 31,
2006, the three months ended March 31, 2006, the period
from October 17, 2005 to December 31, 2005, the period
from January 1, 2005 to October 16, 2005, and the year
ended December 31, 2004, respectively. |
|
(4) |
|
Includes charges (income), net of insurance recoveries, related
to Hurricane Rita of ($2.3) million, $0.2 million,
$0.4 million and $1.1 million, representing (0.4)%,
0.2%, 0.4% and 0.3% of sales, for the year ended
December 31, 2006, the three months ended March 31,
2006, the period from October 17, 2005 to December 31,
2005 and the period from January 1, 2005 to
October 16, 2005, respectively. |
|
(5) |
|
Includes a charge for the settlement of former
shareholders appraisal rights claims related to the
Acquisition of $0.5 million, or 0.5% of sales, and a charge
for the write-off of purchased in-process research and
development |
36
|
|
|
|
|
of $2.8 million, or 0.1% of sales, for the period from
October 17, 2005 to December 31, 2005 and the period
from January 1, 2005 to October 16, 2005, respectively. |
|
(6) |
|
Includes amortization expense for intangible assets of
$3.0 million, $15.4 million, $3.6 million,
$3.0 million, $2.7 million and $2.8 million,
representing 2.0%, 2.8%, 3.0%, 3.0%, 0.9% and 0.9% of sales, for
the three months ended March 31, 2007, the year ended
December 31, 2006, the three months ended March 31,
2006, the period from October 17, 2005 to December 31,
2005, the period from January 1, 2005 to October 16,
2005 and the year ended December 31, 2004. |
|
(7) |
|
Represents expenses, primarily professional fees, incurred by us
related to the Acquisition. |
Segment
Information
The following table sets forth sales, gross profit, gross profit
margin and operating income or loss for our operating segments
for the periods indicated during the last three years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Three Months Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(Dollars in thousands)
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals
|
|
$
|
69,609
|
|
|
$
|
86,920
|
|
|
|
$
|
34,135
|
|
|
$
|
190,673
|
|
|
$
|
41,174
|
|
|
$
|
52,277
|
|
Distribution and Storage
|
|
|
162,508
|
|
|
|
161,329
|
|
|
|
|
47,832
|
|
|
|
268,303
|
|
|
|
60,318
|
|
|
|
76,779
|
|
BioMedical
|
|
|
73,459
|
|
|
|
57,248
|
|
|
|
|
15,685
|
|
|
|
78,478
|
|
|
|
19,348
|
|
|
|
23,407
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
305,576
|
|
|
$
|
305,497
|
|
|
|
$
|
97,652
|
|
|
$
|
537,454
|
|
|
$
|
120,840
|
|
|
$
|
152,463
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals
|
|
$
|
21,475
|
|
|
$
|
23,391
|
|
|
|
$
|
10,494
|
|
|
$
|
39,676
|
|
|
$
|
11,648
|
|
|
$
|
6,026
|
|
Distribution and Storage
|
|
|
46,588
|
|
|
|
47,120
|
|
|
|
|
8,861
|
|
|
|
87,283
|
|
|
|
18,822
|
|
|
|
25,751
|
|
BioMedical
|
|
|
25,743
|
|
|
|
17,702
|
|
|
|
|
2,564
|
|
|
|
27,960
|
|
|
|
6,517
|
|
|
|
8,082
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
93,806
|
|
|
$
|
88,213
|
|
|
|
$
|
21,919
|
|
|
$
|
154,919
|
|
|
$
|
36,987
|
|
|
$
|
39,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
Margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals
|
|
|
30.9
|
%
|
|
|
26.9
|
%
|
|
|
|
30.7
|
%
|
|
|
20.8
|
%
|
|
|
28.3
|
%
|
|
|
11.5
|
%
|
Distribution and Storage
|
|
|
28.7
|
%
|
|
|
29.2
|
%
|
|
|
|
18.5
|
%
|
|
|
32.5
|
%
|
|
|
31.2
|
%
|
|
|
33.5
|
%
|
BioMedical
|
|
|
35.0
|
%
|
|
|
30.9
|
%
|
|
|
|
16.4
|
%
|
|
|
35.6
|
%
|
|
|
33.7
|
%
|
|
|
34.5
|
%
|
Total
|
|
|
30.7
|
%
|
|
|
28.9
|
%
|
|
|
|
22.4
|
%
|
|
|
28.8
|
%
|
|
|
30.6
|
%
|
|
|
26.1
|
%
|
Operating Income
(Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy & Chemicals
|
|
$
|
11,545
|
|
|
$
|
13,717
|
|
|
|
$
|
5,092
|
|
|
$
|
18,957
|
|
|
$
|
5,933
|
|
|
$
|
150
|
|
Distribution & Storage
|
|
|
27,951
|
|
|
|
27,005
|
|
|
|
|
3,947
|
|
|
|
54,545
|
|
|
|
11,053
|
|
|
|
18,038
|
|
BioMedical
|
|
|
14,208
|
|
|
|
8,343
|
|
|
|
|
714
|
|
|
|
15,969
|
|
|
|
3,714
|
|
|
|
4,910
|
|
Corporate
|
|
|
(16,625
|
)
|
|
|
(28,206
|
)
|
|
|
|
(4,683
|
)
|
|
|
(22,600
|
)
|
|
|
(4,914
|
)
|
|
|
(5,811
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
37,079
|
|
|
$
|
20,859
|
|
|
|
$
|
5,070
|
|
|
$
|
66,871
|
|
|
$
|
15,786
|
|
|
$
|
17,287
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Results
of Operations for the Three Months Ended March 31, 2007 and
2006
Sales
Sales for the three months ended March 31, 2007 were
$152.5 million compared to $120.8 million for the
three months ended March 31, 2006, reflecting an increase
of $31.7 million, or 26.2%. E&C segment sales were
$52.3 million for the three months ended March 31,
2007 compared with sales of $41.2 million for three months
ended March 31, 2006, which reflected an increase of
$11.1 million, or 27.0%. This increase in sales resulted
37
primarily from $9.9 million of air cooled heat exchanger
sales from CSC, which was acquired in the second quarter of
2006, and to a lesser extent from higher volume for brazed
aluminum heat exchangers and process systems. D&S segment
sales increased $16.5 million, or 27.4%, to
$76.8 million for the three months ended March 31,
2007 from $60.3 million for the three months ended
March 31, 2006. Sales of bulk storage systems and packaged
gas systems increased $12.4 million and $4.0 million,
respectively, for the three months ended March 31, 2007
compared to the same period in 2006, primarily due to higher
volume as a result of continued growth in the global industrial
gas market, and price increases to absorb escalating raw
material costs. Another contributing factor to the increased
D&S sales in the first quarter of 2007 compared with the
same period in 2006 was favorable foreign currency translation
of approximately $2.5 million as a result of the weakened
U.S. dollar compared to the Euro and Czech Koruna.
BioMedical segment sales for the three months ended
March 31, 2007 were $23.4 million compared to
$19.3 million for the same period in 2006, which reflected
an increase of $4.1 million, or 21.0%. Medical respiratory
product and biological storage system sales increased
$1.1 million and $1.7 million, respectively, due to
higher volume in international markets. Other products sales in
the BioMedical segment increased $1.2 million, primarily
due to higher volume compared to the same period in 2006.
Gross
Profit and Margin
Gross profit for the three months ended March 31, 2007 was
$39.9 million, or 26.1% of sales, versus
$37.0 million, or 30.6% of sales, for the three months
ended March 31, 2006 and reflected an increase of
$2.9 million. E&C segment gross profit decreased
$5.6 million and its margin decreased 16.8 percentage
points, primarily due to lower margins on two complex field
installation projects and lower productivity at our
La Crosse, Wisconsin brazed aluminum heat exchanger
facility as a result of a strike in February 2007, which has
since settled. The two installation projects and the
La Crosse strike had a $3.3 million unfavorable impact
on E&C gross profit for the three months ended
March 31, 2007. Also contributing to the E&C margin
decline was the increase in costs on several other fixed price
contracts that were completed or near completion at
March 31, 2007. The cost increases were primarily
attributable to escalating labor costs for engineers and skilled
welders and higher raw material costs due to a rapid increase in
stainless steel surcharges. In addition, the gross profit for
the three months ended March 31, 2006 included a high
margin heat exchanger and process systems emergency order that
increased the E&C margin by approximately six percentage
points. Gross profit for the D&S segment increased
$6.9 million, or 2.3 percentage points, in the 2007
three month period compared to the 2006 three month period,
primarily due to higher sales volume, manufacturing productivity
improvements, and to a lesser extent the timing of product price
increases in both bulk storage and packaged gas systems to
absorb escalating raw material costs. BioMedical gross profit
increased $1.6 million, or 0.8 percentage points, in
the 2007 period compared to the 2006 period, primarily due to
higher sales volume.
Selling,
General and Administrative (SG&A)
Expenses
SG&A expenses for the three months ended March 31,
2007 were $19.4 million, or 12.8% of sales, compared to
$17.5 million, or 14.5% of sales, for the three months
ended March 31, 2006. SG&A expenses for the E&C
segment were $4.6 million for the three months ended
March 31, 2007 compared to $4.4 million for the three
months ended March 31, 2006, an increase of
$0.2 million. D&S segment SG&A expenses for the
three months ended March 31, 2007 were $6.4 million
compared to $5.8 million for the three months ended
March 31, 2006, an increase of $0.6 million. This
increase was primarily attributable to higher employee-related
and infrastructure costs to support business growth. SG&A
expenses for the BioMedical segment were $2.7 million for
the three months ended March 31, 2007, an increase of
$0.4 million compared to the three months ended
March 31, 2006, which was primarily due to higher sales
volume and increased research and development costs. Corporate
SG&A expenses for the three months ended March 31,
2007 were $5.7 million compared to $4.9 million for
the three months ended March 31, 2006. This increase of
$0.8 million was primarily attributable to Sarbanes-Oxley
implementation costs and expenses associated with this offering
aggregating approximately $0.7 million.
38
Amortization
Expense
Amortization expense for the three months ended March 31,
2007 was $3.0 million, or 2.0% of sales, compared to
$3.6 million, or 3.0% of sales, for the three months ended
March 31, 2006. The decrease of $0.6 million was due
to certain intangible assets being fully amortized at
December 31, 2006.
Employee
Separation and Plant Closure Costs
For the three months ended March 31, 2007 and 2006,
employee separation and plant closure costs were
$0.1 million and $0.2 million, respectively. The costs
for the both periods were related to the idle Plaistow, New
Hampshire facility that is being held for sale. The sale of this
facility is expected to be completed in the second or third
quarter of 2007.
Operating
Income
As a result of the foregoing, operating income for the three
months ended March 31, 2007 was $17.3 million, or
11.3% of sales, an increase of $1.5 million compared to
operating income of $15.8 million, or 13.1% of sales, for
the same period in 2006.
Interest
Expense, Net
Net interest expense for the three months ended March 31,
2007 and 2006 was $6.3 million and $6.5 million,
respectively. The decrease in interest expense of
$0.2 million for the three months ended March 31, 2007
compared to the same period in 2006 was primarily attributable
to decreased long-term debt outstanding as a result of voluntary
principal payments of $50.0 million made on the term loan
portion of our senior secured credit facility with proceeds from
the exercise of warrants and options and the Companys IPO
during 2006, partially offset by higher interest rates on our
senior secured credit facility and the additional interest
incurred in the three months ended March 31, 2007 on our
senior subordinated notes, since the exchange offer was not
completed until April 2007.
Other
Expense and Income
Financing costs amortization were $0.4 million for both the
three months ended March 31, 2007 and 2006, respectively.
For the three months ended March 31, 2007, foreign currency
gains were $0.4 million as compared to foreign currency
gains of $0.1 million for the same period in 2006. This
increase in income was the result of the timing of transactions
in currencies other than functional currencies, primarily in the
D&S and BioMedical segments.
Income
Tax Expense
Income tax expense of $3.7 million and $3.0 million
for the three months ended March 31, 2007 and 2006,
respectively, represented taxes on both U.S. and foreign
earnings at an annual effective income tax rate of 34.1% and
33.0%, respectively. The increase in the annual effective income
tax rate was primarily due to a greater proportion of
U.S. earnings that are taxed at higher rates than the
Companys foreign earnings.
Net
Income
As a result of the foregoing, reported net income for the three
months ended March 31, 2007 and 2006 was $7.2 million
and $6.0 million, respectively.
Results
of Operations for the Year Ended December 31,
2006
Sales
Sales for the year ended December 31, 2006 were
$537.5 million. E&C segment sales were
$190.7 million and benefited from higher volume,
particularly large heat exchanger and process systems projects,
which were driven by continued growth in the LNG and natural gas
segments of the hydrocarbon processing market and
$17.8 million of
39
air cooled heat exchanger sales as a result of the acquisition
of CSC in the second quarter of 2006. D&S segment sales
were $268.3 million as both bulk storage and packaged gas
system volume were favorably affected by continued growth in the
global industrial gas markets, product price increases to absorb
escalating raw material costs and to a lesser extent favorable
foreign currency translation of $4.3 million as a result of
the weaker U.S. dollar compared to the Czech Koruna.
BioMedical segment sales for the year ended December 31,
2006 were $78.5 million and benefited primarily from
continued growth in medical respiratory product volume due to
higher demand in international markets and volume growth in both
the domestic and international biological storage systems.
U.S. medical respiratory products sales were negatively
impacted in 2006 by U.S. Government reimbursement
reductions for liquid oxygen therapy systems announced in 2005.
Gross
Profit and Margin
Gross profit for the year ended December 31, 2006 was
$155.0 million, or 28.8% of sales. E&C segment gross
profit was $40.0 million, or 20.8% of sales. The gross
profit was favorably affected by the higher volume of large heat
exchanger and process systems projects and the inclusion of the
air cooled heat exchanger sales as explained above. The margin,
however, was unfavorably impacted by lower margins on certain
process projects, and in particular two complex long-term field
installation projects. D&S segment gross profit was
$87.0 million, or 32.5% of sales. The gross profit and
related margin benefited from higher sales volume, particularly
for bulk storage systems, timing of bulk storage system and
packaged gas system price increases to absorb escalating raw
material costs, and to a lesser extent manufacturing
productivity improvements. BioMedical segment gross profit was
$28.0 million, or 35.6% of sales, and was favorably
impacted by higher sales volume and improved manufacturing
productivity, particularly for the medical respiratory product
line. In 2005, the transition of the medical respiratory product
line manufacturing from our closed Burnsville, Minnesota
facility to our Canton, Georgia facility was completed.
SG&A
SG&A Expenses for the year ended December 31, 2006
were $72.2 million, or 13.4% of sales. E&C segment
SG&A expenses were $14.0 million, or 7.3% of sales.
During 2006, the E&C segment incurred additional
employee-related and infrastructure expenses to support the
growth in business. Also, the E&C segment received
$2.2 million of insurance proceeds, net of costs, related
to the settlement of an insurance claim for losses and costs
incurred primarily in 2005 at its New Iberia, Louisiana facility
as a result of Hurricane Rita. These proceeds partially offset
the increase in SG&A expenses in 2006. D&S segment
SG&A expenses in 2006 were $25.5 million, or 9.5% of
sales. The D&S segment had growth in employee-related and
infrastructure expenses to support their business growth. In
2006, BioMedical segment SG&A expenses were
$10.2 million, or 13.0% of sales. Corporate SG&A
expenses for the year ended December 31, 2006 were
$22.5 million and were unfavorably affected by higher
employee-related and infrastructure expenses primarily to
support the growth in business and higher public company
expenses, particularly Sarbanes-Oxley implementation expenses,
since the initial public offering in July 2006. In addition, all
operating segments and Corporate were unfavorably impacted by
higher health care expenses.
Amortization
Expense
Amortization expense for the year ended December 31, 2006
was $15.4 million, or 2.9% of sales. The amortization
expense relates to finite-lived intangible assets that were
recorded at fair value on October 17, 2005 as a result of
the Acquisition. Amortization expense for the E&C, D&S
and BioMedical segments was $6.7 million, $6.9 million
and $1.8 million, respectively.
Employee
Separation and Plant Closure Costs
For the year ended December 31, 2006, employee separation
and plant closure costs were $0.4 million and were related
to the idle D&S segment Plaistow, New Hampshire facility
that is being held for sale.
40
Operating
Income (Loss)
As a result of the foregoing, operating income for the year
ended December 31, 2006 was $66.9 million, or 12.4% of
sales. Operating income (loss) for the E&C, D&S and
BioMedical segments and Corporate were $19.0 million, or
10.0% of sales, $54.5 million, or 20.2% of sales,
$16.0 million, or 20.3% of sales, and ($22.6) million,
respectively.
Interest
Expense, Net
For the year ended December 31, 2006, interest expense, net
was $25.5 million and is primarily attributable to the
senior secured credit facility entered into and senior
subordinated notes issued on October 17, 2005 in
conjunction with the Acquisition. The senior secured credit
facility has a variable interest rate and the senior
subordinated notes have a
91/8%
interest rate. The registration rights agreement required us to
file an Exchange Offer Registration Statement and complete the
exchange offer for the senior subordinated notes by
August 14, 2006. Since the exchange offer was not completed
when required, additional interest at a rate of 0.25% above the
stated rate was incurred for the
90-day
period ending November 11, 2006, and additional interest at
a rate 0.50% above the stated rate was incurred commencing
November 12, 2006 and additional interest at a rate of
0.75% above the stated rate was incurred for the
90-day
period commencing February 10, 2007. The exchange offer was
completed in April 2007 at which time this additional interest
ceased accruing. Further information regarding our debt is
located in Note C to our consolidated financial statements
included elsewhere in this prospectus.
Other
Expense and Income
Financing costs amortization expense was $1.5 million for
the year ended December 31, 2006 and is attributable to the
senior secured credit facility entered into and senior
subordinated notes issued on October 17, 2005 in
conjunction with the Acquisition.
For the year ended December 31, 2006, net foreign currency
gains were $0.5 million and were the result of transactions
in currencies other than functional currencies across all
business segments.
Income
Tax Expense
Income tax expense for the year ended December 31, 2006 was
$13.0 million at an effective tax rate of 32.3%. Our income
taxes were favorably affected by higher mix of foreign earnings,
foreign tax credits and research and development tax credits.
Net
Income
As a result of the foregoing, net income for the year ended
December 31, 2006 was $26.9 million.
October 17,
2005 to December 31, 2005 Period
Sales
Sales for the period from October 17, 2005 to
December 31, 2005 were $97.6 million. E&C segment
sales were $34.1 million and benefited from volume
increases in both heat exchangers and process systems, primarily
due to continued demand growth in the hydrocarbon processing
market. D&S segment sales were $47.8 million as bulk
storage systems and packaged gas systems volume remained strong
due to stable demand in the global industrial gas market and
higher product pricing. BioMedical segment sales for the period
from October 17, 2005 to December 31, 2005 were
$15.7 million. Sales of medical respiratory products were
unfavorably affected by lower volume in the United States, and
in particular to one of our major customers, due to announced
reductions in government reimbursement programs for liquid
oxygen therapy systems. This unfavorable volume trend in
U.S. medical respiratory product sales was partially offset
by continued volume growth in medical respiratory product sales
in Europe and Asia and biological storage systems sales in the
U.S., Europe and Asia as we further penetrated these markets. On
an annual basis, 2005 U.S. medical respiratory product
sales were 45% of total medical respiratory product sales and in
2004 U.S. medical respiratory products sales represented
61% of total medical respiratory sales. In addition, annual 2005
biological storage systems sales increased 16% compared to 2004
annual sales.
41
Gross
Profit and Margin
For the period from October 17, 2005 to December 31,
2005, gross profit was $21.9 million, or 22.4% of sales.
Overall, the gross profit was favorably affected by higher
volumes in the D&S and E&C segments. The E&C
gross profit of $10.5 million, or 30.7% of sales, benefited
from the completion of a high margin ethylene heat exchanger and
process system emergency order. The D&S segment gross
profit of $8.9 million, or 18.5% of sales, was also
favorably impacted by improved product pricing. The BioMedical
gross profit of $2.6 million, or 16.4% of sales, benefited
from productivity improvements at the Canton, Georgia facility
related to the manufacturing of medical respiratory products.
The BioMedical segment margins in the period from
January 1, 2005 to October 16, 2005 were negatively
impacted by higher costs related to inefficiencies from
ramping-up
production of the medical respiratory product line after
completing the move from the Burnsville, Minnesota facility to
the Canton, Georgia facility. In addition, overall company gross
profit included a $8.9 million, or 9.1% of sales, charge
for the fair value adjustment of finished goods and
work-in-process
inventory recorded under purchase accounting as a result of the
Acquisition. This fair value inventory adjustment was charged to
cost of sales as the inventory was sold. The D&S and
BioMedical segments gross profit charges were
$6.4 million, or 13.4% of sales, and $2.5 million, or
15.9% of sales, respectively, for this fair value inventory
adjustment. The E&C segment was not required to record an
inventory fair value adjustment due to the use of the percentage
of completion method for revenue recognition in this segment.
SG&A
SG&A expenses for the period from October 17, 2005 to
December 31, 2005 were $13.6 million, or 14.0% of
sales. SG&A expenses for the E&C segment were
$4.3 million, or 12.6% of sales, and were affected by
higher marketing and employee-related costs to support the
business growth and $0.4 million of losses and charges
related to damage caused by Hurricane Rita at our New Iberia,
Louisiana facilities. D&S segment SG&A expenses for
the period from October 17, 2005 to December 31, 2005
were $3.2 million, or 6.7% of sales, and were affected by
higher marketing and employee-related costs to support business
growth. SG&A expenses for the BioMedical segment were
$1.5 million, or 9.6% of sales, for the period from
October 17, 2005 to December 31, 2005. Corporate
SG&A expenses for the period from October 17, 2005 to
December 31, 2005 were $4.6 million and included a
charge of $0.5 million for the settlement of former
shareholders appraisal rights claims as a result of the
Acquisition.
Amortization
Expense
Amortization expense for the period from October 17, 2005
to December 31, 2005 was $3.0 million, or 3.1% of
sales. The amortization expense relates to finite-lived
intangible assets that were recorded at fair value on
October 17, 2005 as a result of the Acquisition.
Amortization expense for the E&C, D&S and BioMedical
segments were $1.0 million, $1.7 million and
$0.3 million, respectively.
Employee
Separation and Plant Closure Costs
For the period from October 17, 2005 to December 31,
2005, we recorded $0.1 million of employee separation and
plant closure costs, primarily related to the closure of the
D&S segment Plaistow, New Hampshire and BioMedical segment
Burnsville, Minnesota facilities.
Operating
Income
As a result of the foregoing, operating income for the period
from October 17, 2005 to December 31, 2005 was
$5.1 million, or 5.2% of sales.
Other
Expenses and Income
Net interest expense and financing costs amortization for the
period from October 17, 2005 to December 31, 2005, was
$5.6 million and $0.3 million, respectively, and
related to the senior secured credit facility that was entered
into, and the notes that were issued, on October 17, 2005
in connection with the Acquisition.
42
Foreign
Currency Loss
We recorded $0.1 million of foreign currency losses due to
certain of our subsidiaries entering into transactions in
currencies other than their functional currencies.
Income
Tax Expense
Income tax benefit of $0.4 million for the period from
October 17, 2005 to December 31, 2005 represents taxes
on both domestic and foreign earnings at an annual effective
income tax rate of 49.3%. Our taxes were affected by tax
benefits from foreign sales and research and development and
foreign tax credits.
Net
Loss
As a result of the foregoing, we reported a net loss for the
period from October 17, 2005 to December 31, 2005 of
$0.5 million.
January 1,
2005 to October 16, 2005 Period
Sales
Sales for the period from January 1, 2005 to
October 16, 2005 were $305.5 million. E&C segment
sales were $86.9 million and benefited from volume
increases in both heat exchangers and process systems as a
result of strong order levels over the past several quarters,
which have included three large orders each of approximately
$20.0 million, driven by continued growth in the LNG and
natural gas segments of the hydrocarbon processing market.
D&S segment sales were $161.3 million as bulk storage
systems and packaged gas systems volume remained strong due to
continued demand growth in the global industrial gas market.
Other factors contributing favorably to D&S segment sales
for this period were higher product pricing, and favorable
foreign currency translation of approximately $3.5 million
as a result of the weaker U.S. dollar compared to the Euro
and Czech Koruna. BioMedical segment sales were
$57.2 million. Sales of medical respiratory products were
unfavorably affected by lower volume in the United States, and
in particular to one of our major customers, primarily resulting
from announced U.S. government reimbursement reductions for
liquid oxygen therapy systems. This unfavorable volume trend in
U.S. medical respiratory product sales was partially offset
by continued sales volume growth in medical respiratory product
sales in Europe and Asia and biological storage systems in the
United States, Europe and Asia as we further penetrated these
markets. See the discussion under the caption
October 17, 2005 to December 31,
2005 Period Sales above for information
regarding the BioMedical segment volume trends.
Gross
Profit and Margin
For the period from January 1, 2005 to October 16,
2005 gross profit was $88.2 million, or 28.9% of sales.
Overall, gross profit was favorably affected by higher volumes
in the D&S and E&C segments, while gross profit margin
was unfavorably affected by higher manufacturing costs in the
BioMedical segment and a shift in product mix in the E&C
segment. The gross profit margins in the E&C segment of
$23.4 million, or 26.9% of sales, during the period saw
overall mix shifts in sales from higher margin heat exchanger
projects to lower margin process systems projects and also a
shift within heat exchangers to lower margin projects. In
addition, the D&S segment gross profit of
$47.1 million, or 29.2% of sales, benefited from price
increases that were implemented during the year to offset higher
raw material steel costs that had been incurred in previous
years. Gross profit in the BioMedical segment of
$17.7 million, or 30.9% of sales, deteriorated primarily
due to lower U.S. medical respiratory product volume,
higher manufacturing costs and inventory valuation adjustments
of $0.6 million primarily in the first half of 2005, as a
result of lower productivity associated with moving the medical
respiratory product line manufacturing from Burnsville,
Minnesota to Canton, Georgia. This transition and
ramp-up of
manufacturing to the productivity levels previously being
achieved at the Burnsville, Minnesota facility took most of 2005
to complete and cost more than originally planned.
43
SG&A
SG&A expenses for the period from January 1, 2005 to
October 16, 2005 were $57.1 million, or 18.7% of
sales. E&C segment SG&A expenses were
$9.4 million, or 10.8% of sales, and were affected by
higher marketing and employee-related costs to support business
growth, and also included $1.1 million of losses and
charges related to damage caused by Hurricane Rita at our New
Iberia, Louisiana facilities. SG&A expenses for the
D&S segment were $18.0 million, or 11.1% of sales and
were affected by higher marketing and employee-related costs to
support business growth, and also included a $2.8 million
charge for the write-off of in-process research and development
related to the acquisition of Changzhou CEM Cryo Equipment Co.,
Ltd. (CEM). SG&A expenses for the BioMedical
segment were $7.0 million, or 12.2% of sales for the period
from January 1, 2005 to October 16, 2005.
Corporate SG&A expenses were $22.7 million and
included a $1.1 million charge for the settlement of a
finders fee claim asserted by a former shareholder in
connection with our 2003 bankruptcy reorganization, and
$9.5 million of stock-based compensation expense. A
significant portion of this stock-based compensation was
incurred as a result of the vesting of stock options in
conjunction with the Acquisition.
Amortization
Expense
Amortization expense for the period from January 1, 2005 to
October 16, 2005 was $2.7 million, or 0.9% of sales,
and related to finite-lived intangible assets that were recorded
in September 2003 under Fresh-Start accounting and acquisition
of CEM in 2005. Amortization expense for the E&C, D&S
and BioMedical segment was $0.1 million, $1.5 million
and $1.1 million, respectively.
Acquisition
Expenses
During the period from January 1, 2005 to October 16,
2005, we incurred $6.6 million of investment banking, legal
and other professional fees related to the Acquisition.
Employee
Separation and Plant Closure Costs
For the period from January 1, 2005 to October 16,
2005, we recorded $1.1 million of employee separation and
plant closure costs, primarily related to the closure of the
D&S segment Plaistow, New Hampshire and BioMedical segment
Burnsville, Minnesota facilities. The costs (benefits) recorded
for this period by the E&C, D&S and BioMedical
segments, and by Corporate were $0.1 million,
$0.5 million, $0.5 million and ($0.1 million),
respectively.
Gain
on Sale of Assets
We recorded a net gain on the sale of assets of
$0.1 million, including a gain recorded at Corporate of
$1.7 million on the settlement of a promissory note
receivable related to the 2003 sale of our former Greenville
Tube, LLC stainless tubing business, a loss of $0.5 million
recorded at Corporate for the write down of the Plaistow
facility held for sale to its estimated fair value and a
$1.2 million loss for the write-off of several assets that
were deemed to be impaired. This impairment loss was
$0.1 million, $0.9 million and $0.2 million for
the E&C segment, BioMedical segment and Corporate,
respectively.
Operating
Income
As a result of the foregoing, operating income for the period
from January 1, 2005 to October 16, 2005 was
$20.9 million, or 6.8% of sales.
Interest
Expense, Net
Net interest expense for the period from January 1, 2005 to
October 16, 2005 was $4.2 million. We experienced
higher interest expense during this period as a result of higher
interest rates and the increase in the outstanding balance under
the revolving credit line of our then existing credit facility.
44
Foreign
Currency Loss
We recorded $0.7 million of foreign currency losses due to
certain of our subsidiaries entering into transactions in
currencies other than their functional currencies.
Income
Tax Expense
Income tax expense of $7.2 million for the period from
January 1, 2005 to October 16, 2005 represents taxes
on both domestic and foreign earnings at an annual effective
income tax rate of 44.6%. Our income tax expense was unfavorably
impacted by approximately $1.4 million due to the
non-deductible charge for purchased in-process research and
development of $2.8 million and Acquisition costs of
$1.2 million.
Net
Income
As a result of the foregoing, we reported net income of
$8.9 million for the period from January 1, 2005 to
October 16, 2005.
Year
Ended December 31, 2004
Sales
Sales for 2004 of $305.6 million were positively affected
by volume and price increases, a recovery of the global
industrial gas market and favorable foreign currency translation
as a result of the weakening of the U.S. dollar compared to
the Euro and Czech Koruna. Sales in the E&C segment for
2004 were $69.6 million and both the heat exchanger and LNG
system product lines benefited from higher volume primarily in
the Asian, African and Middle Eastern markets. D&S segment
sales were $162.5 million in 2004 and benefited favorably
from volume increases in cryogenic bulk storage systems,
cryogenic packaged gas systems and beverage liquid
CO2
systems driven primarily by a recovery in the global industrial
gas market. Price increases and surcharges driven by higher raw
material costs and favorable foreign currency translation as a
result of the weakening of the U.S. Dollar compared to the
Euro and Czech Koruna also had a positive impact on D&S
segment sales. Sales in the BioMedical segment were
$73.4 million. Sales of our biological storage systems and
medical products experienced volume increases in both the U.S.
and European markets. Sales of MRI and other products
deteriorated in 2004 as this product lines primary
customer continued to transfer volume to lower cost
manufacturing regions.
Gross
Profit and Margin
Gross profit for 2004 was $93.8 million or 30.7% of sales.
The gross profit was positively affected by volume increases
across all operating segments, and product price increases and
favorable foreign currency translation in the D&S segment.
The E&C segment gross profit and related margin were
$21.5 million and 30.9% of sales, respectively, in 2004.
The E&C segment benefited from higher volumes and the
delivery of a premium-priced, expedited order that was needed to
put a natural gas producers ethane recovery plant back in
service. A shift to lower margin industrial heat exchangers and
LNG vacuum-insulated pipe, or LNG VIP, had an unfavorable impact
on the E&C segment gross profit margin. D&S segment
gross profit and related margin were $46.6 million and
28.7% of sales, respectively. The D&S segment gross profit
margin was positively affected by product price increases and
surcharges to offset higher raw material costs that had been
incurred, higher sales volume and the realization of savings
from our restructuring efforts. The D&S segment gross
profit margin was unfavorably affected by a shift to lower
margin bulk products. Gross profit and related margin for the
BioMedical segment were $25.7 million and 35.0% of sales,
respectively. Gross profit margins for medical and biological
storage systems products were positively impacted by higher
volume and cost reductions, and MRI and other product margins
were unfavorably affected by higher material costs and
unabsorbed overhead costs due to lower sales volume.
SG&A
SG&A expenses for 2004 were $50.6 million, or 16.6% of
sales, and benefited from cost savings realized as a result of
our continued restructuring efforts. In addition, we incurred
employee incentive compensation expense of $5.3 million for
achieving our operating targets, which was significant compared
to the incentive compensation that
45
had been earned in prior years. E&C segment SG&A
expenses were $8.9 million, or 12.8% of sales and included
$1.2 million of employee incentive compensation expense,
and $0.5 million of selling expense related to the
settlement of a specific customer product claim outside the
normal warranty period. SG&A expenses for the D&S
segment were $16.6 million, or 10.2% of sales, and included
$1.8 million of employee incentive compensation expense,
and $0.4 million of selling expense related to the
settlement of a specific customer product claim outside the
normal warranty period. SG&A expenses for the BioMedical
segment were $9.1 million, or 12.4% of sales, for 2004 and
included $0.6 million of employee incentive compensation
expense. Corporate SG&A expenses were $15.9 million
and included $1.7 million of employee incentive
compensation expense, $2.4 million of stock-based
compensation expense resulting from the sale of
28,797 shares of common stock to our chief executive
officer at a price below the closing market price at the date of
sale and the issuance of stock options to certain key employees.
In addition, Corporate recorded $0.9 million of income from
life insurance proceeds related to our voluntary deferred
compensation plan.
Amortization
Expense
Amortization expense for 2004 was $2.8 million, or 0.9% of
sales, and related to finite-lived intangible assets that were
recorded in September 2003 under Fresh-Start accounting.
Amortization expense for the E&C, D&S and BioMedical
segments was $0.3 million, $1.1 million and
$1.4 million, respectively.
Employee
Separation and Plant Closure Costs
In 2004, we continued our manufacturing facility restructuring
plan, which commenced with the 2003 closure of our E&C
segment sales and engineering office in Westborough,
Massachusetts. We announced in December 2003 and January 2004
the closure of our D&S segment manufacturing facility in
Plaistow, New Hampshire and the BioMedical segment manufacturing
and office facility in Burnsville, Minnesota, respectively. In
each of these facility closures, we did not exit the product
lines manufactured at those sites, but moved manufacturing to
other facilities with available capacity, most notably New
Prague, Minnesota for engineered tank production and Canton,
Georgia for medical respiratory product manufacturing. The
Plaistow facility closure was completed in the third quarter of
2004. We incurred capital expenditures in 2004 of
$2.5 million for improvements and additions to the Canton,
Georgia facility, and completed the closure of the Burnsville,
Minnesota facility in the first quarter of 2005.
During 2004, we recorded employee separation and plant closure
costs of $3.2 million related to the manufacturing facility
reduction efforts and overall headcount reduction programs
described above. The costs recorded by the E&C, D&S
and BioMedical segments and by Corporate were $0.7 million,
$1.3 million, $0.8 million and $0.4 million,
respectively. The total charges for 2004 included
$0.4 million of expense for contract termination costs,
$1.3 million severance and other benefits related to
terminating certain employees at these and other sites, and
$1.5 million for other associated costs. In addition, we
recorded a non-cash inventory valuation charge of
$0.2 million, included in cost of sales, for the write-off
of inventory at these sites. At December 31, 2004, we had a
reserve of $2.8 million remaining for the closure of these
facilities, primarily for lease termination and severance costs.
Loss
on Sale of Assets
In 2004, we recorded a net loss on the sale of assets of
$0.1 million. In conjunction with the closure of the
BioMedical segment Burnsville, Minnesota facility, we sold this
facility in October 2004 for gross proceeds of $4.5 million
and recorded a loss on the sale of $0.4 million. The
proceeds of this sale were used to pay down $0.9 million of
debt outstanding under an industrial revenue bond and the
balance was used for working capital purposes. In April 2004, we
sold for $0.6 million of cash proceeds a vacant building
and a parcel of land at our D&S segment New Prague,
Minnesota facility that was classified as an asset held for sale
in our consolidated balance sheet as of December 31, 2003.
In August 2004, we sold for $1.1 million in cash proceeds,
equipment at our D&S segment Plaistow, New Hampshire
facility, resulting in a $0.6 million gain on the sale of
assets. In addition, we recorded a $0.4 million loss
related to adjusting the Plaistow land and building to fair
value less selling costs based upon an agreement executed in
September 2004. The land and building related to the Plaistow
facility were included as assets held for sale on
our consolidated balance sheet as of December 31, 2004.
46
Operating
Income
As a result of the foregoing, operating income for the year
ended December 31, 2004 was $37.1 million, or 12.1% of
sales.
Equity
Loss
We recorded $0.1 million of equity loss related to our
Coastal Fabrication joint venture in 2004. In February 2004, our
Coastal Fabrication joint venture executed an agreement to
redeem the joint venture partners 50% equity interest. As
a result of the elimination of the joint venture partner and the
assumption of 100% of control by us, the assets, liabilities and
operating results of Coastal Fabrication are included in the
consolidated financial statements subsequent to February 2004.
Interest Expense, Net
Net interest expense for 2004 was $4.8 million. This lower
expense is attributable primarily to our debt restructuring in
September 2003 in conjunction with the Reorganization Plan and
the reduction in the debt balance as a result of
$40.0 million of aggregate voluntary prepayments on our
then existing term loan at the end of 2003 and during 2004.
Derivative
Contracts Valuation Income and Expense
We entered into an interest rate derivative contract in the form
of a collar in March 1999 to manage interest rate risk exposure
relative to our debt. This collar had a notional value of
$19.1 million at December 31, 2004 and expired in
March 2006. The fair value of the contract related to the collar
outstanding at December 31, 2004 is a liability of
$0.3 million and is recorded in accrued interest. The
change in fair value of the contracts related to the collars
during 2004 of $0.1 million is recorded in derivative
contracts valuation income.
Foreign
Currency Gain
We recorded $0.5 million of foreign currency remeasurement
gain in 2004 as result of certain of our subsidiaries entering
into transactions in currencies other than their functional
currency.
Income
Tax Expense
In 2004, we recorded income tax expense of $10.1 million,
which primarily reflects the income tax expense associated with
U.S. and foreign earnings and a reduction in tax accruals for
prior tax periods at an annual effective tax rate of 30.9%.
Net
Income
As a result of the foregoing, we recorded net income of
$22.6 million in 2004.
Orders
and Backlog
We consider orders to be those for which we have received a firm
signed purchase order or other written contractual commitment
from the customer. Backlog is comprised of the portion of firm
signed purchase orders or other written contractual commitments
received from customers that we have not recognized as revenue
upon shipment or under the percentage of completion method.
Backlog can be significantly affected by the timing of orders
for large projects, particularly in the E&C segment, and is
not necessarily indicative of future backlog levels or the rate
at which backlog will be recognized as sales. Orders included in
our backlog may include customary cancellation provisions under
which the customer could cancel part or all of the order at
times subject to the payment of certain costs
and/or
penalties. Our backlog as of March 31, 2007 and as of
December 31, 2006, 2005 and 2004 was $342.2 million,
$319.2 million, $233.6 million and
$129.3 million, respectively. This significant increase in
backlog is primarily attributable to the growth in the global
industrial gas and the LNG and natural gas segments of the
hydrocarbon processing markets served by the E&C and
D&S segments. In addition, the E&C segment
47
backlog at December 31, 2006 included $20.2 million of
air-cooled heat exchangers as a result of the CSC acquisition in
May 2006.
The table below sets forth orders and backlog by segment for the
periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
Three Months
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Ended
|
|
|
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Orders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy &
Chemicals
|
|
$
|
121,793
|
|
|
$
|
130,786
|
|
|
|
$
|
67,232
|
|
|
$
|
230,460
|
|
|
$
|
71,310
|
|
|
|
|
|
Distribution &
Storage
|
|
|
193,156
|
|
|
|
191,188
|
|
|
|
|
45,859
|
|
|
|
296,136
|
|
|
|
76,568
|
|
|
|
|
|
BioMedical
|
|
|
77,893
|
|
|
|
62,396
|
|
|
|
|
13,768
|
|
|
|
79,171
|
|
|
|
26,935
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
392,842
|
|
|
$
|
384,370
|
|
|
|
$
|
126,859
|
|
|
$
|
605,767
|
|
|
$
|
174,813
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Backlog
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy &
Chemicals
|
|
$
|
70,766
|
|
|
$
|
114,633
|
|
|
|
$
|
147,732
|
|
|
$
|
207,668
|
|
|
$
|
226,696
|
|
|
|
|
|
Distribution &
Storage
|
|
|
53,900
|
|
|
|
83,194
|
|
|
|
|
79,524
|
|
|
|
105,070
|
|
|
|
105,666
|
|
|
|
|
|
BioMedical
|
|
|
4,613
|
|
|
|
8,388
|
|
|
|
|
6,383
|
|
|
|
6,415
|
|
|
|
9,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
129,279
|
|
|
$
|
206,215
|
|
|
|
$
|
233,639
|
|
|
$
|
319,153
|
|
|
$
|
342,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Orders for the three months ended March 31, 2007 were
$174.8 million. E&C segment orders for the three
months ended March 31, 2007 were $71.3 million
compared to $111.2 million for the three months ended
December 31, 2006. E&C backlog totaled
$226.7 million at March 31, 2007 compared to
$207.7 million at December 31, 2006. The decline in
orders of $39.9 million, or 36%, was primarily attributable
to the receipt of a process systems order in excess of
$40.0 million for a significant project in West Africa in
the fourth quarter of 2006. Orders for brazed aluminum and air
cooled heat exchangers remained at constant levels for the past
two quarters. D&S orders for the three months ended
March 31, 2007 were $76.6 million compared to
$75.4 million for the three months ended December 31,
2006. D&S backlog totaled $105.7 million at
March 31, 2007 compared to $105.1 million at
December 31, 2006. Overall, D&S orders have remained
strong in recent quarters due to continued demand in the global
industrial gas market. Packaged gas systems orders for the three
months ended March 31, 2007 increased $2.6 million
while bulk storage systems orders decreased by
$1.4 million. BioMedical orders for the three months ended
March 31, 2007 were $26.9 million compared to
$16.7 million for the three months ended December 31,
2006. BioMedical backlog at March 31, 2007 totaled
$9.8 million compared to $6.4 million at
December 31, 2006. The increase in orders of
$10.3 million, or 62%, was primarily due to increased
demand in the international medical respiratory market,
increased demand in both the U.S. and international biological
storage markets, and seasonality. Medical respiratory product,
biological storage systems and other BioMedical product orders
increased $4.3 million, $5.1 million and
$0.9 million, respectively.
Orders for the year ended December 31, 2006 were
$605.8 million. E&C segment orders were
$230.5 million and benefited from the continued strength of
the global industrial gas and LNG and natural gas segments of
the hydrocarbon gas processing market and $19.9 million of
air cooled heat exchanger orders from the acquisition of CSC in
May 2006. In addition, the E&C segment received in the
fourth quarter of 2006 a process systems order in excess of
$40 million for a significant overseas LNG project in West
Africa. D&S segment orders for 2006 were
$296.1 million and were driven by continued growth in the
global industrial gas market. Bulk storage system and packaged
gas system orders were $187.6 million and
$108.5 million, respectively. Orders for the BioMedical
segment for the year ended December 31, 2006 were
$79.2 million. Orders for medical respiratory products,
biological storage systems, and MRI components and other liquid
oxygen products were $34.0 million, $32.5 million and
$12.7 million, respectively. The medical respiratory
products and biological systems orders were driven by continued
penetration and growth of the international markets.
48
For the period from October 17, 2005 to December 31,
2005, orders were $126.9 million. E&C segment orders
of $67.2 million remained strong during this period and
included several large heat exchanger and LNG systems orders,
including an air separation heat exchanger order of
$16.0 million. D&C segment orders of
$45.9 million were driven by continued strong packaged gas
system orders. Bulk storage systems and packaged gas systems
orders were $26.9 million and $18.9 million,
respectively for this period. BioMedical segment orders were
$13.8 million during this period as orders in the European
and Asian market medical respiratory and U.S. biological
storage system products order levels remained strong, while
U.S. medical respiratory product orders continued to
decline. This decline is explained further below.
Orders for the period from January 1, 2005 to
October 16, 2005 were $384.4 million. E&C segment
orders of $130.8 million remained strong during this period
and included a $21.0 million LNG VIP order and a
$10.7 million hydrocarbon processing heat exchanger order.
D&C segment orders of $191.2 million were driven by
continued strong bulk storage systems orders and strong packaged
gas system orders, which were $118.5 million and
$72.7 million, respectively. This strong order level in the
D&S segment was driven by continued demand in the global
industrial gas markets served by us. BioMedical segment orders
were $62.4 million, as orders for international medical
respiratory products and U.S. biological storage system
products continued favorable growth trends due to both continued
market penetration and market growth. U.S. medical
respiratory product orders during this period were unfavorably
impacted by lower orders from a significant customer and
announced government reimbursement reductions for liquid oxygen
therapy systems.
For the year ended December 31, 2004, orders of
$392.9 million were positively affected by improvements in
the markets served by all three segments. During 2004, the
E&C segment showed a significant increase in orders to
$121.8 million, due to increased orders for both the heat
exchangers and LNG systems product lines, including orders of
$20.4 million and $19.3 million. The demand increase
was mainly due to the recovery of the global industrial gas
markets and the continuing development of a worldwide natural
gas market. The D&S segment orders significantly increased
in 2004 to $193.2 million as bulk storage and packaged gas
products experienced increased demand as a result of a recovery
in the global industrial gas market. During 2004, the BioMedical
segment continued its previous trend of increasing order
performance with orders of $77.9 million, driven by strong
demand for medical respiratory products and biological storage
systems both in the U.S. and international markets. Orders for
MRI components continued to decline during 2004 as the product
lines single customer continued to move business to lower
cost manufacturing countries.
Liquidity
and Capital Resources
On July 31, 2006, we completed our initial public offering
of 12,500,000 shares of our common stock for cash proceeds,
before expenses, of $175.3 million. We used
$25.0 million of the net proceeds to repay a portion of the
term loan under our senior secured credit facility. The
remaining $150.3 million of net proceeds was used to pay a
dividend to our stockholders existing immediately prior to the
initial public offering, consisting of affiliates of First
Reserve and certain members of management. On August 25,
2006, a stock dividend of 1,875,000 shares was issued to
the stockholders existing immediately prior to the completion of
the initial public offering. In addition, the senior secured
credit facility was amended upon the completion of the initial
public offering. The amendment primarily increased the size of
the revolving credit facility by $55.0 million to
$115.0 million and increased the amount available for
letters of credit extending beyond one year from their issuance
date to $55.0 million from $35.0 million.
Debt
Instruments and Related Covenants
In connection with the Acquisition, we entered into a
$240.0 million senior secured credit facility and completed
the $170.0 million offering of
91/8%
senior subordinated notes due in 2015. We repaid the term loan
portion of our then existing credit facility (the term loan
portion and revolving credit portion of the facility are
referred to collectively as the 2003 Credit Facility) and
certain other debt on or before October 17, 2005, the
closing date of the Acquisition. The senior secured credit
facility consists of a $180.0 million term loan credit
facility and a $115.0 million revolving credit facility, of
which the entire $115.0 million may be used for the
issuance of letters of credit and bank guarantees,
$55.0 million of which may be letters of credit extending
more than one year from their date of issuance. The term loan
was fully funded on the closing date. The term loan matures on
October 17, 2012 and
49
the revolving credit portion of the senior secured credit
facility matures on October 17, 2010. As a result of an
aggregate of $60.0 million voluntary principal prepayments
since October 2005, the term loan requires no principal payments
until the remaining balloon payment is due on the maturity date.
The interest rate under the senior secured credit facility is,
at our option, the Alternative Base Rate, or ABR, plus 1.0% or
LIBOR plus 2.0% on the term loan, and ABR plus 1.5% or LIBOR
plus 2.5% on the revolving credit portion of the senior secured
credit facility. In addition, we are required to pay an annual
administrative fee of $0.1 million, a commitment fee of
0.5% on the unused revolving credit balance, a letter of credit
participation fee of 2.5% per annum on the letter of credit
exposure and letter of credit issuance fee of 0.25%. The
obligations under the senior secured credit facility are secured
by substantially all of the assets of our domestic subsidiaries
and 65% of the capital stock of our
non-U.S. subsidiaries.
As of March 31, 2007, we had $120.0 million
outstanding under the term loan portion of the senior secured
credit facility, $170.0 million outstanding under the
senior subordinated notes and $22.6 million of letters of
credit and bank guarantees supported by the revolving portion of
the senior secured credit facility. Availability on the
revolving portion of the senior secured credit facility was
$92.4 million at March 31, 2007.
The registration rights agreement related to our senior
subordinated notes required us to file an Exchange Offer
Registration Statement and complete the exchange offer for the
senior subordinated notes by August 14, 2006. Since the
exchange offer was not completed when required, additional
interest at a rate of 0.25% was incurred for the
90-day
period commencing August 14, 2006, additional interest at a
rate of 0.50% was incurred for the
90-day
period commencing November 12, 2006 and additional interest
at a rate of 0.75% was incurred for the
90-day
period commencing February 10, 2007. The exchange offer was
completed on April 6, 2007 and the additional interest
ceased accruing as of that date.
The senior secured credit facility and provisions of the
indenture governing the senior subordinated notes contain a
number of customary covenants, including, but not limited to,
restrictions on our ability to incur additional indebtedness,
create liens or other encumbrances, sell assets, enter into sale
and lease-back transactions, make certain payments, investments,
loans, advances and guarantees, make acquisitions and engage in
mergers and consolidations, pay dividends and distributions, and
make capital expenditures. Our senior secured credit facility
and indenture governing the senior subordinated notes also
include covenants relating to leverage, interest coverage and
fixed charge coverage ratios. We believe that we are in
compliance with all covenants, including its financial
covenants, under the senior secured credit facility and the
indenture.
Chart Ferox, a.s., or, Ferox, our wholly-owned subsidiary that
operates in the Czech Republic, maintains secured revolving
credit facilities with borrowing capacity, including overdraft
protection, of up to $9.6 million, of which
$4.4 million is available only for letters of credit and
bank guarantees. Under the revolving credit facilities, Ferox
may make borrowings in Czech Koruna, Euros and
U.S. dollars. Borrowings in Koruna are at PRIBOR,
borrowings in Euros are at EUROBOR and borrowings in
U.S. dollars are at LIBOR, each with a fixed margin of
0.6%. Ferox is not required to pay a commitment fee to the
lenders under the revolving credit facilities with respect to
the unutilized commitments thereunder. Ferox must pay letter of
credit and guarantee fees equal to 0.75% on the face amount of
each guarantee. Feroxs land and buildings, and accounts
receivable secure $4.6 million and $2.5 million,
respectively, of the revolving credit facilities. At
March 31, 2007, there were no borrowings outstanding under,
and $1.4 million of bank guarantees supported by the Ferox
revolving credit facilities.
Our debt and related covenants are further described in
Note C to our consolidated financial statements included
elsewhere in this prospectus.
Sources
and Uses of Cash
Three
Months Ended March 31, 2007 and 2006
Cash provided by operations for the three months ended
March 31, 2007 was $1.0 million compared with cash
provided by operations of $11.9 million for the three
months ended March 31, 2006. The decrease in the cash
provided by operations in the 2007 period was primarily
attributable to increased inventory to support business growth
and an increase in net unbilled contract revenues due to higher
sales and the timing of progress billings under existing
contracts with customers.
50
Cash used in investing activities for the three months ended
March 31, 2007 was $6.6 million compared to
$2.6 million for the three months ended March 31,
2006. Capital expenditures for the three months ended
March 31, 2007 were $5.0 million compared with
$2.6 million for the three months ended March 31, 2006
and consisted primarily of capital expenditures for the E&C
segment brazed aluminum heat exchanger facility expansion in
La Crosse, Wisconsin and D&S segment expansion in
China to support business growth. Capital expenditures during
the same period in 2006 were primarily for expansion of existing
facilities and construction of a new manufacturing facility in
China to support growth in business. Also, during the three
months ended March 31, 2007, $1.6 million of cash was
used to purchase the remaining minority interest of Chart Ferox
a.s.
For the three months ended March 31, 2007 and 2006, cash
used in financing activities was $0.9 million and
$5.8 million, respectively. During the three months ended
March 31, 2006, $5.0 million of cash was used for
voluntary principal prepayment under the term loan portion of
our senior secured credit facility.
Year
Ended December 31, 2006
Cash provided by operating activities for the year ended
December 31, 2006 was $36.4 million, and was driven by
net income before changes in assets and liabilities and a focus
on working capital management.
For the year ended December 31, 2006, cash used for
investing activities was $38.7 million. $15.9 million
of cash, net of cash acquired, was used to purchase CSC in May
2006. Cash used for capital expenditures for 2006 was
$22.3 million and primarily consisted of E&C segment
heat exchanger and process system facility expansions in
La Crosse, Wisconsin, Houston, Texas, and Tulsa, Oklahoma;
D&S segment bulk tank facility expansions in New Prague,
Minnesota, Decin, Czech Republic, Changzhou, China, and normal
equipment purchases and replacements across all facilities.
Cash provided by financing activities for the year ended
December 31, 2006 was $9.2 million. In May 2006,
$37.1 million and $2.1 million of cash was received
from the exercise of warrants and Rollover Options,
respectively. On July 31, 2006, we completed our initial
public offering and received $172.5 million of cash
proceeds, net of expenses, and paid a cash dividend of
$150.3 million to stockholders existing immediately prior
to the completion of the initial public offering. For the year
ended December 31, 2006, $55.0 million of cash was
primarily used to make voluntary principal payments under the
term loan portion of the senior secured credit facility and
$1.5 million to repay seller notes related to the CEM
acquisition.
October 17,
2005 to December 31, 2005 Period
Cash provided by operating activities for the period from
October 17, 2005 to December 31, 2005 was
$14.6 million, which included cash provided by changes in
working capital components of $3.5 million.
During the period from October 17, 2005 to
December 31, 2005, we used $362.3 million of cash for
investing activities. Cash of $356.6 million was used to
pay proceeds to our former shareholders as a result of the
Acquisition and $5.6 million was used for capital
expenditures. The significant capital expenditures were for the
construction of the new manufacturing facility in China, the
expansion of the biological storage product line manufacturing
facility in New Prague, Minnesota and reinvestment to upgrade
existing facilities to support business growth.
Cash provided by financing activities for the period from
October 17, 2005 to December 31, 2005,was
$348.5 million. In connection with the Acquisition, we
received proceeds of $350.0 million from the senior secured
credit facility and senior subordinated notes and proceeds of
$111.3 million from the sale of stock to affiliates of
First Reserve. These proceeds were used to pay our former
shareholders, repay $76.5 million of long-term debt under
the 2003 Credit Facility, pay former stock option holders
$15.8 million and pay financing and transaction costs of
$11.6 million and $1.8 million, respectively. In
addition, we made a voluntary principal prepayment of
$5.0 million on the term loan.
January 1,
2005 to October 16, 2005 Period
Cash provided by operating activities for the period from
January 1, 2005 to October 16, 2005 was
$15.6 million and included cash used in working capital
components of $10.6 million to support the growth in
business, particularly in the E&C and D&S segments.
51
During the period from January 1, 2005 to October 16,
2005, we used $20.8 million of cash for investing
activities. Cash of $12.0 million, net of cash acquired,
was used to acquire 100% of the equity interest in CEM. The CEM
acquisition is further described in the notes to our
consolidated financial statements included elsewhere in this
prospectus. Cash used for capital expenditures for the period
was $11.0 million. The significant capital expenditures
were for the construction of the new manufacturing facility in
China, the expansion of the biological storage product line
manufacturing facility in New Prague, Minnesota and
reinvestments to upgrade existing facilities to support growth
in our businesses. In addition, we received proceeds of
$1.7 million from the settlement of a promissory note
related to the 2003 sale of our former Greenville Tube, LLC
stainless steel tubing business.
For the period from January 1, 2005 to October 16,
2005, $1.7 million of cash was provided by financing
activities. We borrowed $18.9 million under our revolving
credit facilities, including $10.0 million in the second
quarter of 2005 under the revolving credit portion of the 2003
Credit Facility to finance our acquisition of CEM. In addition,
we made net payments under the revolving credit portion of our
2003 Credit Facility and other revolving credit facilities of
$15.9 million and $1.9 million of scheduled principal
payments under the term loan portion of the 2003 Credit
Facility, and $1.1 million of payments on other long-term
debt. Proceeds from the sale of stock during this period were
$1.7 million.
Year
Ended December 31, 2004
Cash provided by operating activities was $35.1 million for
the year ended December 31, 2004, which was primarily a
result of improved operating performance of all of our business
segments, including increased sales, realized savings due to
continued restructuring efforts and our successful
reorganization under the Bankruptcy Code enabling us to return
to normal payment terms with most of our vendors. This positive
cash flow was partially offset by increased inventory levels,
particularly at the BioMedical segment to ensure uninterrupted
service to customers during the transfer of manufacturing
operations from the Burnsville, Minnesota facility to the
Canton, Georgia facility.
In 2004, net cash used for investing activities was
$3.3 million. Capital expenditures were $9.4 million
and included the expansion of the Canton, Georgia facility to
accommodate the transfer of medical product line manufacturing
to that facility from the Burnsville, Minnesota facility, the
expansion of our operations in China and reinvestment into other
facilities. In addition, we received cash proceeds on the sale
of assets of $6.1 million in 2004, which included
$4.3 million from the sale of the Burnsville, Minnesota
facility, $0.6 million from the sale of a vacant building
and parcel of land at the New Prague, Minnesota facility, and
$1.1 million from the sale of equipment at the Plaistow,
New Hampshire facility.
We used $35.7 million of cash for financing activities in
2004. We paid $33.1 million to reduce our long-term debt.
This amount included voluntary prepayments made in April,
September and December 31, 2004, of $10.0 million,
$12.0 million and $8.0 million respectively, on the
term loan portion of our 2003 Credit Facility. The prepayments
were made due to the significant amount of cash provided by the
operating activities in 2004. Each prepayment reduced all future
scheduled quarterly amortization payments on a pro-rata basis.
Also, we used $1.9 million of cash for our debt
restructuring initiatives including costs associated with the
reorganization. We were required to delay until January 2004,
when our fee applications were approved by the
U.S. Bankruptcy Court, payments of approximately
$0.9 million in bankruptcy related fees to various
professional service providers.
Cash
Requirements
We do not anticipate any unusual cash requirements for working
capital needs, but expect to use $23.0 million to
$25.0 million of cash for capital expenditures for the
remaining nine months of 2007. A significant portion of the
capital expenditures are expected to be used for continued
facility expansions to increase capacity at the E&C segment
La Crosse, Wisconsin facility and the D&S segment
China, Czech Republic and New Prague, Minnesota facilities.
Management believes that these expansions are necessary to
support our current backlog levels and our expected growth due
to an increase in global demand for our products.
For the remaining nine months of 2007, cash requirements for
debt service are forecasted to be approximately
$23.0 million for scheduled interest payments under our
senior secured credit facility and the senior subordinated
52
notes. We are not required to make any scheduled principal
payments during the remaining nine months of 2007 under the term
loan portion of the senior secured credit facility or senior
subordinated notes, but we will consider making voluntary
principal payments on our senior secured credit facility or
repurchasing our senior subordinated notes on the open market to
the extent permitted by our debt covenants with excess cash flow
that is generated. For the remainder of 2007, we expect to use
approximately $21.0 million of cash for both U.S. and
foreign income taxes and contribute approximately
$0.6 million of cash to our four defined benefit pension
plans to meet ERISA minimum funding requirements.
Contractual
Obligations
Our known contractual obligations as of December 31, 2006
and cash requirements resulting from those obligations are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and
|
|
|
|
Total
|
|
|
2007
|
|
|
2008-2009
|
|
|
2010-2011
|
|
|
Thereafter
|
|
|
|
(Dollars in thousands)
|
|
|
Long-term debt
|
|
$
|
290,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
290,000
|
|
Interest on long-term debt(1)
|
|
|
197,976
|
|
|
|
27,115
|
|
|
|
49,123
|
|
|
|
49,123
|
|
|
|
72,615
|
|
Operating leases
|
|
|
15,727
|
|
|
|
3,905
|
|
|
|
5,882
|
|
|
|
3,634
|
|
|
|
2,306
|
|
Pension obligations
|
|
|
875
|
|
|
|
674
|
|
|
|
201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$
|
504,578
|
|
|
$
|
31,694
|
|
|
$
|
55,206
|
|
|
$
|
52,757
|
|
|
$
|
364,921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The interest payments in the above table were estimated based
upon our existing debt structure at December 31, 2006,
which included the senior secured credit facility and senior
subordinated notes, less scheduled debt payments each year, and
the interest rates in effect at December 31, 2006. The
planned funding of the pension and other post-employment
obligations were based upon actuarial and management estimates
taking into consideration the current status of the plans. |
Our commercial commitments as of December 31, 2006, which
include standby letters of credit and bank guarantees, represent
potential cash requirements resulting from contingent events
that require performance by us or our subsidiaries pursuant to
funding commitments, and are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2007
|
|
|
2008-2010
|
|
|
|
(Dollars in thousands)
|
|
|
Standby letters of credit
|
|
$
|
13,629
|
|
|
$
|
12,603
|
|
|
$
|
1,026
|
|
Bank guarantees
|
|
|
18,452
|
|
|
|
15,646
|
|
|
|
2,806
|
|
Total commercial commitments
|
|
$
|
32,081
|
|
|
$
|
28,249
|
|
|
$
|
3,832
|
|
Capital
Structure
As a result of the Acquisition, we had 7,952,180 shares of
common stock issued and outstanding at December 31, 2005.
Also, in connection with the Acquisition, a warrant to purchase
2,651,012 shares of our common stock was issued in November
2005 to FR X Chart Holdings LLC and 2,174,800 stock options,
which we refer to as the New Options, under the Amended and
Restated 2005 Stock Incentive Plan (2005 Stock Incentive
Plan) were granted to management to purchase shares of our
common stock at an exercise price of $6.50 per share. In
addition, certain members of management rolled over 609,851
stock options in the Acquisition from our 2004 Stock Option and
Incentive Plan, the exercise price of which was adjusted to
$3.50 per share. In addition, 566,581 of the Rollover
Options were vested on the closing date of the Acquisition and
the remaining 43,270 Rollover Options vested in the first six
months of 2006. On October 17, 2005, we adopted
SFAS 123(R) Share-Based Payments to account for
our 2005 Stock Incentive Plan. See Recently
Adopted Accounting Standards below for further information
regarding the adoption of SFAS 123(R).
In 2006, we granted 266,390 New Options under the 2005 Stock
Incentive Plan at an exercise price of $12.16 per share.
The New Options are exercisable for a period of ten years and
have two different vesting
53
schedules. As of December 31, 2006, there were 2,441,190
New Options outstanding. 860,840 of the New Options are
time-based, or Time-based Options, and vest 20% per year
over a five-year period, and 1,580,350 of the New Options are
performance-based, or Performance-based Options, and vest based
upon specified returns on First Reserve Fund X, L.P.s
investment in us.
In May 2006, the warrant was exercised at a price of
$14.00 per share, resulting in proceeds of
$37.1 million and 2,651,012 shares were issued to FR X
Chart Holdings LLC and the 609,851 Rollover Options were
exercised for an equivalent number of shares at a price of
$3.50 per share, resulting in proceeds of $2.1 million.
On July 31, 2006, we completed our initial public offering
of 12,500,000 shares of our common stock for cash proceeds,
net of expenses, of $175.3 million. We used
$25.0 million of the net proceeds to repay a portion of the
term loan under our senior secured credit facility. The
remaining $150.3 million of net proceeds was used to pay a
dividend to our stockholders existing immediately prior to the
initial public offering, consisting of affiliates of First
Reserve and certain members of management. On August 25,
2006, a stock dividend of 1,875,000 shares was issued to
the stockholders existing immediately prior to the completion of
the initial public offering. As of December 31, 2006, there
were 25,588,043 shares of common stock issued and
outstanding.
In July and August 2006, we granted restricted stock units
covering 15,980 shares of common stock to non-employee
directors. Each of the six grants of restricted stock units had
a fair market value of $40,000 on the date of grant. The
restricted stock units are expected to fully vest on the first
anniversary of the date of grant or earlier in the event of a
change of control as defined in the 2005 Stock Incentive Plan.
The 2,666 unvested restricted stock units received by
Mr. Ben Guill were forfeited to us as a result of
Mr. Guills March 19, 2007 resignation from our
board of directors.
Off-Balance
Sheet Arrangements
We do not have any off-balance sheet arrangements as defined in
the Securities Act.
Contingencies
We are involved with environmental compliance, investigation,
monitoring and remediation activities at certain of our
operating facilities, and accrue for these activities when
commitments or remediation plans have been developed and when
costs are probable and can be reasonably estimated. Historical
annual cash expenditures for these activities have been charged
against the related environmental reserves. Future expenditures
relating to these environmental remediation efforts are expected
to be made over the next 8 to 14 years as ongoing costs of
remediation programs. Management believes that any additional
liability in excess of amounts accrued, which may result from
the resolution of such matters should not have a material
adverse effect on our financial position, liquidity, cash flows
or results of operations.
In March 2003, CHEL filed for a voluntary administration under
the U.K. Insolvency Act of 1986. It is uncertain whether we will
be subject to any significant liability resulting from
CHELs insolvency administration. See
Business Legal Proceedings.
In 2004, as part of the Plaistow, New Hampshire manufacturing
facility closure, we withdrew from the multiemployer pension
plan related to the Plaistow employees. We continue to carry a
related estimated withdrawal liability of $0.2 million at
December 31, 2006. Any additional liability in excess of
the amount accrued is not expected to have a material adverse
impact on our financial position, liquidity, cash flow or
results of operations.
We are occasionally subject to various other legal claims
related to performance under contracts, product liability, taxes
and other matters, several of which claims assert substantial
damages, in the ordinary course of our business. Based on our
historical experience in litigating these claims, as well as our
current assessment of the underlying merits of the claims and
applicable insurance, if any, we currently believe the
resolution of these other legal claims will not have a material
adverse effect on our financial position, liquidity, cash flows
or results of operations. Future developments may, however,
result in resolution of these legal claims in a way that could
have a material adverse effect. See Risk Factors.
54
Foreign
Operations
During 2006, we had operations in Australia, China, the Czech
Republic, Germany and the United Kingdom, which accounted for
approximately 25.0% of consolidated sales and 17.0% of total
assets at December 31, 2006. Functional currencies used by
these operations include the Australian Dollar, the Chinese
Renminbi Yuan, the Czech Koruna, the Euro and the British Pound.
We are exposed to foreign currency exchange risk as a result of
transactions by these subsidiaries in currencies other than
their functional currencies, and from transactions by our
domestic operations in currencies other than the
U.S. Dollar. The majority of these functional currencies
and the other currencies in which we record transactions are
fairly stable. The use of these currencies, combined with the
use of foreign currency forward purchase and sale contracts, has
enabled us to be sheltered from significant gains or losses
resulting from foreign currency transactions. This situation
could change if these currencies experience significant
fluctuations in their value as compared to the U.S. Dollar.
Application
of Critical Accounting Policies
Our consolidated financial statements have been prepared in
accordance with U.S. generally accepted accounting
principles and are based on the selection and application of
significant accounting policies, which require management to
make estimates and assumptions. Although Fresh-Start accounting
required the selection of appropriate accounting policies for
the Predecessor Company, the significant accounting policies
previously used by the Predecessor Company have generally
continued to be used by us. Management believes the following
are some of the more critical judgmental areas in the
application of its accounting policies that affect its financial
position and results of operations.
Allowance for Doubtful Accounts. We evaluate
the collectibility of accounts receivable based on a combination
of factors. In circumstances where we are aware of a specific
customers inability to meet its financial obligations
(e.g., bankruptcy filings, substantial downgrading of credit
scores), a specific reserve is recorded to reduce the receivable
to the amount we believe will be collected. We also record
allowances for doubtful accounts based on the length of time the
receivables are past due and historical experience. If
circumstances change (e.g.,
higher-than-expected
defaults or an unexpected material adverse change in a
customers ability to meet its financial obligations), our
estimates of the collectibility of amounts due could be changed
by a material amount.
Inventory Valuation Reserves. We determine
inventory valuation reserves based on a combination of factors.
In circumstances where we are aware of a specific problem in the
valuation of a certain item, a specific reserve is recorded to
reduce the item to its net realizable value. We also recognize
reserves based on the actual usage in recent history and
projected usage in the near-term. If circumstances change (e.g.,
lower-than-expected
or
higher-than-expected
usage), estimates of the net realizable value could be changed
by a material amount.
Long-Lived Assets. We monitor our long-lived
assets for impairment indicators on an ongoing basis in
accordance with SFAS No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets. If impairment
indicators exist, we perform the required analysis and record
impairment charges in accordance with SFAS No. 144. In
conducting our analysis, we compare the undiscounted cash flows
expected to be generated from the long-lived assets to the
related net book values. If the undiscounted cash flows exceed
the net book value, the long-lived assets are considered not to
be impaired. If the net book value exceeds the undiscounted cash
flows, an impairment loss is measured and recognized. An
impairment loss is measured as the difference between the net
book value and the fair value of the long-lived assets. Fair
value is estimated based upon either discounted cash flow
analyses or estimated salvage values. Cash flows are estimated
using internal forecasts as well as assumptions related to
discount rates. Changes in economic or operating conditions
impacting these estimates and assumptions could result in the
impairment of long-lived assets.
Goodwill and Other Indefinite-Lived Intangible
Assets. Under SFAS No. 142,
Goodwill and Other Intangible Assets, we evaluate
goodwill and indefinite-lived intangible assets for impairment
on an annual basis. To test for impairment, we are required to
estimate the fair market value of each of our reporting units.
We developed a model to estimate the fair market value of our
reporting units. This fair market value model incorporates our
estimates of future cash flows, estimates of allocations of
certain assets and cash flows among reporting units, estimates
of future growth rates and managements judgment regarding
the applicable discount rates to use to discount those estimated
cash flows. Changes to these judgments and estimates could
result in a
55
significantly different estimate of the fair market value of the
reporting units, which could result in a different assessment of
the recoverability of goodwill and other indefinite-lived
intangible assets.
Pensions. We account for our defined benefit
pension plans in accordance with SFAS No. 87,
Employers Accounting for Pensions, which
requires that amounts recognized in financial statements be
determined on an actuarial basis. Our funding policy is to
contribute at least the minimum funding amounts required by law.
SFAS No. 87 and the policies used by us, notably the
use of a calculated value of plan assets (which is further
described below), generally reduce the volatility of pension
expense from changes in pension liability discount rates and the
performance of the pension plans assets.
A significant element in determining our pension expense in
accordance with SFAS No. 87 is the expected return on
plan assets. We have assumed that the expected long-term rate of
return on plan assets as of December 31, 2006 will be
8.25%. These expected return assumptions were developed using a
simple averaging formula based upon the plans investment
guidelines and the historical returns of equities and bonds.
While over the long term, the investment strategy employed with
our pension plan assets has earned in excess of such rates, we
believe our assumptions for expected future returns are
reasonable. However, we cannot guarantee that we will achieve
these returns in the future. The assumed long-term rate of
return on assets is applied to the market value of plan assets.
This produces the expected return on plan assets that reduces
pension expense. The difference between this expected return and
the actual return on plan assets is deferred. The net deferral
of past asset gains or losses affects the calculated value of
plan assets and, ultimately, future pension expense.
At the end of each year, we determine the rate to be used to
discount plan liabilities. The discount rate reflects the
current rate at which the pension liabilities could be
effectively settled at the end of the year. In estimating this
rate, we look to rates of return on high quality, fixed-income
investments that receive one of the two highest ratings given by
a recognized rating agency and the expected timing of benefit
payments under the plan. At December 31, 2006, we
determined this rate to be 5.75%. Changes in discount rates over
the past three years have not materially affected pension
expense, and the net effect of changes in the discount rate, as
well as the net effect of other changes in actuarial assumptions
and experience, has been deferred as allowed by
SFAS No. 87.
At December 31, 2006, our consolidated net pension
liability recognized was $3.3 million, a decrease of
$4.0 million from December 31, 2005. This reduction in
liability was due to the increase in fair value of plan assets
during 2006 and employer contributions to the plans of
$1.3 million partially offset by benefit payments of
$1.1 million. For the year ended December 31, 2006,
the period from October 17, 2005 to December 31, 2005
and the period from January 1, 2005 to October 16,
2005, we recognized approximately $0.4 million,
$0.01 million and $0.2 million, respectively, of
pension income. The pension income has increased in 2006
compared to 2005 combined periods primarily due to a higher
return on assets and the elimination of service costs in 2006 as
the last one of our four plans was frozen in February 2006.
On September 29, 2006, the Financial Accounting Standards
Board issued Statement of Financial Accounting Standard
No. 158, Employers Accounting for Defined Benefit
Pension and Other Postretirement Plans, an Amendment of FASB
Statements No. 87, 88, 106 and 132(R)
(SFAS 158). SFAS 158 was effective for
public companies for fiscal years ending after December 15,
2006. We adopted the balance sheet recognition provisions of
SFAS 158 at December 31, 2006, the end of our fiscal
year 2006. See Note H of the notes to our consolidated
financial statements included elsewhere in this prospectus
regarding the incremental effect of adopting SFAS 158.
Environmental Remediation Obligations. Our
obligation for known environmental problems at our current and
former manufacturing facilities have been recognized on an
undiscounted basis based on estimates of the cost of
investigation and remediation at each site. Management reviews
our environmental remediation sites quarterly to determine if
additional cost adjustments or disclosures are required. The
characteristics of environmental remediation obligations, where
information concerning the nature and extent of
clean-up
activities is not immediately available and changes in
regulatory requirements frequently occur, result in a
significant risk of increase to the obligations as they mature.
Expected future expenditures are not discounted to present value
and potential insurance recoveries are not recognized until
realized.
Product Warranty Costs. We estimate product
warranty costs and accrue for these costs as products are sold.
Estimates are principally based upon historical product warranty
claims experience over the warranty period for
56
each product line. Due to the uncertainty and potential
volatility of these warranty estimates, changes in assumptions
could materially affect net income.
Revenue Recognition Long-Term
Contracts. We recognize revenue and gross profit
as work on long-term contracts progresses using the percentage
of completion method of accounting, which relies on estimates of
total expected contract revenues and costs. We follow this
method since reasonably dependable estimates of the revenue and
costs applicable to various stages of a contract can be made.
Since the financial reporting of these contracts depends on
estimates, which are assessed continually during the term of the
contract, recognized revenues and profit are subject to
revisions as the contract progresses toward completion.
Revisions in profit estimates are reflected in the period in
which the facts that give rise to the revision become known.
Accordingly, favorable changes in estimates result in additional
profit recognition, and unfavorable changes will result in the
reversal of previously recognized revenue and profits. When
estimates indicate a loss is expected to be incurred under a
contract, cost of sales is charged with a provision for such
loss. As work progresses under a loss contract, revenue and cost
of sales continue to be recognized in equal amounts, and the
excess of costs over revenues is charged to the contract loss
reserve. Change orders resulting in additional revenue and
profit are recognized upon approval by the customer based on the
percentage that incurred costs to date bear to total estimated
costs at completion. We use the percentage of completion method
of accounting primarily in the E&C segment, with the
balance made up by the D&S segment.
Recently
Adopted Accounting Standards
In December 2004, the FASB issued SFAS No. 151,
Inventory Costs. SFAS No. 151 requires
abnormal amounts of inventory costs related to idle facility,
freight handling and wasted material expenses to be recognized
as current period charges. Additionally, SFAS No. 151
requires that allocation of fixed production overheads to the
costs of conversion be based on the normal capacity of the
production facilities. The standard is effective for fiscal
years beginning after June 15, 2005. The adoption of this
statement did not have a material effect on our financial
position, results of operations, liquidity or cash flows.
In June 2005, the FASB issued SFAS No. 154,
Accounting Changes and Error Corrections.
SFAS 154 replaces APB Opinion No. 20, Accounting
Changes and SFAS 3, Reporting Accounting
Changes in Interim Financial Statements. SFAS 154
requires that a voluntary change in accounting principle be
applied retrospectively with all prior period financial
statements presented on the new accounting principle.
SFAS 154 also requires that a change in method of
depreciating and amortizing a long-lived asset be accounted for
prospectively as a change in estimate, and the correction of
errors in previously issued financial statements should be
termed a restatement. SFAS 154 is effective for accounting
changes and corrections of errors made in fiscal years beginning
after December 15, 2005. The implementation of
SFAS 154 did not have an impact on our present consolidated
financial statements and will only affect financial statements
to the extent there are future accounting changes or errors.
In September 2006, the FASB issued SFAS No. 158,
Employers Accounting for Defined Pension Benefit
Plans and Other Postretirement Plans. This statement
requires recognition on the balance sheet of the underfunded or
overfunded status of pension and postretirement benefit plans.
SFAS No. 158 also requires the recognition of changes
in the funded status through other comprehensive income in the
year that the changes occur. The amount of net periodic benefit
cost recognized in an entitys results of operation will
not change. SFAS No. 158 is effective for fiscal years
ending after December 15, 2006. We adopted
SFAS No. 158 as of December 31, 2006. The
adoption of this statement had no material effect on our
financial position, results of operations, liquidity or cash
flows.
We adopted the provisions of FASB Interpretation No. 48,
Accounting for Uncertainty in Income Taxes
(FIN 48) on January 1, 2007. Previously,
we had accounted for tax contingencies in accordance with SFAS
No. 5, Accounting for Contingencies. As required by
FIN 48, which clarifies SFAS No. 109, Accounting for
Income Taxes, we recognize the financial statement benefit of a
tax position only after determining that the relevant tax
authority would more likely than not sustain the position
following an audit. For tax positions meeting the more likely
than not threshold, the amount recognized in the financial
statements is the largest benefit that has a greater than
50 percent likelihood of being realized upon ultimate
settlement with the relevant tax authority. At the adoption
date, we applied FIN 48 to all tax positions for which the
statute of limitations remained open. As a result of the
implementation of FIN 48, we did not recognize material
adjustments in the liability for unrecognized tax benefits.
57
Recently
Issued Accounting Standards
In September 2006, the FASB issued Statement of Financial
Accounting Standards No. 157, Fair Value
Measurements (SFAS No. 157) which is
effective for fiscal years beginning after November 15,
2007. SFAS No. 157 defines fair value to be applied to
U.S. GAAP guidance requiring use of fair value, establishes
a framework for measuring fair value and expands the disclosure
requirements for fair value measurements. We are currently
evaluating the impact of SFAS No. 157 on our financial
position and results of operations.
In February 2007, the FASB issued SFAS No. 159,
The Fair Value Option for Financial Assets and Financial
Liabilities including an amendment of FASB Statement
No. 115. SFAS No. 159 permits entities to choose to
measure many financial instruments and certain other items at
fair value that are not currently required to be measured at
fair value, with unrealized gains and losses related to these
financial instruments reported in earnings at each subsequent
reporting date. This statement is effective for fiscal years
beginning after November 15, 2007. We are currently
evaluating the impact of SFAS No. 159 on its financial
position and results of operations.
Quantitative
and Qualitative Disclosures About Market Risk
In the normal course of business, our operations are exposed to
continuing fluctuations in foreign currency values and interest
rates that can affect the cost of operating and financing.
Accordingly, we address a portion of these risks through a
program of risk management.
Our primary interest rate risk exposure results from the current
senior secured credit facilitys various floating rate
pricing mechanisms. We entered into an interest rate derivative
contract, or collar, in March 1999 to manage interest rate risk
exposure relative to our debt. This collar had a notional amount
of $4.4 million at December 31, 2005 and expired in
March 2006. The fair value of the contract related to the collar
outstanding December 31, 2005 is a liability of less than
$0.1 million and is recorded in accrued interest. If
interest rates were to increase 200 basis points (2%) from
March 31, 2007 rates, and assuming no changes in debt from
the March 31, 2007 levels, our additional annual expense
would be approximately $2.4 million on a pre-tax basis.
The Company has assets, liabilities and cash flows in foreign
currencies creating exposure to foreign currency exchange
fluctuations in the normal course of business. Charts
primary exchange rate exposure is with the Euro, the British
pound, the Czech koruna and the Chinese yuan. Monthly
measurement, evaluation and forward exchange rate contracts are
employed as methods to reduce this risk. The Company enters into
foreign exchange forward contracts to hedge anticipated and
firmly committed foreign currency transactions. Chart does not
use derivative financial instruments for speculative or trading
purposes. The terms of the contracts are one year or less. The
Company held immaterial positions in foreign exchange forward
contracts at March 31, 2007.
Covenant
Compliance
We believe that our senior secured credit facility and the
indenture governing our outstanding notes are material
agreements, that the covenants are material terms of these
agreements and that information about the covenants is material
to an investors understanding of our financial condition
and liquidity. The breach of covenants in the senior secured
credit facility that are tied to ratios based on Adjusted
EBITDA, as defined below, could result in a default under the
senior secured credit facility and the lenders could elect to
declare all amounts borrowed due and payable. Any such
acceleration would also result in a default under our indenture.
Additionally, under the senior secured credit facilities and
indenture, our ability to engage in activities such as incurring
additional indebtedness, making investments and paying dividends
is also tied to ratios based on Adjusted EBITDA.
58
Covenant levels and pro forma ratios for the four quarters ended
March 31, 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Four Quarters Ended
|
|
|
|
|
|
|
March 31,
|
|
|
|
Covenant Level
|
|
|
2007 Ratio
|
|
|
Senior Secured Credit
Facility(1)
|
|
|
|
|
|
|
|
|
Minimum Adjusted EBITDA to cash
interest ratio
|
|
|
2.00
|
x
|
|
|
3.58x
|
|
Maximum funded indebtedness to
Adjusted EBITDA ratio
|
|
|
6.25
|
x
|
|
|
3.07x
|
|
Indenture(2)
|
|
|
|
|
|
|
|
|
Minimum pro forma Adjusted EBITDA
to pro forma fixed charge coverage ratio required to incur
additional debt pursuant to ratio provisions(3)
|
|
|
2.0
|
x
|
|
|
3.6x
|
|
|
|
|
(1) |
|
The senior secured credit facility requires us to maintain an
Adjusted EBITDA to cash interest ratio starting at a minimum of
2.00x and a funded indebtedness to Adjusted EBITDA ratio
starting at a maximum of 6.50x. Failure to satisfy these ratio
requirements would constitute a default under the senior secured
credit facility. If lenders under the senior secured credit
facility failed to waive any such default, repayment obligations
under the senior secured credit facility could be accelerated,
which would also constitute a default under the indenture. |
|
(2) |
|
Our ability to incur additional debt and make certain restricted
payments under our indenture, subject to specified exceptions,
is tied to an Adjusted EBITDA to fixed charge ratio of at least
2.0 to 1.0. |
|
(3) |
|
The ratio is calculated giving pro forma effect to the
Acquisition and the incurrence of debt under the indenture and
the senior secured credit facility. |
Adjusted EBITDA as used herein is defined as net income before
interest expense, provision for income taxes, depreciation and
amortization and further adjusted to exclude non-recurring
items, non-cash items and other adjustments permitted in
calculating covenants contained in the related senior secured
credit facility and indenture governing the notes, as shown in
the table below. We believe that the inclusion of supplementary
adjustments to EBITDA applied in presenting Adjusted EBITDA are
appropriate to provide additional information to investors to
demonstrate compliance with financing covenants and our ability
to pay dividends. The presentation of Adjusted EBITDA, a
non-GAAP financial measure, and ratios based thereon, do not
comply with U.S. generally accepted accounting principles.
59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Company
|
|
|
|
|
|
|
January 1,
|
|
|
|
October 17,
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
Three Months Ended
|
|
|
|
December 31,
|
|
|
October 16,
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
|
2005
|
|
|
2006
|
|
|
2006
|
|
|
2007
|
|
|
|
(In Thousands)
|
|
Net income (loss)
|
|
$
|
22,600
|
|
|
$
|
8,858
|
|
|
|
$
|
(506
|
)
|
|
$
|
26,895
|
|
|
$
|
6,045
|
|
|
$
|
7,178
|
|
Income tax expense (benefit)
|
|
|
10,134
|
|
|
|
7,159
|
|
|
|
|
(441
|
)
|
|
|
13,044
|
|
|
|
2,980
|
|
|
|
3,713
|
|
Interest expense net(a)
|
|
|
4,712
|
|
|
|
4,164
|
|
|
|
|
5,556
|
|
|
|
25,461
|
|
|
|
6,545
|
|
|
|
6,346
|
|
Depreciation and amortization(b)
|
|
|
8,490
|
|
|
|
6,808
|
|
|
|
|
4,396
|
|
|
|
22,449
|
|
|
|
5,194
|
|
|
|
4,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
45,936
|
|
|
$
|
26,989
|
|
|
|
$
|
9,005
|
|
|
$
|
87,849
|
|
|
$
|
20,764
|
|
|
$
|
22,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
$
|
45,936
|
|
|
$
|
26,989
|
|
|
|
$
|
9,005
|
|
|
$
|
87,849
|
|
|
$
|
20,764
|
|
|
$
|
22,228
|
|
Stock-based compensation expense(c)
|
|
|
2,433
|
|
|
|
9,508
|
|
|
|
|
437
|
|
|
|
1,907
|
|
|
|
321
|
|
|
|
361
|
|
Inventory valuation charge(d)
|
|
|
|
|
|
|
|
|
|
|
|
8,903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition expenses(e)
|
|
|
|
|
|
|
6,602
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-process research and
development charge(f)
|
|
|
|
|
|
|
2,768
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hurricane and storm costs
(recoveries)(g)
|
|
|
|
|
|
|
1,057
|
|
|
|
|
406
|
|
|
|
(1,593
|
)
|
|
|
182
|
|
|
|
|
|
Offering costs(h)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
260
|
|
Employee separation and plant
closure costs(i)
|
|
|
3,346
|
|
|
|
1,700
|
|
|
|
|
255
|
|
|
|
396
|
|
|
|
162
|
|
|
|
99
|
|
Reorganization expenses(j)
|
|
|
706
|
|
|
|
1,470
|
|
|
|
|
88
|
|
|
|
162
|
|
|
|
45
|
|
|
|
|
|
Appraisal rights settlement(k)
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management fees(l)
|
|
|
380
|
|
|
|
306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) loss on sale of assets(m)
|
|
|
133
|
|
|
|
(131
|
)
|
|
|
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
$
|
52,934
|
|
|
$
|
50,269
|
|
|
|
$
|
19,672
|
|
|
$
|
88,721
|
|
|
$
|
21,474
|
|
|
$
|
22,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Includes derivative contract valuation income or expense for
interest rate collars to manage interest exposure relative to
term debt. |
|
(b) |
|
The period from October 17, 2005 to December 31, 2005,
the year ended December 31, 2006, the three months ended
March 31, 2006 and the three months ended March 31,
2007 include financing costs amortization of $0.3 million,
$1.5 million, $0.4 million and $0.4 million,
respectively. |
|
(c) |
|
Represents stock-based compensation charges for stock and stock
options issued to key employees and directors, and an additional
charge for the cash-out of stock options in the period from
January 1, 2005 to October 16, 2005 as a result of the
Acquisition. Although it may be of limited relevance to holders
of our debt instruments, it may be of more relevance to our
equity holders, since such equity holders ultimately bear such
expenses |
|
(d) |
|
Represents a non-cash inventory valuation charge recorded in
cost of sales for the adjustment of inventory to fair value as a
result of purchase accounting as of October 17, 2005, the
closing date of the Acquisition. Under purchase accounting,
inventory was adjusted to the fair value as of the date
indicated above, and a corresponding charge was taken in the
subsequent period from October 17, 2005 to
December 31, 2005 cost of sales as the inventory was sold. |
60
|
|
|
(e) |
|
Represents acquisition expenses, primarily professional fees,
incurred by us as a result of the Acquisition. |
|
(f) |
|
Represents a non-cash charge for purchased in-process research
and development in conjunction with the acquisition of CEM in
2005. |
|
(g) |
|
Represents losses and costs incurred related to Hurricane Rita
at our New Iberia, Louisiana facilities, net of insurance
recoveries. |
|
(h) |
|
Represents offering expenses, primarily professional fees,
incurred by us as a result of this offering. |
|
(i) |
|
Includes inventory valuation charges recorded in cost of sales,
and severance expenses, facility exit costs and non-operating
expenses related to the execution of our operational
restructuring plan, which primarily included moving the
Burnsville, Minnesota manufacturing operations to Canton,
Georgia and closing the Plaistow, New Hampshire manufacturing
facility. See Managements Discussion and Analysis of
Financial Condition and Results of Operations for
additional information. |
|
(j) |
|
Represents pre-bankruptcy debt restructuring-related fees,
professional fees and expenses, and a claim settlement related
to our 2003 bankruptcy reorganization. See
Managements Discussion and Analysis of Financial
Condition and Results of Operations for additional
information. |
|
(k) |
|
Represents a charge for the settlement of former Predecessor
Company stockholders appraisal rights claims as a result
of the Acquisition. |
|
(l) |
|
Represents non-recurring management fees charged by our
Predecessor Company majority stockholders, which are not charged
by First Reserve. |
|
(m) |
|
Includes non-recurring gains and losses and charges on the sale,
disposal or impairment of assets. See Managements
Discussion and Analysis of Financial Condition and Results of
Operations for additional information. |
61
INDUSTRY
OVERVIEW
Our products and services are important components to the liquid
gas supply chain. They are employed in cryogenic liquid
production, purification, transportation, distribution, storage
and other processes in which cryogenic liquids are converted
into the desired gases. These processes are important to the use
of hydrocarbon and industrial gases. Important applications
include LNG liquefaction and regasification, gas to liquids,
natural gas and petrochemical processing, industrial gas
production, transportation and storage, home healthcare
applications and biomedical research. Accordingly, global demand
for natural gas and industrial gases are fundamental drivers of
our business.
Natural gas usage is increasing rapidly due to its advantageous
environmental characteristics, superior heat efficiency, and
growth in other applications such as petrochemical feedstock.
According to the International Energy Agency or IEA, the
consumption of natural gas will exceed that of coal by 2015. The
Energy Information Administration or EIA, projects that global
natural gas usage will grow 2.4% annually from 2002 to 2020
compared to 2.0% for oil and 2.3% for coal.
Growing
Natural Gas Consumption
Source: LNG World Energy Outlook May
19-20, 2005
International Energy Agency presentation
Source: Industrial Energy Outlook 2005 July 2005
Energy Information Administration Publication
LNG is expected to be the fastest growing segment of the natural
gas value chain. New supplies of natural gas are largely found
in areas that are long distances from the consumers of natural
gas. In circumstances where pipeline transport is not feasible,
natural gas must be converted into a more compact, liquid form,
in order to effectively transport it to the required location.
Products that enable the liquefaction of natural gas and
re-gasification of LNG for transportation and storage are
critical to the LNG industry.
The LNG liquefaction process is currently the largest LNG market
for our products. Our heat exchangers, cold boxes,
vacuum-insulated pipe, or VIP, and other products are used by
customers in the LNG market to liquefy, transport, distribute
and store natural gas. According to the IEA, investments in
global LNG facilities are expected to total approximately
$250 billion from 2001 to 2030.
Energy Ventures Analysis projects LNG liquefaction capacity to
increase 15.2% per annum from 2005 through 2011.
62
Source: Energy Ventures
Analysis, 2005
Commensurate with the increased LNG liquefaction investment and
capacity, transportation of LNG is expected to outpace pipeline
transport of natural gas over the next couple decades. The IEA
expects the transportation of LNG in 2030 to be more than six
times the level in 2001. Once this LNG reaches its end market it
will either be re-gasified for pipeline distribution or
distributed or stored in LNG format using cryogenic tanks where
there is no pipeline infrastructure.
Source: LNG World Energy Outlook May
19-20, 2005
International Energy Agency presentation
Hydrocarbon processing is another substantial market for our
products. In natural gas processing, customers employ cryogenic
equipment to separate and purify natural gas and then to further
separate natural gas into its component elements such as ethane,
propane, butane, other natural gas to liquids and by-products
such as helium. In petrochemical processing, customers use
cryogenic separation and purification processes to convert
natural gas elements into ethylene (the basic building block of
plastics), propylene and numerous other industrial chemicals.
The hydrocarbon processing market uses many of the products from
our cryogenic categories in the gas separation and purification
processes and the subsequent storage and distribution of liquid
gases. Major customers for our products in the hydrocarbon
processing markets are large multinational firms in the oil and
gas industry, and large engineering and construction firms.
Industrial gas demand is another fundamental driver of our
business. Growth in the industrial gas market is driven by the
underlying demand for products that require oxygen, nitrogen,
argon and other air gases. Producers of industrial gases
separate atmospheric air into its component gases using
cryogenic processes. The resultant liquid gases are then stored
and transported for ultimate use by a wide variety of customers
in the petrochemical, electronics, glass, paper, metals, food,
fertilizer, welding, enhanced oil recovery and medical
industries. The industrial gas market uses our products
throughout this process, for the separation, purification,
storage and distribution of gases. Notably, the oil and
chemicals sector is a substantial user of industrial gases, for
stimulating well pressure, refining oil, producing
petrochemicals and other applications.
63
According to Spiritus Consulting, or Spiritus, revenue in the
industrial gas market grew at 6.6% per annum from 1999 to
2004. Spiritus projects the global industrial gas market to grow
at 7.0% per annum through 2009, fueled by growth of
9.0% per annum in Asia, the Middle East and Africa. The
following graph was prepared by us using data from the Spiritus
Consulting Report, 2004.
Industrial
Gas Sales Growth by Region
Source: Spiritus Consulting Report, 2004
Our BioMedical segment is primarily driven by growth in home
healthcare and biomedical research. Growth in the home
healthcare market is being driven by the trend of decreased
hospital inpatient stays in favor of lower cost outpatient
treatments as well as by the aging U.S. population.
According to U.S. Census data, the U.S. population
aged 65 and over will grow from 35.0 million in 2000 to
46.8 million by 2015.
Growth in
U.S. Elderly Population
Aged 65+
Source: U.S. Census Bureau, 2000
Growth in an aging population as well as increases in the number
of respiratory disease cases is expected to increase demand for
respiratory therapy and home-based oxygen devices. Respiratory
therapy, which includes liquid oxygen systems, oxygen
compression systems and oxygen concentrators, is a primary
product service of our BioMedical segment.
Similarly, the global expansion of bio-tech and stem cell
research, and cord blood storage is expected to increase demand
for our biological storage products for storing biological
material. Additionally, U.S. Homeland Security initiatives
in response to acts of bio-terrorism should drive greater demand
for our biological storage products. Global artificial
insemination is expected to grow as countries are moving toward
independence in their dairy and beef production.
We believe that equipment suppliers that are diversified in
terms of product offerings that span the entire supply chain for
users of hydrocarbon and industrial gases will continue to be
industry leaders.
64
BUSINESS
Overview
We are a leading independent global manufacturer of highly
engineered equipment used in the production, storage and end-use
of hydrocarbon and industrial gases, based on our sales and the
estimated sales of our competitors. We supply engineered
equipment used throughout the global liquid gas supply chain.
The largest portion of end-use applications for our products is
energy-related, accounting for 56% of sales and 58% of orders in
2006, and 79% of backlog at December 31, 2006. We are a
leading manufacturer of standard and engineered equipment
primarily used for low-temperature and cryogenic applications.
We have developed an expertise in cryogenic systems and
equipment, which operate at low temperatures sometimes
approaching absolute zero (0 kelvin;
−273o
Centigrade;
−459o
Fahrenheit). The majority of our products, including
vacuum-insulated containment vessels, heat exchangers, cold
boxes and other cryogenic components, are used throughout the
liquid gas supply chain for the purification, liquefaction,
distribution, storage and end-use of hydrocarbon and industrial
gases.
Our primary customers are large, multinational producers and
distributors of hydrocarbon and industrial gases and their
suppliers. We sell our products and services to more than 2,000
customers worldwide. We have developed long-standing
relationships with leading companies in the gas production, gas
distribution, gas processing, LNG, chemical and industrial gas
industries, including Air Products, Praxair, Airgas, Air
Liquide, JGC Corporation, or JGC, Bechtel Corporation, General
Electric, or GE, ExxonMobil, British Petroleum, or BP, and
ConocoPhillips, many of whom have been purchasing our products
for over 20 years.
We have attained this position by capitalizing on our low-cost
global manufacturing footprint, technical expertise and
know-how, broad product offering, reputation for quality, and by
focusing on attractive, growing markets. We have an established
sales and customer support presence across the globe and
low-cost manufacturing operations in the United States, Central
Europe and China. We believe we are the number one or two
equipment supplier in all of our primary end-use markets. For
the three months ended March 31, 2007 and 2006, we
generated sales of $152.5 million and $120.8 million,
respectively. For the year ended December 31, 2006, the
combined year ended December 31, 2005 and the year ended
December 31, 2004, we generated sales of
$537.5 million, $403.1 million and
$305.6 million, respectively.
We believe that we are well-positioned to benefit from a variety
of long-term trends driving demand in our industry, including:
|
|
|
|
|
increasing demand for natural gas and the geographic dislocation
of supply and consumption, which is resulting in the need for a
global network for LNG;
|
|
|
|
increasing demand for natural gas processing, particularly in
the Middle East, as crude oil producers look to utilize the gas
portions of their reserves; and
|
|
|
|
increased demand for natural and industrial gases resulting from
rapid economic growth in developing areas, particularly Central
and Eastern Europe and China.
|
The following charts show the proportion of our revenues
generated by each operating segment as well as our estimate of
the proportion of revenue generated by end-user for the combined
year ended December 31, 2006.
|
|
|
Sales By Segment
|
|
Sales By End-User
|
|
|
|
|
65
Our
Competitive Strengths
Although we are subject to a number of competitive factors that
we describe at the end of this competitive strengths section, we
believe that the following competitive strengths position us to
enhance our growth and profitability:
Focus on Attractive Growing End Markets. We
anticipate growing demand in the end markets we serve, with
particularly strong growth in LNG, natural gas processing,
specific international markets across all segments and
biomedical equipment. Energy Ventures Analysis projects global
LNG liquefaction capacity to increase 15.2% per annum from
2005 through 2011 and the International Energy Agency expects
the natural gas industry to invest approximately
$250 billion in LNG facilities from 2001 to 2030. In
addition, international demand for our products is being driven
by growing manufacturing capacity and industrial activity in
developing areas, particularly Central and Eastern Europe and
China. Rapid economic development in these areas has caused a
significant increase in the demand for natural and industrial
gases. According to Spiritus Consulting, the global market for
industrial gas is projected to grow 7.0% per annum from
2004 through 2009.
Substantial Revenue Visibility. We have a
large and growing backlog, which provides us with a high degree
of visibility in our forecasted revenue. Our backlog is
comprised of the portion of signed purchase orders or other
written contractual commitments received from customers that we
have not recognized as revenue under the percentage of
completion method or based upon shipment. Our backlog as of
March 31, 2007, December 31, 2006, December 31,
2005 and December 31, 2004 was $342.2 million,
$319.2 million, $233.6 million and
$129.3 million, respectively. Projects for energy-related
applications totaled approximately $251.0 million in
backlog as of December 31, 2006.
Leading Market Positions. We believe we are
the #1 or #2 equipment supplier in each of our primary
end markets both domestically and internationally. Based on our
relationships with key customers, we believe that our strong
industry positioning makes us typically one of only two or three
suppliers qualified to provide certain products to key
customers. As our customers continue to rationalize their
vendors, we expect to gain additional market share and that the
benefit of our leading position will become more pronounced.
Diverse, Long-Standing Customer Base. We
currently serve over 2,000 customers worldwide. Our primary
customers are large, multinational producers and distributors of
hydrocarbon and industrial gases that provide us with revenue
stability. Customers and end-users also include high growth LNG
processors, petrochemical processors and biomedical companies.
We have developed strong, long-standing relationships with these
customers, many of whom have been purchasing products from us or
one of our predecessors for over 20 years.
Our primary customers and end-users include Air Products,
Praxair, Airgas, Air Liquide, JGC, Bechtel Corporation, GE,
ExxonMobil, BP and ConocoPhillips.
Highly Flexible and Low-Cost Manufacturing
Base. Given our long-term investment in global
manufacturing facilities and specialized equipment, we have
developed a substantial comparative scale and geographic
advantage within the markets for the cryogenic products that we
manufacture. The scale enables cost efficiencies and the
geographic reach provides access to customers that we believe
would be difficult for a potential competitor to replicate. With
more than 1.9 million square feet of manufacturing space
across 12 primary facilities and three continents, we have
substantial operational flexibility. We are a low-cost producer
for our products across all segments. In addition, the high cost
of capital and economies of scale required for this type of
manufacturing create significant barriers for new entrants.
Product Expertise, Quality, Reliability and
Know-How. Within our end markets, we have
established a reputation for quality, reliability and technical
innovation. We believe that the main drivers of our target
customers purchasing decisions are a suppliers
product expertise, quality, reliability and know-how rather than
pricing and terms, giving us an advantage based on our
reputation and consequent brand recognition. The value of this
brand recognition is significantly enhanced by the extended life
cycle of our products and the high cost to our target customers
of product failure. As a focused provider of highly engineered
cryogenic equipment, we believe it would be difficult for a new
entrant to duplicate our capabilities.
66
Experienced Management Team. We have assembled
a strong senior management team with over 250 combined
years of related experience. We have a balance of entrepreneurs,
internally developed leaders and experienced managers from
analogous industries. The team has grown into a cohesive unit
with complementary management and operational skills. The
current management team is largely responsible for the strong
financial performance experienced since 2003.
We compete in a number of niche markets with a number of
competitors that are major corporations, some of which have
substantially greater technical, financial and marketing
resources than we do. Our ability to capitalize on our strengths
could be hampered by our competitors ability to use their
resources to adapt to changing market demands earlier than we
are able to do so. For an additional discussion regarding our
ability to compete in the highly competitive markets in which we
operate, see Risk Factors.
Business
Strategy
We believe that we are well-positioned to maintain our
leadership in providing highly engineered equipment for use in
low-temperature and cryogenic applications and to meet the
worlds growing demand for hydrocarbon and industrial gases
with more economical, reliable and environmentally friendly
systems. The principal elements of our strategy are as follows:
Continue to develop innovative, high-growth, energy-specific
products. We plan to continue to focus on
extending our cryogenic technological leadership, both to
capitalize on increasing demand for energy and to create new
applications. We believe that we are well positioned to benefit
from increased demand for LNG, natural gas processing and gas to
liquid, or GTL, solutions. Our engineering, technical and
marketing employees actively assist customers in specifying
their needs and in determining appropriate products to meet
those needs. Current product development includes subsea VIP,
synthetic gas, hydrogen recovery, small-scale bulk gas
distribution solutions and LNG/GTL production systems.
Leverage our global platform to capitalize on growing
international demand. We expect growth in
hydrocarbon and industrial gas demand and investment over the
next five years in the Middle East, Central and Eastern Europe,
Russia and China. We believe that our historic and planned
investment in our manufacturing facilities in the Czech Republic
and China and the investment in sales and marketing capabilities
in these markets, supplemented by our continuing investment in
our U.S. facilities, has positioned us to increase our
market share in these growing international markets. We believe
we are well-positioned to make acquisitions of complementary
businesses to expand our global infrastructure.
Capitalize on our position as a market
leader. We plan to continue to grow our
long-standing relationships with the leading users of cryogenic
equipment. Our engineering and development teams partner with
our customers to better understand and meet their cryogenic
equipment needs, particularly in the growing LNG and
international markets. We intend to grow our customer base as
industrial gas producers increasingly outsource bulk tank
storage and other non-core parts of their business.
Maintain our position as a low-cost producer while continuing
to improve operating performance. We believe we
are the lowest cost manufacturer for most of our products and we
intend to continue to leverage our scale, scope, technical
expertise and know-how to deliver to our customers higher
quality and more reliable products and services at lower cost.
Our largest manufacturing facility is in the Czech Republic,
which allows us to achieve considerable cost savings versus our
competitors. In addition, we believe China, where we are
experiencing significant growth, will be a sustainable low-cost
labor environment. We maintain a disciplined approach to capital
expenditures. We intend to make capacity investments in
energy-related and growing international industrial markets
where we expect to realize significant and timely returns, and
to also leverage our existing operating capacity in other
markets.
Segments
and Products
We operate in three segments: (i) E&C,
(ii) D&S and (iii) BioMedical. While each segment
manufactures and markets different cryogenic equipment and
systems to distinct end-users, they all share a reliance on our
heat
67
transfer and low temperature storage know-how and expertise. The
E&C and D&S segments manufacture products used in
energy-related applications.
Energy
and Chemicals Segment
Our principal products within the E&C segment, which
accounted for 35% of sales for the year ended December 31,
2006, are focused on process equipment, primarily heat
exchangers and LNG systems, which include cold boxes and LNG
vacuum-insulated pipe, used by major natural gas, petrochemical
processing and industrial gas companies in the production of
their products. Our products in the E&C segment include the
following:
Heat
Exchangers
We are a leading designer and manufacturer of brazed aluminum
and air cooled heat exchangers. Using technology pioneered by
us, our brazed aluminum heat exchangers are incorporated into
systems such as cold boxes to facilitate the progressive cooling
and liquefaction of air or hydrocarbon mixtures for the
subsequent recovery or purification of component gases. In
hydrocarbon processing industries, our brazed aluminum heat
exchangers allow producers to obtain purified hydrocarbon
by-products, such as methane, ethane, propane and ethylene,
which are commercially marketable for various industrial or
residential uses. In the industrial gas market, our brazed
aluminum heat exchangers are used to obtain high purity
atmospheric gases, such as oxygen, nitrogen and argon, which
have numerous diverse industrial applications. Our air cooled
heat exchangers are used in multiple markets, including
hydrocarbon, petrochemical and industrial gas processing, and
power generation. Heat exchangers are engineered to the
customers requirements and range in price from very
minimal for a relatively simple unit to as high as
$10 million for multiple units on a major project.
The heat exchangers market has seen significant demand
improvement over the last few years, resulting primarily from
increased activity in the LNG and natural gas segments of the
hydrocarbon processing market as well as the Asian industrial
gas market. In the future, management believes that continuing
efforts by petroleum producing countries to better utilize
stranded natural gas and previously flared gases, as well as
efforts to broaden their industrial base, present a promising
source of demand for our heat exchangers and cold box systems.
Demand for heat exchangers in developed countries is expected to
continue as firms upgrade their facilities for greater
efficiency and regulatory compliance.
Our principal competitors for brazed aluminum heat exchangers
are The Linde Group, Sumitomo, Kobe and Nordon, and we face
competition from a variety of competitors for air cooled heat
exchangers. Management believes that we are the only producer of
large brazed aluminum heat exchangers in the United States and
that we are the leader in the global cryogenic heat exchanger
market. Major customers for our heat exchangers in the
industrial gas market include Air Liquide, Air Products and
Praxair. In the hydrocarbon processing market, major customers
and end-users include BP, ConocoPhillips, ExxonMobil, Saudi
Aramco and contractors such as JGC, Bechtel, Jacobs and KBR.
Cold
Boxes
We are a leading designer and fabricator of cold boxes. Cold
boxes are highly engineered systems used to significantly reduce
the temperature of gas mixtures to the point where component
gases liquefy and can be separated and purified for further use
in multiple industrial, scientific and commercial applications.
In the hydrocarbon processing market, our cold box systems are
used in natural gas processing and in the petrochemical
industry. In the industrial gas market, cold boxes are used to
separate air into its major atmospheric components, including
nitrogen, oxygen and argon, where the gases are used in a
diverse range of applications such as the quick-freezing of
food, wastewater treatment and industrial welding. The
construction of a cold box generally consists of one or more
brazed aluminum heat exchangers and other equipment packaged in
a box consisting of metal framing and a complex
system of piping and valves. Cold boxes, which are designed and
fabricated to order, sell in the price range of $1 million
to $20 million, with the majority of cold boxes priced
between $1 million and $2 million.
68
We have a number of competitors for fabrication of cold boxes,
including The Linde Group, Air Products and many smaller
fabrication-only facilities around the world. Principal
customers and end-users for our cold boxes include Air Liquide,
ABB Lummus, BP, Bechtel, Saudi Aramco, Stone and Webster, and
KBR.
LNG
Vacuum Insulated Pipe
This product line consists of vacuum-insulated pipe used for LNG
transportation, or LNG VIP, within both export and import
terminals. This is a new and growing market as new LNG
infrastructure is added around the world. LNG VIP is fabricated
to order with projects varying in size from $500,000 to
$25 million. Our competitors in the LNG VIP market include
Technip and ITP. In general, our customers are the major
contractors such as Technip and Bechtel. LNG VIP competes
directly with mechanically insulated pipe which takes longer to
install and requires higher maintenance over its life.
Distribution
and Storage Segment
Through our D&S segment, which accounted for 50% of our
sales for the year ended December 31, 2006, we are a
leading supplier of cryogenic equipment to the global bulk and
packaged industrial gas markets. Demand for the products
supplied by this segment is driven primarily by the significant
installed base of users of cryogenic liquids as well as new
applications and distribution technologies for cryogenic
liquids. Our products span the entire spectrum of the industrial
gas market from small customers requiring cryogenic packaged
gases to large users requiring custom engineered cryogenic
storage systems. Our products in the D&S segment include
the following:
Cryogenic
Bulk Storage Systems
We are a leading supplier of cryogenic bulk storage systems of
various sizes ranging from 500 gallons to 180,000 gallons. Using
sophisticated vacuum insulation systems placed between inner and
outer vessels, these bulk storage systems are able to store and
transport liquefied industrial gases and hydrocarbon gases at
temperatures from
-100o
Fahrenheit to temperatures nearing absolute zero. End use
customers for our cryogenic storage tanks include industrial gas
producers and distributors, chemical producers, manufacturers of
electrical components, health care organizations, food
processors and businesses in the oil and natural gas industries.
Prices for our cryogenic bulk storage systems range from $10,000
to $1 million. Global industrial gas producers and
distributors, including Air Products, Air Liquide, The Linde
Group, Praxair and Messer, are significant customers for our
cryogenic bulk storage systems. In addition, Airgas is a
significant customer in the North American industrial gas
market. On a worldwide basis, we compete primarily with
Taylor-Wharton, a Harsco company in this product area. In the
European and Asian markets, we compete with several suppliers
owned by the global industrial gas producers as well as
independent regional suppliers.
Cryogenic
Packaged Gas Systems
We are a leading supplier of cryogenic packaged gas systems of
various sizes ranging from 160 liters to 2,000 liters.
Cryogenic liquid cylinders are used extensively in the packaged
gas industry to allow smaller quantities of liquid to be easily
delivered to the customers of the industrial gas distributors on
a
full-for-empty
or fill on site basis. Principal customers for our liquid
cylinders are the same global industrial gas producers as the
North American industrial gas distributors who purchase our
cryogenic bulk storage systems. We compete on a worldwide basis
primarily with Harsco in this product area. We have developed
two technologies in the packaged gas product area: ORCA
Micro-Bulk systems and
Tri-fecta®
Laser Gas assist systems. ORCA Micro-Bulk systems bring the ease
of use and distribution economics of bulk gas supply to
customers formerly supplied by high pressure or cryogenic liquid
cylinders. The ORCA Micro-Bulk system is the substantial market
leader in this growing product line. The
Tri-fecta®
Laser Gas assist system was developed to meet the assist
gas performance requirements for new high powered lasers
being used in the metal fabrication industry.
Cryogenic
Systems and Components
Our line of cryogenic components, including VIP, engineered bulk
gas installations and specialty liquid nitrogen end-use
equipment are recognized in the market for their reliability,
quality and performance. These
69
products are sold to industrial gas producers, as well as to a
diverse group of distributors, resellers and end users. We
compete with a number of suppliers of cryogenic systems and
components, including Acme Cryogenics, Vacuum Barrier
Corporation and others.
LNG
Vehicle Fuel Systems
This product line consists of LNG and liquid/compressed natural
gas refueling systems for centrally fueled fleets of vehicles
powered by natural gas, such as fleets operated by metropolitan
transportation authorities, refuse haulers and heavy-duty truck
fleets. Competition for LNG fueling and storage systems is based
primarily on product design, customer support and service,
dependability and price.
Beverage
Liquid
CO2
Systems
This product line consists primarily of vacuum-insulated, bulk
liquid
CO2
containers used for beverage carbonation in restaurants,
convenience stores and cinemas, in sizes ranging from 100 pounds
to 750 pounds of liquid
CO2
storage. We also manufacture and market non-insulated, bulk
fountain syrup containers for
side-by-side
installation with our
CO2
systems. Our beverage systems are sold to national
restaurant chains, soft drink companies and
CO2
distributors. Our primary competitors for our bulk liquid
CO2
beverage delivery systems are Taylor-Wharton and other
producers of high-pressure gaseous
CO2
cylinders.
Cryogenic
Services
We operate three locations in the United States providing
installation, service and maintenance of cryogenic products
including storage tanks, liquid cylinders, cryogenic trailers,
cryogenic pumps and VIP.
BioMedical
Segment
The BioMedical segment, which accounted for 15% of our sales for
the year ended December 31, 2006, consists of various
product lines built around our core competencies in cryogenics,
but with a focus on the medical and biological users of the
liquids and gases instead of the large producers and
distributors of cryogenic liquids. Our products in the
BioMedical segment include the following:
Medical
Products
Our medical oxygen product line is comprised of a limited range
of medical respiratory products, including liquid oxygen systems
and ambulatory oxygen systems, both of which are used for the
in-home supplemental oxygen treatment of patients with chronic
obstructive pulmonary diseases, such as bronchitis, emphysema
and asthma.
Individuals for whom supplemental oxygen is prescribed generally
receive an oxygen system from a home healthcare provider,
medical equipment dealer, or gas supplier. The provider or
physician usually selects which type of oxygen system to
recommend to its customers: liquid oxygen systems, oxygen
concentrators or high-pressure oxygen cylinders. Of these
modalities, physicians generally believe that liquid oxygen
offers greater long-term therapeutic benefits by providing the
option of increased patient ambulation.
Our primary competitor in the medical products line is
Puritan-Bennett, a division of Tyco International, Ltd. We
believe that competition for liquid oxygen systems is based
primarily upon product quality, performance, reliability,
ease-of-service
and price and focus our marketing strategies on these
considerations.
Biological
Storage Systems
This product line consists of vacuum-insulated containment
vessels for the storage of biological materials. The primary
markets for this product line include medical laboratories,
biotech/pharmaceutical, research facilities, blood and tissue
banks, veterinary laboratories, large-scale repositories and
artificial insemination, particularly in the beef and dairy
industry.
70
The significant competitors for biological storage systems
include a few large companies worldwide, such as Taylor-Wharton,
Air Liquide and IBP. These products are sold through multiple
channels of distribution specifically applicable to each market
sector. The distribution channels range from highly specialized
cryogenic storage systems providers to general supply and
catalogue distribution operations to breeding service providers.
Historically, competition in this field has been focused on
design, reliability and price. Additionally, we believe our
understanding of the end-users applications and concerns
enables us to sell a total value package.
Alternatives to vacuum insulated containment vessels include
mechanical, electrically powered refrigeration.
MRI
Components
The basis of the MRI technique is that the magnetic properties
of certain nuclei of the human body can be detected, measured
and converted into images for analysis. MRI equipment uses
high-strength magnetic fields, applied radio waves and
high-speed computers to obtain cross-sectional images of the
body. The major components of the MRI assembly are a series of
concentric thermal shields and a supercooled electromagnet
immersed in a liquid helium vessel, a cryostat, that maintains a
constant, extremely low temperature (4 kelvin;
-452o
Fahrenheit) to achieve superconductivity. We manufacture large
cryostats, various cryogenic interfaces, electrical
feed-throughs and various other MRI components that are used to
transfer power
and/or
cryogenic fluids from the exterior of the MRI unit to the
various layers of the cryostat and superconducting magnet. We
currently sell all of our MRI components to GE, a leading
worldwide manufacturer of MRI equipment.
Engineering
and Product Development
Our engineering and product development activities are focused
on developing new and improved solutions and equipment for the
users of cryogenic liquids. Our engineering, technical and
marketing employees actively assist customers in specifying
their needs and in determining appropriate products to meet
those needs. Portions of our engineering expenditures typically
are charged to customers, either as separate items or as
components of product cost.
Competition
We believe we can compete effectively around the world and that
we are a leading competitor in our markets. Competition is based
primarily on performance and the ability to provide the design,
engineering and manufacturing capabilities required in a timely
and cost-efficient manner. Contracts are usually awarded on a
competitive bid basis. Quality, technical expertise and
timeliness of delivery are the principal competitive factors
within the industry. Price and terms of sale are also important
competitive factors. Because independent third-party prepared
market share data is not available, it is difficult to know for
certain our exact position in our markets, although we believe
we rank among the leaders in each of the markets we serve. We
base our statements about industry and market positions on our
reviews of annual reports and published investor presentations
of our competitors and augment this data with information
received by marketing consultants conducting competition
interviews and our sales force and field contacts.
Marketing
We market our products and services throughout the world
primarily through direct sales personnel and through independent
sales representatives and distributors. The technical and custom
design nature of our products requires a professional, highly
trained sales force. While each salesperson and sales
representative is expected to develop a highly specialized
knowledge of one product or group of products within one of our
segments, each salesperson and certain sales representatives are
able to sell many products from different segments to a single
customer. We use independent sales representatives and
distributors to market our products and services in certain
foreign countries that we serve and in certain North American
markets. These independent sales representatives supplement our
direct sales force in dealing with language and cultural
matters. Our domestic and foreign independent sales
representatives earn commissions on sales, which vary by product
type.
71
Backlog
The dollar amount of our backlog as of March 31, 2007,
December 31, 2006, December 31, 2005 and
December 31, 2004 was $342.2 million,
$319.1 million, $233.6 million and
$129.3 million, respectively. Backlog is comprised of the
portion of firm signed purchase orders or other written
contractual commitments received from customers that we have not
recognized as revenue under the percentage of completion method
or based upon shipment. Backlog can be significantly affected by
the timing of orders for large products, particularly in the
E&C segment, and the amount of backlog at March 31,
2007, described above is not necessarily indicative of future
backlog levels or the rate at which backlog will be recognized
as sales. For further information about our backlog, including
backlog by segment, see Managements Discussion and
Analysis of Financial Condition and Results of Operations.
Customers
We sell our products to gas producers, distributors and
end-users across the industrial gas, hydrocarbon and chemical
processing industries in countries throughout the world. While
no single customer exceeded 10% of consolidated sales in 2006,
2005 or 2004, sales to our top ten customers accounted for 42%,
39% and 45% of consolidated sales in 2006, 2005 and 2004,
respectively. Our sales to particular customers fluctuate from
period to period, but the global gas producer and distributor
customers tend to be a consistently large source of revenue for
us. Our supply contracts are generally contracts for
requirements only. While our customers are obligated
to purchase a certain percentage of their supplies from us,
there are no minimum requirements. Also, many of our contracts
may be cancelled on as little as one months notice. To
minimize credit risk from trade receivables, we review the
financial condition of potential customers in relation to
established credit requirements before sales credit is extended
and monitor the financial condition of customers to help ensure
timely collections and to minimize losses. In addition, for
certain domestic and foreign customers, particularly in the
E&C segment, we require advance payments, letters of credit
and other such guarantees of payment. Certain customers also
require us to issue letters of credit or performance bonds,
particularly in instances where advance payments are involved,
as a condition of placing the order. We believe our
relationships with our customers are generally good.
Intellectual
Property
Although we have a number of patents, trademarks and licenses
related to our business, no one of them or related group of them
is considered by us to be of such importance that its expiration
or termination would have a material adverse effect on our
business. In general, we depend upon technological capabilities,
manufacturing quality control and application of know-how,
rather than patents or other proprietary rights, in the conduct
of our business.
Raw
Materials and Suppliers
We manufacture most of the products we sell. The raw materials
used in manufacturing include aluminum products (including
sheets, bars, plate and piping), stainless steel products
(including sheets, plates, heads and piping), palladium oxide,
carbon steel products (including sheets, plates and heads), 9%
nickel steel products (including heads and plates), valves and
gauges and fabricated metal components. Most raw materials are
available from multiple sources of supply. We believe our
relationships with our raw material suppliers and other vendors
are generally good. The commodity metals we use have experienced
significant cost increases. We have generally been able to
recover these cost increases through product price increases and
surcharges in our contracts with customers. However, there are
no assurances that we will be able to recover future increases
in commodity metal costs through our customer contracts. We
foresee no acute shortages of any raw materials that would have
a material adverse effect on our operations.
Employees
As of March 31, 2007, we had 2,686 employees, including
1,694 domestic employees and 992 international employees. These
employees consisted of 906 salaried, 324 bargaining unit hourly
and 1,456 non-bargaining unit hourly.
72
We are a party to one collective bargaining agreement with the
International Association of Machinists and AerospaceWorkers
covering 324 employees at our La Crosse, Wisconsin heat
exchanger facility. In February 2007, we entered into a new
three-year agreement to replace the previous agreement, which
expired at that time. In 2005, through another one of our
operating subsidiaries, we were a party to the agreement with
the United Steel Workers of America, which covered 222 employees
at our New Prague, Minnesota facility. On November 16,
2005, pursuant to an approved stipulation election agreement,
the bargaining unit employees voted to decertify the United
Steel Workers of America as its bargaining representative. The
election results were certified on November 23, 2005. Over
the past several years, we have experienced one work stoppage.
In connection with the negotiation of the new collective
bargaining agreement for our La Crosse, Wisconsin facility
described above, we experienced a work stoppage from the time
that the previous agreement expired on February 3, 2007,
until the terms of the new agreement were reached on
February 7, 2007. The brief work stoppage had no material
impact on the Company, and we continue to believe that our
relationships with our employees are generally good.
Environmental
Matters
Our operations have historically included and currently include
the handling and use of hazardous and other regulated
substances, such as various cleaning fluids used to remove
grease from metal, that are subject to federal, state and local
environmental laws and regulations. These regulations impose
limitations on the discharge of pollutants into the soil, air
and water, and establish standards for their handling,
management, use, storage and disposal. We monitor and review our
procedures and policies for compliance with environmental laws
and regulations. Our management is familiar with these
regulations, and supports an ongoing program to maintain our
adherence to required standards.
We are involved with environmental compliance, investigation,
monitoring and remediation activities at certain of our owned
manufacturing facilities and at one owned facility that is
leased to a third party. We believe that we are currently in
substantial compliance with all known environmental regulations.
We accrue for certain environmental remediation-related
activities for which commitments or remediation plans have been
developed and for which costs can be reasonably estimated. These
estimates are determined based upon currently available facts
regarding each facility. Actual costs incurred may vary from
these estimates due to the inherent uncertainties involved.
Future expenditures relating to these environmental remediation
efforts are expected to be made over the next 8 to 14 years
as ongoing costs of remediation programs. Although we believe we
have adequately provided for the cost of all known environmental
conditions, additional contamination or changes in regulatory
posture concerning our on-going remedial efforts could result in
more costly remediation measures than budgeted, or those we
believe are adequate or required by existing law. We believe
that any additional liability in excess of amounts accrued which
may result from the resolution of such matters will not have a
material adverse effect on our financial position, liquidity,
cash flows or results of operations.
Properties
We occupy 26 principal facilities totaling approximately
2.3 million square feet, with the majority devoted to
manufacturing, assembly and storage. Of these manufacturing
facilities, approximately 1.7 million square feet are owned
and 0.6 million square feet are occupied under operating
leases. We consider our manufacturing facilities sufficient to
meet our current and planned operational needs in the BioMedical
segment. However, we have commenced the expansion of our
E&C and D&S segment facilities over the next few years
to meet significant current order backlog levels and expected
growth in business as both we and our competitors reach
capacity. We lease approximately 15,200 square feet for our
corporate office in Garfield Heights, Ohio. Our major owned
facilities in the United States are subject to mortgages
securing our senior secured credit facility.
As a result of our operational restructuring activities, we
closed our D&S manufacturing facility in Plaistow, New
Hampshire in the third quarter of 2004. We have entered into an
agreement to sell the idle building and a portion of the land at
our Plaistow, New Hampshire facility. We expect to complete the
sale in the second or third quarter of 2007. The Plaistow, New
Hampshire facility is classified as an asset held for
sale in our unaudited consolidated balance sheet as of
March 31, 2007.
73
The following table sets forth certain information about
facilities occupied by us as of March 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
Location
|
|
Segment
|
|
Square Feet
|
|
|
Ownership
|
|
|
Use
|
|
La Crosse, Wisconsin
|
|
Energy & Chemicals
|
|
|
149,000
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
New Iberia, Louisiana
|
|
Energy & Chemicals
|
|
|
62,400
|
|
|
|
Leased
|
|
|
Manufacturing
|
New Iberia, Louisiana
|
|
Energy & Chemicals
|
|
|
35,000
|
|
|
|
Leased
|
|
|
Manufacturing
|
The Woodlands, Texas
|
|
Energy & Chemicals
|
|
|
29,000
|
|
|
|
Leased
|
|
|
Office
|
Houston, Texas
|
|
Energy & Chemicals
|
|
|
103,000
|
|
|
|
Leased
|
|
|
Manufacturing/Office
|
Tulsa, Oklahoma
|
|
Energy & Chemicals
|
|
|
58,500
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
Tulsa, Oklahoma
|
|
Energy & Chemicals
|
|
|
140,000
|
|
|
|
Leased
|
|
|
Manufacturing/Office
|
Wolverhampton, United Kingdom
|
|
Energy & Chemicals
|
|
|
1,600
|
|
|
|
Leased
|
|
|
Office
|
Changzhou, China
|
|
Distribution & Storage
|
|
|
130,000
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
Changzhou, China
|
|
Distribution & Storage
|
|
|
55,000
|
|
|
|
Leased
|
|
|
Manufacturing/Office
|
Changzhou, China
|
|
Distribution & Storage
|
|
|
40,000
|
|
|
|
Leased
|
|
|
Manufacturing
|
Decin, Czech Republic
|
|
Distribution & Storage
|
|
|
638,000
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
Houston, Texas
|
|
Distribution & Storage
|
|
|
22,000
|
|
|
|
Owned
|
|
|
Service
|
Plaistow, New Hampshire(1)
|
|
Distribution & Storage
|
|
|
164,400
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
Shanghai, China
|
|
Distribution & Storage
|
|
|
1,900
|
|
|
|
Leased
|
|
|
Office
|
Solingen, Germany
|
|
Distribution & Storage
|
|
|
3,000
|
|
|
|
Leased
|
|
|
Office
|
Canton, Georgia
|
|
Distribution &
Storage/BioMedical
|
|
|
154,000
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
Jasper, Georgia
|
|
Distribution &
Storage/BioMedical
|
|
|
32,500
|
|
|
|
Leased
|
|
|
Warehouse/Service
|
New Prague, Minnesota
|
|
Distribution &
Storage/BioMedical
|
|
|
254,000
|
|
|
|
Owned
|
|
|
Manufacturing/Service/Office
|
Denver, Colorado
|
|
BioMedical
|
|
|
109,000
|
|
|
|
Owned
|
|
|
Manufacturing
|
Marietta, Georgia
|
|
BioMedical
|
|
|
11,100
|
|
|
|
Leased
|
|
|
Office/Lab
|
Bracknell, United Kingdom
|
|
BioMedical
|
|
|
12,500
|
|
|
|
Leased
|
|
|
Office/Warehouse
|
Lidcombe, Australia
|
|
BioMedical
|
|
|
2,400
|
|
|
|
Leased
|
|
|
Office/Warehouse
|
New Prague, Minnesota
|
|
BioMedical
|
|
|
11,700
|
|
|
|
Leased
|
|
|
Warehouse
|
Burnsville, Minnesota(2)
|
|
Corporate/Distribution &
Storage
|
|
|
7,000
|
|
|
|
Leased
|
|
|
Office
|
Garfield Heights, Ohio
|
|
Corporate
|
|
|
15,200
|
|
|
|
Leased
|
|
|
Office
|
Clarksville, Arkansas(3)
|
|
Discontinued operation
|
|
|
110,000
|
|
|
|
Owned
|
|
|
Manufacturing/Office
|
|
|
|
(1) |
|
This facility is being held for sale. |
|
(2) |
|
This facility was vacated in early May 2007; however, the lease
expires in January 2008. |
|
(3) |
|
This facility is leased from us, with a purchase option, by the
company that owns certain assets of the former Greenville Tube
LLC stainless steel tubing business. |
Regulatory
Environment
We are subject to federal, state and local regulations relating
to the discharge of materials into the environment, production
and handling of our hazardous and regulated materials and our
products and the conduct and condition of our production
facilities. We do not believe that these regulatory requirements
have had a material effect upon our capital expenditures,
earnings or competitive position. We are not anticipating any
material capital expenditures in 2007 that are directly related
to regulatory compliance matters. We are also not aware of any
pending or potential regulatory changes that would have a
material adverse impact on our business.
Legal
Proceedings
In March 2003, we completed the closure of our Wolverhampton,
United Kingdom manufacturing facility, operated by CHEL, and all
current heat exchanger manufacturing is being conducted at our
LaCrosse, Wisconsin
74
facility. On March 28, 2003, CHEL filed for a voluntary
administration under the U.K. Insolvency Act of 1986.
CHELs application for voluntary administration was
approved on April 1, 2003 and an administrator was
appointed. Additionally, we received information that indicated
that CHELs net pension plan obligations had increased
significantly primarily due to a decline in plan asset values
and interest rates as well as an increase in plan liabilities,
resulting in an estimated plan deficit of approximately
$12.0 million. Based on our financial condition, in March
2003 we determined not to advance funds to CHEL in amounts
necessary to fund CHELs obligations. Since CHEL was
unable to fund its net pension plan deficit, pay remaining
severance due to former employees or pay other creditors, the
trustees of the CHEL pension plan requested a decision to
wind-up the
plan from a U.K. pension regulatory board. That board approved
the wind-up
as of March 28, 2003.
We do not believe that we are legally obligated to fund the net
pension deficit of the CHEL pension plan because CHEL, which is
no longer one of our consolidated subsidiaries, was the sponsor
of the pension plan and the entity with primary responsibility
for the plan. In addition, we considered ourselves and our
consolidated subsidiaries legally released from being the
primary obligor of any CHEL liabilities. Further, at the time
the insolvency administrator assumed control of CHEL, we no
longer had control of the assets or liabilities of CHEL. As a
result, in March 2003, we wrote-off our net investment in CHEL.
In addition, any claims of CHEL against us were discharged in
bankruptcy as part of our Reorganization Plan.
While no claims presently are pending against us related to
CHELs insolvency, persons impacted by the insolvency or
others could bring a claim against us asserting that we are
directly responsible for pension and benefit related liabilities
of CHEL. Although we would contest any claim of this kind, we
can provide no assurance that claims will not be asserted
against us in the future. To the extent we have a significant
liability related to CHELs insolvency and pension
wind-up,
satisfaction of that liability could have a material adverse
impact on our liquidity, results of operations and financial
position.
On July 8, 2003, we and all of our then majority-owned
U.S. subsidiaries filed voluntary petitions for
reorganization relief under Chapter 11 of the
U.S. Bankruptcy Code with the U.S. Bankruptcy Court
for the District of Delaware to implement an agreed upon senior
debt restructuring plan through a prepackaged plan of
reorganization. None of our
non-U.S. subsidiaries
were included in the filing in the Bankruptcy Court. On
September 15, 2003, we and all of our then majority-owned
U.S. subsidiaries emerged from Chapter 11 bankruptcy
proceedings pursuant to the Amended Joint Prepackaged
Reorganization Plan of Chart Industries, Inc. and Certain
Subsidiaries, dated September 3, 2003. We have resolved all
proofs of claim asserted in the bankruptcy proceedings,
including the settlement in July 2005 of a finders fee
claim in the amount of $1.1 million asserted by one of our
former stockholders, against which we had filed an objection in
the Bankruptcy Court. All bankruptcy proceedings were closed in
May 2006.
We are occasionally subject to various other legal claims
related to performance under contracts, product liability, taxes
and other matters, several of which claims assert substantial
damages, in the ordinary course of our business. Based on our
historical experience in litigating these claims, as well as our
current assessment of the underlying merits of the claims and
applicable insurance, if any, we currently believe the
resolution of these other legal claims will not have a material
adverse effect on our financial position, liquidity, cash flows
or results of operations. Future developments may, however,
result in resolution of these legal claims in a way that could
have a material adverse effect. See Risk Factors.
75
MANAGEMENT
The following table sets forth the name, age as of
April 30, 2007 and position of each person that serves as
an executive officer or director of our company. Our directors
each serve for a term of one year until the next annual meeting
of stockholders and our executive officers each serve for a term
of one year at the discretion of the board of directors.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Samuel F. Thomas
|
|
|
55
|
|
|
Chairman of the Board of Directors,
Chief Executive Officer and President
|
Michael F. Biehl
|
|
|
51
|
|
|
Executive Vice President, Chief
Financial Officer and Treasurer
|
Matthew J. Klaben
|
|
|
38
|
|
|
Vice President, General Counsel and
Secretary
|
James H. Hoppel, Jr.
|
|
|
43
|
|
|
Chief Accounting Officer,
Controller and Assistant Treasurer
|
Kenneth W. Moore
|
|
|
37
|
|
|
Director
|
Timothy H. Day
|
|
|
36
|
|
|
Director
|
Steven W. Krablin
|
|
|
57
|
|
|
Director
|
Michael W. Press
|
|
|
60
|
|
|
Director
|
Richard E. Goodrich
|
|
|
63
|
|
|
Director
|
Samuel F. Thomas was elected Chairman of our board
of directors on March 27, 2007 and has served as our Chief
Executive Officer and President and as a member of our board of
directors since October 2003. Prior to joining our company,
Mr. Thomas was Executive Vice President of Global
Consumables at ESAB Holdings Ltd., a provider of welding
consumables and equipment. In addition to his most recent
position at ESAB, Mr. Thomas was responsible for ESAB N.
America during his employment at ESAB Holdings Ltd. Prior to
joining ESAB in February 1999, Mr. Thomas was Vice
President of Friction Products for Federal Mogul, Inc. Prior to
its acquisition by Federal Mogul in 1998, Mr. Thomas was
employed by T&N plc from 1976 to 1998, where he served from
1991 as chief executive of several global operating divisions,
including industrial sealing, camshafts and friction products.
Michael F. Biehl has been our Executive Vice
President since April 2006, served as our Chief Accounting
Officer from October 2002 until March 2006, and has been our
Chief Financial Officer and Treasurer since July 2001. Prior to
joining us, Mr. Biehl served as Vice President, Finance and
Treasurer at Oglebay Norton Company, an industrial minerals
mining and processing company. Prior to joining Oglebay Norton
in 1992, Mr. Biehl worked in the audit practice of
Ernst & Young LLP in Cleveland, Ohio from 1978 to 1992.
Matthew J. Klaben is our Vice President, General
Counsel and Secretary. Prior to joining us in March 2006,
Mr. Klaben was a partner at the law firm of Calfee,
Halter & Griswold LLP in Cleveland, Ohio from January
2005 until March 2006, and an associate from April 1998 until
December 2004. Before that, Mr. Klaben was an associate at
the law firm of Jones Day in Cleveland, Ohio from September 1995
until April 1998.
James H. Hoppel, Jr. is our Chief Accounting
Officer, Controller and Assistant Treasurer and has served in
this position since April 2006. Mr. Hoppel joined Chart in
November 2004 as our Controller. Prior to joining us,
Mr. Hoppel served as Vice President, Finance for W.W.
Holdings, LLC, a manufacturer and distributor of doors and
hardware. Prior to joining W.W. Holdings in 2001,
Mr. Hoppel held various finance and accounting positions
with different organizations, including the Transaction Services
and Audit practices of PricewaterhouseCoopers LLP in Cleveland,
Ohio.
Kenneth W. Moore has been a member of our board of
directors since the Acquisition in October 2005. Mr. Moore
is a Managing Director of First Reserve Corporation and joined
that firm in January 2004. Prior to joining First Reserve
Corporation, Mr. Moore was a Vice President at Morgan
Stanley, an investment bank, from 2000 until 2004. Prior to
joining Morgan Stanley, Mr. Moore was an Associate at Chase
Securities from 1998 until 2000. Mr. Moore also serves as a
director of Dresser-Rand Group, Inc.
Timothy H. Day has been a member of our board of
directors since the Acquisition in October 2005. Mr. Day is
a Director of First Reserve Corporation, which he joined in
November 2000. Before joining First Reserve Corporation,
Mr. Day was employed at WorldOil.com where he was a Vice
President in charge of Operations.
76
Prior to that time, Mr. Day spent three years with SCF
Partners, a private equity investment group and three years with
CS First Boston and Salomon Brothers.
Steven W. Krablin became a director on
July 25, 2006. From January 1996 until April
2005, Mr. Krablin served as the Senior Vice President and
Chief Financial Officer of National Oilwell Varco Inc. or its
predecessors, a major manufacturer and distributor of oil and
gas drilling equipment and related services for land and
offshore drilling rigs. Prior to 1996, Mr. Krablin served
as Senior Vice President and Chief Financial Officer of Enterra
Corporation until its merger with Weatherford International.
Mr. Krablin also serves as a director of Penn Virginia
Corporation, an energy company engaged in the exploration,
acquisition, development and production of crude oil and natural
gas, and Hornbeck Offshore Services, Inc., a provider of
offshore vessels to the offshore oil and gas industry.
Michael W. Press became a director on
August 15, 2006 and has been designated as our lead
independent director. Mr. Press has been
self-employed since 2001. Prior to that, he spent 27 years
in the energy industry in senior management and executive
positions. From 1997 to 2001, Mr. Press was Chief Executive
Officer of KBC Advanced Technologies plc, an international
petroleum consulting firm. Mr. Press also serves as a
director of Petrofac Ltd. and T-3 Energy Services, Inc.
Richard E. Goodrich became a director on
August 15, 2006. Mr. Goodrich is a retired Executive
Vice President and Chief Financial Officer of Chicago
Bridge & Iron Company N.V. (CB&I), an
engineering, procurement and construction company that provides
services to customers in the chemicals and energy industries.
Prior to retiring, Mr. Goodrich served as Executive Vice
President and Chief Financial Officer of CB&I from 2001 to
2005, and until June 2006, as acting Chief Financial Officer.
Mr. Goodrich serves as a director of Gundle/SLT
Environmental, Inc.
Composition
of the Board of Directors
Our board of directors currently consists of six directors and
has one vacancy. Each of Messrs. Goodrich, Krablin and
Press is independent under the listing standards of the Nasdaq
Global Market. The listing standards of the Nasdaq Global Market
generally require that a majority of an issuers board of
directors consist of independent directors, but provide for a
phase-in period of one year from the date of listing. In
accordance with this phase-in rule, we intend to have a board of
directors consisting of a majority of independent directors
within one year of our initial public offering. Mr. Press
has been designated as our lead independent director.
Board
Committees
Our board of directors has an audit committee, a compensation
committee and a nominations and corporate governance committee.
Audit
Committee
Our audit committee consists of Richard E. Goodrich, Steven W.
Krablin and Michael W. Press. Mr. Krablin serves as
the audit committee chairman. Our board of directors has
determined that each of Messrs. Goodrich and Krablin qualifies
as an audit committee financial expert as such term
is defined in Item 401(h) of
Regulation S-K.
The audit committee is governed by a written charter which will
be reviewed, and amended if necessary, on an annual basis. The
audit committees responsibilities include
(1) appointing, retaining, compensating, evaluating and
terminating our independent auditors and approving in advance
any audit or non-audit engagement or relationship between us and
such auditor, (2) approving the overall scope of the audit,
(3) assisting the board in monitoring the integrity of our
financial statements, the independent accountants
qualifications and independence, the performance of the
independent accountants and our internal audit function and our
compliance with legal and regulatory requirements,
(4) annually reviewing an independent auditors report
describing the auditing firms internal quality-control
procedures and any material issues raised by the most recent
internal quality-control review, or peer review, of the auditing
firm, (5) discussing the annual audited financial and
quarterly statements with management and the independent
auditors, (6) discussing earnings press releases, as well
as financial information and earnings guidance provided to
analysts and rating agencies, (7) discussing policies with
respect to risk assessment and risk management, (8) meeting
separately, periodically, with management, internal auditors and
the
77
independent auditor, (9) reviewing with the independent
auditor any audit problems or difficulties and managements
response, (10) setting clear hiring policies for employees
or former employees of the independent auditors,
(11) annually reviewing the adequacy of the audit
committees written charter, (12) reviewing with
management any legal matters that may have a material impact on
us and our financial statements and (13) reporting
regularly to the full board of directors.
The audit committee has approved and adopted a Code of Ethical
Business Conduct for all employees and an additional Officer
Code of Ethics for all of our executives and financial officers,
copies of which are available on our website at
www.chart-ind.com. Information contained on this website
does not constitute a part of this prospectus.
Compensation
Committee
Our compensation committee consists of Richard E. Goodrich,
Steven W. Krablin and Michael W. Press. Mr. Goodrich
serves as the compensation committee chairman. The compensation
committee is responsible for (1) reviewing key employee
compensation policies, plans and programs, (2) reviewing
and approving the compensation of our chief executive officer
and other executive officers, (3) developing and
recommending to the board of directors compensation for board
members, (4) reviewing and approving employment contracts
and other similar arrangements between us and our executive
officers, (5) reviewing and consulting with the chief
executive officer on the selection of officers and evaluation of
executive performance and other related matters,
(6) administration of stock plans and other incentive
compensation plans, (7) overseeing compliance with any
applicable compensation reporting requirements of the SEC,
(8) approving the appointment and removal of trustees and
investment managers for pension fund assets, (9) retaining
consultants to advise the committee on executive compensation
practices and policies and (10) handling such other matters
that are specifically delegated to the compensation committee by
the board of directors from time to time.
Nominations
and Corporate Governance Committee
Our nominations and corporate governance committee consists of
Richard E. Goodrich, Steven W. Krablin, and Michael W.
Press. Mr. Press serves as the chairman of the committee.
The nominations and corporate governance committee is
responsible for (1) developing, recommending and reviewing
the adequacy of the corporate governance principles applicable
to us, (2) consulting with our audit committee and the
board of directors regarding the adoption of a code of conduct
applicable to all employees and directors when required by the
rules of Nasdaq and adopting procedures for monitoring and
enforcing compliance with such code of conduct,
(3) reviewing our compliance with state and federal laws
and regulations and with the Nasdaq corporate governance listing
requirements, (4) making recommendations to the board of
directors regarding the size and composition of the board of
directors, (5) establishing criteria for the selection of
new directors to serve on the board of directors and reviewing
the appropriate skills and characteristics required of
directors, (6) identifying, screening and recommending
nominees to be proposed by us for election as directors at the
annual meeting of stockholders, or to fill vacancies,
(7) considering and reviewing the qualifications of any
nominations of director candidates validly made by stockholders,
(8) reviewing the committee structure of the board of
directors and recommending directors to serve as members of each
committee, (9) overseeing the annual evaluation of
management, the board of directors, its members and committees
and (10) establishing criteria for and leading the annual
performance self-evaluation of the board of directors and each
committee.
Compensation
Committee Interlocks and Insider Participation
Since May 23, 2007, our compensation committee has
consisted of Richard E. Goodrich, Steven W. Krablin
and Michael W. Press. From August 15, 2006 until
May 23, 2007, our compensation committee consisted of
Richard E. Goodrich, Timothy H. Day and Michael W. Press. During
2006, Ben A. Guill (a former director) and Kenneth W. Moore also
served as members of our compensation committee. None of
Messrs. Goodrich, Krablin, Press, Day, Guill or Moore is a
present or past employee or officer of ours or any of our
subsidiaries. Messrs. Day and Moore are employees of First
Reserve, a related party with which we have engaged in certain
transactions described in Certain Related Party
Transactions. None of our executive officers has served on
the board or compensation committee (or other committee serving
an equivalent function) of any other entity, one of whose
executive officers served on our board or compensation committee.
78
Executive
Compensation
Compensation
Discussion and Analysis
The primary objectives of the compensation committee of our
board of directors with respect to the determination and
administration of our companys executive compensation
programs historically have been to:
|
|
|
|
|
create and enhance stockholder value by attracting and retaining
key executive talent;
|
|
|
|
align our executive officers incentives with stockholder
value creation by tying compensation to the achievement of
measurable operational and strategic objectives; and
|
|
|
|
award compensation at levels commensurate with each executive
officers performance, experience and responsibilities.
|
Historically, our committees guiding philosophy with
respect to executive officer compensation has emphasized
performance-based compensation. Accordingly, our committee
historically has provided for significant cash incentive
compensation awards and the vesting of a portion of stock option
grants based upon financial and stock performance, including, in
the case of pre-initial public offering stock option grants, the
return on investment that First Reserve Fund X, L.P. realizes
when and if it disposes of its remaining ownership interest in
us. To achieve its objectives, our compensation committee
historically has maintained compensation plans that tie a
substantial portion of overall compensation for our named
executive officers to our financial performance and the price of
our common stock. Historically, our executive compensation
program has been intended to provide base salaries below the
median of executives at companies considered to be peers, with a
total potential compensation package (including
performance-based compensation) above median among such
historical peers if maximum performance levels were achieved.
Companies that may have been considered peers or potential peers
for compensation purposes before our initial public offering,
however, may not be the same companies that our compensation
committee selects as peers for compensation purposes in the
future.
Since October 2005, we have been controlled by our largest
stockholder, FR X Chart Holdings, LLC, an affiliate of First
Reserve. With the exception of 2007 targets under the Chart
Industries, Inc. Incentive Compensation Plan and 2007 base
salary levels, described below, all compensation arrangements
currently in place were put in place prior to our initial public
offering, which was completed on July 31, 2006, and were
not modified, except for those modifications necessary to
reflect our companys public company status, in connection
with the initial public offering. Although our board of
directors and compensation committee were responsible for the
implementation and administration of all of our current benefit
and compensation plans before our initial public offering, all
compensation decisions relating to the Chief Executive Officer
and the other executive officers named in the 2006 Summary
Compensation Table below were subject to the review of First
Reserve directly or through its representatives. Moreover, the
board of directors under which our executive compensation plans
were adopted before our initial public offering was comprised of
Mr. Ben A. Guill (a former director), Mr. Day,
Mr. Moore and Mr. Thomas. The compensation committee
of the board of directors was comprised of Mr. Guill,
Mr. Day and Mr. Moore, all of whom are affiliated with
First Reserve.
As part of and subsequent to our initial public offering, we
have appointed three additional independent directors to our
board of directors and have altered the membership of our
compensation committee so that a majority of the members were
independent directors until May 23, 2007 and all of the
members are independent at the present time. Currently, the
compensation committee is comprised of Mr. Goodrich
(Chairperson), Mr. Press and Mr. Krablin. Mr. Day
was a member of our compensation committee until May 23,
2007, when he was replaced on the committee by Mr. Krablin.
Our compensation committee presently is undertaking a review of
our entire executive compensation program for our executive
officers, with the assistance of Mercer Human Resource
Consulting, an independent outside compensation consulting firm,
engaged by the committee. This review includes a study to
determine the companies that should be considered as peer group
companies for executive compensation purposes, as well as a
review of our compensation objectives and philosophy, and the
individual components of our total compensation package for
executive officers. This review is ongoing at the present time.
Accordingly, except as otherwise indicated, this Compensation
Discussion and Analysis reflects a discussion of our historical
compensation objectives and philosophy, as well as the
historical elements of our total executive officer compensation
package.
79
At the time of the Acquisition, while we were a private company,
we entered into new employment agreements with Mr. Thomas
and Mr. Biehl, and the compensation committee implemented
new executive compensation programs, substantially as they are
today. We subsequently entered into employment agreements with
Mr. Klaben and Mr. Hoppel in March and May of 2006,
respectively, while we were a private company before our initial
public offering. The terms of all four employment agreements
were negotiated by or with the input of representatives of First
Reserve based upon prevailing market conditions for private
equity investments and factors specific to the circumstances of
our company and our executive officers.
Our Chief Executive Officer periodically evaluates the
performance of all other senior executives, and our board and
compensation committee periodically evaluate the Chief Executive
Officers and other executive officers performance,
in each case based on quantitative and qualitative performance
criteria. These evaluations take place informally as well as
formally in the setting of board and compensation committee
meetings, and are considered by the committee in making
individual compensation determinations.
Elements
of Compensation
Executive compensation consists of the following primary
components:
Base Salary. Base salaries are reviewed
annually, and adjusted from time to time to reflect performance,
experience, responsibilities and market conditions. Salary
review is conducted by the compensation committee before or
during the early part of the fiscal year for which the base
salary will become effective. The compensation committee is
responsible for setting the base salary of the Chief Executive
Officer, and historically has taken into account his individual
responsibilities, performance and experience, and the
competitive market compensation paid by other companies of
similar size in a similar industry. The current base salary for
the CEO, which is $450,000 for 2007, an increase from $400,000
for 2006, was determined after a survey of certain potential
peer group companies and based on the experience of the members
of the compensation committee, taking into account his
individual responsibilities, performance and experience relative
to those of chief executive officers at companies similarly
situated to the company. Increases in base salary with respect
to the executive officers, other than the Chief Executive
Officer, are recommended to the compensation committee by the
Chief Executive Officer. In making this recommendation, the CEO
considers each executive officers individual
responsibilities, performance and experience, and competitive
market compensation paid by similarly situated companies in
similar geographic markets. However, any increase in base salary
is granted at the sole discretion of the compensation committee.
The current base salaries for the executive officers other than
the Chief Executive Officer and President are $245,000 for the
Executive Vice President, Chief Financial Officer and Treasurer
for 2007 (an increase from $235,000 for 2006), $200,000 for the
Vice President, General Counsel and Secretary for 2007 (an
increase from $193,000 for 2006) and $170,000 for the Chief
Accounting Officer, Controller and Assistant Treasurer (an
increase from $154,000 for 2006).
Annual and Other Cash Incentive Awards. In
addition to their base salary, executive officers are eligible
to earn an annual cash incentive bonus. Under the 2006 Chart
Executive Incentive Compensation Plan (the 2006 Bonus
Plan), adopted by the board of directors and approved by
our stockholders on March 1, 2006 and July 18, 2006,
respectively, executive officers were eligible to earn a cash
incentive bonus for 2006 if performance exceeded threshold
amounts in an amount up to a pre-determined percentage, ranging
from 90% to 165% of the executive officers base salary
(with higher ranked officers being compensated at a higher
percentage of base salary), at maximum performance levels. The
compensation committee established performance targets under the
2006 Bonus Plan for the 2006 fiscal year. The material targets
included working capital and EBITDA targets. When these targets
were set in early 2006, they were set at levels that were
believed to represent significant performance that would involve
some difficulty at the threshold levels, increased difficulty at
the 100% target levels, and significant difficulty at the
maximum target levels, in each case relative to historical
trends and future expectations at the time the levels were set.
Management believes that EBITDA is a typical performance measure
among private equity portfolio companies, and that EBITDA and
working capital also reflect key performance measures used to
track the companys value, operational performance and cash
flow externally and internally. The 2006 Bonus Plan provides
that if actual performance falls below the minimum threshold for
a performance objective, the executive officer will receive no
payment based on that objective, and provides for payment
determination on a straight-line basis for performance between
the minimum performance threshold and 100% target and between
100% target and
80
maximum target level. Following the end of the fiscal year, the
compensation committee determines (i) whether and to what
extent any of the established performance objectives have been
satisfied, and (ii) for each executive officer employed as
of the last day of the fiscal year, the actual bonus to which
such executive officer shall be entitled. The committee has
determined that our financial performance for our 2006 fiscal
year has exceeded the maximum target levels for each executive
officer performance measure under the 2006 Bonus Plan.
Accordingly, we paid the following cash payments under the 2006
Bonus Plan to our executive officers on March 15, 2007:
Chief Executive Officer and President, $660,000; Executive Vice
President, Chief Financial Officer and Treasurer, $352,500; Vice
President, General Counsel and Secretary, $202,650; and Chief
Accounting Officer, Controller and Assistant Treasurer, $138,600.
In addition to any incentive awards granted under the 2006 Bonus
Plan, Mr. Klaben received a signing bonus, in the amount of
$25,000, as an inducement related to his joining our company in
March 2006.
In March 2006, Messrs. Thomas, Biehl and Hoppel received
annual bonus incentive compensation, pursuant to the terms of
the Chart Industries, Inc. 2005 Incentive Compensation Plan, in
the amount of $600,000, $319,800 and $106,500, respectively.
Mr. Klaben did not receive a cash incentive bonus under
this plan, as he was not our employee during our 2005 fiscal
year. The target amounts, performance measures (which included
earnings before interest, taxes, depreciation, amortization and
restructuring charges (EBITDAR), but not working capital) and
thresholds set under our 2005 Incentive Compensation Plan, which
was adopted before we were acquired by affiliates of First
Reserve in October 2005, were different than those under our
2006 Bonus Plan, reflecting anticipated performance of the
company and performance measure priorities in early 2005 as set
by our compensation committee and board of directors in the
period prior to the Acquisition.
Beginning with our 2007 fiscal year and going forward, annual
cash bonuses, if any, will be awarded under the Chart
Industries, Inc. Incentive Compensation Plan (the
Incentive Compensation Plan), which was adopted by
the board of directors and approved by our stockholders on July
17 and July 18, 2006, respectively. The Incentive
Compensation Plan provides the compensation committee with
greater flexibility to establish performance criteria and
performance periods for which cash incentive compensation will
be awarded. Under the Incentive Compensation Plan, a performance
period may be for a fiscal year or a multi-year cycle, as
determined by the compensation committee, and the performance
objectives upon the attainment of which target incentive bonuses
will be awarded may be based on one or more of certain
performance criteria which may relate to us, one or more of our
subsidiaries, our divisions or units, or any combination of the
foregoing, and may be applied on an absolute basis
and/or be
relative to one or more peer group companies or indices, or any
combination thereof, all as the committee shall determine. The
compensation committee may appropriately adjust any performance
evaluation under a performance objective or objectives to
reflect or exclude certain extraordinary events that may occur
during the performance period. If there is a change in control,
as defined in the Incentive Compensation Plan, the compensation
committee will determine promptly, in its discretion, whether
and to what extent the performance criteria have been met or
will be deemed to have been met for the year in which the change
in control occurs and for any completed performance period for
which a determination under the plan has not been made. If the
committee determines the criteria have been met, participants
will receive their bonuses as soon as practicable, but in no
event more than 30 days after the determination.
Pursuant to the terms of the Incentive Compensation Plan, no
executive officer or other participant may receive a bonus, with
respect to any fiscal year, in excess of $5.0 million. The
committee has absolute discretion to reduce or eliminate the
amount otherwise payable under the Incentive Compensation Plan
and to establish rules or procedures which limit the amount
payable to a participant to an amount that is less than the
amount otherwise approved as that participants target
incentive bonus.
Our compensation committee has set annual incentive compensation
targets and performance measures for our 2007 fiscal year under
the Incentive Compensation Plan. Under these targets, our
executive officers are eligible to earn a cash incentive bonus
for our 2007 fiscal year if performance exceeds threshold
amounts in an amount up to a pre-determined percentage, ranging
from 97.5% to 165% of the executive officers base salary
(with higher ranked officers being compensated at a higher
percentage of base salary), at maximum performance levels. The
performance measures established under the Incentive
Compensation Plan for the 2007 fiscal year for executive
officers are operating income, net income and working capital.
The committee selected these
81
measures for 2007 in an effort to more closely align executive
officer cash bonus measures to measures that are believed to be
meaningful indications of our performance for our public
stockholders. These performance measures were set at levels that
were believed to represent, when they were set in early 2007,
significant performance that would involve some difficulty at
the threshold levels, increased difficulty at the 100% target
levels, and significant difficulty at the maximum levels, in
each case relative to historical trends and future expectations
at the time the levels were set. Following the end of the 2007
fiscal year, the compensation committee will determine
(i) whether and to what extent any of the established
performance objectives have been satisfied for 2007, and
(ii) for each executive officer employed as of the last day
of 2007, the actual bonus to which such executive officer will
be entitled for 2007. Executive officers will be entitled to the
following cash payments under the Incentive Compensation Plan
for 2007, based on a percentage of 2007 base salary, if company
performance meets the minimum performance threshold for each
performance measure, meets the 100% target for each performance
measure, or meets or exceeds the maximum target level for each
performance measure for 2007, respectively: Chief Executive
Officer and President, $0, $495,000 and $742,500, respectively;
Executive Vice President, Chief Financial Officer and Treasurer,
$0, $245,000 and $367,500, respectively; Vice President, General
Counsel and Secretary, $0, $140,000 and $210,000, respectively;
and Chief Accounting Officer, Controller and Assistant
Treasurer, $0, $110,500 and $165,750, respectively. If actual
performance falls below the minimum performance threshold for a
performance measure, the executive officer will receive no
payment based on that measure, and for performance levels
between the minimum performance threshold and 100% target, and
between 100% target and the maximum target level, payments are
determined based on a straight-line relationship. Once bonus
amounts have been determined, those bonuses, if any, are
required to be paid to executive officers by March 15, 2008.
Payments made under the 2006 Bonus Plan and the Incentive
Compensation Plan are intended to be exempt from the deduction
limitations of Section 162(m) of the Internal Revenue Code
under transition reliance period rules applicable to
compensation paid pursuant to a plan that existed before we
became publicly held and that was disclosed in our initial
public offering prospectus.
Consistent with our historical compensation philosophy, the
annual incentive performance bonus historically has been a
significant portion of total compensation. The purpose of both
the 2006 Bonus Plan and the Incentive Compensation Plan is to
attract, retain, motivate and reward participants by providing
them with the opportunity to earn competitive compensation
directly linked to our performance. The plans were designed to
provide our executive officers with incentive compensation based
upon the achievement of pre-established performance goals. The
performance criteria are tied to company, rather than individual
performance. This approach historically has been taken by our
company in light of our historical emphasis on performance-based
compensation tied to company financial and stock performance,
rather than qualitative individual performance assessments.
Equity Compensation. All of our executive
officers have received equity compensation under one or both of
our 2004 Stock Option and Incentive Plan or our Amended and
Restated 2005 Stock Incentive Plan. We have not adopted stock
ownership guidelines, and, therefore, our stock incentive plans
have provided the principal method for our executive officers to
acquire equity interests in our company.
Amended
and Restated 2005 Stock Incentive Plan
The Amended and Restated Chart Industries, Inc. 2005 Stock
Incentive Plan (the 2005 Stock Incentive Plan) was
initially adopted effective November 23, 2005, in
connection with the Acquisition. The plan, as amended and
restated, was adopted by the board of directors and approved by
our stockholders in connection with our initial public offering.
The 2005 Stock Incentive Plan was amended and restated at that
time to reflect the fact that our public company status made
certain provisions under the original plan no longer applicable.
The 2005 Stock Incentive Plan provides for the grant of
non-qualified stock options, stock appreciation rights,
restricted stock, restricted stock units, and other stock-based
grants, including shares of our common stock sold to our
non-employee directors, executive officers, other key employees
and consultants. The 2005 Stock Incentive Plan is administered
by our board of directors, which may delegate its duties and
powers in whole or in part to any committee thereof. The board
has delegated administration of the 2005 Stock Incentive Plan to
the compensation committee.
Despite the flexibility afforded under the 2005 Stock Incentive
Plan to award a variety of equity-based awards, the compensation
committee has awarded to the executive officers only stock
options to date. The compensation
82
committee may in the future, as part of its evaluation of
overall executive compensation arrangements, make grants of
other kinds of equity compensation awards to our executive
officers or other employees. To date, the compensation committee
has granted to our executive officers under the 2005 Stock
Incentive Plan certain options as non-qualified stock options,
which have been granted as follows: approximately 35% vest and
become exercisable over the passage of time, which we refer to
as time options, assuming the holder thereof
continues to be employed by us, and the remaining portion vests
and becomes exercisable based upon the achievement of certain
performance targets, which we refer to as performance
options. Time options generally become exercisable by the
holder of the option in installments of 20% on each of the first
five anniversaries of the grant date. The performance based
stock options vest based upon the return on investment that
First Reserve Fund X, L.P. realizes if and when it
liquidates its ownership interest in us. Performance options
generally become exercisable based upon the Fund X
Net Return, which is the amount received by First Reserve
Fund X, L.P. in cash (and/or in-kind based upon the fair
market value of securities or other property received by First
Reserve Fund X, L.P.) in respect of its investment in us
divided by the amount of the investment by First Reserve
Fund X, L.P. in us, which we refer to as the Fund X
Investment.
In our 2006 fiscal year, we awarded options covering a total of
108,555 shares of common stock, at an exercise price of
$12.16 per share, to executive officers, under the 2005
Stock Incentive Plan. Mr. Klaben was awarded an option
covering 99,592 shares of common stock, in connection with the
commencement of his employment as Vice President, General
Counsel and Secretary of the company on March 29, 2006 as a
result of negotiations between us and Mr. Klaben to induce
Mr. Klaben to accept employment with us, and
Mr. Hoppel was awarded an option covering 8,963 shares of
common stock in recognition of Mr. Hoppels
appointment as our Chief Accounting Officer, in connection with
grants to a number of employees, on April 27, 2006. Each of
the options granted on March 29 and April 27, 2006 have
similar terms, which are as follows: they have a
10-year term
unless they are earlier terminated and approximately 35% are
time options, and the remaining portion are
performance options, each as described above.
With respect to the non-qualified stock options granted under
the 2005 Stock Incentive Plan, we will be entitled to a tax
deduction in the year in which the non-qualified stock option is
exercised in an amount equal to the amount by which the fair
market value of the shares underlying the non-qualified stock
options on the date of exercise exceeds the exercise price of
the option. For a description of the compensation expense we
incurred in 2006 related to stock options held by executive
officers, and related valuation assumptions under, see note
(1) to 2006 Summary Compensation Table.
The 2005 Stock Incentive Plan is intended to aid us in
recruiting and retaining key employees, directors and
consultants of outstanding ability and to motivate such
employees, directors or consultants to exert their best efforts
on behalf of us and our affiliates by providing incentives
through the granting of awards. Our compensation committee
historically has taken the view that providing our executive
officers with a proprietary interest in our success further
aligns the incentives of our executive officers with those of
our stockholders. The allocation of option awards between time
vesting and performance vesting allows us to satisfy both
components of our compensation philosophy which focuses on
retaining top executive talent and aligning the incentives of
our executive officers with our stockholders. The fact that the
vesting of 65% of the stock options that have been granted to
our executive officers are tied directly to the return on the
Fund X Investment is consistent with the fact that the
grants were made during a time when the company was under the
control of a private equity investor. However, this is not
inconsistent with our overall executive compensation philosophy,
as an increase in stock value which benefits a significant
stockholder should benefit all stockholders.
In connection with the completion of our initial public
offering, we made a 9.95928-for-one adjustment with respect to
the number of shares underlying options outstanding under our
2005 Stock Incentive Plan at the time of our initial public
offering and a corresponding adjustment to the exercise prices
of such options. These options included the options under the
2005 Stock Incentive Plan held by executive officers. The
9.95928-for-one adjustment with respect to the number of shares
underlying options outstanding at the time of our initial public
offering reflected both the 4.6263-for-one stock split on our
shares of common stock outstanding before the consummation of
the initial public offering, plus additional adjustments to both
the exercise price and the number of shares underlying the
options in order also to take into account, consistent with
applicable tax standards and in accordance with the terms of the
2005 Stock Incentive Plan, the decrease in value of our
pre-initial public
83
offering common stock which resulted from the payment of the
dividends received by our stockholders existing immediately
prior to the initial public offering. Other than through these
adjustments to their options, option holders would not have
participated in the stock split or the dividends. In accordance
with SFAS 123(R), Share Based Payments, we
concluded that this cumulative 9.95928-for-one adjustment to the
shares underlying options resulted in no additional stock-based
compensation expense because our 2005 Stock Incentive Plan
includes an anti-dilution modification provision that applies to
share splits and extraordinary cash dividends, such as those
that took place in connection with our initial public offering,
and this modification represents an adjustment to keep the
option holders in the same economic position as they were in
before our initial public offering with respect to their options.
2004
Stock Option and Incentive Plan
The Chart Industries, Inc. 2004 Stock Option and Incentive Plan
(the 2004 Stock Plan), was adopted effective
February 12, 2004 and approved by our stockholders on
July 18, 2006. The 2004 Plan permits the grant of
nonqualified stock options to our and our affiliates
employees. Prior to the consummation of our initial public
offering, all options that were outstanding under the 2004 Stock
Plan were fully vested and exercised, and no options remain
outstanding under the 2004 Stock Plan. We have not made any
additional grants under the 2004 Stock Plan since the completion
of our initial public offering, and we do not intend to make any
grants under the 2004 Stock Plan going forward. For a
description of stock options under our 2004 Stock Option Plan
exercised in 2006 by executive officers, consisting of options
held by Messrs. Thomas and Biehl, see 2006 Stock
Option Exercises and Stock Vested Table. Those employees
who exercised their options outstanding under the 2004 Stock
Plan in 2006 before our initial public offering, including
Messrs. Thomas and Biehl, became holders of our common
stock before our initial public offering and, accordingly,
participated ratably in the cash dividend paid to our
stockholders existing immediately prior to the initial public
offering from the net proceeds of the initial public offering,
and participated ratably in the stock dividend we distributed to
the same pre-initial public offering stockholders on
August 25, 2006 as part of the initial public offering,
which we distributed after our initial public offering
underwriters did not exercise their over-allotment option.
Messrs. Thomas and Biehl received $5,866,697 and $328,493,
respectively, as stockholders in the cash dividend and 73,181
and 4,097 shares of our common stock, respectively, as
stockholders in the stock dividend. See Management
Equity below.
Deferred Compensation. The terms of our
Amended and Restated Voluntary Deferred Income Plan are
described below under 2006 Nonqualified Deferred
Compensation Table. Participation in this plan is entirely
voluntary, and we presently do not offer any matching monies or
contributions. We offered this plan to our executive officers to
defer their compensation to subsequent years to help with their
personal tax planning. Of the executive officers, only
Mr. Thomas elected to participate in this plan in 2006, and
he deferred part of his bonus payable for our 2005 fiscal year
in 2006 under this plan.
Other Benefits. Executive officers are
eligible to participate in all of our employee benefit plans,
including our 401(k) Plan, health, life and disability
insurance, retirement, deferred compensation and fringe
benefits, as well as any equity compensation plans, as in effect
from time to time, on the same basis as those benefits are
generally made available to other senior executives of the
company.
Additionally, all of our executive officers receive automobile
allowances. In accordance with our performance-based
compensation philosophy, we intend to continue to maintain
modest executive benefits and perquisites for officers; however,
the compensation committee in its discretion may revise, amend
or add to the officers executive benefits and perquisites
if it deems it advisable.
Option
Grant Policies
For stock options granted under the 2005 Stock Incentive Plan,
the exercise price per share is equal to the fair market value
on the applicable date of grant. In March 2006 we hired an
independent valuation firm to determine the fair market value of
our common stock as of March 31, 2006. All stock options
granted to our employees, including our executive officers,
during our 2006 fiscal year and prior to our initial public
offering were granted at fair market value, on the grant date in
accordance with the valuation determined by our independent,
outside valuation firm. The value of these options is reflected
in our consolidated financial statements, based upon the
applicable accounting guidance, using a fair market value
formulation derived from the price at which we initially
proposed to offer our
84
stock to the public in our initial public offering, which was
significantly higher than the price at which we actually offered
our stock to the public. Equity grants in the form of restricted
stock units made to our non-employee directors, as discussed
below under Director Compensation, were granted and
reflected in our consolidated financial statements, based upon
the applicable accounting guidance, at fair market value, as
determined by the market price per share of a share of our
common stock on the date of grant. Other than with respect to
regular annual grants of restricted stock units made to our
non-employee directors as described below, we do not have any
program, plan or policy which requires us to grant equity
compensation on specified dates; however, we have not made any
equity grants in connection with the release or withholding of
material non-public information.
Change in
Control Payments
None of the executive officers respective employment
agreements provide for change in control payments; however
accelerated vesting of outstanding time options will occur upon
a change in control (as defined in the 2005 Stock Incentive
Plan) pursuant to the terms of the 2005 Stock Incentive Plan.
Immediately prior to a change in control of us, the
exercisability of the time options will automatically accelerate
with respect to 100% of the shares of our common stock subject
to the time options. In addition, subject to the holder of the
options continued employment, in the event First Reserve
Fund X, L.P. sells 100% of its interest in us to a third
party prior to October 17, 2008 and, as a result of such
sale, the Fund X Net Return is less than 2.50 times the
Fund X Investment, but an internal rate of return of
greater than 30% is realized, the performance options will
accelerate with respect to 45% of the shares of our common stock
subject to the performance option.
Immediately upon any change in control (as defined in our
Amended and Restated Voluntary Deferred Income Plan)
Mr. Thomas interest in all amounts credited to his
account under the plan shall fully and immediately vest and
become nonforfeitable. There currently are no company
contributions credited to Mr. Thomas account or any
other employees account under this plan. In addition, our
executive officers may receive payments under our Incentive
Compensation Plan following a change in control (as defined in
the Incentive Compensation Plan) if the compensation committee
determines the performance criteria have been met, as described
above under Elements of Compensation Annual
and Other Cash Incentive Awards.
For more information on change in control and severance
benefits, see Other Potential Post-Employment
Payments below.
Anticipated
Changes in Executive Compensation
Our executive compensation programs will continue in their
current form until such time as the compensation committee
determines in its discretion that revisions to our current plans
or replacement plans are advisable. As discussed above, our
compensation committee presently is undertaking a review of our
entire executive compensation program for our executive
officers, with the assistance of an independent outside
compensation consulting firm engaged by the committee. This
review and determinations of our compensation committee may
result in changes in our compensation arrangements and analysis
in the future, including the peers against which our committee
measures executive compensation, changes in equity or other
long-term incentives, and other changes as the committee may
determine.
As mentioned above, following our initial public offering, the
membership of the compensation committee was altered to include
two independent directors. Since May 23, 2007, our
compensation committee has consisted solely of independent
directors.
85
2006
Summary Compensation Table
The following table and related notes and discussion summarize
compensation earned for our 2006 fiscal year by our four
executive officers who served as executive officers during and
at the end of 2006, who we refer to as our named executive
officers, presented in accordance with SEC rules.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
Non-Equity
|
|
|
All Other
|
|
|
|
|
Name and Principal
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
Total
|
|
Position
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
($)(1)
|
|
|
Compensation(2)
|
|
|
($)(3)
|
|
|
($)
|
|
|
Samuel F. Thomas
|
|
|
2006
|
|
|
$
|
400,000
|
|
|
|
|
|
|
$
|
384,618
|
|
|
$
|
660,000
|
|
|
$
|
30,404
|
|
|
$
|
1,475,022
|
|
(Chairman, Chief Executive Officer
and President)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael F. Biehl
|
|
|
2006
|
|
|
$
|
235,000
|
|
|
|
|
|
|
$
|
115,385
|
|
|
$
|
352,500
|
|
|
$
|
33,089
|
|
|
$
|
735,974
|
|
(Executive Vice President, Chief
Financial Officer and Treasurer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matthew J. Klaben
|
|
|
2006
|
|
|
$
|
146,977
|
|
|
$
|
25,000
|
(5)
|
|
$
|
169,021
|
|
|
$
|
202,650
|
|
|
$
|
10,818
|
|
|
$
|
554,466
|
|
(Vice President, General Counsel
and Secretary)(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James H. Hoppel, Jr.
|
|
|
2006
|
|
|
$
|
153,000
|
|
|
|
|
|
|
$
|
52,178
|
|
|
$
|
138,600
|
|
|
$
|
36,993
|
|
|
$
|
380,771
|
|
(Chief Accounting Officer,
Controller and Assistant Treasurer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The option awards and the dollar values included in the option
awards column are set forth in the table below. These awards
were all granted pursuant to the 2005 Stock Incentive Plan and
include awards granted in and prior to 2006. The dollar values
shown in the table above are the aggregate dollar amounts
recognized for financial statement reporting purposes for the
fiscal year ended December 31, 2006, in accordance with
SFAS 123(R), Share-Based Payment, and SEC rules
for executive compensation disclosure. The following assumptions
were used in calculating the amounts listed: |
|
|
|
The fair value of the options granted on November 23, 2005
was estimated using the Black-Scholes option pricing model with
the following weighted average assumptions: risk-free interest
rate of 4.80 percent; dividend yields of 0.0 percent;
volatility factors of the expected market price of the
Companys common shares of 47.0 percent and a weighted
average expected life of 7.5 years for the options. |
|
|
|
The fair value of the options granted on March 29, 2006 was
estimated using the Black-Scholes option pricing model with the
following weighted average assumptions: risk-free interest rate
of 5.0 percent; dividend yields of 0.0 percent;
volatility factors of the expected market price of the
Companys common shares of 47.0 percent and a weighted
average expected life of 7.5 years for the options. |
|
|
|
The fair value of the options granted on April 27, 2006 was
estimated using the Black-Scholes option pricing model with the
following weighted average assumptions: risk-free interest rate
of 5.3 percent; dividend yields of 0.0 percent;
volatility factors of the expected market price of the
Companys common shares of 47.0 percent and a weighted
average expected life of 7.5 years for the options. |
|
|
|
Volatility was calculated using an average of the Predecessor
Companys historical closing stock price on the OTCBB from
October 2, 2003 to October 14, 2005. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Options(x)
|
|
|
Time Options(y)
|
|
|
|
|
|
|
|
|
|
Compensation
|
|
|
|
|
|
|
|
|
Compensation
|
|
|
|
|
|
|
Number of
|
|
|
Expense
|
|
|
|
|
|
Number of
|
|
|
Expense
|
|
|
|
Grant Date
|
|
|
Options
|
|
|
($)(z)
|
|
|
Grant Date
|
|
|
Options
|
|
|
($)(z)
|
|
|
Samuel F. Thomas
|
|
|
11/23/2005
|
|
|
|
435,215
|
|
|
$
|
|
|
|
|
11/23/2005
|
|
|
|
237,388
|
|
|
$
|
384,618
|
|
Michael F. Biehl
|
|
|
11/23/2005
|
|
|
|
130,563
|
|
|
$
|
|
|
|
|
11/23/2005
|
|
|
|
71,216
|
|
|
$
|
115,385
|
|
Matthew J. Klaben
|
|
|
3/29/2006
|
|
|
|
64,735
|
|
|
$
|
|
|
|
|
3/29/2006
|
|
|
|
34,857
|
|
|
$
|
169,021
|
|
James H. Hoppel, Jr.
|
|
|
11/23/2005
|
|
|
|
43,525
|
|
|
$
|
|
|
|
|
11/23/2005
|
|
|
|
23,738
|
|
|
$
|
38,462
|
|
|
|
|
4/27/2006
|
|
|
|
5,826
|
|
|
$
|
|
|
|
|
4/27/2006
|
|
|
|
3,137
|
|
|
$
|
13,716
|
|
|
|
|
|
(x)
|
Performance option grants are described below under Equity
and Incentive Plan Awards Amended and Restated Chart
Industries, Inc. 2005 Stock Incentive Plan and generally
become exercisable based on
|
86
|
|
|
|
|
the Fund X Net Return which is based on the
amount received by First Reserve Fund X, L.P. in respect of
its investment in us, as described below under Equity and
Incentive Plan Awards Amended and Restated Chart
Industries, Inc. 2005 Stock Incentive Plan. None of the
performance options have vested and we have not been able to
predict when or if the Fund X Net Return will reach a
minimum threshold amount or other events will occur that will
result in any performance option grants ever becoming
exercisable. Accordingly, under applicable accounting rules, we
did not recognize any expense with respect to these options for
2006. We may record additional stock-based compensation expense
in future periods related to the performance options granted
under the 2005 Stock Incentive Plan to the named executive
officers, if it becomes probable that any of the future
performance criteria will be achieved. Primarily as a result of
the vesting of the performance-based options based on the
Fund X Net Return upon completion of this offering, we
estimate that we will incur a pre-tax, non-cash stock-based
compensation expense of approximately $7.0 million in the
period in which this offering is consummated.
|
|
|
|
|
(y)
|
Time option grants are described below under Equity and
Incentive Plan Awards Amended and Restated Chart
Industries, Inc. 2005 Stock Incentive Plan and become
exercisable annually and ratably over five years after the grant
date as described below under Equity and Incentive Plan
Awards Amended and Restated Chart Industries, Inc.
2005 Stock Incentive Plan.
|
|
|
|
|
(z)
|
Aggregate dollar amounts recognized as stock-based compensation
expense for financial statement reporting purposes under
SFAS 123(R) for fiscal 2006.
|
|
|
|
(2) |
|
Reflects amounts of incentive compensation earned under our 2006
Bonus Plan. Our compensation committee determined that our
financial performance for 2006 has exceeded the maximum target
levels for each named executive officer performance measure
under the 2006 Bonus Plan. We paid the 2006 Bonus Plan cash
payments to our named executive officers on March 15, 2007. |
|
(3) |
|
All Other Compensation includes the following payments made on
behalf of our executive officers. All amounts are calculated
based on the aggregate incremental actual cost, in dollars, to
us of the benefit listed. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Perquisites
|
|
|
|
|
|
|
|
|
|
|
|
|
and Other
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
Personal
|
|
|
Contributions
|
|
|
|
|
|
|
|
|
|
Benefits
|
|
|
to 401(k) Plan
|
|
|
Total
|
|
|
|
Year
|
|
|
($)(x)
|
|
|
($)(y)
|
|
|
($)
|
|
|
Samuel F. Thomas
|
|
|
2006
|
|
|
$
|
12,000
|
|
|
$
|
18,404
|
|
|
$
|
30,404
|
|
Michael F. Biehl
|
|
|
2006
|
|
|
$
|
12,000
|
|
|
$
|
21,089
|
|
|
$
|
33,089
|
|
Matthew J. Klaben
|
|
|
2006
|
|
|
$
|
7,200
|
|
|
$
|
3,618
|
|
|
$
|
10,818
|
|
James H. Hoppel, Jr.
|
|
|
2006
|
|
|
$
|
16,867
|
|
|
$
|
20,126
|
|
|
$
|
36,993
|
|
|
|
|
|
(x)
|
In 2006, each of the named executive officers received an
automobile allowance. In addition to his automobile allowance in
the amount of $9,600, Mr. Hoppel received a travel
allowance in the amount of $7,267 in connection with his efforts
related to our initial public offering.
|
|
|
(y)
|
Includes 401(k) plan matching contributions made by us and
401(k) plan profit sharing. Company contributions under our
401(k) plan for 2006 are subject to adjustment downward based on
nondiscrimination testing in the first quarter of 2007.
|
|
|
|
(4) |
|
Mr. Klaben joined our company on March 29, 2006. |
|
(5) |
|
Mr. Klaben received a $25,000 signing bonus in connection
with commencement of his employment with us in March 2006. |
87
2006
Grants of Plan-Based Awards Table
The following table and related notes and discussion summarize
grants of equity and non-equity incentive compensation awards to
our named executive officers for our 2006 fiscal year, presented
in accordance with SEC rules.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Future Payouts
|
|
|
Number of
|
|
|
Exercise or
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Future Payouts Under
|
|
|
Under Equity
|
|
|
Securities
|
|
|
Base Price
|
|
|
Grant Date
|
|
|
|
|
|
|
|
|
|
Non-Equity Incentive Plan Awards
|
|
|
Incentive Plan Awards
|
|
|
Underlying
|
|
|
of Option
|
|
|
Fair Value
|
|
|
|
|
|
|
Approval
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Options
|
|
|
Awards
|
|
|
of Option
|
|
Name
|
|
Grant Date
|
|
|
Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)
|
|
|
($/Sh)(3)
|
|
|
Awards
|
|
|
Samuel F. Thomas
|
|
|
|
(1)
|
|
|
|
|
|
$
|
|
|
|
$
|
440,000
|
|
|
$
|
660,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael F. Biehl
|
|
|
|
(1)
|
|
|
|
|
|
$
|
|
|
|
$
|
235,000
|
|
|
$
|
352,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matthew J. Klaben
|
|
|
|
(1)
|
|
|
|
|
|
$
|
|
|
|
$
|
135,100
|
|
|
$
|
202,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3/29/2006
|
(2)
|
|
|
3/22/2006
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,857
|
|
|
$
|
12.16
|
(3)
|
|
$
|
487,709
|
|
|
|
|
3/29/2006
|
(4)
|
|
|
3/22/2006
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,889
|
(4)
|
|
$
|
|
|
|
|
64,735
|
(4)
|
|
|
|
|
|
$
|
12.16
|
(3)
|
|
$
|
|
|
James H. Hoppel, Jr.
|
|
|
|
(1)
|
|
|
|
|
|
$
|
|
|
|
$
|
92,400
|
|
|
$
|
138,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4/27/2006
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,137
|
|
|
$
|
12.16
|
(3)
|
|
$
|
44,036
|
|
|
|
|
4/27/2006
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,340
|
(4)
|
|
$
|
|
|
|
|
5,826
|
(4)
|
|
|
|
|
|
$
|
12.16
|
(3)
|
|
$
|
|
|
|
|
|
(1)
|
|
Granted pursuant to the Chart
Industries, Inc. 2006 Bonus Plan, described in Equity and
Incentive Plan Awards 2006 Chart Executive Incentive
Compensation Plan below.
|
|
(2)
|
|
Time options granted pursuant to
the 2005 Stock Incentive Plan, described in Equity and
Incentive Plan Awards Amended and Restated Chart
Industries, Inc. 2005 Stock Incentive Plan below.
|
|
(3)
|
|
In March 2006, we hired an
independent valuation firm to determine the fair market value of
our common stock as of March 31, 2006. All stock options
granted to our employees, including our executive officers,
during fiscal 2006 and prior to our initial public offering were
granted at fair market value on the grant date in accordance
with the valuation determined by our independent, outside
valuation firm. The value of these options is reflected in our
consolidated financial statements, based upon the applicable
accounting guidance, using a fair market value formulation
derived from the price at which we initially proposed to offer
our stock to the public in our initial public offering, which
was significantly higher than the price at which we actually
offered our stock to the public.
|
|
(4)
|
|
Performance options granted
pursuant to the 2005 Stock Incentive Plan, as described in
Equity and Incentive Plan Awards Amended and
Restated Chart Industries, Inc. 2005 Stock Incentive Plan
below. The performance options become exercisable based upon the
Fund X Net Return, which is the amount received
by First Reserve Fund X, L.P. in cash (and/or
in-kind
based upon the fair market value of securities or other property
received by First Reserve) in respect of its investment in us
divided by the amount of the investment by First Reserve
Fund X, L.P. in us, which we refer to as the Fund X
Investment. In the event the Fund X Net Return is less than
2.25 times the Fund X Investment, the performance options
will be cancelled. If the Fund X Net Return is 2.25 times
the Fund X Investment, then 23% of the performance options
will vest, which we have presented in the table above as the
threshold amount. Subject to the holder of the
options continued employment, in the event First Reserve
Fund X, L.P. sells 100% of its interest in us to a third
party prior to October 17, 2008 and, as a result of such
sale, the Fund X Net Return is less than 2.50 times the
Fund X Investment, but an internal rate of return of
greater than 30% is realized by First Reserve Fund X, L.P.,
the performance options granted prior to completion of our
initial public offering will vest with respect to 45% of the
shares of our common stock subject to the performance options.
In the event the Fund X Net Return is 4.00 times the
Fund X Net Investment or greater, the performance options
granted prior to completion of our initial public offering will
vest with respect to 100% of the shares of our common stock
subject to performance options which we have presented in the
table above as the maximum amount. No
target amount is presented for the performance
options, as the vesting of the performance options is based
entirely on the Fund X Net Return and there is no target
for that measure.
|
88
Discussion
of Summary Compensation Table and Grants of Plan-Based Awards
Table
We are party to an employment agreement with each of our named
executive officers. Each employment agreement sets forth the
terms of that officers employment, including among other
things, salary, bonus, certain non-equity incentive plan
benefits and other compensation. Certain material terms of each
executive officers employment agreement are described
below. For more terms, including post-termination and
restrictive covenants, see Other Potential Post-Employment
Payments Restrictive Covenants that Apply During and
After Termination of Employment.
In 2006, we granted time options and performance options to each
of Mr. Klaben and Mr. Hoppel. The material terms of
the grants and the 2005 Stock Incentive Plan under which they
were granted are described below. See Equity
and Incentive Plan Awards Amended and Restated Chart
Industries, Inc. 2005 Stock Incentive Plan.
Samuel
F. Thomas
On November 23, 2005, we entered into an employment
agreement with Samuel F. Thomas, pursuant to which
Mr. Thomas serves as our Chairman, Chief Executive Officer
and President for a three year rolling term. Under the
agreement, Mr. Thomas is entitled to an annual base salary
of $450,000 for 2007 payable in regular installments in
accordance with our usual payroll practices. Mr. Thomas is
also eligible to earn an annual bonus award, for each full year
during the term of his employment agreement, of up to 150% of
his annual bonus target, which target for calendar year 2006 was
$440,000 and for calendar year 2007 is $495,000 under our
Incentive Compensation Plan and may be increased in the sole
discretion of our board of directors, based upon the achievement
of annual performance targets established by our board.
Mr. Thomas is also generally entitled to participate in our
employee benefit plans on the same basis as those benefits are
generally made available to our other senior executives. Under
the employment agreement, Mr. Thomas is entitled to receive
an automobile allowance in the amount of $1,000 per month.
Michael
F. Biehl
On December 1, 2005, we entered into an employment
agreement with Michael F. Biehl, pursuant to which
Mr. Biehl serves as our Executive Vice President, Chief
Financial Officer and Treasurer for a two year rolling term.
Under the agreement, Mr. Biehl is entitled to an annual
base salary of $245,000 for 2007 payable in regular installments
in accordance with our usual payroll practices. Mr. Biehl
is also eligible to earn an annual bonus award, for each full
year during the term of his employment agreement, of up to 150%
of his annual base salary, based upon the achievement of annual
performance targets established by our board under our Incentive
Compensation Plan. Mr. Biehl is also generally entitled to
participate in our employee benefit plans on the same basis as
those benefits are generally made available to our other senior
executives. Under the employment agreement, Mr. Biehl is
entitled to receive an automobile allowance in the amount of
$1,000 per month.
Matthew
J. Klaben
On March 29, 2006, we entered into an employment agreement
with Matthew J. Klaben, pursuant to which Mr. Klaben serves
as our Vice President and General Counsel for a rolling one year
term. Under the agreement, Mr. Klaben is entitled to an
annual base salary of $200,000 for 2007, payable in regular
installments in accordance with our usual payroll practices.
Mr. Klaben received a one-time $25,000 signing bonus in
2006 and is eligible to earn an annual bonus award, for each
full year during the term of his employment agreement, of up to
105% of his annual base salary, based upon the achievement of
annual performance targets established by our board under our
Incentive Compensation Plan. Mr. Klaben is also generally
entitled to participate in our employee benefit plans on the
same basis as those benefits are generally made available to our
other senior executives. Under the employment agreement,
Mr. Klaben is entitled to receive an automobile allowance
in the amount of $800 per month.
James
H. Hoppel, Jr.
On May 5, 2006, we entered into an employment agreement
with James H. Hoppel, Jr. pursuant to which Mr. Hoppel
serves as our Chief Accounting Officer, Controller and Assistant
Treasurer for a rolling term of one year. Under the agreement,
Mr. Hoppel is entitled to an annual base salary of $170,000
for 2007, payable in regular
89
installments in accordance with our usual payroll practices.
Mr. Hoppel is also eligible to earn an annual bonus award
for the 2007 fiscal year and subsequent years during the term of
his employment agreement, of up to 97.5% of his annual base
salary, based upon the achievement of annual performance targets
established by our board under our Incentive Compensation Plan.
Mr. Hoppel is also generally entitled to participate in our
employee benefit plans on the same terms as those benefits are
generally made available to our other senior executives. Under
the employment agreement, Mr. Hoppel is entitled to receive
an automobile allowance in the amount of $800 per month.
Our compensation committee has determined that our financial
performance for 2006 has exceeded the maximum target levels for
each named executive officer performance measure under our 2006
Bonus Plan. Accordingly, we paid the following cash incentive
bonuses to our named executive officers under the 2006 Bonus
Plan on March 15, 2007: Mr. Thomas, $660,000,
Mr. Biehl, $352,500; Mr. Klaben, $202,650; and
Mr. Hoppel, $138,600. Based on these amounts, each
executive officers salary paid for 2006 and incentive
bonus under the 2006 Bonus Plan accounts for the following
percentage of his total 2006 compensation, respectively, based
on the total amount shown in the 2006 Summary Compensation
Table: Mr. Thomas, 27% and 45%; Mr. Biehl, 32% and
48%; Mr. Klaben, 27% and 37%; and Mr. Hoppel, 40% and
36%.
Equity
and Incentive Plan Awards
2006
Chart Executive Incentive Compensation Plan
Cash bonuses payable to the executive officers are payable
pursuant to and in accordance with the 2006 Bonus Plan. We
adopted the 2006 Bonus Plan effective March 1, 2006. The
2006 Bonus Plan was approved by our stockholders on
July 18, 2006. The material performance targets under the
2006 Bonus Plan, as established by the compensation committee of
the board, include working capital and EBITDA targets.
Management believes that EBITDA is a typical performance measure
among private equity portfolio companies, and EBITDA and working
capital also reflect key performance measures used to track our
companys value, operational performance and cash flow
externally and internally. If our performance relative to the
2006 Bonus Plans targets exceeds threshold amounts,
participants may earn a bonus of up to a pre-determined
percentage of the participants base salary, ranging from
90% to 165% of the participants base salary at maximum
performance levels. Actual performance below the minimum
performance threshold for a performance objective will result in
no payment based on that objective. Our compensation committee
has determined that our financial performance for 2006 has
exceeded the maximum target levels for each named executive
officer performance measure under the 2006 Bonus Plan. We paid
the cash payments to our named executive officers set forth in
the 2006 Summary Compensation Table under the caption
Non-Equity Incentive Plan Compensation.
Amended
and Restated Chart Industries, Inc. 2005 Stock Incentive
Plan
We initially adopted the 2005 Stock Incentive Plan effective
November 23, 2005. We adopted the amended and restated 2005
Stock Incentive Plan on July 17, 2006 and the 2005 Stock
Incentive Plan was approved by our stockholders on July 18,
2006.
The 2005 Stock Incentive Plan provides for the grant of
(1) options that are not incentive stock options,
(2) stock appreciation rights, which we refer to as SARs,
(3) restricted stock, (4) restricted stock units, and
(5) other stock-based grants, including the shares of our
common stock sold to our non-employee directors, executive
officers, other key employees and consultants. As of
April 30, 2007, there were 3,414,916 shares of common
stock reserved for issuance under the 2005 Stock Incentive Plan.
The 2005 Stock Incentive Plan is administered by our board of
directors, which has delegated its duties and powers in whole or
in part to our compensation committee. The committee has the
full power and authority to establish the terms and conditions
of any award consistent with the provisions of the 2005 Stock
Incentive Plan and to waive any such terms and conditions at any
time. The committee also has the authority to grant awards under
the 2005 Stock Incentive Plan. The committee is authorized to
interpret the 2005 Stock Incentive Plan, to establish, amend and
rescind any rules and regulations relating to the 2005 Stock
Incentive Plan and to make any other determinations that it
deems necessary or desirable for the administration of the 2005
Stock Incentive Plan. The
90
committee is authorized to correct any defect or supply any
omission or reconcile any inconsistency in the 2005 Stock
Incentive Plan in the manner and to the extent the committee
deems necessary or desirable.
The exercise price per share for options is equal to the fair
market value on the applicable date of grant, subject to any
adjustments to outstanding options permitted in connection with
significant transactions, such as our initial public offering.
An option holder may exercise an option by written notice and
payment of the exercise price (1) in cash, (2) to the
extent permitted by the board, by the surrender of a number of
shares of common stock already owned by the option holder for at
least six months (or such other period as established from time
to time by the board to avoid adverse accounting treatment
applying generally accepted accounting principles), (3) in
a combination of cash and shares of common stock (as qualified
by clause (2)), (4) through the delivery of
irrevocable instructions to a broker to sell shares obtained
upon the exercise of the option and deliver to us an amount
equal to the exercise price for the shares of common stock being
purchased or (5) through such cashless exercise procedures
as the board may permit. Option holders who are subject to the
withholding of federal and state income tax as a result of
exercising an option may satisfy the income tax withholding
obligation through the withholding of a portion of the shares of
common stock to be received upon exercise of the option.
Prior to completion of our initial public offering, we granted
under the 2005 Stock Incentive Plan options to acquire an
aggregate of 2,441,190 shares of common stock as
non-qualified stock options. In fiscal 2006, Mr. Klaben was
awarded an option to purchase 99,592 shares of our common stock,
consisting of time options to purchase 34,857 shares of our
common stock and performance options to purchase 64,735 shares
of our common stock, in connection with the commencement of his
employment as Vice President, General Counsel and Secretary of
the company on March 29, 2006, and Mr. Hoppel was
awarded an option to purchase 8,963 shares of our common stock,
consisting of a time option to purchase 3,137 shares of our
common stock and a performance option to purchase
5,826 shares of our common stock, in connection with grants
to a number of employees prior to our initial public offering to
incentivize their future service to us, on April 27, 2006.
Each of the options granted prior to the initial public
offering, including those granted on March 29 and April 27,
2006, have similar terms, which are as follows: approximately
35% vest and become exercisable over the passage of time, which
we refer to as time options, assuming the holder
thereof continues to be employed by us, and the remaining
portion vests and becomes exercisable based upon the achievement
of certain performance targets, which we refer to as
performance options. The time options become
exercisable by the holder of the option in installments of 20%
on each of the first five anniversaries of the grant date. The
performance options become exercisable based upon the
Fund X Net Return. Each of the options granted on March 29
and April 27, 2006, as listed in the table above, have a
10-year term
unless they are earlier terminated. See
Executive Compensation
Compensation Discussion and Analysis Amended and
Restated 2005 Stock Incentive Plan.
Immediately prior to a change in control of us (as defined in
the 2005 Stock Incentive Plan), the exercisability of the time
options granted prior to completion of our initial public
offering will automatically accelerate with respect to 100% of
the shares of our common stock subject to the unvested time
options. In addition, subject to the holder of the options
continued employment, in the event First Reserve Fund X,
L.P. sells 100% of its interest in us to a third party prior to
October 17, 2008 and, as a result of such sale, the
Fund X Net Return is less than 2.50 times the Fund X
Investment, but an internal rate of return of greater than 30%
is realized by First Reserve Fund X, L.P., the performance
options granted prior to completion of our initial public
offering will vest with respect to 45% of the shares of our
common stock subject to the performance option. As of the date
of this prospectus, we have made additional stock option grants
to employees other than executive officers covering an aggregate
of 50,000 shares of common stock since completion of our
initial public offering, but we have made no additional grants
of stock options to executive officers. We have also made grants
of restricted stock units to non-employee directors, as
described below. See Director Compensation.
91
2006
Outstanding Equity Awards at Fiscal Year-End Table
The following table and related notes and discussion present
information about equity awards held by our named executive
officers at December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
of
|
|
|
Number of
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
Securities
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
|
|
|
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Unearned
|
|
|
Option
|
|
|
Option
|
|
|
|
Options (#)
|
|
|
Options (#)
|
|
|
Options
|
|
|
Exercise
|
|
|
Expiration
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable(1)
|
|
|
(#)
|
|
|
Price ($)
|
|
|
Date
|
|
|
Samuel F. Thomas
|
|
|
|
|
|
|
|
|
|
|
100,099
|
(3)
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
|
|
|
47,478
|
|
|
|
189,910
|
(2)
|
|
|
|
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
Michael F. Biehl
|
|
|
|
|
|
|
|
|
|
|
30,029
|
(3)
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
|
|
|
14,243
|
|
|
|
56,973
|
(2)
|
|
|
|
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
Matthew J. Klaben
|
|
|
|
|
|
|
|
|
|
|
14,889
|
(3)(7)
|
|
$
|
12.16
|
|
|
|
3/29/2016
|
|
|
|
|
|
|
|
|
34,857
|
(4)(6)
|
|
|
|
|
|
$
|
12.16
|
|
|
|
3/29/2016
|
|
James H. Hoppel, Jr.
|
|
|
|
|
|
|
|
|
|
|
10,011
|
(3)
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
|
|
|
4,748
|
|
|
|
18,990
|
(2)
|
|
|
|
|
|
$
|
6.50
|
|
|
|
11/23/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
1,340
|
(3)(7)
|
|
$
|
12.16
|
|
|
|
4/27/2016
|
|
|
|
|
|
|
|
|
3,137
|
(5)(6)
|
|
|
|
|
|
$
|
12.16
|
|
|
|
4/27/2016
|
|
|
|
|
(1)
|
|
The securities underlying
unexercised options which are unexercisable are also included in
the aggregate dollar amount recognized for financial statement
reporting purposes, in accordance with SFAS 123(R) and SEC
rules for executive compensation disclosure, in the Option
Awards column of the 2006 Summary Compensation Table.
|
(2)
|
|
These securities underlying
unexercised options represent time options granted under the
2005 Stock Incentive Plan on November 23, 2005, which will
vest ratably on each of November 23, 2007, 2008, 2009 and
2010.
|
(3)
|
|
These securities underlying
unexercised options represent performance options granted under
the 2005 Stock Incentive Plan. The performance options become
exercisable based upon the Fund X Net Return,
which is the amount received by First Reserve Fund X, L.P.
in cash (and/or in-kind based upon the fair market value of
securities or other property received by First Reserve
Fund X, L.P.) in respect of its investment in us divided by
the amount of the investment by First Reserve Fund X, L.P.
in us, which we refer to as the Fund X Investment. The
performance options are reported in the table above based on our
achieving threshold performance levels, or a Fund X Net
Return of 2.25 times the Fund X Investment, at which
level 23% of the performance options would vest. At a
Fund X Net Return below that level, no performance options
would become exercisable, except that, subject to the holder of
the options continued employment, in the event First
Reserve sells 100% of its interest in us to a third party prior
to October 17, 2008 and, as a result of such sale, the
Fund X Net Return is less than 2.50 times the Fund X
Investment, but an internal rate of return of greater than 30%
is realized by First Reserve Fund X, L.P., the performance
options granted prior to completion of our initial public
offering will vest with respect to 45% of the shares of our
common stock subject to the performance option. This measure has
not been used for purposes of presenting the table above, as it
was not possible on December 31, 2006 to estimate when
First Reserve Fund X, L.P. may sell 100% of its investment
in us. See Equity and Incentive Plan Awards
Amended and Restated Chart Industries, Inc. 2005 Stock Incentive
Plan for more information about these options and the 2005
Stock Incentive Plan.
|
(4)
|
|
These securities underlying
unexercised options represent time options granted under the
2005 Stock Incentive Plan, which will vest ratably on each of
March 29, 2007, 2008, 2009, 2010 and 2011.
|
(5)
|
|
These securities underlying
unexercised options represent time options granted under the
2005 Stock Incentive Plan, which will vest ratably on each of
April 27, 2007, 2008, 2009, 2010 and 2011.
|
(6)
|
|
These stock options are also
included in the All Other Option Awards column of
the 2006 Grants of Plan-Based Awards Table.
|
(7)
|
|
These stock options are also
included in the Estimated Future Payouts Under Equity
Incentive Plan Awards column of the 2006 Grants of
Plan-Based Awards Table.
|
92
2006
Option Exercises and Stock Vested Table
The following table and related notes and discussion present
information about the number of shares issued upon option
exercises, and the value realized on exercise, by our named
executive officers in 2006.
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares
|
|
|
Value
|
|
|
|
Acquired
|
|
|
Realized
|
|
|
|
on Exercise
|
|
|
on Exercise
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
Samuel F. Thomas
|
|
|
437,645
|
(1)(2)
|
|
$
|
9,924,381
|
(3)
|
Michael F. Biehl
|
|
|
24,505
|
(1)(2)
|
|
$
|
555,708
|
(3)
|
|
|
|
(1) |
|
These stock options, which were granted under our 2004 Stock
Plan, were exercised on May 19, 2006, prior to our initial
public offering. The options became exercisable on multiple
dates on or before October 17, 2005. |
|
(2) |
|
The number of shares acquired on exercise has been adjusted to
give effect to a 4.6263-for-one stock split of our common stock
that occurred on July 20, 2006. |
|
(3) |
|
In March 2006, we hired an independent valuation firm to
determine the fair market value of our common stock as of
March 31, 2006. The value realized upon exercise is based
on the difference between that fair market value, as determined
by the independent valuation firm (which we consider to be the
fair market value of our stock on May 19, 2006), and the
pre-initial public offering exercise price of the options. The
fair market value of our stock on May 19, 2006, the date of
option exercise, before our initial public offering, is not
comparable to the fair market value of our stock after our
initial public offering as a result of the significant changes
to our equity capital structure that took place immediately
before and as part of our initial public offering. The value
realized upon exercise has not been adjusted to reflect the
income and other taxes paid or owed by Messrs. Thomas and
Biehl upon exercise of the options, which were substantial and
all of which have been borne personally by Messrs. Thomas
and Biehl. |
2006
Nonqualified Deferred Compensation Table
The following table and related notes and discussion present
information about the amount of compensation deferred, and the
earnings accrued thereon, by our named executive officers in
2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate
|
|
|
|
Executive
|
|
|
Registrant
|
|
|
Aggregate
|
|
|
Aggregate
|
|
|
Balance
|
|
|
|
Contributions in
|
|
|
Contributions in
|
|
|
Earnings
|
|
|
Withdrawals/
|
|
|
at Last
|
|
|
|
Last FY
|
|
|
Last FY
|
|
|
in Last FY
|
|
|
Distributions
|
|
|
FYE
|
|
Name
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Samuel F. Thomas
|
|
$
|
99,600
|
(1)
|
|
$
|
|
|
|
$
|
10,354
|
|
|
$
|
|
|
|
$
|
109,954
|
|
|
|
|
(1) |
|
The amount of executive contributions listed in the table was
included in the aggregate amount of bonus earned by
Mr. Thomas in the bonus column of our 2005 Summary
Compensation Table. |
Pursuant to the Companys Amended and Restated Chart
Industries, Inc. Voluntary Deferred Income Plan (the
Deferred Income Plan), eligible employees are
entitled to elect to defer up to 100% of their compensation,
consisting of total salary, bonuses and commissions payable in a
calendar year. Regardless of the circumstances under which a
participants relationship with the Company terminates, all
deferrals made pursuant to the plan will be fully vested.
Contributions made by the Company, and any gains or losses on
such contributions, vest as follows: 33% upon completion of one
year of participation; 67% upon completion of two years of
participation; and 100% upon completion of three years of
participation in the plan. Elections are made by participants in
the taxable year immediately prior to the taxable year to which
the deferral pertains, and are effective as of the first day of
such taxable year. The Deferred Income Plan is unfunded and all
benefits under the plan are payable solely from the general
assets of the Company.
Benefits under the Deferred Income Plan are payable upon the
participants reaching his or her normal or early
retirement date or termination of employment. Payments are made
either in a lump sum, or in equal annual installments for a
period of years, as designated by the participant at the time of
deferral. Payments may be
93
accelerated under the Deferred Income Plan in the event that
(1) a participants interest upon termination does not
exceed $10,000; (2) a plan interest is awarded to a former
spouse of a participant under court order; (3) a
change in control (as defined under the operation of
the Deferred Income Plan) occurs; (4) a participant has an
unforeseeable emergency; (5) a participant becomes
disabled; or (6) death occurs prior or subsequent to
commencement or completion of payment of benefits, respectively.
In no event may a participant receive more than one distribution
as a result of an unforeseeable emergency in any calendar year.
A participant may also elect to receive an in-service
distribution at the time of completing an election of deferral,
and such payment is payable in a lump sum on the in-service
withdrawal date. For information regarding post-termination
payments under the plan, see Other Potential
Post-Employment Payments.
Participants in the Deferred Income Plan may direct the
investment of their balance held within the plan among a number
of alternative investment fund options, and earnings and losses
on participants investments are determined based on the
individual performance of the underlying investment options. A
participant may regularly change their investment allocation
within the plan. A rabbi trust has been established under the
plan to hold assets separate from our other assets for the
purpose of paying future participant benefit obligations. Assets
held in the rabbi trust are available to our general creditors
in the event of our insolvency.
Notwithstanding anything in the Deferred Income Plan to the
contrary, the Deferred Income Plan is administered in accordance
with the requirements of, or to meet the requirements for
exemption from, Section 409A of the Internal Revenue Code.
Other
Potential Post-Employment Payments
The table below reflects the amount of compensation payable to
each of the named executive officers of our company in the event
of termination of the executives employment. The amount of
compensation payable to each named executive officer upon
termination by us without Cause (as defined below) or
resignation by the executive with Good Reason (as defined
below), termination by us with Cause or resignation by the
executive without Good Reason, in the event of Disability (as
defined below) or death and termination following a Change in
Control (as defined below) are set forth below. All of the
compensation arrangements described below were put in place
prior to our initial public offering, which occurred on
July 25, 2006. Although our board of directors and
compensation committee were responsible for the implementation
of all of the payment arrangements described below, the terms of
all of the post-employment payment arrangements were subject to
the review of First Reserve directly or through its
representatives on our board of directors.
The amounts shown assume that such termination was effective as
of December 29, 2006, the last business day of 2006, and
thus include amounts earned through such time and are estimates
of the amounts which would be paid out to the executives upon
their termination. The actual amounts to be paid out can only be
determined at the time of an executives separation from
our company.
Payments
made upon Involuntary Termination for Cause or
Resignation without Good Reason
Salary, Bonus and Benefits. Pursuant to the
terms of each named executive officers employment
agreement, in the event that a named executive officer is
terminated by us for Cause or resigns for Good
Reason, he will be entitled to receive his base salary,
annual bonus and benefits, including accrued but unpaid
vacation, that are earned but unpaid as of the date of
termination in a lump sum. Under the terms of each employment
agreement, Cause is defined as the executives
willful failure to perform duties, commission of, or plea of
guilty or no contest to a felony or crime involving moral
turpitude, willful malfeasance or misconduct which is
demonstrably injurious to us or our subsidiaries, material
breach of the material terms of the agreement, commission of an
act of gross negligence, corporate waste, disloyalty or
unfaithfulness to us which adversely affects our business or
that of our subsidiaries or affiliates, or any other act or
course of conduct which will demonstrably have a material
adverse effect on us or a subsidiary or an affiliates
business. Under the terms of each employment agreement,
Good Reason is defined as any of the following
events occurring without the executives consent: a
substantial diminution in the executives position or
duties, material adverse change in reporting lines or assignment
of duties materially inconsistent with his position, or any
reduction in base salary or material reduction in employee
benefits not affecting all other senior executives.
94
Treatment of Nonqualified Stock Options. Under
the terms of the stock option agreement under which the
non-qualified stock options were awarded to the named executive
officers, in the event that a named executive officer is
terminated by us for Cause or resigns without Good Reason, the
unvested portion of all time options and all performance options
will be cancelled.
Treatment of Deferred Compensation. Under the
terms of the Deferred Income Plan, in the event that
Mr. Thomas employment is terminated due to
(i) conviction of certain crimes enumerated in the Deferred
Income Plan; or (ii) any breach of the duty of loyalty to
us, any acts of omission in the performance of his company
duties not in good faith or which involve intentional misconduct
or a knowing violation of law, or any transaction in the
performance of his company duties from which he derived an
improper personal benefit (Cause Under Deferred Income
Plan), Mr. Thomas will not be entitled to receive any
benefits or payments under the terms of the plan, other than his
deferrals, which would be paid in a lump sum.
Payments
made upon Involuntary Termination Without Cause or Resignation
for Good Reason
Salary, Bonus and Benefits. Pursuant to the
terms of each named executive officers employment
agreement, in the event that a named executive officer is
terminated by us without Cause or resigns for Good Reason, he
will be entitled to receive his base salary, annual bonus and
benefits, including accrued but unpaid vacation, that are earned
but unpaid as of the date of termination and, subject to the
execution and delivery of a release of claims against us and
compliance with the restrictive covenants described below
under Restrictive Covenants that Apply During
and After Termination of Employment, (i) the greater
of the executives current base salary or highest base
salary paid within the employment term, payable in installments
as follows: Mr. Thomas, for three years; Mr. Biehl,
for two years; Mr. Klaben and Mr. Hoppel, for one
year; and (ii) continued coverage under our group health
plans on the same basis as active employees as follows:
Mr. Thomas, for three years; Mr. Biehl, for two years;
Mr. Klaben and Mr. Hoppel, for one year. To the extent
that continued coverage is not permissible under the terms of
such plans beyond eighteen months, we may instead pay an amount
equal to the premium subsidy we would have otherwise paid on the
executive officers behalf for such coverage.
Treatment of Nonqualified Stock Options. Under
the terms of the stock option agreement under which the
non-qualified stock options were awarded to the named executive
officers, in the event that a named executive officer is
terminated by us without Cause or resigns for Good Reason,
including retirement at age 60, provided the executive has
completed ten years of service with us (Retirement),
any unvested time options will be cancelled by us without
consideration. No named executive officer was eligible for
Retirement on December 29, 2006, and accordingly, the table
below does not present any option benefits associated with
Retirement. With respect to performance options, we will
determine whether and to what extent the performance options
would have vested as of the date of such termination, based upon
the Fund X Net Return net of all expenses, taxes incurred
by us or one of our subsidiaries, and payment of management
options and based upon the fair market value of us, as
determined in good faith by the board, in its sole discretion,
assuming a hypothetical liquidation of us or the sale of us to a
third party, subject to certain appraisal rights. Any portion of
the performance options that we, or an independent investment
banker, as applicable, determines would have vested, will be
deemed vested, and the remainder of the unvested options will be
forfeited.
Treatment of Deferred Compensation. Under the
terms of the Deferred Income Plan, in the event that
Mr. Thomas employment is terminated by us without
Cause Under Deferred Income Plan or by resignation for Good
Reason, Mr. Thomas will be entitled to receive an amount
equal to his vested account, payable as a lump sum. The payment
will be made on or about the first day of the third month
following termination.
Payments
made upon Termination by Reason of Death or
Disability
Salary, Bonus and Benefits. Pursuant to the
terms of each named executive officers employment
agreement, in the event that a named executive officer is
terminated by reason of death or becomes physically or mentally
incapacitated and therefore unable to for a period of six
consecutive months or an aggregate of nine months in any
twenty-four consecutive month period to perform his duties
(Disability) he will be entitled to receive his base
salary, annual bonus and benefits, including accrued but unpaid
vacation, that are earned but unpaid as of the date of
termination and, a pro rata portion of the annual bonus, if any,
that the executive would have been entitled to receive
95
for the year in which the termination occurs, based on our
actual results for the year and the percentage of the fiscal
year that has elapsed through the date of the executives
termination of employment.
Treatment of Nonqualified Stock Options. Under
the terms of the stock option agreement under which the
non-qualified stock options were awarded to the executive
officers, in the event that a named executive officer is
terminated due to death or Disability, any time options that
would have vested in the calendar year in which such termination
occurs, will become fully vested. With respect to performance
options, we will determine whether and to what extent the
performance option would have vested as of the date of such
termination, based upon the Fund X Net Return net of all
expenses, taxes incurred by us or one of our subsidiaries, and
payment of management options and based upon the fair market
value of us, as determined in good faith by the board, in its
sole discretion, assuming a hypothetical liquidation of us or
the sale of us to a third party, subject to certain appraisal
rights. Any portion of the performance option that we, or an
independent investment banker, as applicable, determines would
have vested, will be deemed vested, and the remainder of the
unvested options will be forfeited.
Treatment of Deferred Compensation. Under the
terms of the Deferred Income Plan, in the event that
Mr. Thomas employment is terminated due to Disability
(as defined in the Deferred Income Plan), the benefit payable to
him under the Deferred Income Plan will vest, as of the date of
the disability determination. In the event that
Mr. Thomas employment is terminated due to death, we
will distribute Mr. Thomas account as soon as
practicable following the date of death. In the event that
either death or Disability occurs prior to commencement of the
payment of benefits, payments will be made as a lump sum. In the
event that Mr. Thomas employment is terminated due to
death following the commencement of the payment of benefits, but
prior to the completion of all such benefits, we will continue
to make installment payments over the remainder of the period,
as though he had survived.
Payments
made upon Expiration of Employment Term
Salary, Bonus and Benefits. Pursuant to the
terms of each named executive officers employment
agreement, in the event that the employment of a named executive
officer is terminated upon expiration of the employment term
without renewal, he will be entitled to receive his base salary,
annual bonus and benefits, including accrued but unpaid
vacation, that are earned but unpaid as of the date of
termination. No named executive officers employment
agreement could have terminated on December 29, 2006 as a
result of the rolling term of the agreement, since we could not
have provided the required notice one, two or three years before
expiration under the terms of the applicable agreement.
Accordingly, no benefits are shown in the table below related to
expiration of the employment agreement term on December 29,
2006.
Treatment of Nonqualified Stock Options. Under
the terms of the stock option agreement under which the
non-qualified stock options were awarded to the executive
officers, in the event that the employment of a named executive
officer is terminated upon expiration of the employment term
without renewal, the unvested portion of all time options and
all performance options will be cancelled by us without
consideration..
Treatment of Deferred Compensation. Under the
terms of the Deferred Income Plan, in the event that
Mr. Thomas employment is terminated upon expiration
of the employment term without renewal, Mr. Thomas will be
entitled to receive an amount equal to his vested account,
payable as a lump sum. The payment will be made on or about the
first day of the seventh month following termination.
Payments
made upon Change in Control
Salary, Bonus and Benefits. The named
executive officers employment agreements do not address
termination of employment upon a change in control. Accordingly,
any benefits or payments in such a case would be determined by
the nature of the termination of employment, such as resignation
without Good Reason, resignation with Good Reason, termination
by us for Cause, termination by us without Cause, or otherwise.
Treatment of Nonqualified Stock Options. Under
the terms of the stock option agreement under which the
non-qualified stock options were awarded to the named executive
officers, in the event of the occurrence of any of the following
events: (i) the sale or disposition, in one or a series of
related transactions, of all or substantially all, of our assets
to any person or group, other than First Reserve Fund X,
L.P., its affiliates and certain other persons, as
96
specified in the 2005 Stock Incentive Plan; (ii) any person
or group, other than First Reserve Fund X, L.P., it
affiliates and certain other persons, as specified in the 2005
Stock Incentive Plan, is or becomes the beneficial owner of more
than 50% of the total voting power of the our total stock,
including by way of merger, consolidation, tender or exchange
offer or otherwise; or (iii) during any period of two
consecutive years, individuals who at the beginning of such
period constituted the board (together with any new directors
whose election by such board or whose nomination for election by
our stockholders was approved by a vote of a majority of our
directors, then still in office, who were either directors at
the beginning of such period or whose election or nomination for
election was previously so approved) cease for any reason to
constitute a majority of the board then in office (each, a
Change in Control), the time options will
immediately become fully vested and exercisable.
Treatment of Deferred Compensation. Under the
terms of the Deferred Income Plan, in the event that (1) a
person other than our employee stock ownership trust, becomes
the beneficial owner, directly or indirectly, of our outstanding
common stock having 51% or more of the total number of votes
which may be cast for directors; or (2) during any period
of two consecutive years, individuals who at the beginning of
such period constituted the board of directors (together with
any new directors whose election by such board or whose
nomination for election by the our stockholders was approved by
a vote of two-thirds of the our directors, then still in office,
who were either directors at the beginning of such period) cease
for any reason to constitute a majority of the board, then in
office, Mr. Thomas interest in all amounts credited
to his account under the plan will fully and immediately vest
and become nonforfeitable.
Restrictive
Covenants that Apply During and After Termination of
Employment
Each of Messrs. Thomas, Biehl, Klaben and Hoppel is also
subject under the terms of his employment agreement to a
customary covenant not to disclose confidential information
during the term of his employment and at all times thereafter
and to customary covenants not to compete and not to solicit
employees or customers during the employment term and for
(a) three years following termination of employment for any
reason, in the case of Mr. Thomas, (b) two years
following termination of employment for any reason, in the case
of Mr. Biehl, and (c) one year following termination
of employment for any reason, in the case of Messrs. Klaben
and Hoppel.
Assuming that the employment of each named executive officer was
terminated under each of the following circumstances on
December 29, 2006, the last business day of 2006, and based
on the terms of the applicable agreements and plans described
above, payments made and benefits provided would have the
following estimated values:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
Termination for
|
|
|
Termination without
|
|
|
|
|
|
|
|
|
|
Cause/Resignation by
|
|
|
Cause/Resignation by
|
|
|
|
|
|
|
|
|
|
Executive without
|
|
|
Executive for
|
|
|
|
|
|
Change in
|
|
|
|
Good Reason
|
|
|
Good Reason
|
|
|
Disability/Death
|
|
|
Control(7)
|
|
|
Base Salary(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
1,200,000
|
|
|
$
|
|
|
|
$
|
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
470,000
|
|
|
$
|
|
|
|
$
|
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
193,000
|
|
|
$
|
|
|
|
$
|
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
154,000
|
|
|
$
|
|
|
|
$
|
|
|
Annual Bonus(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
|
|
|
$
|
656,384
|
|
|
$
|
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
|
|
|
$
|
350,568
|
|
|
$
|
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
|
|
|
$
|
201,540
|
|
|
$
|
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
|
|
|
$
|
137,841
|
|
|
$
|
|
|
97
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Involuntary
|
|
|
Involuntary
|
|
|
|
|
|
|
|
|
|
Termination for
|
|
|
Termination without
|
|
|
|
|
|
|
|
|
|
Cause/Resignation by
|
|
|
Cause/Resignation by
|
|
|
|
|
|
|
|
|
|
Executive without
|
|
|
Executive for
|
|
|
|
|
|
Change in
|
|
|
|
Good Reason
|
|
|
Good Reason
|
|
|
Disability/Death
|
|
|
Control(7)
|
|
|
Health and Welfare Benefits(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
40,373
|
|
|
$
|
|
|
|
$
|
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
24,805
|
|
|
$
|
|
|
|
$
|
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
11,829
|
|
|
$
|
|
|
|
$
|
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
11,829
|
|
|
$
|
|
|
|
$
|
|
|
Accelerated vesting of time
options(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,844,030
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
553,206
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
141,171
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
197,101
|
|
Accelerated vesting of performance
options(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
1,901,672
|
|
|
$
|
1,901,672
|
|
|
$
|
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
570,495
|
|
|
$
|
570,495
|
|
|
$
|
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
117,980
|
|
|
$
|
117,980
|
|
|
$
|
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
200,800
|
|
|
$
|
200,800
|
|
|
$
|
|
|
Deferred Compensation(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
TOTAL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel F. Thomas
|
|
$
|
|
|
|
$
|
3,142,045
|
|
|
$
|
2,558,056
|
|
|
$
|
1,844,030
|
|
Michael F. Biehl
|
|
$
|
|
|
|
$
|
1,065,300
|
|
|
$
|
921,063
|
|
|
$
|
553,206
|
|
Matthew J. Klaben
|
|
$
|
|
|
|
$
|
322,809
|
|
|
$
|
319,520
|
|
|
$
|
141,171
|
|
James H. Hoppel, Jr.
|
|
$
|
|
|
|
$
|
366,629
|
|
|
$
|
338,641
|
|
|
$
|
197,101
|
|
|
|
|
(1) |
|
The base salary levels of the executive officers under their
employment agreements at December 31, 2006 were as follows:
Mr. Thomas, $400,000; Mr. Biehl, $235,000;
Mr. Klaben, $193,000; and Mr. Hoppel, $154,000. These
2006 amounts were used in calculating the hypothetical payment
shown. The base salary levels of the executive officers have
been adjusted, effective January 1, 2007, as follows:
Mr. Thomas, $450,000; Mr. Biehl, $245,000;
Mr. Klaben, $200,000; and Mr. Hoppel, $170,000. The
amounts in the table do not include accrued but unused vacation,
since the policy governing vacation for the executive officers
mandates the forfeiture of all accrued vacation for the current
year not used by the end of the year, and each scenario assumed
termination of employment with no business days remaining in the
year. |
|
(2) |
|
Our 2006 Bonus Plan, under which incentive bonuses would be paid
for 2006, generally requires a participant to be employed on the
last day of the fiscal year in order to receive a bonus. Since
each executive officer is assumed to be terminated before the
end of the year in the table above, no bonus amounts are shown
for the year in question unless otherwise required under the
terms of the executive officers employment agreement. The
bonus amounts payable upon termination due to death or
disability as set forth above assumes realization of our maximum
performance goals under the 2006 Bonus Plan, as set forth under
the Estimated Future Payouts Under Non-Equity Incentive
Plan Awards portion of the 2006 Grants of Plan-Base Awards
Table above and in the 2006 Summary Compensation Table above,
and have been prorated based on the number of days in the year
through December 29 relative to a full
365-day year. |
|
(3) |
|
Heath and welfare benefits consist of health care and dental.
These benefits after termination of employment for 2007 have
been calculated based on actual cost to us for 2007. Health and
welfare benefits for 2008, in the case |
98
|
|
|
|
|
of Messrs. Thomas and Biehl, and 2009, in the case of
Mr. Thomas, have been calculated on the basis of actual
cost for 2007 plus an assumed 10% annual increase in medical
benefits cost and an assumed 3% annual increase in dental
benefit cost. |
|
(4) |
|
The value of the time options that vest upon a Change in Control
represents the difference between the aggregate market value of
the shares underlying the unvested portion of these options on
December 29, 2006, at $16.21 per share, the closing price
of our common stock on that day, and the aggregate exercise
price of the options. The calculation for each named executive
officer is as follows: Mr. Thomas, 189,910 shares, at
a market price of $16.21 per share, for an aggregate market
value of $3,078,448, minus $1,234,418, the aggregate exercise
price for the shares; Mr. Biehl, 56,973 shares, at a
market price of $16.21 per share, for an aggregate market
value of $923,529, minus $370,323, the aggregate exercise price
for the shares; Mr. Klaben, 34,857 shares, at a market
price of $16.21 per share, for an aggregate market value of
$565,032, minus $423,861, the aggregate exercise price for the
shares; and Mr. Hoppel, 22,127 shares, at a market
price of $16.21 per share, for an aggregate market value of
$358,685, minus $161,584, the aggregate exercise price for the
shares. |
|
(5) |
|
The performance options that were granted under the 2005 Stock
Incentive Plan could partially vest under the option agreements
as of the date of termination of employment as a result of
involuntary termination without Cause, resignation for Good
Reason, or termination due to Disability or death based upon
calculation of a hypothetical Fund X Net Return at the date
of termination, net of certain deductions. The Fund X Net
Return is calculated assuming a hypothetical liquidation of us
or a sale of us to a third party implying a fair market value at
such date, net of expenses, taxes incurred by us and payment of
management options. The Fund X Net Return net of the
applicable deductions was calculated, solely for purposes of the
presentation above, and based on actual vesting examples upon
termination of employment of optionees during 2007, to reach the
45% performance option vesting threshold under our option
agreements at December 29, 2006 using a fair market value
based on a stock price of $16.21 per share, which
represented the closing price of our common stock on
December 29, 2006, and the amounts initially invested in us
by First Reserve Fund X, L.P. and the cash returned to
First Reserve Fund X, L.P. before December 29, 2006
and cash expected to be returned to First Reserve Fund X,
L.P. in respect of its initial investment in us in the
hypothetical transaction, less estimated expenses, taxes and
payment of management options based on a hypothetical sale of us
in a change in control transaction. Actual amounts may have
resulted in different payouts than those shown in the table
above. Therefore, 45% of the performance options were assumed to
vest at the termination date based on the foregoing. Because of
the uncertainty in calculating the components of the applicable
formula, actual vesting may have been higher or lower than this
amount, had an actual calculation been performed in connection
with an actual employment termination on December 29, 2006.
The calculation of the value shown in the table for each named
executive officer is as follows: Mr. Thomas,
195,847 shares, at a market price of $16.21 per share,
for an aggregate market value of $3,174,678, minus $1,273,006,
the aggregate exercise price for the shares; Mr. Biehl,
58,753 shares, at a market price of $16.21 per share,
for an aggregate market value of $952,392, minus $381,897, the
aggregate exercise price for the shares; Mr. Klaben,
29,131 shares, at a market price of $16.21 per share,
for an aggregate market value of $472,209, minus $354,229, the
aggregate exercise price for the shares; and Mr. Hoppel,
22,208 shares, at a market price of $16.21 per share,
for an aggregate market value of $359,991, minus $159,191, the
aggregate exercise price for the shares. We do not believe any
named executive officer would have had the right at
December 29, 2006 to terminate his employment under the
circumstances described above. |
|
(6) |
|
No benefit is shown for deferred compensation because there are
no contributions by us or any above-market returns on any
participant moneys in the Deferred Income Plan for any named
executive officer. All balances in the Deferred Income Plan
represent solely the named executive officers
contributions or market earnings on those contributions. For
more information, see 2006 Nonqualified
Deferred Compensation Table. |
|
(7) |
|
Assumes termination of employment results from resignation
without Good Reason. If resignation were for Good Reason, or if
termination resulted from involuntary termination without Cause,
see the applicable column in the table for the salary
continuation, acceleration of performance options, or other
applicable benefits that could apply in such case. |
99
2006 Director
Compensation Table
The following table and related notes and discussion summarize
compensation paid to our non-employee directors for our 2006
fiscal year, presented in accordance with SEC rules.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
Stock
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Awards
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
($)(1)
|
|
|
($)
|
|
|
Timothy H. Day
|
|
$
|
24,000
|
|
|
$
|
40,000
|
|
|
$
|
64,000
|
|
Richard E. Goodrich
|
|
$
|
28,500
|
|
|
$
|
40,000
|
|
|
$
|
68,500
|
|
Ben A. Guill
|
|
$
|
22,000
|
|
|
$
|
40,000
|
|
|
$
|
62,000
|
|
Steven W. Krablin
|
|
$
|
30,500
|
|
|
$
|
40,000
|
|
|
$
|
70,500
|
|
Kenneth W. Moore
|
|
$
|
22,000
|
|
|
$
|
40,000
|
|
|
$
|
62,000
|
|
Michael W. Press
|
|
$
|
26,000
|
|
|
$
|
40,000
|
|
|
$
|
66,000
|
|
|
|
|
(1) |
|
As of December 31, 2006, the directors held restricted
stock units in the following amounts: Timothy H. Day, 2,666
restricted stock units; Ben A. Guill, 2,666 restricted stock
units; Richard E. Goodrich, 2,658 restricted stock units; Steven
W. Krablin, 2,666 restricted stock units; Kenneth W. Moore,
2,666 restricted stock units; and Michael W. Press, 2,658
restricted stock units. The grant date fair value of each
restricted stock unit grant reported in this column, calculated
in accordance with SFAS 123R, is $40,000. The 2,666
unvested restricted stock units received by Mr. Guill were
forfeited to us as a result of Mr. Guills
March 19, 2007 resignation from our board of directors. |
Director
Compensation
Directors who are also employees do not receive any additional
compensation for services performed as a member of our board of
directors or any committees thereof. We pay our non-employee
directors an annual retainer of $32,000, payable in equal
quarterly installments, and grant annually to each non-employee
director restricted stock units covering a number of shares of
common stock with a fair market value of $40,000 on the date of
grant under the 2005 Stock Incentive Plan. The restricted stock
units fully vest on the first anniversary of the date of grant
or earlier, in the event of a change in control (as defined in
the 2005 Stock Incentive Plan) or the director ceasing to serve
on the board due to death or disability (as defined in the 2005
Stock Incentive Plan). The restricted stock units are expected
to be settled in shares of our common stock, the receipt of
which may be deferred by each director for a period ranging from
the first anniversary of the restricted stock unit vesting date
to the tenth anniversary of the restricted stock unit vesting
date, or, if elected, earlier upon separation of service from
the board or a change in control, in both cases, to the extent
permitted under Section 409A of the Internal Revenue Code.
Messrs. Guill, Day, Krablin and Moore each received 2,666
restricted stock units in our 2006 fiscal year at the time of
our initial public offering, and each of Messrs. Press
and Goodrich received 2,658 restricted stock units in
connection with their appointment to our board of directors in
our 2006 fiscal year. The 2,666 unvested restricted stock units
received by Mr. Guill were forfeited to us as a result of
Mr. Guills March 19, 2007 resignation from our
board of directors. Messrs. Day, Goodrich, Krablin, Moore
and Press each received 1,787 restricted stock units on
May 23, 2007 in connection with their re-election as
directors at our 2007 annual meeting of stockholders.
In addition to the compensation described above, the chairperson
of our audit committee receives an additional $8,000 annual
retainer, and the chairpersons of our other board committees
receive an additional $4,000 annual retainer, in each case in
equal quarterly installments. Additionally, we pay our
non-employee directors a fee of $2,000 for board meetings
attended in person (up to six meetings and $1,000 per
meeting thereafter) and a fee of $1,000 for board meetings
attended telephonically. In connection with meetings of the
committees of our board of directors, we pay our non-employee
directors who attend committee meetings in person a fee of
$1,000 per meeting and a fee of $500 per meeting for
committee meetings attended telephonically. In addition,
directors must accumulate investments of at least $100,000 in
our common stock during their first 24 months on our board.
Shares of our common stock issued upon settlement of restricted
stock units will count towards the $100,000 requirement.
100
Management
Equity
In connection with the Acquisition, the compensation committee
elected to adjust, in accordance with the terms of our 2004
Stock Plan and the agreement and plan of merger, a portion of
certain then-outstanding stock options held by certain executive
officers or members of senior management to represent options to
acquire shares of our common stock after the Acquisition. All
other then-outstanding stock options were cashed out pursuant to
the merger agreement. All such rollover options were exercised
in the second quarter of 2006 for $3.50 per share. All
shares of common stock acquired upon the exercise of such
rollover options are now subject to the terms of the management
stockholders agreements. See Certain Related Party
Transactions.
101
PRINCIPAL
AND SELLING STOCKHOLDERS
The following table and accompanying footnotes show information
regarding the beneficial ownership of our common stock as of
April 30, 2007 before and after this offering by:
|
|
|
|
|
each person who is known by us to own beneficially more than 5%
of our common stock;
|
|
|
|
each member of our board of directors and each of our named
executive officers;
|
|
|
|
all members of our board of directors and our executive officers
as a group; and
|
|
|
|
each selling stockholder selling shares in this offering.
|
The number of shares and percentages of beneficial ownership
after the offering are based on 27,539,532 shares of our
common stock that will be issued and outstanding immediately
after this offering, assuming exercise of the underwriters
over-allotment option in full, including 1,891,876 shares
that may be sold to the underwriters pursuant to their
over-allotment option and shares currently subject to options
that are expected to be exercised in connection with this
offering. Stock options that may vest as a result of First
Reserve Fund X, L.P.s sale of shares in the offering
have not been shown in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Beneficially
|
|
|
|
|
|
Shares Beneficially
|
|
|
|
|
|
|
Owned Immediately
|
|
|
|
|
|
Owned Immediately
|
|
|
|
|
|
|
Prior to this Offering
|
|
|
Shares to
|
|
|
After this Offering
|
|
|
|
|
|
|
|
|
|
Percent of
|
|
|
be sold in
|
|
|
|
|
|
Percent of
|
|
|
|
|
Name of Beneficial Holder
|
|
Number
|
|
|
Common
|
|
|
this Offering
|
|
|
Number
|
|
|
Common
|
|
|
|
|
|
First Reserve Fund X, L.P.(2)
|
|
|
12,376,214
|
|
|
|
48.3
|
%
|
|
|
12,376,214
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Capital Research and Management
Company(3)
|
|
|
2,266,400
|
|
|
|
8.9
|
%
|
|
|
0
|
|
|
|
2,266,400
|
|
|
|
8.2
|
%
|
|
|
|
|
Samuel F. Thomas(4)
|
|
|
498,304
|
|
|
|
1.9
|
%
|
|
|
120,000
|
|
|
|
378,304
|
|
|
|
1.4
|
%
|
|
|
|
|
Michael F. Biehl(5)
|
|
|
42,845
|
|
|
|
*
|
|
|
|
20,000
|
|
|
|
22,845
|
|
|
|
*
|
|
|
|
|
|
Matthew J. Klaben(6)
|
|
|
9,471
|
|
|
|
*
|
|
|
|
0
|
|
|
|
9,471
|
|
|
|
*
|
|
|
|
|
|
James H. Hoppel, Jr.(7)
|
|
|
7,875
|
|
|
|
*
|
|
|
|
0
|
|
|
|
7,875
|
|
|
|
*
|
|
|
|
|
|
Kenneth W. Moore(8)(9)
|
|
|
0
|
|
|
|
*
|
|
|
|
0
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Timothy H. Day(8)(10)
|
|
|
0
|
|
|
|
*
|
|
|
|
0
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Steven W. Krablin(11)
|
|
|
0
|
|
|
|
*
|
|
|
|
0
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Michael W. Press(12)
|
|
|
2,000
|
|
|
|
*
|
|
|
|
0
|
|
|
|
2,000
|
|
|
|
*
|
|
|
|
|
|
Richard E. Goodrich(13)
|
|
|
2,000
|
|
|
|
*
|
|
|
|
0
|
|
|
|
2,000
|
|
|
|
*
|
|
|
|
|
|
Thomas M. Carey(14)
|
|
|
37,559
|
|
|
|
*
|
|
|
|
26,481
|
|
|
|
11,078
|
|
|
|
*
|
|
|
|
|
|
Steven T. Shaw(15)
|
|
|
33,758
|
|
|
|
*
|
|
|
|
33,758
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Gerd Kirchgassner(16)
|
|
|
6,330
|
|
|
|
*
|
|
|
|
6,330
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Mark H. Ludwig(17)
|
|
|
22,346
|
|
|
|
*
|
|
|
|
7,161
|
|
|
|
15,185
|
|
|
|
*
|
|
|
|
|
|
Toni M. Massa(18)
|
|
|
3,902
|
|
|
|
*
|
|
|
|
3,164
|
|
|
|
738
|
|
|
|
*
|
|
|
|
|
|
Eric M. Rottier(19)
|
|
|
7,914
|
|
|
|
*
|
|
|
|
7,914
|
|
|
|
0
|
|
|
|
*
|
|
|
|
|
|
Gregory F. Zaic(20)
|
|
|
6,441
|
|
|
|
*
|
|
|
|
6,348
|
|
|
|
93
|
|
|
|
*
|
|
|
|
|
|
Kevin J. Blount(21)
|
|
|
2,655
|
|
|
|
*
|
|
|
|
2,373
|
|
|
|
282
|
|
|
|
*
|
|
|
|
|
|
James Fischman(22)
|
|
|
2,270
|
|
|
|
*
|
|
|
|
1,583
|
|
|
|
687
|
|
|
|
*
|
|
|
|
|
|
William P. Haukoos(23)
|
|
|
1,328
|
|
|
|
*
|
|
|
|
1,187
|
|
|
|
141
|
|
|
|
*
|
|
|
|
|
|
All directors and officers as a
group (9 persons)
|
|
|
562,495
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
422,495
|
|
|
|
1.5
|
%
|
|
|
|
|
|
|
|
(1) |
|
We will grant the underwriters an option to purchase an
additional 1,891,876 shares in this offering. In accordance
with Commission rules, each beneficial owners holdings
have been calculated assuming full exercise of outstanding
options covering Common Stock, if any, exercisable by such owner
within 60 days after April 30, 2007, but no exercise
of outstanding options covering Common Stock held by any other
person. |
102
|
|
|
(2) |
|
48.3% of our common stock is owned by FR X Chart Holdings
LLC, or Chart Holdings, which in turn is 100% owned and managed
by First Reserve Fund X, L.P., or Fund X. First
Reserve GP X, L.P., or GP X, is the general partner of
Fund X. First Reserve GP X, Inc., or GP X, Inc.,
is the general partner of GP X. First Reserve Corporation
is the advisor to Fund X. (In this footnote we refer to
Fund X, GP X and GP X, Inc. collectively as, the
Fund Entities.) The officers of GP X Inc.
are William E. Macaulay, John A. Hill, Alan G. Schwartz,
Cathleen M. Ellsworth, J.W.G. (Will) Honeybourne, Alex T.
Krueger, Mark A. McComiskey, Kenneth W. Moore, Thomas J.
Sikorski, Jennifer C. Zarrilli, Timothy H. Day, Joseph Robert
Edwards, J. Hardy Murchison, Glenn J. Payne, Kristin A. Custar,
Rahman P. DArgenio, Brian K. Lee, Bingfeng Leng, Timothy
K. OKeefe, Jeffrey K. Quake, Daniel S. Rice, Anne E. Gold,
Valeria A. Thomason, Damien T.J. Harris, Francesco Giuliani,
Neil J. Hartley, Joshua R. Weiner, Avik Dey, Dod E. Wales, Joel
C. Lambert and Matthew S. Raben who are all employees of First
Reserve. Decisions with respect to voting and investments are
made by the Investment Committee of First Reserve, made up of a
subset of these officers that includes the officers named above
except for Ms. Thomason and Mr. Harris. With respect
to investments held by these entities, decisions with respect to
operations oversight are made by the subset of these officers
that work most closely on a given investment, which includes
Messrs. Macaulay, Moore and Day in the case of Chart
Industries, Inc. The shares consist of
12,376,214 shares directly owned by Chart Holdings. In
addition, there are 8,906 aggregate shares of Common Stock
underlying the restricted stock units of the company issued to
each of Messrs. Day and Moore under the 2005 Stock
Incentive Plan, 5,332 of which will vest on July 25, 2007
and 3,574 of which will vest on May 23, 2008. These shares
have not been included in the table above. The
Fund Entities (but not Chart Holdings) are entitled to a
portion of the profits from the sale of such restricted stock
units and any underlying shares of Common Stock, and may
therefore be deemed to share beneficial ownership over such
securities. The address of FR X Chart Holdings LLC,
Fund X, GP X, GP X, Inc. and First Reserve is
c/o First Reserve Corporation, One Lafayette Place,
Greenwich, Connecticut 06830. |
|
(3) |
|
According to a Schedule 13G filed with the SEC on
February 12, 2007, Capital Research and Management Company,
as of December 29, 2006, has sole voting power and sole
dispositive voting power over 2,266,400 shares. Capital
Research and Management Company is located at 333 South
Hope Street, Los Angeles, California 90071. |
|
(4) |
|
Shares beneficially owned by Mr. Thomas include
134,998 shares that were transferred to a trust of which
Mr. Thomas is the grantor and the current beneficiary and
47,478 shares which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(5) |
|
Shares beneficially owned by Mr. Biehl include
14,243 shares prior to this offering and 6,243 shares
after this offering, which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(6) |
|
Shares beneficially owned by Mr. Klaben include
6,971 shares which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(7) |
|
Shares beneficially owned by Mr. Hoppel include
5,375 shares which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(8) |
|
Mr. Moore is a Managing Director of First Reserve
Corporation and GP X, Inc. Mr. Day is a Director of
First Reserve Corporation and GP X, Inc. Mr. Moore and
Mr. Day each disclaim beneficial ownership of any shares of
the issuers equity securities owned by such entities or
their affiliates (including First Reserve
Fund X, L.P.). |
|
(9) |
|
Shares beneficially owned by Mr. Moore consist of 2,666
restricted stock units, which will vest on July 25, 2007,
and 1,787 restricted stock units, which will vest on
May 23, 2008. These shares have not been included in the
table above. See footnote 2. |
|
(10) |
|
Shares beneficially owned by Mr. Day consist of 2,666
restricted stock units, which will vest on July 25, 2007,
and 1,787 restricted stock units, which will vest on
May 23, 2008. These shares have not been included in the
table above. See footnote 2. |
|
(11) |
|
Shares beneficially owned by Mr. Krablin consist of 2,666
restricted stock units, which will vest on July 25, 2007,
and 1,787 restricted stock units, which will vest on
May 23, 2008. These shares have not been included in the
table above. |
103
|
|
|
(12) |
|
Shares beneficially owned by Mr. Press include 2,658
restricted stock units, which will vest on August 15, 2007,
and 1,787 restricted stock units, which will vest on
May 23, 2008. These shares have not been included in the
table above. |
|
(13) |
|
Shares beneficially owned by Mr. Goodrich include 2,658
restricted stock units, which will vest on August 15, 2007,
and 1,787 restricted stock units, which will vest on
May 23, 2008. These shares have not been included in the
table above. |
|
(14) |
|
Shares beneficially owned by Mr. Carey include
11,078 shares prior to this offering and after this
offering which he has the right to acquire within 60 days
of April 30, 2007 through the exercise of stock options. |
|
(15) |
|
Shares beneficially owned by Mr. Shaw include
11,078 shares prior to this offering and 0 shares
after this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(16) |
|
Shares beneficially owned by Mr. Kirchgassner include
6,330 shares prior to this offering and 0 shares after
this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(17) |
|
Shares beneficially owned by Mr. Ludwig include
5,185 shares prior to this offering and after this offering
which he has the right to acquire within 60 days of
April 30, 2007 through the exercise of stock options. |
|
(18) |
|
Shares beneficially owned by Ms. Massa include
3,602 shares prior to this offering and 438 shares
after this offering which she has the right to acquire within
60 days at April 30, 2007 through the exercise of
stock options. |
|
(19) |
|
Shares beneficially owned by Mr. Rottier include
7,914 shares prior to this offering and 0 shares after
this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(20) |
|
Shares beneficially owned by Mr. Zaic include
885 shares prior to this offering and 93 shares after
this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(21) |
|
Shares beneficially owned by Mr. Blount include
2,655 shares prior to this offering and 282 shares
after this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(22) |
|
Shares beneficially owned by Mr. Fischman include
1,770 shares prior to this offering and 187 shares
after this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
(23) |
|
Shares beneficially owned by Mr. Haukoos include
1,328 shares prior to this offering and 141 shares
after this offering which he has the right to acquire within
60 days of April 30, 2007 through the exercise of
stock options. |
|
* |
|
Less than 1%. |
104
CERTAIN
RELATED PARTY TRANSACTIONS
Management
Stockholders Agreements
In connection with our initial public offering, we entered into
amended and restated management stockholders agreements,
effective as of April 1, 2006, with certain members of our
management, including Messrs. Thomas, Biehl, Klaben and
Hoppel, which we refer to as the management stockholders, and FR
X Chart Holdings LLC.
Tag-Along Rights. If FR X Chart Holdings LLC
wishes to transfer shares of common stock other than pursuant to
a registered offering, a transfer pursuant to Rule 144
under the Securities Act, a transfer with the approval of the
members of the board not affiliated with FR X Chart Holdings LLC
or a transfer by FR X Chart Holdings LLC to any of its
affiliates or partners or our employees, then each management
stockholder shall have the right to tag-along and participate,
on a pro rata basis, in such transfer of common stock. The
tag-along rights will terminate upon the date that FR X Chart
Holdings LLC and its affiliates cease to be the beneficial owner
(as defined in
Rule 13d-3
of the Exchange Act) of at least 30% of our outstanding common
stock.
Piggyback Registration
Rights. Pursuant to and subject to the terms of
the amended and restated management stockholders
agreements, each management stockholder will have the
opportunity to include in registered sales of our common stock
(other than an initial public offering or relating to any
employee benefit plan or corporate merger, acquisition or
reorganization) and any shelf registration statement filed by us
with respect to our common stock, all or any part of the
registrable securities (as such term is defined in
the amended and restated management stockholders
agreements) then held by such management stockholder. We will
pay all of the expenses associated with an offering of such
shares. Underwriting discounts will be shared proportionately.
Stockholders
Agreement
In connection with the initial public offering, we and First
Reserve or one of its affiliates entered into a stockholders
agreement pursuant to which First Reserve or its affiliates has
the right to request us to register the sale of securities held
by First Reserve or its affiliates, on their behalf and may
require us to make available shelf registration statements
permitting sales of securities into the market from time to time
over an extended period. In addition, First Reserve or one of
its affiliates has the ability to exercise certain piggyback
registration rights in connection with registered offerings
initiated by us.
In addition, pursuant to the terms of the stockholders
agreement, for so long as First Reserve or one of its affiliates
continues to hold (1) less than 50% but at least 25% of our
outstanding common stock, it shall have the right to designate
three director nominees, (2) less than 25% but more than
10% of our outstanding common stock, it will have the right to
designate two director nominees, and (3) 10% of our
outstanding common stock, it will have the right to designate
one director nominee. Once First Reserve or its affiliates holds
less than 10% of our outstanding common stock, it will have no
right to designate directors pursuant to the stockholders
agreement. We have agreed that neither First Reserve nor any
affiliate, director, officer or employee of First Reserve who
may serve as officer, director
and/or
employee of ours will be liable to us (i) by reason of any
business decision or transaction undertaken by First Reserve,
which may be adverse to our interests, (ii) by reason of
any activity undertaken by First Reserve or by any other person
in which First Reserve may have an investment or other financial
interest which is in competition with us or (iii) without
limiting the effect of Section 144 of the Delaware General
Corporation Law, by reason of any transaction with First
Reserve, or any transaction in which First Reserve will have a
financial interest, unless the party seeking to assert such
liability proves, by clear and convincing evidence, that such
transaction was not fair to us at the time it was authorized by
the board of directors or a committee thereof.
Warrant
to Purchase our Shares
On November 23, 2005, we issued a warrant to FR X Chart
Holdings LLC to purchase up to 2,651,012 shares of our
common stock at a per share purchase price of $14.00 (subject to
adjustment per the terms of the warrant). The warrant was
exercised on a cash basis in May 2006 and we issued
2,651,012 shares to FR X Chart Holdings LLC under the
warrant.
105
Legal
Fees
On April 1, 2006, Matthew J. Klaben became our Vice
President, General Counsel and Secretary. Prior to joining us in
March 2006, Mr. Klaben was a partner with the law firm of
Calfee, Halter & Griswold LLP. During the three months
ended March 31, 2006, we paid $41,765 in legal fees and
expenses to the law firm of Calfee, Halter & Griswold
LLP for legal services rendered.
106
DESCRIPTION
OF INDEBTEDNESS
Senior
Secured Credit Facility
Overview
In connection with the Acquisition, we entered into a senior
secured credit facility with Citicorp North America, Inc., as
administrative agent, Citigroup Global Markets Inc., as joint
lead arranger and joint book manager, Morgan Stanley Senior
Funding, Inc., as joint lead arranger, joint book manager and
syndication agent and each lender party thereto. In connection
with our initial public offering, we received the requisite
consents and commitments from existing lenders and other
financial institutions to amend the senior secured credit
facility to increase the size of the revolving credit facility
by $55.0 million to $115.0 million, remove certain
restrictions on our ability to consummate the initial public
offering and on the use of proceeds as well as make certain
other amendments. The amendment was effective as of the date of
the consummation of the initial public offering. The description
of our senior secured credit facility that follows gives effect
to this amendment.
The senior secured credit facility provides senior secured
financing of $295.0 million, consisting of:
|
|
|
|
|
a $180.0 million term loan facility; and
|
|
|
|
a $115.0 million revolving credit facility.
|
The term loan portion of our senior secured credit facility was
fully funded on October 17, 2005 and we had approximately
$92.4 million of borrowing capacity under the revolving
portion of our senior secured credit facility at March 31,
2007, after giving effect to approximately $22.6 million of
letters of credit and bank guarantees outstanding at that date.
Since October 17, 2005, we have repaid $60.0 million
in principal amount of the term loan facility.
Upon the occurrence of certain events, we may request an
increase to the existing term loan facility
and/or the
existing revolving credit facility in an amount not to exceed
$100.0 million, subject to receipt of commitments by
existing lenders or other financial institutions reasonably
acceptable to the administrative agent.
We are the borrower for the term loan facility and the revolving
credit facility. The revolving credit facility includes
borrowing capacity available for letters of credit and for
borrowings on
same-day
notice, referred to as swingline loans.
Interest
Rate and Fees
Borrowings under the senior secured credit facility bear
interest at a rate equal to an applicable margin plus, at our
option, either (a) a base rate determined by reference to
the highest of (1) the rate that the administrative agent
announces from time to time as its base commercial lending rate,
(2) the three month certificate of deposit rate plus 0.5%
and (3) the federal funds rate plus 0.5% or (b) a
LIBOR rate determined by the applicable screen rate or by
reference to the costs of funds for deposits in
U.S. dollars for the interest period relevant to such
borrowing adjusted for certain additional costs.
The initial applicable margin for borrowings under the revolving
credit facility is 1.50% with respect to base rate borrowings
and 2.50% with respect to LIBOR borrowings. After we deliver our
financial statements for the first fiscal quarter ending at
least six months after the closing date, such applicable margin
will be reduced to 1.25% and 2.25%, respectively if our leverage
ratio is less than 5.0 to 1.0 but greater than or equal to 4.0
to 1.0, and to 1.00% and 2.00%, respectively if our leverage
ratio is less than 4.0 to 1.0. The applicable margin for
borrowings under the term loan facility is presently 1.00% with
respect to base rate borrowings and 2.00% with respect to LIBOR
borrowings.
In addition to paying interest on outstanding principal under
the senior secured credit facility, we are required to pay a
commitment fee to the lenders under the revolving credit
facility in respect of the unutilized commitments thereunder.
The initial commitment fee rate is 0.50% per annum (which
fee will be reduced to 0.375% per annum if our leverage
ratio is less than 4.0 to 1.0). We also have to pay letter of
credit fees equal to the applicable margin then in effect with
respect to LIBOR loans under the revolving credit facility on
the aggregate undrawn amount of all
107
letters of credit outstanding. We also have to pay to each bank
issuing a letter of credit fees equal to 0.25% on the face
amount of each letter of credit and other customary documentary
and processing charges.
Prepayments
The senior secured credit facility requires us to prepay
outstanding term loans, subject to certain exceptions, with:
|
|
|
|
|
beginning in the year ending December 31, 2006, 75% (which
percentage will be reduced to 50% if our leverage ratio is equal
to or less than 4.75 and greater than 3.75 to 1.00, and to 25%
if our leverage ratio is equal to or less than 3.75 to 1.00 and
greater than 2.75 to 1.00, and to 0% if our leverage ratio is
equal to or less than 2.75 to 1.00) of our annual excess cash
flow;
|
|
|
|
100% of the net cash proceeds in excess of an amount to be
determined from non-ordinary course asset sales and casualty and
condemnation events, if we do not reinvest or contract to
reinvest those proceeds within 12 months and use such
proceeds within 18 months of receipt, subject to certain
limitations;
|
|
|
|
100% of the net cash proceeds of any incurrence of debt, other
than certain debt permitted under the senior secured credit
facility; and
|
|
|
|
100% of amounts in excess of an aggregate amount of
$5.0 million in respect of certain claims arising out of
the Acquisition, subject to certain exceptions.
|
The foregoing mandatory prepayments other than from excess cash
flow will be applied first, to the next eight installments of
the term loan facility and second, to the remaining installments
of the term loan facility on a pro rata basis. Mandatory
prepayments from excess cash flow and optional prepayments will
be applied to the remaining installments of the term loan
facility at our direction. Each lender has the right to decline
any mandatory prepayment of its term loans in which case the
amount of such prepayment will be retained by us.
We may voluntarily prepay outstanding loans under the senior
secured credit facility at any time without premium or penalty,
other than customary breakage costs with respect to
LIBOR loans.
Amortization
We are required to repay installments on the loans under the
term loan facility in quarterly principal amounts equal to 0.25%
of their funded total principal amount for the first six years
and nine months, subject to reduction of these quarterly
amortization payments based on term loan prepayments, with the
remaining amount payable on the date that is seven years from
the date of the closing of the senior secured credit facility.
Principal amounts outstanding under the revolving credit
facility will be due and payable in full at maturity, five years
from the date of the closing of the senior secured credit
facility.
Guarantee
and Security
All our obligations under the senior secured credit facility are
unconditionally guaranteed by each of our existing and future
domestic wholly-owned subsidiaries (subject to exceptions with
respect to immaterial subsidiaries and with respect to any
guaranty that could create materially adverse tax consequences)
referred to, collectively, as Domestic Guarantors.
All our obligations under the senior secured credit facility and
the guarantees of our obligations under the senior secured
credit facility by the Domestic Guarantors are secured by
substantially all our assets and the assets of each Domestic
Guarantor, including, but not limited to, the following:
|
|
|
|
|
subject to certain exceptions, a pledge of the capital stock of
each direct and indirect domestic subsidiary owned by us or a
Domestic Guarantor (other than subsidiaries substantially all of
whose assets consist of stock in controlled foreign
corporations) and 65% of the capital stock of each first tier
foreign subsidiary owned by us or a Domestic Guarantor and of
each first tier domestic subsidiary owned by us or a Domestic
Guarantor substantially all of whose assets consist of stock in
controlled foreign corporations; and
|
108
|
|
|
|
|
subject to certain exceptions, a security interest in
substantially all of the tangible and intangible assets owned by
us and each Domestic Guarantor.
|
Certain
Covenants and Events of Default
The senior secured credit facility contains a number of
covenants that, among other things, restrict, subject to certain
exceptions, our ability and the ability of each of our
subsidiaries to:
|
|
|
|
|
sell assets;
|
|
|
|
incur additional indebtedness;
|
|
|
|
prepay, redeem or repurchase other indebtedness (including the
notes);
|
|
|
|
pay dividends and distributions or repurchase capital stock;
|
|
|
|
create liens on assets;
|
|
|
|
make investments, loans or advances;
|
|
|
|
make capital expenditures;
|
|
|
|
make certain acquisitions;
|
|
|
|
engage in mergers or consolidations;
|
|
|
|
engage in certain transactions with affiliates;
|
|
|
|
amend certain material agreements governing indebtedness
(including the notes);
|
|
|
|
change the business conducted by us and our subsidiaries;
|
|
|
|
enter into agreements that restrict dividends from subsidiaries;
|
|
|
|
enter into sale and lease-back transactions; and
|
|
|
|
enter into swap agreements.
|
In addition, the senior secured credit facility requires us to
maintain the following financial covenants:
|
|
|
|
|
a maximum consolidated net leverage ratio; and
|
|
|
|
a minimum interest coverage ratio.
|
The senior secured credit facility also contains certain
customary affirmative covenants and events of default.
As of December 31, 2006, we were in compliance in all
material respects with all covenants and provisions contained
under our senior secured credit facility.
Senior
Subordinated Notes
General
In October 2005, we issued
91/8% senior
subordinated notes that mature on October 15, 2015 in an
aggregate principal amount of $170.0 million in a private
transaction not subject to the registration requirements under
the Securities Act. The net proceeds from that financing were
used to finance the Acquisition and pay related fees and
expenses. On March 8, 2007, we commenced an exchange offer
to exchange the notes for identical freely tradeable notes
registered under the Securities Act.
Guarantees
The notes are guaranteed, on a senior subordinated, unsecured
basis, by each of our direct and indirect wholly-owned
subsidiaries that were domestic subsidiaries on the issue date.
109
Ranking
The notes are our general unsecured senior subordinated
obligations that rank junior to our existing and future senior
indebtedness, including obligations under the senior secured
credit facility, equally in right of payment with all of our
future senior subordinated debt and senior in right of payment
to all of our future subordinated debt, if any. They are
effectively subordinated in right of payment to all of our
existing and future secured debt to the extent of the value of
the assets securing such debt, and are structurally subordinated
to all obligations of our subsidiaries that are not guarantors.
Optional
Redemption
At any time prior to October 15, 2008, we may on any one or
more occasions redeem up to 35% of the aggregate principal
amount of notes issued under the indenture (including any
additional notes issued after the issue date) at a redemption
price of 109.125% of the principal amount, plus accrued and
unpaid interest and additional interest, if any, to, but not
including, the redemption date, with the net cash proceeds of
one or more equity offerings (such as this offering); provided
that:
(1) at least 65% of the aggregate principal amount of notes
issued under the indenture (excluding notes held by us and our
subsidiaries) remains outstanding immediately after the
occurrence of such redemption; and
(2) the redemption occurs within 180 days of the date
of the closing of such equity offering.
Except pursuant to the preceding paragraph or as otherwise set
forth below, the notes will not be redeemable at our option
prior to October 15, 2010. We are not, however, prohibited
from acquiring the notes by means other than a redemption,
whether pursuant to a tender offer, open market purchase or
otherwise, so long as the acquisition does not violate the terms
of the indenture.
On or after October 15, 2010, we may redeem all or a part
of the notes at the redemption prices (expressed as percentages
of principal amount) set forth below plus accrued and unpaid
interest and additional interest, if any, on the notes to be
redeemed, to, but not including, the applicable redemption date,
if redeemed during the twelve month period beginning on October
15 of the years indicated below, subject to the rights of
holders on the relevant record date to receive interest on the
relevant interest payment date.
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2010
|
|
|
104.563
|
%
|
2011
|
|
|
103.042
|
%
|
2012
|
|
|
101.521
|
%
|
2013 and thereafter
|
|
|
100.000
|
%
|
In addition, at any time prior to October 15, 2010, we may
also redeem all or a part of the notes at a redemption price
equal to 100% of the principal amount of notes to be redeemed,
plus the applicable premium (an amount intended to approximate a
make-whole price based on the price of a
U.S. treasury security plus 50 basis points) as of,
and accrued and unpaid interest and additional interest, if any,
to, but not including, the redemption date, subject to the
rights of holders on the relevant record date to receive
interest due on the relevant interest payment date. Though the
notes may be redeemed prior to October 15, 2010 in this
way, because any make-whole premium would be
prohibitively expensive, we do not expect to make a redemption
pursuant to this provision of the indenture.
Change
of Control
In the event of a change of control, which is defined in the
indenture governing the notes, each holder of the notes will
have the right to require us to repurchase all or any part of
such holders notes at a purchase price in cash equal to
101% of the principal amount thereof, plus accrued and unpaid
interest to the date of purchase.
110
Covenants
The indenture governing the notes contains certain covenants
that, among other things, limit our ability and the ability of
some of our subsidiaries to:
|
|
|
|
|
incur additional debt or issue certain preferred shares;
|
|
|
|
pay dividends on or make distributions in respect of our or any
of our restricted subsidiaries capital stock or make other
restricted payments;
|
|
|
|
make certain investments;
|
|
|
|
sell certain assets;
|
|
|
|
create liens on certain debt without securing the notes;
|
|
|
|
consolidate, merge, sell or otherwise dispose of all or
substantially all of our assets;
|
|
|
|
enter into certain transactions with our affiliates; and
|
|
|
|
designate our subsidiaries as unrestricted subsidiaries.
|
Events
of Default
The indenture governing the notes also provides for events of
default which, if any of them occurs, would permit or require
the principal of and accrued interest on such notes to become or
to be declared to be due and payable.
As of December 31, 2006 we were in compliance in all
material respects with all covenants and provisions contained
under the indenture governing the notes.
Exchange
Offer
The registration rights agreement related to the senior
subordinated notes required us to file an Exchange Offer
Registration Statement and complete the exchange offer for the
senior subordinated notes by August 14, 2006. Since the
exchange offer was not completed when required, additional
interest at a rate of 0.25% was incurred for the 90-day period
commencing August 14, 2006, additional interest at a rate
of 0.50% was incurred for the
90-day
period commencing November 12, 2006 and additional interest
at a rate of 0.75% was incurred for the
90-day
period commencing February 10, 2007. The exchange offer was
completed on April 6, 2007 and the additional interest
ceased accruing as of that date.
Chart
Ferox Credit Facility
Chart Ferox, a.s., our wholly-owned subsidiary located in the
Czech Republic, currently maintains secured revolving credit
facilities with borrowing capacity of up to $9.6 million,
of which $4.4 million is available only for letters of
credit and bank guarantees. At December 31, 2006, there
were no borrowings outstanding under, and $1.5 million of
bank guarantees supported by, the Ferox revolving credit
facilities. Ferox is the only borrower under these revolving
credit facilities.
Under the revolving credit facility, Ferox may make borrowings
in Czech Koruna, Euros and U.S. dollars. Borrowings in
Koruna are at PRIBOR, borrowings in Euros are at EURIBOR and
borrowings in U.S. dollars are at LIBOR, each with a fixed
margin of 0.6%. Ferox is not required to pay a commitment fee to
the lenders under the revolving credit facility in respect of
the unutilized commitments thereunder. Ferox must pay letter of
credit and guarantee fees equal to 0.75% on the face amount of
each guarantee.
Feroxs land and buildings secure and accounts receivable
secure $4.6 million and $2.5 million, respectively, of
this revolving credit facility.
111
DESCRIPTION
OF CAPITAL STOCK
The following is a description of the material terms of our
amended and restated certificate of incorporation and amended
and restated bylaws. We refer you to our amended and restated
certificate of incorporation and amended and restated bylaws,
copies of which have been filed as exhibits to the registration
statement of which this prospectus forms a part.
Authorized
Capitalization
As of April 30, 2007, our authorized capital stock consists
of 150,000,000 shares of common stock, par value
$0.01 per share, of which 25,636,578 shares were
issued and outstanding (including shares currently subject to
options that are expected to be exercised in connection with
this offering), and 10,000,000 shares of preferred stock,
par value $0.01 per share, of which no shares are currently
issued and outstanding.
Common
Stock
Voting Rights. Holders of common stock are
entitled to one vote per share on all matters to be voted upon
by the stockholders. The holders of common stock do not have
cumulative voting rights in the election of directors.
Dividend Rights. Subject to the rights of the
holders of any preferred stock that may be outstanding, holders
of our common stock are entitled to receive equally and ratably,
share for share dividends as may be declared by our board of
directors out of funds legally available to pay dividends.
Dividends upon our common stock may be declared by the board of
directors at any regular or special meeting, and may be paid in
cash, in property, or in shares of capital stock. Before payment
of any dividend, there may be set aside out of any of our funds
available for dividends, such sums as the board of directors
deems proper as reserves to meet contingencies, or for
equalizing dividends, or for repairing or maintaining any of our
property, or for any proper purpose, and the board of directors
may modify or abolish any such reserve. The senior secured
credit facility and the indenture governing the notes impose
restrictions on our ability to declare dividends with respect to
our common stock.
Liquidation Rights. Upon liquidation,
dissolution, distribution of assets or other winding up, the
holders of common stock are entitled to receive ratably the
assets available for distribution to the stockholders after
payment of liabilities and the liquidation preference of any of
our outstanding preferred stock. Neither a sale of substantially
all of the property and assets of the corporation nor a
consolidation or merger of the corporation into another
corporation shall be deemed a liquidation of the company.
Other Matters. The common stock has no
preemptive or conversion rights and is not subject to further
calls or assessment by us. There are no redemption or sinking
fund provisions applicable to the common stock. All outstanding
shares of our common stock, including the common stock offered
in this offering, are fully paid and non-assessable.
Preferred
Stock
Our amended and restated certificate of incorporation authorizes
our board of directors to establish one or more series of
preferred stock and to determine, with respect to any series of
preferred stock, the terms and rights of that series, including:
|
|
|
|
|
the designation of the series;
|
|
|
|
the number of shares of the series, which our board may, except
where otherwise provided in the preferred stock designation,
increase or decrease, but not below the number of shares then
outstanding;
|
|
|
|
whether dividends, if any, will be cumulative or non-cumulative
and the dividend rate of the series;
|
|
|
|
the dates at which dividends, if any, will be payable;
|
|
|
|
the redemption rights and price or prices, if any, for shares of
the series;
|
|
|
|
the terms and amounts of any sinking fund provided for the
purchase or redemption of shares of the series;
|
112
|
|
|
|
|
the amounts payable on shares of the series in the event of any
voluntary or involuntary liquidation, dissolution or
winding-up
of the affairs of our company, or upon any distribution of
assets of our company;
|
|
|
|
whether the shares of the series will be convertible into shares
of any other class or series, or any other security, of our
company or any other corporation, and, if so, the specification
of the other class or series or other security, the conversion
price or prices or rate or rates, any rate adjustments, the date
or dates as of which the shares will be convertible and all
other terms and conditions upon which the conversion may be made;
|
|
|
|
the preferences and special rights, if any, of the series and
the qualifications and restrictions, if any, of the series;
|
|
|
|
the voting rights, if any, of the holders of the series; and
|
|
|
|
such other rights, powers and preferences with respect to the
series as our board of directors may deem advisable.
|
Anti-Takeover
Effects of Certain Provisions of Delaware Law and our Amended
and Restated Certificate of Incorporation and Amended and
Restated Bylaws
Certain provisions of our amended and restated certificate of
incorporation and amended and restated bylaws, which are
summarized in the following paragraphs, may have an
anti-takeover effect and may delay, defer or prevent a tender
offer or takeover attempt that a stockholder might consider in
its best interest, including those attempts that might result in
a premium over the market price for the shares held by
stockholders.
Removal
of Directors; Vacancies
Our amended and restated certificate of incorporation provides
that (i) prior to the date on which First Reserve or an
affiliate ceases to own at least 40% of the voting power of all
shares of stock entitled to vote generally in the election of
directors, directors may be removed for any reason upon the
affirmative vote of holders of at least a majority of the voting
power of all then outstanding shares of stock entitled to vote
generally in the election of directors, voting together as a
single class and (ii) on and after the date on which First
Reserve or an affiliate ceases to own at least 40% of the voting
power of all shares of stock entitled to vote generally in the
election of directors, directors may be removed with or without
cause, at any time by the affirmative vote of holders of at
least 75% of the voting power of all the then outstanding shares
of stock entitled to vote generally in the election of
directors, voting together as a single class. In addition, our
amended and restated bylaws also provide that any vacancies on
our board of directors will be filled by the affirmative vote of
a majority of the remaining directors, although less than a
quorum or by the sole remaining director.
No
Cumulative Voting
The Delaware General Corporation Law, or DGCL, provides that
stockholders are not entitled to the right to cumulate votes in
the election of directors unless our amended and restated
certificate of incorporation provides otherwise. Our amended and
restated certificate of incorporation prohibits cumulative
voting.
Calling
of Special Meetings of Stockholders
Our amended and restated certificate of incorporation and
amended and restated bylaws provide that special meetings of our
stockholders may be called at any time only by the chairman of
the board of directors, the board of directors or a committee of
the board which has been designated by the board of directors.
Stockholder
Action by Written Consent
The DGCL permits stockholder action by written consent unless
otherwise provided by our amended and restated certificate of
incorporation. Our amended and restated certificate of
incorporation precludes stockholder action by written consent
after the date on which First Reserve or an affiliate ceases to
hold at least 40% in voting power of all shares entitled to vote
generally in the election of our directors.
113
Advance
Notice Requirements for Stockholder Proposals and Director
Nominations
Our amended and restated bylaws provide that stockholders
seeking to nominate candidates for election as directors or to
bring business before an annual meeting of stockholders must
provide timely notice of their proposal in writing to the
corporate secretary.
Generally, to be timely, a stockholders notice must be
received at our principal executive offices not less than 90
calendar days nor more than 120 calendar days prior to the first
anniversary of the date on which we first mailed our proxy
materials for the preceding years annual meeting or at
such other time as specified in our amended and restated bylaws.
Our amended and restated bylaws also specify requirements as to
the form and content of a stockholders notice. These
provisions may impede stockholders ability to bring
matters before an annual meeting of stockholders or make
nominations for directors at an annual meeting of stockholders.
Supermajority
Provisions
The DGCL provides generally that the affirmative vote of a
majority of the outstanding shares entitled to vote is required
to amend a corporations certificate of incorporation or
bylaws, unless the certificate of incorporation requires a
greater percentage. Our amended and restated certificate of
incorporation provides that the following provisions in our
amended and restated certificate of incorporation and amended
and restated bylaws may only be amended, altered, repealed or
rescinded by a vote of at least 75% of the voting power of all
of the outstanding shares of our stock entitled to vote
generally in the election of directors:
|
|
|
|
|
the removal of directors;
|
|
|
|
the limitation of stockholder action by written consent;
|
|
|
|
the ability to call a special meeting of stockholders being
vested solely in our chairman of the board, our board of
directors and any committee of the board of directors which has
been designated by our board of directors;
|
|
|
|
the advance notice requirements for stockholder proposals and
director nominations; and
|
|
|
|
the amendment provision requiring that the above provisions be
amended only with a 75% supermajority vote.
|
In addition, our amended and restated certificate of
incorporation grants our board of directors the authority to
amend or repeal our bylaws without a stockholder vote in any
manner not inconsistent with the laws of the State of Delaware
or our amended and restated certificate of incorporation.
Limitations
on Liability and Indemnification of Officers and
Directors
The DGCL authorizes corporations to limit or eliminate the
personal liability of directors to corporations and their
stockholders for monetary damages for breaches of
directors fiduciary duties. Our amended and restated
certificate of incorporation includes a provision that
eliminates the personal liability of directors for monetary
damages for breach of fiduciary duty as a director, except:
|
|
|
|
|
for breach of duty of loyalty;
|
|
|
|
for acts or omissions not in good faith or involving intentional
misconduct or knowing violation of law;
|
|
|
|
under Section 174 of the DGCL (unlawful dividends); or
|
|
|
|
for transactions from which the director derived improper
personal benefit.
|
Our amended and restated certificate of incorporation and
amended and restated bylaws provide that we must indemnify our
directors and officers to the fullest extent authorized by the
DGCL. We are also expressly authorized to, and do, carry
directors and officers insurance providing coverage
for our directors, officers and certain employees for some
liabilities. We believe that these indemnification provisions
and insurance are useful to attract and retain qualified
directors and executive officers.
114
The limitation of liability and indemnification provisions in
our amended and restated certificate of incorporation and
amended and restated bylaws may discourage stockholders from
bringing a lawsuit against directors for breach of their
fiduciary duty. These provisions may also have the effect of
reducing the likelihood of derivative litigation against
directors and officers, even though such an action, if
successful, might otherwise benefit us and our stockholders. In
addition, your investment may be adversely affected to the
extent we pay the costs of settlement and damage awards against
directors and officers pursuant to these indemnification
provisions.
We have entered into indemnification agreements with each of our
directors and officers providing for additional indemnification
protection beyond that provided by the directors and
officers liability insurance policy. In the
indemnification agreements, we have agreed, subject to certain
exceptions, to indemnify and hold harmless the director or
officer to the maximum extent then authorized or permitted by
the provisions of the amended and restated certificate of
incorporation, the DGCL, or by any amendment(s) thereto.
There is currently no pending material litigation or proceeding
involving any of our directors, officers or employees for which
indemnification is sought.
Delaware
Anti-takeover Statute
We have opted out of Section 203 of the DGCL. Subject to
specified exceptions, Section 203 prohibits a publicly held
Delaware corporation from engaging in a business
combination with an interested stockholder for
a period of three years after the date of the transaction in
which the person became an interested stockholder.
Business combinations include mergers, asset sales
and other transactions resulting in a financial benefit to the
interested stockholder. Subject to various
exceptions, an interested stockholder is a person
who together with his or her affiliates and associates, owns, or
within three years did own, 15% or more of the
corporations outstanding voting stock. These restrictions
generally prohibit or delay the accomplishment of mergers or
other takeover or
change-in-control
attempts.
Transfer
Agent and Registrar
National City Bank is the transfer agent and registrar for our
common stock.
Listing
Our common stock trades on the Nasdaq Global Market under the
symbol GTLS.
Authorized
but Unissued Capital Stock
The DGCL does not require stockholder approval for any issuance
of authorized shares. However, the listing requirements of
Nasdaq, which would apply so long as our common stock is listed
on the Nasdaq Global Market, require stockholder approval of
certain issuances (other than a public offering) equal to or
exceeding 20% of the then outstanding voting power or then
outstanding number of shares of common stock, as well as for
certain issuances of stock in compensatory transactions. These
additional shares may be used for a variety of corporate
purposes, including future public offerings, to raise additional
capital or to facilitate acquisitions. One of the effects of the
existence of unissued and unreserved common stock may be to
enable our board of directors to issue shares to persons
friendly to current management, which issuance could render more
difficult or discourage an attempt to obtain control of our
company by means of a merger, tender offer, proxy contest or
otherwise, and thereby protect the continuity of our management
and possibly deprive the stockholders of opportunities to sell
their shares of common stock at prices higher than prevailing
market prices.
115
SHARES ELIGIBLE
FOR FUTURE SALE
We cannot predict what effect, if any, market sales of shares of
common stock or the availability of shares of common stock for
sale will have on the market price of our common stock.
Nevertheless, sales of substantial amounts of common stock in
the public market, or the perception that such sales could
occur, could materially and adversely affect the market price of
our common stock and could impair our future ability to raise
capital through the sale of our equity or equity-related
securities at a time and price that we deem appropriate.
As of April 30, 2007, we had a total of
25,636,578 shares of common stock outstanding (including
shares currently subject to options that are expected to be
exercised in connection with this offering). Of the outstanding
shares, the shares sold in our initial public offering and in
this offering or resold in reliance on securities law exemptions
will be freely tradable without restriction or further
registration under the Securities Act, except that any shares
held by our affiliates, as that term is defined
under Rule 144 of the Securities Act, may be sold only in
compliance with the limitations described below. The remaining
outstanding shares of common stock will be deemed
restricted securities as that term is defined under
Rule 144. Restricted securities may be sold in the public
market only if registered or if they qualify for an exemption
from registration under Rule 144, 144(k) or Rule 701
under the Securities Act, which are summarized below.
Under our stockholders agreement and management
stockholders agreements, we may be required to register
the sale of shares of certain management stockholders. Certain
management stockholders will have the ability to exercise
certain registration rights in connection with registered
offerings initiated by us. Immediately after this offering, our
executive officers will beneficially own 418,495 shares
entitled to these registration rights, disregarding any
performance options that may vest as a result of the offering.
See Certain Related Party Transactions.
Rule 144
In general, under Rule 144 as currently in effect, a person
(or persons whose shares are required to be aggregated),
including an affiliate, who has beneficially owned shares of our
common stock for at least one year is entitled to sell in any
three-month period a number of shares that does not exceed the
greater of:
|
|
|
|
|
1% of the then-outstanding shares of common stock, or
approximately 256,366 shares assuming no exercise by the
underwriters of their option to purchase additional
shares; and
|
|
|
|
the average weekly reported volume of trading in the common
stock on the Nasdaq Global Market during the four calendar weeks
preceding the date on which notice of sale is filed, subject to
restrictions.
|
Sales under Rule 144 are also subject to manner of sale
provisions and notice requirements and to the availability of
current public information about us.
Rule 144(k)
In addition, a person who is not deemed to have been an
affiliate of ours at any time during the 90 days preceding
a sale and who has beneficially owned the shares proposed to be
sold for at least two years, would be entitled to sell those
shares under Rule 144(k) without regard to the manner of
sale, public information, volume limitation or notice
requirements of Rule 144. To the extent that our affiliates
sell their shares, other than pursuant to Rule 144 or a
registration statement, the purchasers holding period for
the purpose of effecting a sale under Rule 144 commences on
the date of transfer from the affiliate.
Rule 701
In general, under Rule 701 of the Securities Act as
currently in effect, any of our employees, consultants or
advisors who purchases shares of our common stock from us
pursuant to options granted prior to our initial public offering
under our then-existing stock option plans or other written
agreement is eligible to resell those shares in reliance on
Rule 144, but without compliance with some of the
restrictions, including the holding period, contained in
Rule 144. The 418,495 shares that will be held by
management immediately after this offering are presently
eligible for resale, subject to the lock-up agreements described
below.
116
Lock-Up
Agreements
In connection with this offering, we, the selling stockholders
(except FR X Chart Holdings LLC), each of our
executive offices and directors and certain members of
management that are parties to the management stockholders
agreements have agreed with the underwriters, subject to certain
exceptions, not to sell, dispose of or hedge any of our common
stock or securities convertible into or exchangeable for shares
of common stock, during the period ending 90 days after the
date of this prospectus, except with the prior written consent
of the representatives of the underwriters. See
Underwriting.
117
MATERIAL
UNITED STATES FEDERAL INCOME AND
ESTATE TAX CONSEQUENCES TO
NON-U.S. HOLDERS
The following is a summary of material United States federal
income and estate tax consequences of the purchase, ownership
and disposition of our common stock as of the date hereof.
Except where noted, this summary deals only with common stock
that is held as a capital asset by a
non-U.S. holder.
A
non-U.S. holder
means a beneficial owner of our common stock (other than an
entity that is treated as a partnership for United States
federal income tax purposes) that is not for United States
federal income tax purposes any of the following:
|
|
|
|
|
an individual citizen or resident of the United States;
|
|
|
|
a corporation (or any other entity treated as a corporation for
United States federal income tax purposes) created or organized
in or under the laws of the United States, any state thereof or
the District of Columbia;
|
|
|
|
an estate the income of which is subject to United States
federal income taxation regardless of its source; or
|
|
|
|
a trust if it (1) is subject to the primary supervision of
a court within the United States and one or more United States
persons have the authority to control all substantial decisions
of the trust or (2) has a valid election in effect under
applicable United States Treasury regulations to be treated as a
United States person.
|
This summary is based upon provisions of the Internal Revenue
Code of 1986, as amended, or the Code, and regulations, rulings
and judicial decisions as of the date hereof. Those authorities
may be changed, perhaps retroactively, so as to result in United
States federal income and estate tax consequences different from
those summarized below. This summary does not address all
aspects of United States federal income and estate taxes and
does not deal with foreign, state, local or other tax
considerations that may be relevant to
non-U.S. holders
in light of their personal circumstances. In addition, it does
not represent a detailed description of the United States
federal income and estate tax consequences applicable to
non-U.S. holders that are subject to special treatment under the
United States federal income tax laws (including United States
expatriates, controlled foreign corporations,
passive foreign investment companies, companies that
accumulate earnings to avoid United States federal income tax,
foreign tax-exempt organizations, partnerships or other
pass-through entities for United States federal income tax
purposes (or one of such entities beneficial owners),
banks, financial institutions or insurance companies, dealers or
traders in securities, and persons that hold our common stock as
part of straddle, hedge,
conversion transaction, or other integrated risk
transaction). We cannot assure non-U.S. holders that a change in
law will not alter significantly the tax considerations that we
describe in this summary.
If a partnership holds our common stock, the United States tax
treatment of a partner will generally depend upon the status of
the partner and the activities of the partnership. Non-U.S.
holders that are partners of a partnership holding our common
stock should consult their tax advisors.
Non-U.S. holders that are considering the purchase of our
common stock should consult their own tax advisors concerning
the particular United States federal income and estate tax
consequences of the ownership of the common stock, as well as
the consequences arising under the laws of any other taxing
jurisdiction.
Dividends
Dividends received by a
non-U.S. holder
of our common stock generally will be subject to withholding of
United States federal income tax at a 30% rate or such lower
rate as may be specified by an applicable income tax treaty, on
the gross amount of any dividends received in respect of our
common stock. However, dividends that are effectively connected
with the conduct of a trade or business by the
non-U.S. holder
within the United States (and, where a tax treaty applies, are
attributable to a United States permanent establishment (or, for
a non-U.S. holder that is an individual, a fixed base) of the
non-U.S. holder)
are not subject to the withholding tax, provided the non-U.S.
holder submits to us a completed Internal Revenue Service Form
W-8 ECI (or other applicable form). Instead, such dividends are
generally subject to United States federal income tax on a net
income basis in the same manner as if the
non-U.S. holder
were a United States person as defined under the Code, unless an
applicable income tax treaty provides otherwise. Any such
effectively connected dividends received by a non-U.S. holder
that is a foreign
118
corporation may be subject to an additional branch profits
tax at a 30% rate or such lower rate as may be specified
by an applicable income tax treaty.
A
non-U.S. holder
of our common stock who wishes to claim the benefit of an
applicable treaty rate for dividends will be required
(a) to complete Internal Revenue Service
Form W-8BEN
(or other applicable form) and certify under penalty of perjury
that such holder is not a United States person as defined under
the Code and is eligible for treaty benefits or (b) if our
common stock is held through certain foreign intermediaries, to
satisfy the relevant certification requirements of applicable
United States Treasury regulations. Special certification and
other requirements apply to certain
non-U.S. holders
that are pass-through entities rather than corporations or
individuals.
A
non-U.S. holder
of our common stock eligible for a reduced rate of United States
withholding tax pursuant to an income tax treaty may obtain a
refund of any excess amounts withheld by timely filing an
appropriate claim for refund with the Internal Revenue Service.
Gain on
Disposition of Common Stock
Any gain realized on the disposition of our common stock
generally will not be subject to United States federal income or
withholding tax unless:
|
|
|
|
|
the gain is effectively connected with a trade or business of
the
non-U.S. holder
in the United States (and, if required by an applicable income
tax treaty, is attributable to a United States permanent
establishment (or, for a non-U.S. holder that is an
individual, a fixed base) of the
non-U.S. holder);
|
|
|
|
the
non-U.S. holder
is an individual who is present in the United States for
183 days or more in the taxable year of the disposition,
and certain other conditions are met; or
|
|
|
|
we are or have been a United States real property holding
corporation for United States federal income tax purposes
at any time during the shorter of the five-year period ending on
the date of disposition and the
non-U.S. holders
holding period for our common stock.
|
An individual
non-U.S. holder
described in the first bullet point immediately above will be
subject to tax on the net gain derived from the sale in the same
manner as if the non-U.S. holder were a United States
person as defined under the Code. An individual
non-U.S. holder
described in the second bullet point immediately above will be
subject to a flat 30% tax on the gain derived from the sale,
which may be offset by United States source capital losses, even
though the individual is not considered a resident of the United
States. If a
non-U.S. holder
that is a foreign corporation falls under the first bullet point
immediately above, it will be subject to tax on its net gain in
the same manner as if it were a United States person as defined
under the Code and, in addition, may be subject to the branch
profits tax equal to 30% of its effectively connected earnings
and profits or at such lower rate as may be specified by an
applicable income tax treaty.
We believe we are not and do not anticipate becoming a
United States real property holding corporation for
United States federal income tax purposes.
Federal
Estate Tax
Common stock held by an individual who is a non-U.S. person
(as defined for U.S. federal estate tax purposes) at the
time of death will be included in such individuals gross
estate for United States federal estate tax purposes, and may be
subject to U.S. federal estate tax, unless an applicable
estate tax or other treaty provides otherwise.
Information
Reporting and Backup Withholding
We must report annually to the Internal Revenue Service and to
each
non-U.S. holder
the amount of dividends paid to such holder and the tax withheld
with respect to such dividends, regardless of whether
withholding was required. Copies of the information returns
reporting such dividends and withholding may also be made
available to the tax authorities in the country in which the
non-U.S. holder
resides under the provisions of an applicable income tax treaty.
119
A
non-U.S. holder
will be subject to backup withholding (currently at the rate of
28%) for dividends paid to such holder unless such holder
certifies under penalty of perjury that it is a
non-U.S. person
(and the payor does not have actual knowledge or reason to know
that such person is a United States person as defined under the
Code), or such holder otherwise establishes an exemption.
Information reporting and, depending on the circumstances,
backup withholding will apply to the proceeds of a sale of our
common stock within the United States or conducted through
certain United States-related financial intermediaries, unless
the beneficial owner certifies under penalty of perjury that it
is a
non-U.S. holder
(and the payor does not have actual knowledge or reason to know
that the beneficial owner is a United States person as defined
under the Code), or such owner otherwise establishes an
exemption.
Any amounts withheld under the backup withholding rules may be
allowed as a refund or a credit against a
non-U.S. holders
United States federal income tax liability provided the required
information is furnished to the Internal Revenue Service.
120
UNDERWRITING
Under the terms and subject to the conditions contained in an
underwriting agreement dated the date of this prospectus, the
underwriters named below, for whom Morgan Stanley &
Co. Incorporated, Lehman Brothers Inc. and Goldman,
Sachs & Co. will act as joint book-runners and
representatives, have severally agreed to purchase, and we have
agreed to sell to them, severally, the number of shares
indicated in the table below.
|
|
|
Underwriters
|
|
Number of Shares
|
|
Morgan Stanley & Co.
Incorporated
|
|
3,468,441
|
Lehman Brothers Inc.
|
|
3,468,441
|
Goldman, Sachs &
Co.
|
|
3,468,441
|
Natexis Bleichroeder Inc.
|
|
1,576,564
|
Simmons & Company
International
|
|
630,626
|
|
|
|
Total
|
|
12,612,513
|
|
|
|
The underwriters are offering the common stock subject to their
acceptance of the shares from the selling stockholders and
subject to prior sale. The underwriting agreement provides that
the obligations of the several underwriters to pay for and
accept delivery of the common stock offered by this prospectus
are subject to the approval of certain legal matters by their
counsel and to certain other conditions. The underwriters are
obligated to take and pay for all of the common stock offered by
this prospectus if any such shares are taken. However, the
underwriters are not required to take or pay for the shares
covered by the underwriters over-allotment option
described below.
The underwriters initially propose to offer part of the shares
of common stock directly to the public at the public offering
price listed on the cover page of this prospectus and part to
certain dealers at a price that represents a concession not in
excess of $0.60 a share under the public offering price. After
the initial offering of the shares of common stock, the offering
price and other selling terms may from time to time be varied by
the representatives.
We have granted to the underwriters an option, exercisable for
30 days from the date of this prospectus, to purchase up to
an aggregate of 1,891,876 additional shares of common stock at
the public offering price listed on the cover page of this
prospectus, less underwriting discounts and commissions. The
underwriters may exercise this option solely for the purpose of
covering over-allotments, if any, made in connection with the
offering of the shares of common stock offered by this
prospectus. To the extent the option is exercised, each
underwriter will become obligated, subject to specified
conditions, to purchase approximately the same percentage of
additional shares of common stock as the number listed next to
the underwriters name in the preceding table bears to the
total number of shares of common stock listed next to the names
of all underwriters in the preceding table. If the
underwriters option is exercised in full, the total price
to the public would be $308,218,266.25, the total
underwriters discounts and commissions would be
$14,640,730.26, total proceeds to the selling stockholders would
be $255,284,830.63 and total proceeds to us would be
$38,292,705.37.
The following table shows the per share and total underwriting
discounts and commissions to be paid to the underwriters by the
selling stockholders and us. Such amounts are shown assuming
both no exercise and full exercise by the underwriters of their
over-allotment option.
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid by the Selling Stockholders
|
|
No Exercise
|
|
|
Full Exercise
|
|
|
|
|
|
Per Share
|
|
$
|
1.0094
|
|
|
$
|
1.0094
|
|
|
|
|
|
Total
|
|
$
|
12,731,070.62
|
|
|
$
|
12,731,070.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid by Chart Industries, Inc.
|
|
No Exercise
|
|
|
Full Exercise
|
|
|
|
|
|
Per Share
|
|
$
|
0
|
|
|
$
|
1.0094
|
|
|
|
|
|
Total
|
|
$
|
0
|
|
|
$
|
1,909,659.63
|
|
|
|
|
|
The expenses of this offering payable by us, not including the
underwriting discounts and commissions, are estimated at
$0.9 million.
121
Our common stock is listed on the Nasdaq Global Market under the
symbol GTLS.
We, the selling stockholders (except FR X Chart
Holdings LLC), each of our executive officers and directors and
certain members of management parties to management stockholders
agreements have agreed that, without the prior written consent
of the representatives, none of us will, during the period
ending 90 days after the date of this prospectus:
|
|
|
|
|
offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell,
grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any
shares of common stock or any securities convertible into or
exercisable or exchangeable for common stock or file any
registration statement under the Securities Act of 1933 (other
than a registration statement on
Form S-8)
with respect to the foregoing; or
|
|
|
|
enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences
of ownership of the common stock,
|
whether any transaction described above is to be settled by
delivery of common stock or such other securities, in cash or
otherwise.
The restrictions described in the previous paragraph do not
apply to:
|
|
|
|
|
the sale of shares to the underwriters pursuant to the
underwriting agreement;
|
|
|
|
the issuance by us of shares of common stock upon the exercise
of an option or a warrant or the conversion of a security
outstanding on the date of this prospectus of which the
underwriters have been advised in writing;
|
|
|
|
grants, issuances, or exercises under our existing employee
benefits plans;
|
|
|
|
the issuance of common stock in connection with the acquisition
of, or joint venture with, another company, provided that the
recipient agrees to be bound by the restrictions described in
the previous paragraph;
|
|
|
|
transactions by any person other than us relating to shares of
common stock or other securities acquired in open market
transactions after the completion of the offering of the shares;
|
|
|
|
transfers by any person other than us of shares of common stock
or any security convertible, exchangeable for or exercisable
into common stock as a bona fide gift or gifts as a result of
operation of law or testate or in testate succession, provided
that such transferee agrees to be bound by the restrictions
described in the previous paragraph;
|
|
|
|
transfers by any person other than us to a trust, partnership,
limited liability company or other entity, all of the beneficial
interests of which are held, directly, or indirectly by such
person or such persons spouse or children, provided that
such transferee agrees to be bound by the restrictions described
in the previous paragraph; or
|
|
|
|
distributions by any person other than us of shares of common
stock or any security convertible, exchangeable for or
exercisable into common stock to limited partners or
stockholders of such person, provided that such distributee
agrees to be bound by the restrictions described in the previous
paragraph.
|
In order to facilitate the offering of the common stock, the
underwriters may engage in transactions that stabilize, maintain
or otherwise affect the price of the common stock. Specifically,
the underwriters may sell more shares than they are obligated to
purchase under the underwriting agreement, creating a short
position. A short sale is covered if the short
position is no greater than the number of shares available for
purchase by the underwriters under the over-allotment option.
The underwriters can close out a covered short sale by
exercising the over-allotment option or purchasing shares in the
open market. In determining the source of shares to close out a
covered short sale, the underwriters will consider, among other
things, the open market price of shares compared to the price
available under the over-allotment option. The underwriters may
also sell shares in excess of the over-allotment option,
creating a naked short position. The underwriters
must close out any naked short position by purchasing shares in
the open market. A naked short position is more likely to be
created if the underwriters are concerned that there may be
downward pressure on the price of the common stock in the open
market after pricing that could adversely affect investors who
purchase in the offering. As an additional means of facilitating
the offering, the
122
underwriters may bid for, and purchase, common stock in the open
market to stabilize the price of the common stock. The
underwriting syndicate may also reclaim selling concessions
allowed to an underwriter or a dealer for distributing common
stock in the offering, if the syndicate repurchases previously
distributed common stock to cover syndicate short positions, or
to stabilize the price of the common stock. These activities may
raise or maintain the market price of the common stock above
independent market levels or prevent or retard a decline in the
market price of our common stock. The underwriters are not
required to engage in these activities and may end any of these
activities at any time.
The underwriters may also impose a penalty bid. This occurs when
a particular underwriter repays to the underwriters a portion of
the underwriting discount received by it because the
representatives have repurchased shares of common stock sold by
or for the account of such underwriter in stabilizing or short
covering transactions.
Purchases to cover a short position and stabilizing transactions
may have the effect of preventing or retarding a decline in the
market price of our stock, and together with the imposition of
the penalty bid, may stabilize, maintain or otherwise affect the
market price of the common stock. As a result, the price of the
common stock may be higher than the price that otherwise might
exist in the open market. If these activities are commenced,
they may be discontinued at any time. These transactions may be
effected on the Nasdaq Global Market, in the
over-the-counter
market or otherwise.
In connection with this offering, the underwriters and any
selling group members who are a qualified market maker on the
Nasdaq Global Market, may engage in passive market making
transactions in the common stock on the Nasdaq Global Market in
accordance with Rule 103 of Regulation M under the
Securities Exchange of 1934, as amended, during the period
beginning on the later of one business day before the pricing of
this offering or the commencement of offers or sales of the
common stock, and ending through the completion of distribution.
Passive market makers must comply with applicable volume and
price limitations and must be identified as passive market
makers. In general, a passive market maker must display its bid
at a price not in excess of the highest independent bid for the
security; if all independent bids are lowered below the passive
market makers bid, however the bid must then be lowered
when purchase limits are exceeded.
A prospectus in electronic format may be made available by one
or more of the underwriters. The representatives may agree to
allocate a number of shares to underwriters for sale to their
online brokerage account holders. The representatives will
allocate shares to underwriters that may make Internet
distributions on the same basis as other allocations. In
addition, shares may be sold by the underwriters to securities
dealers who resell shares to online brokerage account holders.
From time to time, some of the underwriters and their affiliates
have provided, and may continue to provide, investment banking,
commercial banking and capital raising services to us and our
affiliates for fees and commissions that we believe are
customary. Morgan Stanley Senior Funding, Inc. acts as joint
lead arranger, joint bookrunner and syndication agent and
Natexis Banques Populaires acts as co-documentation agent and
are lenders under our senior secured credit facility. Morgan
Stanley & Co. Incorporated and Natexis Bleichroeder
Inc. acted as placement agents for our senior subordinated notes
and all of the underwriters, except Goldman, Sachs &
Co., acted as underwriters for our initial public offering.
We and the selling stockholders have agreed to indemnify the
underwriters against certain liabilities, including liabilities
under the Securities Act.
European
Economic Area
In relation to each Member State of the European Economic Area
which has implemented the Prospectus Directive (each, a Relevant
Member State), each underwriter has represented and agreed that
with effect from and including the date on which the Prospectus
Directive is implemented in that Relevant Member State (the
Relevant Implementation Date) it has not made and will not make
an offer of shares to the public in that Relevant Member State
prior to the publication of a prospectus in relation to the
shares which has been approved by the competent authority in
that Relevant Member State or, where appropriate, approved in
another Relevant Member State and notified to the competent
authority in that Relevant Member State, all in accordance with
the Prospectus Directive,
123
except that it may, with effect from and including the Relevant
Implementation Date, make an offer of shares to the public in
that Relevant Member State at any time:
(a) to legal entities which are authorised or regulated to
operate in the financial markets or, if not so authorised or
regulated, whose corporate purpose is solely to invest in
securities;
(b) to any legal entity which has two or more of
(1) an average of at least 250 employees during the last
financial year; (2) a total balance sheet of more than
43,000,000 and (3) an annual net turnover of more
than 50,000,000, as shown in its last annual or
consolidated accounts;
(c) to fewer than 100 natural or legal persons (other than
qualified investors as defined in the Prospectus Directive)
subject to obtaining the prior consent of the representatives
for any such offer; or
(d) in any other circumstances which do not require the
publication by the Issuer of a prospectus pursuant to
Article 3 of the Prospectus Directive.
For the purposes of this provision, the expression an
offer of shares to the public in relation to any
shares in any Relevant Member State means the communication in
any form and by any means of sufficient information on the terms
of the offer and the shares to be offered so as to enable an
investor to decide to purchase or subscribe the shares, as the
same may be varied in that Relevant Member State by any measure
implementing the Prospectus Directive in that Relevant Member
State and the expression Prospectus Directive means Directive
2003/71/EC
and includes any relevant implementing measure in each Relevant
Member State.
United
Kingdom
Each underwriter has represented and agreed that:
(a) it has only communicated or caused to be communicated
and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity
(within the meaning of Section 21 of the FSMA) received by
it in connection with the issue or sale of the shares in
circumstances in which Section 21(1) of the FSMA does not
apply to us; and
(b) it has complied and will comply with all applicable
provisions of the FSMA with respect to anything done by it in
relation to the shares in, from or otherwise involving the
United Kingdom.
124
VALIDITY
OF THE SHARES
The validity of the issuance of the shares of common stock to be
sold in this offering will be passed upon for us by Simpson
Thacher & Bartlett LLP, New York, New York.
Shearman & Sterling LLP, New York, New York will act
as counsel to the underwriters. Shearman & Sterling
LLP represents First Reserve on other matters.
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
The accompanying consolidated balance sheets of Chart
Industries, Inc. and subsidiaries as of December 31, 2006
and 2005, and the related consolidated statements of operations,
shareholders equity and cash flows for the year ended
December 31, 2006, the period from October 17, 2005
through December 31, 2005, the period from January 1,
2005 through October 16, 2005 and the year ended
December 31, 2004, which are referred to and made part of
this prospectus and registration statement have been audited by
Ernst & Young LLP, independent registered public
accounting firm, as set forth in their report thereon, appearing
elsewhere herein, and are included in reliance upon such report
given on the authority of such firm as experts in accounting and
auditing.
WHERE YOU
CAN FIND MORE INFORMATION
We have filed with the SEC a registration statement on
Form S-1
under the Securities Act with respect to the sale of shares of
our common stock being offered hereby. This prospectus, which
forms a part of the registration statement, does not contain all
of the information set forth in the registration statement and
exhibits and schedules. For further information with respect to
us and the shares of our common stock, reference is made to the
registration statement. Statements contained in this prospectus
as to the contents of any contract or other document are not
necessarily complete. We are currently subject to the
informational requirements of the Exchange Act and, in
accordance therewith, file reports and other information with
the SEC. The registration statement and the exhibits and
schedules to the registration statement, such reports and other
information can be inspected and copied at the Public Reference
Room of the SEC located at 100 F Street, N.E., Washington
D.C. 20549. Copies of such materials, including copies of
all or any portion of the registration statement, can be
obtained from the Public Reference Room of the SEC at prescribed
rates. You can call the SEC at
1-800-SEC-0330
to obtain information on the operation of the Public Reference
Room. Such materials may also be accessed electronically by
means of the SECs home page on the Internet
(http://www.sec.gov).
125
INDEX TO
FINANCIAL STATEMENTS
|
|
|
|
|
Audited Consolidated Financial
Statements:
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-7
|
|
|
|
|
F-8
|
|
|
|
|
|
|
Unaudited Consolidated
Financial Statements:
|
|
|
|
|
|
|
|
F-48
|
|
|
|
|
F-49
|
|
|
|
|
F-50
|
|
|
|
|
F-51
|
|
F-1
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
Chart Industries, Inc.
We have audited the accompanying consolidated balance sheets of
Chart Industries, Inc. and subsidiaries as of December 31,
2006 and 2005, and the related consolidated statements of
operations, shareholders equity and cash flows for the
year ended December 31, 2006, the period from
October 17, 2005 through December 31, 2005, the period
from January 1, 2005 through October 16, 2005, and the
year ended December 31, 2004. These financial statements
are the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. We were not engaged to perform an
audit of the Companys internal control over financial
reporting. Our audit included consideration of internal control
over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not
for the purpose of expressing an opinion on the effectiveness of
the Companys internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by
management, and evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable
basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the
consolidated financial position of Chart Industries, Inc. and
subsidiaries at December 31, 2006 and 2005, and the
consolidated results of their operations and their cash flows
for the year ended December 31, 2006, the period from
October 17, 2005 through December 31, 2005, the period
from January 1, 2005 through October 16, 2005, and the
year ended December 31, 2004, in conformity with
U.S. generally accepted accounting principles.
As more fully described in Notes H and I to the
consolidated financial statements on December 31, 2006 and
October 17, 2005, the Company adopted the provisions of
Statement of Financial Accounting Standards No. 158
Employees Accounting for Defined Benefit Pension and
Other Post-Retirement Plans, and changed its method of
accounting for stock based compensation by adopting the fair
value recognition provisions of Statement of Financial
Accounting Standards No. 123(R), Share Based
Payments, respectively.
Cleveland, Ohio
March 13, 2007
F-2
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(Dollars in thousands, except per share amounts)
|
|
|
ASSETS
|
Current Assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
18,854
|
|
|
$
|
11,326
|
|
Accounts receivable, net
|
|
|
76,762
|
|
|
|
62,463
|
|
Inventories, net
|
|
|
72,857
|
|
|
|
53,132
|
|
Unbilled contract revenue
|
|
|
32,993
|
|
|
|
21,305
|
|
Prepaid expenses
|
|
|
5,558
|
|
|
|
3,037
|
|
Other current assets
|
|
|
20,527
|
|
|
|
12,552
|
|
Assets held for sale
|
|
|
3,084
|
|
|
|
3,084
|
|
|
|
|
|
|
|
|
|
|
Total Current Assets
|
|
|
230,635
|
|
|
|
166,899
|
|
Property, plant and equipment, net
|
|
|
85,723
|
|
|
|
63,701
|
|
Goodwill
|
|
|
247,144
|
|
|
|
236,742
|
|
Identifiable intangible assets, net
|
|
|
146,623
|
|
|
|
154,063
|
|
Other assets, net
|
|
|
14,750
|
|
|
|
14,236
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$
|
724,875
|
|
|
$
|
635,641
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS EQUITY
|
Current Liabilities
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
48,031
|
|
|
$
|
30,328
|
|
Customer advances and billings in
excess of contract revenue
|
|
|
45,200
|
|
|
|
24,683
|
|
Accrued salaries, wages and
benefits
|
|
|
24,734
|
|
|
|
19,797
|
|
Warranty reserve
|
|
|
4,765
|
|
|
|
3,598
|
|
Other current liabilities
|
|
|
15,761
|
|
|
|
17,606
|
|
Short-term debt
|
|
|
750
|
|
|
|
2,304
|
|
|
|
|
|
|
|
|
|
|
Total Current
Liabilities
|
|
|
139,241
|
|
|
|
98,316
|
|
Long-term debt
|
|
|
290,000
|
|
|
|
345,000
|
|
Long-term deferred tax liability,
net
|
|
|
55,466
|
|
|
|
56,038
|
|
Other long-term liabilities
|
|
|
20,434
|
|
|
|
19,957
|
|
Shareholders
Equity
|
|
|
|
|
|
|
|
|
Common stock, par value
$.01 per share 150,000,000 and
9,500,000 shares authorized, as of December 31, 2006
and 2005, respectively, 25,588,043 and 7,952,180 shares
issued and outstanding at December 31, 2006 and 2005,
respectively See Note A
|
|
|
256
|
|
|
|
80
|
|
Additional paid-in
capital See Note A
|
|
|
185,567
|
|
|
|
117,304
|
|
Retained earnings (deficit)
|
|
|
26,389
|
|
|
|
(506
|
)
|
Accumulated other comprehensive
income (loss)
|
|
|
7,522
|
|
|
|
(548
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
219,734
|
|
|
|
116,330
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND
SHAREHOLDERS EQUITY
|
|
$
|
724,875
|
|
|
$
|
635,641
|
|
|
|
|
|
|
|
|
|
|
F-3
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
Year
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
Year
|
|
|
|
Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
|
|
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
$
|
537,454
|
|
|
$
|
97,652
|
|
|
|
$
|
305,497
|
|
|
$
|
305,576
|
|
Cost of sales
|
|
|
382,535
|
|
|
|
75,733
|
|
|
|
|
217,284
|
|
|
|
211,770
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
154,919
|
|
|
|
21,919
|
|
|
|
|
88,213
|
|
|
|
93,806
|
|
Selling, general and
administrative expenses
|
|
|
72,214
|
|
|
|
13,659
|
|
|
|
|
57,140
|
|
|
|
50,565
|
|
Amortization expense
|
|
|
15,438
|
|
|
|
2,973
|
|
|
|
|
2,686
|
|
|
|
2,809
|
|
Acquisition expenses
|
|
|
|
|
|
|
|
|
|
|
|
6,602
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
396
|
|
|
|
139
|
|
|
|
|
1,057
|
|
|
|
3,169
|
|
Loss (gain) on sale of assets
|
|
|
|
|
|
|
78
|
|
|
|
|
(131
|
)
|
|
|
133
|
|
Equity expense in joint venture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
88,048
|
|
|
|
16,849
|
|
|
|
|
67,354
|
|
|
|
56,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
66,871
|
|
|
|
5,070
|
|
|
|
|
20,859
|
|
|
|
37,079
|
|
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(25,461
|
)
|
|
|
(5,565
|
)
|
|
|
|
(4,192
|
)
|
|
|
(4,760
|
)
|
Financing costs amortization
|
|
|
(1,536
|
)
|
|
|
(308
|
)
|
|
|
|
|
|
|
|
|
|
Derivative contracts valuation
income
|
|
|
|
|
|
|
9
|
|
|
|
|
28
|
|
|
|
48
|
|
Foreign currency gain (loss)
|
|
|
533
|
|
|
|
(101
|
)
|
|
|
|
(659
|
)
|
|
|
465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26,464
|
)
|
|
|
(5,965
|
)
|
|
|
|
(4,823
|
)
|
|
|
(4,247
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and minority interest
|
|
|
40,407
|
|
|
|
(895
|
)
|
|
|
|
16,036
|
|
|
|
32,832
|
|
Income tax expense (benefit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
|
19,376
|
|
|
|
1,902
|
|
|
|
|
9,420
|
|
|
|
8,031
|
|
Deferred
|
|
|
(6,332
|
)
|
|
|
(2,343
|
)
|
|
|
|
(2,261
|
)
|
|
|
2,103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,044
|
|
|
|
(441
|
)
|
|
|
|
7,159
|
|
|
|
10,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before minority
interest
|
|
|
27,363
|
|
|
|
(454
|
)
|
|
|
|
8,877
|
|
|
|
22,698
|
|
Minority interest, net of taxes
|
|
|
(468
|
)
|
|
|
(52
|
)
|
|
|
|
(19
|
)
|
|
|
(98
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
26,895
|
|
|
$
|
(506
|
)
|
|
|
$
|
8,858
|
|
|
$
|
22,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common
share basic
|
|
$
|
1.70
|
|
|
$
|
(0.06
|
)
|
|
|
$
|
1.65
|
|
|
$
|
4.22
|
|
Net income (loss) per common
share diluted
|
|
$
|
1.65
|
|
|
$
|
(0.06
|
)
|
|
|
$
|
1.57
|
|
|
$
|
4.10
|
|
Weighted average number of common
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
15,835
|
|
|
|
7,952
|
|
|
|
|
5,366
|
|
|
|
5,351
|
|
Diluted
|
|
|
16,269
|
|
|
|
7,952
|
|
|
|
|
5,638
|
|
|
|
5,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-4
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Accumulated
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Retained
|
|
|
Other
|
|
|
Shareholders
|
|
|
|
Shares
|
|
|
|
|
|
Paid-In
|
|
|
Earnings
|
|
|
Comprehensive
|
|
|
Equity
|
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Capital
|
|
|
(Deficit)
|
|
|
(Loss) Income
|
|
|
(Deficit)
|
|
|
|
(Dollars and shares in thousands)
|
|
|
Balance at December 31,
2003, Predecessor Company
|
|
|
5,325
|
|
|
|
53
|
|
|
|
89,812
|
|
|
|
31
|
|
|
|
911
|
|
|
|
90,807
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,600
|
|
|
|
|
|
|
|
22,600
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,635
|
|
|
|
2,635
|
|
Minimum pension liability
adjustment, net of taxes of $671
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,243
|
)
|
|
|
(1,243
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,992
|
|
Issuance of common shares
|
|
|
33
|
|
|
|
1
|
|
|
|
840
|
|
|
|
|
|
|
|
|
|
|
|
841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
2004, Predecessor Company
|
|
|
5,358
|
|
|
|
54
|
|
|
|
90,652
|
|
|
|
22,631
|
|
|
|
2,303
|
|
|
|
115,640
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,858
|
|
|
|
|
|
|
|
8,858
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,240
|
)
|
|
|
(2,240
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,618
|
|
Stock option pay-out adjustment,
net of tax of $1,621
|
|
|
|
|
|
|
|
|
|
|
(2,628
|
)
|
|
|
|
|
|
|
|
|
|
|
(2,628
|
)
|
Issuance of common shares
|
|
|
51
|
|
|
|
|
|
|
|
1,691
|
|
|
|
|
|
|
|
|
|
|
|
1,691
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at October 16,
2005, Predecessor Company
|
|
|
5,409
|
|
|
$
|
54
|
|
|
$
|
89,715
|
|
|
$
|
31,489
|
|
|
$
|
63
|
|
|
$
|
121,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-5
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS
EQUITY (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Retained
|
|
|
Other
|
|
|
Total
|
|
|
|
Shares
|
|
|
|
|
|
Paid-In
|
|
|
(Loss)
|
|
|
Comprehensive
|
|
|
Shareholders
|
|
|
|
Outstanding
|
|
|
Amount
|
|
|
Capital
|
|
|
Earnings
|
|
|
(Loss) Income
|
|
|
Equity
|
|
|
|
(Dollars and shares in thousands)
|
|
|
Balance at October 17,
2005 (Date of Acquisition)
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Equity contributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash investment
|
|
|
7,952
|
|
|
|
17
|
|
|
|
111,281
|
|
|
|
|
|
|
|
|
|
|
|
111,298
|
|
Rollover of Predecessor Company
vested stock options
|
|
|
|
|
|
|
|
|
|
|
5,947
|
|
|
|
|
|
|
|
|
|
|
|
5,947
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(506
|
)
|
|
|
|
|
|
|
(506
|
)
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(286
|
)
|
|
|
(286
|
)
|
Minimum pension liability
adjustment, net of taxes of $162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(262
|
)
|
|
|
(262
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,054
|
)
|
Compensation expense recognized
for employee stock options
|
|
|
|
|
|
|
|
|
|
|
139
|
|
|
|
|
|
|
|
|
|
|
|
139
|
|
Stock split (See Note A)
|
|
|
|
|
|
|
63
|
|
|
|
(63
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
2005, Company
|
|
|
7,952
|
|
|
$
|
80
|
|
|
$
|
117,304
|
|
|
$
|
(506
|
)
|
|
$
|
(548
|
)
|
|
$
|
116,330
|
|
Equity contributions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26,895
|
|
|
|
|
|
|
|
26,895
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,638
|
|
|
|
6,638
|
|
Minimum pension liability
adjustment, net of taxes of $885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,432
|
|
|
|
1,432
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,070
|
|
Compensation expense recognized
for employee stock options
|
|
|
|
|
|
|
|
|
|
|
1,748
|
|
|
|
|
|
|
|
|
|
|
|
1,748
|
|
Initial public offering, net
proceeds
|
|
|
12,500
|
|
|
|
125
|
|
|
|
172,367
|
|
|
|
|
|
|
|
|
|
|
|
172,492
|
|
Cash dividends
|
|
|
|
|
|
|
|
|
|
|
(150,313
|
)
|
|
|
|
|
|
|
|
|
|
|
(150,313
|
)
|
Exercise of warrants
|
|
|
2,651
|
|
|
|
26
|
|
|
|
37,077
|
|
|
|
|
|
|
|
|
|
|
|
37,103
|
|
Exercise of options
|
|
|
610
|
|
|
|
6
|
|
|
|
2,128
|
|
|
|
|
|
|
|
|
|
|
|
2,134
|
|
Stock dividend
|
|
|
1,875
|
|
|
|
19
|
|
|
|
(19
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax benefit on non-qualifying
stock options
|
|
|
|
|
|
|
|
|
|
|
5,275
|
|
|
|
|
|
|
|
|
|
|
|
5,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
2006, Company
|
|
|
25,588
|
|
|
$
|
256
|
|
|
$
|
185,567
|
|
|
$
|
26,389
|
|
|
$
|
7,522
|
|
|
$
|
219,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-6
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
Year
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
Year
|
|
|
|
Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
|
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
26,895
|
|
|
$
|
(506
|
)
|
|
|
$
|
8,858
|
|
|
$
|
22,600
|
|
Adjustments to reconcile net income
(loss) to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory purchase accounting charge
|
|
|
|
|
|
|
8,903
|
|
|
|
|
|
|
|
|
|
|
Reorganization value in excess of
amounts allocable to identifiable assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,430
|
|
Financing costs amortization
|
|
|
1,536
|
|
|
|
308
|
|
|
|
|
|
|
|
|
|
|
Employee stock and stock option
related compensation expense
|
|
|
1,907
|
|
|
|
437
|
|
|
|
|
9,509
|
|
|
|
2,433
|
|
Employee separation and plant
closure costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
177
|
|
Loss (gain) on sale of assets
|
|
|
|
|
|
|
78
|
|
|
|
|
(131
|
)
|
|
|
133
|
|
Purchased in-process research and
development charge
|
|
|
|
|
|
|
|
|
|
|
|
2,768
|
|
|
|
|
|
Depreciation and amortization
|
|
|
20,913
|
|
|
|
4,088
|
|
|
|
|
6,808
|
|
|
|
8,490
|
|
Equity loss from joint venture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51
|
|
Foreign currency transaction (gain)
loss
|
|
|
(533
|
)
|
|
|
101
|
|
|
|
|
659
|
|
|
|
(465
|
)
|
Minority interest
|
|
|
734
|
|
|
|
95
|
|
|
|
|
29
|
|
|
|
198
|
|
Deferred income tax expense
(benefit)
|
|
|
(6,332
|
)
|
|
|
(2,343
|
)
|
|
|
|
(2,261
|
)
|
|
|
2,103
|
|
Changes in assets and liabilities,
net of effects from Acquisition:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(9,621
|
)
|
|
|
(8,267
|
)
|
|
|
|
(8,611
|
)
|
|
|
(4,661
|
)
|
Inventory
|
|
|
(15,366
|
)
|
|
|
2,812
|
|
|
|
|
(6,463
|
)
|
|
|
(11,566
|
)
|
Unbilled contract revenues and
other current assets
|
|
|
(19,974
|
)
|
|
|
2,687
|
|
|
|
|
(11,039
|
)
|
|
|
2,903
|
|
Accounts payable and other current
liabilities
|
|
|
21,049
|
|
|
|
2,317
|
|
|
|
|
6,634
|
|
|
|
4,602
|
|
Deferred income taxes
|
|
|
(1,599
|
)
|
|
|
779
|
|
|
|
|
731
|
|
|
|
|
|
Customer advances and billings in
excess of contract revenue
|
|
|
16,789
|
|
|
|
3,146
|
|
|
|
|
8,150
|
|
|
|
6,631
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided By Operating
Activities
|
|
|
36,398
|
|
|
|
14,635
|
|
|
|
|
15,641
|
|
|
|
35,059
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(22,253
|
)
|
|
|
(5,601
|
)
|
|
|
|
(11,038
|
)
|
|
|
(9,379
|
)
|
Proceeds from sale of assets
|
|
|
|
|
|
|
|
|
|
|
|
2,220
|
|
|
|
6,057
|
|
Acquisition of business, net of
cash acquired
|
|
|
(15,927
|
)
|
|
|
|
|
|
|
|
(12,147
|
)
|
|
|
|
|
Payments to Predecessor Company
shareholders for Acquisition
|
|
|
|
|
|
|
(356,649
|
)
|
|
|
|
|
|
|
|
|
|
Other investing activities
|
|
|
(484
|
)
|
|
|
|
|
|
|
|
166
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used In Investing
Activities
|
|
|
(38,664
|
)
|
|
|
(362,250
|
)
|
|
|
|
(20,799
|
)
|
|
|
(3,317
|
)
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from long-term debt
|
|
|
|
|
|
|
350,000
|
|
|
|
|
|
|
|
|
|
|
Borrowings on revolving credit
facilities
|
|
|
4,250
|
|
|
|
2,605
|
|
|
|
|
18,901
|
|
|
|
1,742
|
|
Payments on revolving credit
facilities
|
|
|
(4,339
|
)
|
|
|
(4,790
|
)
|
|
|
|
(15,916
|
)
|
|
|
(1,742
|
)
|
Principal payments on long-term debt
|
|
|
(56,517
|
)
|
|
|
(81,457
|
)
|
|
|
|
(2,968
|
)
|
|
|
(33,148
|
)
|
Proceeds from equity contribution
|
|
|
|
|
|
|
111,298
|
|
|
|
|
|
|
|
|
|
|
Payment of financing costs
|
|
|
(854
|
)
|
|
|
(11,558
|
)
|
|
|
|
|
|
|
|
|
|
Payment of exercised stock options
|
|
|
|
|
|
|
(15,756
|
)
|
|
|
|
|
|
|
|
|
|
Payment of Acquisition costs
|
|
|
|
|
|
|
(1,853
|
)
|
|
|
|
|
|
|
|
|
|
Initial public offering proceeds,
net
|
|
|
172,496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividend payment
|
|
|
(150,313
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant and option exercise proceeds
|
|
|
39,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt restructuring-related fees paid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,882
|
)
|
Payments on interest rate collars
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(805
|
)
|
Proceeds from sale of stock
|
|
|
|
|
|
|
|
|
|
|
|
1,691
|
|
|
|
400
|
|
Tax benefit from exercise of stock
options
|
|
|
5,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(309
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided By (Used In)
Financing Activities
|
|
|
9,235
|
|
|
|
348,489
|
|
|
|
|
1,708
|
|
|
|
(35,744
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and
cash equivalents
|
|
|
6,969
|
|
|
|
874
|
|
|
|
|
(3,450
|
)
|
|
|
(4,002
|
)
|
Effect of exchange rate changes on
cash
|
|
|
559
|
|
|
|
(1,018
|
)
|
|
|
|
106
|
|
|
|
216
|
|
Cash and cash equivalents at
beginning of period
|
|
|
11,326
|
|
|
|
11,470
|
|
|
|
|
14,814
|
|
|
|
18,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS AT END
OF PERIOD
|
|
$
|
18,854
|
|
|
$
|
11,326
|
|
|
|
$
|
11,470
|
|
|
$
|
14,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-7
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
(Dollars and shares in thousands, except per share
amounts)
NOTE A
Nature of Operations and Summary of Significant Accounting
Policies
Nature of Operations: Chart Industries, Inc.
(the Company), is a leading global supplier of
standard and custom-engineered products and systems serving a
wide variety of low-temperature and cryogenic applications. The
Company has developed an expertise in cryogenic systems and
equipment, which operate at low temperatures sometimes
approaching absolute zero. The majority of the Companys
products, including vacuum-insulated containment vessels, heat
exchangers, cold boxes and other cryogenic components, are used
throughout the liquid-gas supply chain for the purification,
liquefaction, distribution, storage and use of industrial gases
and hydrocarbons. The Company has domestic operations located in
seven states, including the principal executive offices located
in Garfield Heights, Ohio, and an international presence in
Australia, China, the Czech Republic, Germany and the United
Kingdom.
Principles of Consolidation: The consolidated
financial statements include the accounts of the Company and its
subsidiaries. Intercompany accounts and transactions are
eliminated in consolidation. Investments in affiliates where the
Companys ownership is between 20 percent and
50 percent, or where the Company does not have control but
has the ability to exercise significant influence over
operations or financial policy, are accounted for under the
equity method. The Companys Chart Heat Exchangers Limited
(CHEL) subsidiary, the equity of which was
100 percent owned by the Company, filed for a voluntary
administration under the U.K. Insolvency Act of 1986 on
March 28, 2003, as more fully described in Note K to
the consolidated financial statements. Since CHEL is not under
the control of the Company subsequent to March 28, 2003,
the consolidated financial statements do not include the
accounts or results of CHEL subsequent to this date.
Basis of Presentation: The consolidated
financial statements have been adjusted as of and for the year
ended December 31, 2005 to give effect to the
4.6263-for-one stock split of the Companys common stock
that occurred on July 20, 2006, and related adjustments to
its capital structure and stock options that were effected upon
the completion of the Companys initial public offering
(IPO) further described below.
On July 31, 2006, the Company completed its IPO of
12,500 shares of its common stock for net proceeds of
$175,313. As a result of the IPO, FR X Chart Holdings LLC, an
affiliate of First Reserve Fund X, L.P (First
Reserve), was no longer the majority shareholder of the
Company. On August 1, 2006, $25,000 of the net proceeds was
used to repay a portion of the term loan portion of the senior
secured credit facility. The remaining $150,313 of net proceeds
was used to pay a dividend to the stockholders existing
immediately prior to the completion of the IPO, consisting of
affiliates of First Reserve and certain members of management.
On August 25, 2006, a stock dividend of 1,875 shares
was issued to the stockholders existing immediately prior to the
completion of the IPO.
On August 2, 2005, the Company, certain stockholders of the
Company (the Principal Stockholders), First Reserve
Fund X, L.P. (First Reserve) and CI
Acquisition, Inc., a wholly owned subsidiary of First Reserve
(CI Acquisition), entered into an agreement and plan
of merger (Merger Agreement). The Merger Agreement
provided for the sale of shares of common stock of the Company
owned by the Principal Stockholders (Principal
Stockholders Shares) to CI Acquisition, which is referred
to as the Stock Purchase, and the merger of CI
Acquisition with and into the Company, with the Company
surviving the merger as a wholly-owned indirect subsidiary of
First Reserve, which is referred to as the Merger.
The Stock Purchase and Merger are collectively referred to as
the Acquisition. Upon satisfaction of the conditions
to the Stock Purchase, CI Acquisition agreed to purchase the
Principal Stockholders Shares for a purchase price (the
Per Share Purchase Price) equal to $65.74 per
share in cash, minus the result of (i) the expenses of the
Company related to the Acquisition (as provided in the Merger
Agreement) divided by (ii) the number of fully-diluted
shares of Company common stock outstanding immediately before
the closing (assuming full exercise of all Company stock options
and warrants). The Merger Agreement provided for the occurrence
of the Merger after the closing of the Stock Purchase, and
provided that at the effective time of the Merger each share of
Company common stock outstanding (other than treasury stock,
shares held by Buyer or CI Acquisition, and shares with respect
to which appraisal rights have been exercised under Delaware
law) will be converted into the right to receive the Per Share
Purchase Price (or the price paid in the Stock
F-8
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
Purchase, if greater) in cash, without interest (the
Merger Consideration). Furthermore, the Merger
Agreement provided that the holders of outstanding warrants and
stock options to acquire shares of common stock of the Company
(other than any stock options adjusted to represent options to
acquire stock of the surviving corporation in the Merger) will
be entitled to receive an amount in cash equal to the product of
(i) the number of shares of common stock of the Company
issuable upon the exercise of the surrendered warrant or option,
as applicable, as of immediately prior to the effective time of
the Merger multiplied by (ii) the excess of the Merger
consideration over the per share exercise price of the warrant
or option, subject to applicable withholding taxes. The Merger
Agreement further provided that after the Merger, no holders of
common stock, warrants or options (other than any stock options
adjusted to represent options to acquire stock of the surviving
corporation in the Merger) outstanding before the Merger will
have any rights in respect of such common stock, warrants or
options, other than the right to receive the cash referred to
above.
On October 17, 2005, the closing of the Acquisition (the
Closing Date) took place under the terms of the
Merger Agreement. The Stock Purchase was made by CI Acquisition
for a Per Share Purchase Price of $64.75 per share of
common stock ($65.74 per share, less the Companys
transaction expenses of $0.99 per share) and immediately
following the Stock Purchase, the Merger occurred. At the
effective time of the Merger, each outstanding share of the
Companys common stock (other than treasury stock, shares
held by First Reserve or CI Acquisition, and shares as to which
appraisal rights were exercised under Delaware law) was
converted into the right to receive $64.75 per share and CI
Acquisition merged with and into Chart Industries, Inc. (which
is referred to after the merger as the Company). In
the Merger, outstanding warrants and stock options to acquire
common stock of the Company (other than any stock options
adjusted to represent options to acquire the stock of the
surviving corporation in the Merger) were likewise cancelled and
treated in accordance with the terms of the Merger Agreement.
Certain stock options outstanding immediately before the Merger
were not cancelled and were adjusted under the terms of the
Merger Agreement to represent options to acquire the
Companys common stock after the Merger. The purchase price
related to the Acquisition was $456,662 and included $356,649 of
cash paid for common stock and warrants outstanding, $15,756 of
cash paid for Predecessor Company stock options, repayment of
$76,458 of existing pre-Acquisition credit facility and certain
other debt, $1,852 of First Reserves acquisition expenses
and vested stock options of the Company and its subsidiaries
prior to the Acquisition (Predecessor Company)
valued at $5,947 to acquire stock of the Company.
The table below summarizes the fair value assigned to the
Companys assets and liabilities within the balance sheet
as of October 17, 2005 as a result of the Acquisition, in
accordance with Statement of Financial Accounting Standard
(SFAS) No. 141, Business
Combinations:
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
20,861
|
|
Accounts receivable, net
|
|
|
54,594
|
|
Inventories, net
|
|
|
65,005
|
|
Unbilled contract revenue
|
|
|
22,667
|
|
Prepaid expenses
|
|
|
3,544
|
|
Other current assets
|
|
|
5,396
|
|
Assets held for sale
|
|
|
3,084
|
|
Deferred income taxes, net
|
|
|
4,900
|
|
|
|
|
|
|
Total Current Assets
|
|
|
180,051
|
|
F-9
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
Property, plant and equipment
|
|
|
61,189
|
|
Goodwill
|
|
|
236,823
|
|
Identifiable intangible assets
|
|
|
157,162
|
|
Other assets
|
|
|
13,357
|
|
|
|
|
|
|
Total Assets
|
|
$
|
648,582
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
31,469
|
|
Customer advances and billings in
excess of contract revenue
|
|
|
23,546
|
|
Accrued salaries, wages and
benefits
|
|
|
16,069
|
|
Warranty reserve
|
|
|
3,439
|
|
Other current liabilities
|
|
|
25,620
|
|
Short-term debt
|
|
|
4,486
|
|
|
|
|
|
|
Total Current
Liabilities
|
|
|
104,629
|
|
Long-term debt
|
|
|
350,000
|
|
Long-term deferred tax liability,
net
|
|
|
56,978
|
|
Other non-current liabilities
|
|
|
18,392
|
|
Minority interest
|
|
|
1,337
|
|
Shareholders
equity
|
|
$
|
117,246
|
|
|
|
|
|
|
Total Liabilities and
Shareholder Equity
|
|
$
|
648,582
|
|
|
|
|
|
|
The consolidated financial statements and accompanying notes as
of December 31, 2006 and 2005, and the year ended
December 31, 2006 and the period October 17, 2005 to
December 31, 2005 are for the Company. The consolidated
financial statements and the accompanying notes for the period
from January 1 to October 16, 2005 and for the year ended
December 31, 2004 are for the Predecessor Company.
Cash and Cash Equivalents: The Company
considers all investments with an initial maturity of three
months or less when purchased to be cash equivalents. The
December 31, 2006 and 2005 balances include money market
investments.
Concentrations of Credit Risks: The Company
sells its products to gas producers, distributors and end-users
across the industrial gas, hydrocarbon and chemical processing
industries in countries all over the world. Approximately 52%,
51% and 52% of sales were made in or exported to foreign
countries in 2006, 2005 and 2004, respectively. While no single
customer exceeded ten percent of consolidated sales in 2006,
2005 or 2004, sales to the Companys top ten customers
accounted for 42%, 39% and 45% of consolidated sales in 2006,
2005 and 2004, respectively. The Companys sales to
particular customers fluctuate from period to period, but the
gas producer and distributor customers of the Company tend to be
a consistently large source of revenue for the Company. To
minimize credit risk from trade receivables, the Company reviews
the financial condition of potential customers in relation to
established credit requirements before sales credit is extended
and monitors the financial condition of customers to help ensure
timely collections and to minimize losses. Additionally, for
certain domestic and foreign customers, particularly in the
Energy and Chemicals segment, the Company requires advance
payments, letters of credit and other such guarantees of
payment. Certain customers also require the Company to issue
letters of credit or performance bonds, particularly in
instances where advance payments are involved, as a condition of
placing the order.
The Company is also subject to concentrations of credit risk
with respect to its cash and cash equivalents and forward
foreign currency exchange contracts. To minimize credit risk
from these financial instruments, the Company enters into these
arrangements with major banks and other high credit quality
financial institutions and
F-10
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
invests only in high-quality instruments. The Company does not
expect any counterparties to fail to meet their obligations in
this area.
Allowance for Doubtful Accounts: The Company
evaluates the collectibility of accounts receivable based on a
combination of factors. In circumstances where the Company is
aware of a specific customers inability to meet its
financial obligations (e.g., bankruptcy filings, or substantial
downgrading of credit scores), a specific reserve is recorded to
reduce the receivable to the amount the Company believes will be
collected. The Company also records allowances for doubtful
accounts based on the length of time the receivables are past
due and historical experience. The allowance for doubtful
accounts balance at December 31, 2006 and 2005 was $1,125
and $1,304, respectively.
Inventories: Inventories are stated at the
lower of cost or market with cost being determined by the
first-in,
first-out (FIFO) method at December 31, 2006
and 2005. The components of inventory are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Raw materials and supplies
|
|
$
|
32,404
|
|
|
$
|
26,385
|
|
Work in process
|
|
|
20,974
|
|
|
|
13,003
|
|
Finished goods
|
|
|
19,479
|
|
|
|
13,744
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
72,857
|
|
|
$
|
53,132
|
|
|
|
|
|
|
|
|
|
|
Inventory Valuation Reserves: The Company
determines inventory valuation reserves based on a combination
of factors. In circumstances where the Company is aware of a
specific problem in the valuation of a certain item, a specific
reserve is recorded to reduce the item to its net realizable
value. The Company also recognizes reserves based on the actual
usage in recent history and projected usage in the near-term. If
circumstances change (e.g.,
lower-than-expected
or
higher-than-expected
usage), estimates of the net realizable value could be changed
by a material amount.
Property, Plant and Equipment: At
October 17, 2005, property, plant and equipment was
recorded at fair value under SFAS 141 Business
Combinations. The depreciable lives were adjusted to
reflect the estimated remaining useful life of each asset and
all existing accumulated depreciation of the Predecessor Company
was eliminated. Subsequent to October 17, 2005, all capital
expenditures for property, plant and equipment are stated on the
basis of cost. Expenditures for maintenance, repairs and
renewals are charged to expense as incurred, whereas major
improvements are capitalized. The cost of applicable assets is
depreciated over their estimated useful lives. Depreciation is
computed using the straight-line method for financial reporting
purposes and accelerated methods for income tax purposes.
Depreciation expense was $5,475 for the year ended
December 31, 2006, $1,115 for the period from
October 17, 2005 to December 31, 2005, $4,122 for the
period January 1, 2005 to October 16, 2005, and $5,681
for the year ended December 31, 2004. The following table
summarizes the components of property, plant and equipment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
Classification
|
|
Estimated Useful Life
|
|
2006
|
|
|
2005
|
|
|
Land and buildings
|
|
20-35 years (buildings)
|
|
$
|
43,379
|
|
|
$
|
33,886
|
|
Machinery and equipment
|
|
3-12 years
|
|
|
28,908
|
|
|
|
19,750
|
|
Computer equipment, furniture and
fixtures
|
|
3-7 years
|
|
|
3,626
|
|
|
|
2,383
|
|
Construction in process
|
|
|
|
|
17,795
|
|
|
|
8,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93,708
|
|
|
|
64,263
|
|
Less accumulated depreciation
|
|
|
|
|
(7,985
|
)
|
|
|
(562
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Total property, plant and
equipment, net
|
|
|
|
$
|
85,723
|
|
|
$
|
63,701
|
|
|
|
|
|
|
|
|
|
|
|
|
F-11
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
The Company monitors its property, plant and equipment, and
finite-lived intangible assets for impairment indicators on an
ongoing basis in accordance with Statement of Financial
Accounting Standards (SFAS) No. 144,
Accounting for the Impairment or Disposal of Long-Lived
Assets. If impairment indicators exist, the Company
performs the required analysis and records impairment charges in
accordance with SFAS No. 144. In conducting its
analysis, the Company compares the undiscounted cash flows
expected to be generated from the long-lived assets to the
related net book values. If the undiscounted cash flows exceed
the net book value, the long-lived assets are considered not to
be impaired. If the net book value exceeds the undiscounted cash
flows, an impairment loss is measured and recognized. An
impairment loss is measured as the difference between the net
book value and the fair value of the long-lived assets. Fair
value is estimated based upon either discounted cash flow
analyses or estimated salvage values. Cash flows are estimated
using internal forecasts as well as assumptions related to
discount rates. Changes in economic or operating conditions
impacting these estimates and assumptions could result in the
impairment of long-lived assets.
Goodwill and Other Intangible Assets: In
conjunction with the Acquisition as previously, the Company
recorded $236,742 of goodwill and $153,320 of other intangible
assets. In accordance with SFAS No. 142,
Goodwill and Other Intangible Assets, the Company
does not amortize goodwill or other indefinite-lived intangible
assets, but reviews them at least annually for impairment using
a measurement date of October 1st. The Company amortizes
intangible assets that have finite useful lives over their
useful lives.
SFAS No. 142 requires that indefinite-lived intangible
assets be tested for impairment and that goodwill be tested for
impairment at the reporting unit level on an annual basis. Under
SFAS No. 142, a company determines the fair value of
any indefinite-lived intangible assets, compares the fair value
to its carrying value and records an impairment loss if the
carrying value exceeds its fair value. Goodwill is tested
utilizing a two-step approach. After recording any impairment
losses for indefinite-lived intangible assets, a company is
required to determine the fair value of each reporting unit and
compare the fair value to its carrying value, including
goodwill, of such reporting unit (step one). If the fair value
exceeds the carrying value, no impairment loss would be
recognized. If the carrying value of the reporting unit exceeds
its fair value, the goodwill of the reporting unit may be
impaired. The amount of the impairment, if any, would then be
measured in step two, which compares the implied fair value of
the reporting
F-12
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
units goodwill with the carrying amount of that goodwill.
The following table displays the gross carrying amount and
accumulated amortization for finite-lived intangible assets and
indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
December 31, 2006
|
|
|
December 31, 2005
|
|
|
|
Average
|
|
|
Gross
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
Estimated
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
|
Useful Life
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amortization
|
|
|
Finite-lived assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unpatented technology
|
|
|
9 years
|
|
|
$
|
9,400
|
|
|
$
|
(1,364
|
)
|
|
$
|
9,400
|
|
|
$
|
(235
|
)
|
Patents
|
|
|
10 years
|
|
|
|
8,138
|
|
|
|
(1,287
|
)
|
|
|
8,138
|
|
|
|
(298
|
)
|
Product names
|
|
|
14 years
|
|
|
|
2,580
|
|
|
|
(255
|
)
|
|
|
940
|
|
|
|
(10
|
)
|
Backlog
|
|
|
14 months
|
|
|
|
6,720
|
|
|
|
(6,336
|
)
|
|
|
5,440
|
|
|
|
(1,110
|
)
|
Non-compete agreements
|
|
|
3 years
|
|
|
|
3,474
|
|
|
|
(977
|
)
|
|
|
1,344
|
|
|
|
(280
|
)
|
Licenses and certificates
|
|
|
18 months
|
|
|
|
48
|
|
|
|
(48
|
)
|
|
|
48
|
|
|
|
(20
|
)
|
Customer relations
|
|
|
13 years
|
|
|
|
101,066
|
|
|
|
(8,647
|
)
|
|
|
96,906
|
|
|
|
(1,480
|
)
|
Other
|
|
|
|
|
|
|
60
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
131,486
|
|
|
$
|
(18,923
|
)
|
|
$
|
122,216
|
|
|
$
|
(3,433
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
|
|
|
$
|
247,144
|
|
|
|
|
|
|
$
|
236,742
|
|
|
|
|
|
Trademarks and trade names
|
|
|
|
|
|
|
34,060
|
|
|
|
|
|
|
|
35,280
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
281,204
|
|
|
|
|
|
|
$
|
272,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for intangible assets subject to
amortization was $15,438 for the year ended December 31,
2006, $2,973 for the period October 17, 2005 to
December 31, 2005, $2,686 for the period January 1,
2005 to October 16, 2005, and $2,809 for the year ended
December 31, 2004, and is estimated to range from
approximately $10,800 to $9,500 annually for fiscal years 2007
through 2011, respectively.
Financial Instruments: The fair values of cash
equivalents, accounts receivable and short-term bank debt
approximate their carrying amount because of the short maturity
of these instruments.
Derivative Instruments: The Company utilizes
certain derivative financial instruments to enhance its ability
to manage risk, including interest rate risk and foreign
currency risk that exists as part of ongoing business
operations. Derivative instruments are entered into for periods
consistent with related underlying exposures and do not
constitute positions independent of those exposures. The Company
does not enter into contracts for speculative purposes, nor is
it a party to any leveraged derivative instrument.
The Companys primary interest rate risk exposure results
from various floating rate pricing mechanisms in the
consolidated term loan and revolving credit facility. This
interest rate risk has been partially managed by the use of an
interest rate derivative contract relating to a portion of the
term debt. The interest rate derivative contract was a collar
and resulted in putting a cap on the base LIBOR interest rate at
approximately 7.0 percent and a floor at approximately
5.0 percent on certain portions of the Companys
floating rate term debt. The Predecessor Company entered into an
interest rate collar in March 1999 to manage interest rate risk
exposure relative to its term debt. This collar, in the amount
of $4,430 at December 31, 2005, expired in March 2006. The
Companys interest rate collar did not qualify as a hedge
under the provisions of SFAS No. 133, Accounting
for Derivative Instruments and Hedging Activities, which
required such a collar to be recorded in the consolidated
balance sheet at fair value. Changes in their fair value must be
recorded in the consolidated statement of operations. The fair
value of the contract related to the collar outstanding at
December 31, 2005 of $5 is recorded in accrued interest.
F-13
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
The change in fair value for the period October 17, 2005 to
December 31, 2005, period January 1, 2005 to
October 16, 2005, and year ended December 31, 2004, of
$9, $28 and $48, respectively, is recorded in derivative
contracts valuation income.
The Company is exposed to foreign currency exchange risk as a
result of transactions in currencies other than the functional
currency of certain subsidiaries. The Company utilizes foreign
currency forward purchase and sale contracts to manage the
volatility associated with foreign currency purchases and
certain intercompany transactions in the normal course of
business. Contracts typically have maturities of less than one
year. Principal currencies include the Euro, British Pound and
Czech Koruna. The Companys foreign currency forward
contracts do not qualify as hedges under the provisions of
SFAS No. 133.
The Company held foreign exchange forward sale contracts for
notional amounts as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31
|
|
|
|
2006
|
|
|
2005
|
|
|
Euros
|
|
|
7,200
|
|
|
|
2,400
|
|
Product Warranties: The Company provides
product warranties with varying terms and durations for the
majority of its products. The Company records warranty expense
in cost of sales. The Company estimates product warranty costs
and accrues for these costs as products are sold. Estimates are
principally based upon historical product warranty claims
experience over the warranty period for each product line. The
changes in the Companys consolidated warranty reserve are
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
Year
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
Year
|
|
|
|
Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Balance at beginning of period
|
|
$
|
3,598
|
|
|
$
|
3,439
|
|
|
|
$
|
2,812
|
|
|
$
|
3,208
|
|
Warranty expense
|
|
|
4,210
|
|
|
|
515
|
|
|
|
|
2,206
|
|
|
|
1,522
|
|
Warranty usage
|
|
|
(3,043
|
)
|
|
|
(356
|
)
|
|
|
|
(1,579
|
)
|
|
|
(1,918
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period
|
|
$
|
4,765
|
|
|
$
|
3,598
|
|
|
|
$
|
3,439
|
|
|
$
|
2,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity: The Company reports
comprehensive income in its consolidated statement of
shareholders equity. The components of accumulated other
comprehensive income (loss) are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Foreign currency translation
adjustments
|
|
$
|
6,352
|
|
|
$
|
(286
|
)
|
Minimum pension liability
adjustments net of taxes of $885 and $162 at December 31,
2006 and 2005, respectively
|
|
$
|
1,170
|
|
|
|
(262
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7,522
|
|
|
$
|
(548
|
)
|
|
|
|
|
|
|
|
|
|
In 2004, the Company finalized the liquidation of the BioMedical
operation in Solingen, Germany and recognized $403 of foreign
currency gain, $258 net of tax, related to the elimination
of the foreign currency translation adjustments previously
recorded as part of this entity.
Revenue Recognition: For the majority of the
Companys products, revenue is recognized when products are
shipped, title has transferred and collection is reasonably
assured. For these products, there is also persuasive evidence
of an arrangement and the selling price to the buyer is fixed or
determinable. For brazed aluminum heat exchangers, cold boxes,
liquefied natural gas fueling stations and engineered tanks, the
Company uses the percentage of completion method of accounting.
Earned revenue is based on the percentage that incurred costs
F-14
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
to date bear to total estimated costs at completion after giving
effect to the most current estimates. Earned revenue on
contracts in process at December 31, 2006, 2005 and 2004,
totaled $216,760, $126,122 and $47,978, respectively. Timing of
amounts billed on contracts varies from contract to contract and
could cause significant variation in working capital needs.
Amounts billed on percentage of completion contracts in process
at December 31, 2006, 2005 and 2004 totaled $224,366,
$125,971 and $43,343, respectively. The cumulative impact of
revisions in total cost estimates during the progress of work is
reflected in the proper period as these changes become known.
Earned revenue reflects the original contract price adjusted for
agreed upon claims and change orders, if any. Losses expected to
be incurred on contracts in process, after consideration of
estimated minimum recoveries from claims and change orders, are
charged to operations as soon as such losses are known. Change
orders resulting in additional revenue and profit are recognized
upon approval by the customer based on the percentage that
incurred costs to date bear to total estimated costs at
completion.
Distribution Costs: The Company records
distribution costs, including warehousing and freight related to
product shipping, in cost of sales.
Advertising Costs: The Company incurred
advertising costs of $2,684 for the year ended December 31,
2006, $556 for the period October 17, 2005 to
December 31, 2005, $2,151 for the period January 1,
2005 to October 16, 2005, and $2,833 for the year ended
December 31, 2004. Such costs are expensed as incurred.
Research and Development Costs: The Company
incurred research and development costs of $3,876 for the year
ended December 31, 2006, $805 for the period
October 17, 2005 to December 31, 2005, $2,198 for the
period January 1, 2005 to October 16, 2005, and $3,279
for the year ended December 31, 2004. Such costs are
expensed as incurred.
Foreign Currency Translation: The functional
currency for the majority of the Companys foreign
operations is the applicable local currency. The translation
from the applicable foreign currencies to U.S. dollars is
performed for balance sheet accounts using exchange rates in
effect at the balance sheet date and for revenue and expense
accounts using a weighted average exchange rate during the
period. The resulting translation adjustments are recorded as a
component of shareholders equity. Gains or losses
resulting from foreign currency transactions are charged to
operations as incurred.
Deferred Income Taxes: The Company and its
U.S. subsidiaries file a consolidated federal income tax
return. Deferred income taxes are provided for temporary
differences between financial reporting and the consolidated tax
return in accordance with the liability method. A valuation
allowance is provided against net deferred tax assets if
conditions indicate that it is more likely than not that the
benefit related to such assets will not be realized.
Employee Stock Options: In 2005 and 2006, the
Company granted stock options (New Options), under
the 2005 Stock Incentive Plan (Stock Incentive Plan)
to certain management employees. In addition, under the
Companys 2004 Stock Option and Incentive Plan (2004
Plan) certain management employees rolled over stock
options (Rollover Options). The Company adopted
SFAS 123(R)Share- Based Payments, on
October 17, 2005 using the modified prospective method, to
account for these New Options. The New Options are exercisable
for a period of ten years and have two different vesting
schedules. The time-based (Time-based Options) vest
annually in equal installments over a five-year period and the
performance-based (Performance-based Options) vest
based upon specified actual returns on First Reserves
investment in the Company. Furthermore, certain of the Rollover
Options were vested on the Closing Date of the Acquisition. In
April 2006, the Board of Directors took action to vest all
remaining Rollover Options that had not been previously vested.
The New Options generally may not be transferred. The
Companys policy is to issue authorized shares upon the
exercise of any stock options. In addition, all of the 2004
stock options under the 2004 Plan of the Predecessor Company,
except for the Rollover Options described above, were deemed to
be exercised in conjunction with the Acquisition. These 2004
Options were accounted for under the intrinsic value method of
APB Opinion No. 25 Accounting for Stock Issued to
Employees
F-15
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
and related interpretations in accounting for employee stock
options. See Note I for further discussions regarding the
stock options.
Earnings per share: The following table
presents calculations of income (loss) per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
Year
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
Year
|
|
|
|
Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Net income (loss)
|
|
$
|
26,895
|
|
|
$
|
(506
|
)
|
|
|
$
|
8,858
|
|
|
$
|
22,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common
share basic
|
|
$
|
1.70
|
|
|
$
|
(0.06
|
)
|
|
|
$
|
1.65
|
|
|
$
|
4.22
|
|
Net income (loss) per common
share diluted
|
|
$
|
1.65
|
|
|
$
|
(0.06
|
)
|
|
|
$
|
1.57
|
|
|
$
|
4.10
|
|
Weighted average number of common
shares outstanding basic
|
|
|
15,835
|
|
|
|
7,952
|
|
|
|
|
5,366
|
|
|
|
5,351
|
|
Incremental shares issuable upon
assumed exercise of stock warrants
|
|
|
|
|
|
|
|
|
|
|
|
61
|
|
|
|
15
|
|
Incremental shares issuable upon
assumed conversion and exercise of stock options
|
|
|
434
|
|
|
|
|
|
|
|
|
211
|
|
|
|
150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shares diluted
|
|
|
16,269
|
|
|
|
7,952
|
|
|
|
|
5,638
|
|
|
|
5,516
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The assumed conversion of the Companys potentially
dilutive stock options and warrants was anti-dilutive for the
period from October 17, 2005 to December 31, 2005. For
the purposes of computing diluted earnings per share, weighted
average common share equivalents do not include 1,041 stock
options and 1,360 warrants for the period from October 17,
2005 to December 31, 2005 as the effect would be
anti-dilutive.
Reclassifications: Certain prior year amounts
have been reclassified to conform to current year presentation.
Use of Estimates: The preparation of financial
statements in conformity with accounting principles generally
accepted in the United States requires management to make
estimates and assumptions that affect the amounts reported in
the financial statements and accompanying notes. Actual results
could differ from those estimates.
Recently Adopted Accounting Standards: In
December 2004, the FASB issued SFAS No. 151,
Inventory Costs. SFAS No. 151 requires
abnormal amounts of inventory costs related to idle facility,
freight handling and wasted material expenses to be recognized
as current period charges. Additionally, SFAS No. 151
requires that allocation of fixed production overheads to the
costs of conversion be based on the normal capacity of the
production facilities. The Company adopted the statement on
January 1, 2006 and the statement did not have a material
effect on our financial position, results of operations,
liquidity or cash flows.
In June 2005, the FASB issued SFAS No. 154,
Accounting Changes and Error Corrections.
SFAS 154 replaces APB Opinion No. 20, Accounting
Changes and SFAS 3, Reporting Accounting
Changes in Interim Financial Statements. SFAS 154
requires that a voluntary change in accounting principle be
applied retrospectively with all prior period financial
statements presented on the new accounting principle.
SFAS 154 also requires that a change in method of
depreciating and amortizing a long-lived asset be accounted for
prospectively as a change in estimate, and the correction of
errors in previously issued financial statements should be
termed a restatement. SFAS 154 is effective for accounting
changes and corrections of errors made in fiscal years beginning
after December 15, 2005. The implementation of
SFAS 154 did not have an impact on our present consolidated
financial statements and will only affect financial statements
to the extent there are future accounting changes or errors.
F-16
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
In December 2004, the FASB issued SFAS No. 123
(revised 2004), Share-Based Payment.
SFAS No. 123(R) is a revision of
SFAS No. 123, Accounting for Stock-Based
Compensation and supersedes Accounting Principles Board
(APB) Opinion No. 25, Accounting for
Stock Issued to Employees, and amends
SFAS No. 95, Statement of Cash Flows.
SFAS 123(R) requires all share-based payments to employees,
including grants of employee stock options, to be recognized in
the financial statements based on their fair values and
eliminates the pro forma disclosure option allowed under
SFAS 123. SFAS 123(R)is effective for nonpublic
entities for fiscal years beginning after
December 15, 2005. We adopted SFAS 123(R) on
October 17, 2005 in conjunction with the Acquisition.
In September 2006, the FASB issued SFAS No. 158,
Employers Accounting for Defined Pension Benefit
Plans and Other Postretirement Plans. This statement
requires recognition on the balance sheet of the underfunded or
overfunded status of pension and postretirement benefit plans.
SFAS No. 158 also requires the recognition of changes
in the funded status through other comprehensive income in the
year that the changes occur. In addition, SFAS No. 158
requires additional disclosures about the future effects on net
periodic benefit cost that arise from the delayed recognition of
gains or losses. SFAS No. 158 also requires that
defined benefit plan assets and obligations be measured as of
the date of the employers fiscal year end balance sheet.
The recognition and disclosure provisions of
SFAS No. 158 are effective for fiscal years ending
after December 15, 2006. The requirement to measure plan
assets and benefit obligations as of the date of the
employers fiscal year end balance sheet is effective for
fiscal years ending after December 15, 2008. The Company
adopted SFAS No. 158 as of December 31, 2006 (See
Note H). The adoption of this statement had no effect on
our financial position, results of operations, liquidity or cash
flows.
Recently Issued Accounting Pronouncements. In
June 2006, the Financial Accounting Standards Board (FASB)
issued Interpretation No. 48. Accounting for
Uncertainty in Income Taxes an interpretation of
FASB Statement No. 109 (FIN 48). FIN 48
clarifies the accounting for uncertainty in income taxes by
prescribing thresholds and attributes for the financial
statement recognition and measurement of a tax position taken or
expected to be taken in a tax return. The interpretation also
provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, and disclosure.
FIN 48 is effective for fiscal years beginning after
December 15, 2006. The Company is currently evaluating the
impact of adopting FIN 48 on its financial position and
results of operations.
In September 2006, the FASB issued Statement of Financial
Accounting Standards No. 157, Fair Value
Measurements (SFAS No. 157) which is
effective for fiscal years beginning after November 15,
2007. SFAS No. 157 defines fair value to be applied to
U.S. GAAP guidance requiring use of fair value, establishes
a framework for measuring fair value and expands the disclosure
requirements for fair value measurements. The Company is
currently evaluating the impact of SFAS No. 157 on its
financial position and results of operations.
F-17
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
NOTE B
Balance Sheet Components
The following table summarizes the components of other current
assets, other assets, net, other current liabilities and other
long-term liabilities on the Companys consolidated balance
sheet as of December 31, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Other current assets:
|
|
|
|
|
|
|
|
|
Deposits
|
|
$
|
2,003
|
|
|
$
|
306
|
|
Deferred income taxes
|
|
|
7,417
|
|
|
|
6,429
|
|
Other receivables
|
|
|
11,107
|
|
|
|
5,817
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
20,527
|
|
|
$
|
12,552
|
|
|
|
|
|
|
|
|
|
|
Other assets net:
|
|
|
|
|
|
|
|
|
Deferred financing costs
|
|
$
|
11,068
|
|
|
$
|
11,749
|
|
Cash value life insurance
|
|
|
1,640
|
|
|
|
1,265
|
|
Other
|
|
|
2,042
|
|
|
|
1,222
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
14,750
|
|
|
$
|
14,236
|
|
|
|
|
|
|
|
|
|
|
Other current liabilities:
|
|
|
|
|
|
|
|
|
Accrued interest
|
|
$
|
5,144
|
|
|
$
|
4,599
|
|
Accrued other taxes
|
|
|
678
|
|
|
|
1,948
|
|
Accrued rebates
|
|
|
4,013
|
|
|
|
3,152
|
|
Accrued employee separation and
plant closure costs
|
|
|
1,868
|
|
|
|
1,986
|
|
Accrued other
|
|
|
4,058
|
|
|
|
5,921
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,761
|
|
|
$
|
17,606
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities:
|
|
|
|
|
|
|
|
|
Accrued environmental
|
|
$
|
6,658
|
|
|
$
|
6,608
|
|
Accrued pension cost
|
|
|
3,355
|
|
|
|
7,233
|
|
Minority interest
|
|
|
2,111
|
|
|
|
1,103
|
|
Accrued contingencies and other
|
|
|
8,310
|
|
|
|
5,013
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
20,434
|
|
|
$
|
19,957
|
|
|
|
|
|
|
|
|
|
|
F-18
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
NOTE C
Debt and Credit Arrangements
The following table shows the components of the Companys
borrowings at December 31, 2006 and 2005, respectively.
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Senior term loan, due October 2012
and September 2009, respectively, average interest rate of 6.93%
and 6.62% at December 31, 2006 and 2005, respectively
|
|
$
|
120,000
|
|
|
$
|
175,000
|
|
Subordinated notes, due 2015,
interest accrued at 9.125%
|
|
|
170,000
|
|
|
|
170,000
|
|
Revolving foreign credit facility
and other short-term debt
|
|
|
750
|
|
|
|
2,304
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
290,750
|
|
|
|
347,304
|
|
Less: current maturities
|
|
|
750
|
|
|
|
2,304
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
$
|
290,000
|
|
|
$
|
345,000
|
|
|
|
|
|
|
|
|
|
|
In connection with the Acquisition, the Company entered into a
senior secured credit facility (the Senior Credit
Facility) and completed a $170,000 offering of
91/8% senior
subordinated notes (the Subordinated Notes). The
Company repaid the then existing credit facility of the
Predecessor Company, as described further below, and certain
other debt on or before October 17, 2005, the Closing Date
of the Acquisition. The Senior Credit Facility consists of a
$180,000 term loan facility (the Term Loan) and a
$115,000 revolving credit facility (the Revolver),
of which $55,000 may be used for letters of credit extending
beyond one year from their date of issuance. The Term Loan and
Subordinated Notes were fully funded on the Closing Date. The
Term Loan matures on October 17, 2012 and the Revolver
matures on October 17, 2010. As a result of four voluntary
principal prepayments in December 2005, and March, June and
August 2006, the Term Loan does not require any principal
payments prior to the maturity date. The interest rate under the
Senior Credit Facility is, at the Companys option, the
Alternative Base Rate (ABR) plus 1.0% or LIBOR plus
2.0% on the Term loan and ABR plus 1.5% or LIBOR plus 2.5% on
the Revolver. The applicable interest margin on the Revolver
could decrease based upon the leverage ratio calculated at each
fiscal quarter end. In addition, the Company is required to pay
an annual administrative fee of $100, a commitment fee of 0.5%
on the unused Revolver balance, a letter of credit participation
fee of 2.5% per annum on the letter of credit exposure and
a letter of credit issuance fee of 0.25%. The obligations under
the Senior Credit Facility are secured by substantially all of
the assets of the Companys U.S. Subsidiaries and 65%
of the capital stock of the Companys
non-U.S. Subsidiaries.
The Subordinated Notes are due in 2015 with interest payable
semi-annually on April 15th and October 15th. The
registration rights agreement required the Company to file an
Exchange Offer Registration Statement and complete the exchange
offer for the Subordinated Notes by August 14, 2006. Since
the exchange offer was not completed when required, additional
interest at a rate of 0.25% per annum accrued on the
Subordinated Notes for the
90-day
period ending November 11, 2006. Additional interest will
accrue in further increments of 0.25%, per annum up to a maximum
of 1.0%, per annum each subsequent
90-day
period until the exchange offer is completed. On
November 12, 2006 and February 10, 2007, the
additional interest rate on the Subordinated Notes increased by
0.50% per annum and 0.75% per annum, respectively. The
Company expects the exchange offer to be completed in April 2007
at which time additional interest will cease accruing.
Any of the Subordinated Notes may be redeemed solely at the
Companys option beginning on October 15, 2010. The
initial redemption price is 104.563 percent of the
principal amount, plus accrued interest. Also, any of the notes
may be redeemed solely at the Companys option at any time
prior to October 15, 2010, plus accrued interest and a
make-whole premium. In addition, before
October 15, 2008, up to 35 percent of the Subordinated
Notes may be redeemed solely at the Companys option at a
price of 109.125 percent of the principal amount, plus
accrued
F-19
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
interest, using the proceeds from sales of certain kinds of
capital stock. The Subordinated Notes are general unsecured
obligations of the Company and are subordinated in right of
payment to all existing and future senior debt of the Company,
including the Senior Credit Facility, pari passu in right of
payment with all future senior subordinated indebtedness of the
Company, senior in right of payment with any future indebtedness
of the Company that expressly provided for its subordination to
the Subordinated Notes, and unconditionally guaranteed jointly
and severally by substantially all of the Companys
U.S. Subsidiaries.
The Senior Credit Facility agreement and provisions of the
indenture governing the Subordinated Notes contain a number of
customary covenants, including, but not limited to, restrictions
on the Companys ability to incur additional indebtedness,
create liens or other encumbrances, sell assets, enter into sale
and lease-back transactions, make certain payments, investments,
loans, advances or guarantees, make acquisitions and engage in
mergers or consolidations, pay dividends and distributions, and
make capital expenditures. The Senior Credit Facility also
includes covenants relating to leverage and interest coverage.
At December 31, 2006, there was $120,000 and $170,000
outstanding under the Term Loan and Subordinated Notes,
respectively, and letters of credit and bank guarantees totaling
$30,570 supported by the Revolver.
Chart Ferox, a.s. (Ferox), a wholly-owned subsidiary
of the Company, maintains secured revolving credit facilities
with borrowing capacity, including overdraft protection, of up
to $9,600, of which $4,400 is available only for letters of
credit and bank guarantees. Under the revolving credit
facilities, Ferox may make borrowings in Czech Koruna, Euros and
U.S. dollars. Borrowings in Koruna are at PRIBOR,
borrowings in Euros are at EUROBOR and borrowings in
U.S. dollars are at LIBOR, each with a fixed margin of
0.6 percent. Ferox is not required to pay a commitment fee
to the lenders under the revolving credit facilities in respect
to the unutilized commitments thereunder. Ferox must pay letter
of credit and guarantee fees equal to 0.75 percent on the
face amount of each guarantee. Feroxs land and buildings,
and accounts receivable secure $4,600 and $2,500, respectively,
of the revolving credit facilities. At December 31, 2006,
there were no borrowings outstanding under, and $1,511 of bank
guarantees supported by the Ferox revolving credit facilities.
The scheduled annual maturities of long-term debt and credit
arrangements at December 31, 2006, are as follows:
|
|
|
|
|
Year
|
|
Amount
|
|
|
2007
|
|
$
|
|
|
2008
|
|
|
|
|
2009
|
|
|
|
|
2010
|
|
|
|
|
2011 and thereafter
|
|
$
|
290,000
|
|
|
|
|
|
|
|
|
$
|
290,000
|
|
|
|
|
|
|
The Company paid interest of $25,570 for the year ended
December 31, 2006, $1,085 for the period October 17,
2005 to December 31, 2005, $4,397 for the period
January 1, 2005 to October 16, 2006, and $5,615 for
the year ended December 31, 2004.
The Company believes that the fair value of its Subordinated
Notes is approximately $180,000 at December 31, 2006 based
on actual market trading and approximates carrying value at
December 31, 2005. The fair value of the term loan portion
of its Senior Credit Facility is estimated based on the present
value of the underlying cash flows discounted at the
Companys estimated borrowing rate. Under such method the
Companys Term Loan approximated its carrying value at
December 31, 2006 and 2005.
F-20
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
NOTE D
Employee Separation and Plant Closure Costs
In 2004, the Company continued its manufacturing facility
reduction plan, which commenced in 2002. These actions resulted
in the announcements of the closure of the Companys
Distribution and Storage segment manufacturing facility in
Plaistow, New Hampshire and the BioMedical segment manufacturing
and office facility in Burnsville, Minnesota, respectively. In
2004, the Company completed the shutdown of the Plaistow, New
Hampshire manufacturing facility and continued the shutdown of
the Burnsville, Minnesota manufacturing facility, which was
completed in the first quarter of 2005. In each of these
facility closures, the Company did not exit the product lines
manufactured at those sites, but moved the manufacturing to
other facilities with available capacity, most notably New
Prague, Minnesota for engineered tank production and Canton,
Georgia for medical respiratory production. During 2006, 2005
and 2004, the Company recorded employee separation and plant
closure costs related to these facility reduction plans and also
recorded non-cash inventory valuation charges included in cost
of sales at certain of these sites.
The following tables summarize the Companys employee
separation and plant closure costs activity for 2006, 2005 and
2004.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006 Company
|
|
|
|
|
|
|
Distribution
|
|
|
Energy &
|
|
|
|
|
|
|
|
|
|
BioMedical
|
|
|
& Storage
|
|
|
Chemicals
|
|
|
Corporate
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Other associated costs
|
|
|
|
|
|
|
396
|
|
|
|
|
|
|
|
|
|
|
|
396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
|
|
|
|
396
|
|
|
|
|
|
|
|
|
|
|
|
396
|
|
Reserve usage
|
|
|
(118
|
)
|
|
|
(396
|
)
|
|
|
|
|
|
|
|
|
|
|
(514
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
(118
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(118
|
)
|
Reserves as of January 1, 2006
|
|
|
239
|
|
|
|
190
|
|
|
|
1,557
|
|
|
|
|
|
|
|
1,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserve as of December 31,
2006
|
|
$
|
121
|
|
|
$
|
190
|
|
|
$
|
1,557
|
|
|
$
|
|
|
|
$
|
1,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 17, 2005 to December 31, 2005
Company
|
|
|
|
|
|
|
Distribution
|
|
|
Energy &
|
|
|
|
|
|
|
|
|
|
BioMedical
|
|
|
& Storage
|
|
|
Chemicals
|
|
|
Corporate
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
17
|
|
|
$
|
(120
|
)
|
|
$
|
78
|
|
|
$
|
86
|
|
|
$
|
61
|
|
Other associated costs
|
|
|
2
|
|
|
|
102
|
|
|
|
(26
|
)
|
|
|
|
|
|
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
19
|
|
|
|
(18
|
)
|
|
|
52
|
|
|
|
86
|
|
|
|
139
|
|
Inventory valuation in cost of
sales
|
|
|
149
|
|
|
|
|
|
|
|
|
|
|
|
(34
|
)
|
|
|
115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
168
|
|
|
|
(18
|
)
|
|
|
52
|
|
|
|
52
|
|
|
|
254
|
|
Reserve usage
|
|
|
(33
|
)
|
|
|
(97
|
)
|
|
|
(48
|
)
|
|
|
(57
|
)
|
|
|
(235
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
135
|
|
|
|
(115
|
)
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
19
|
|
Reserves as of October 17,
2005
|
|
|
104
|
|
|
|
305
|
|
|
|
1,553
|
|
|
|
5
|
|
|
|
1,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserve as of December 31,
2005
|
|
$
|
239
|
|
|
$
|
190
|
|
|
$
|
1,557
|
|
|
$
|
|
|
|
$
|
1,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-21
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 1, 2005 to October 16, 2005
Predecessor Company
|
|
|
|
|
|
|
Distribution
|
|
|
Energy &
|
|
|
|
|
|
|
|
|
|
BioMedical
|
|
|
& Storage
|
|
|
Chemicals
|
|
|
Corporate
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
|
|
|
$
|
41
|
|
|
$
|
|
|
|
$
|
(159
|
)
|
|
$
|
(118
|
)
|
Other associated costs
|
|
|
540
|
|
|
|
465
|
|
|
|
129
|
|
|
|
41
|
|
|
|
1,175
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
540
|
|
|
|
506
|
|
|
|
129
|
|
|
|
(118
|
)
|
|
|
1,057
|
|
Inventory valuation in cost of
sales
|
|
|
643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,183
|
|
|
|
506
|
|
|
|
129
|
|
|
|
(118
|
)
|
|
|
1,700
|
|
Reserve usage
|
|
|
(1,451
|
)
|
|
|
(542
|
)
|
|
|
(133
|
)
|
|
|
(370
|
)
|
|
|
(2,496
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
(268
|
)
|
|
|
(36
|
)
|
|
|
(4
|
)
|
|
|
(488
|
)
|
|
|
(796
|
)
|
Reserves as of January 1, 2005
|
|
|
372
|
|
|
|
341
|
|
|
|
1,557
|
|
|
|
493
|
|
|
|
2,763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserve as of October 16, 2005
|
|
$
|
104
|
|
|
$
|
305
|
|
|
$
|
1,553
|
|
|
$
|
5
|
|
|
$
|
1,967
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2004 Predecessor
Company
|
|
|
|
|
|
|
Distribution
|
|
|
Energy &
|
|
|
|
|
|
|
|
|
|
BioMedical
|
|
|
& Storage
|
|
|
Chemical
|
|
|
Corporate
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
381
|
|
|
$
|
215
|
|
|
$
|
303
|
|
|
$
|
398
|
|
|
$
|
1,297
|
|
Contract termination costs
|
|
|
|
|
|
|
317
|
|
|
|
29
|
|
|
|
|
|
|
|
346
|
|
Other associated costs
|
|
|
406
|
|
|
|
726
|
|
|
|
412
|
|
|
|
(18
|
)
|
|
|
1,526
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
787
|
|
|
|
1,258
|
|
|
|
744
|
|
|
|
380
|
|
|
|
3,169
|
|
Inventory valuation in costs of
sales
|
|
|
97
|
|
|
|
80
|
|
|
|
|
|
|
|
|
|
|
|
177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
884
|
|
|
|
1,338
|
|
|
|
744
|
|
|
|
380
|
|
|
|
3,346
|
|
Reserve usage
|
|
|
(512
|
)
|
|
|
(1,530
|
)
|
|
|
(1,369
|
)
|
|
|
(562
|
)
|
|
|
(3,973
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
372
|
|
|
|
(192
|
)
|
|
|
(625
|
)
|
|
|
(182
|
)
|
|
|
(627
|
)
|
Reserves as of January 1, 2004
|
|
|
|
|
|
|
533
|
|
|
|
2,182
|
|
|
|
675
|
|
|
|
3,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserve as of December 31,
2004
|
|
$
|
372
|
|
|
$
|
341
|
|
|
$
|
1,557
|
|
|
$
|
493
|
|
|
$
|
2,763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE E
Acquisitions
On May 26, 2006, the Company acquired the common stock of
Cooler Service Company, Inc. (CSC) based in Tulsa,
OK. The consideration paid was $15,927, net of cash acquired,
including transaction costs. The acquisition was funded with
cash on hand. The fair value of the net assets acquired and
goodwill at the date of acquisition was $8,050 and $8,654,
respectively. CSC designs and manufactures air cooled heat
exchangers for multiple markets, including hydrocarbon,
petrochemical and industrial gas processing, and power
generation. CSC has been included in the Companys Energy
and Chemical segment and contributed $17,774 of sales to the
2006 consolidated statement of operations from the date of
acquisition through December 31, 2006.
On May 16, 2005, the Company acquired 100 percent of
the equity interest in Changzhou CEM Cryo Equipment Co., Ltd.
(CEM), a foreign owned enterprise established under
the laws of the Peoples Republic of China. The purchase
price was $13,664, consisting of cash of $12,147 and the
issuance of a promissory note of $1,466 payable to the seller.
The fair value of the net assets acquired and goodwill at the
date of acquisition was $8,894 and $4,770, respectively. For the
period January 1, 2005 to October 17, 2005, the
Company recorded a
F-22
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
charge of $2,768 for the write-off of purchased in-process
research and development that was included in the fair value of
net assets acquired. CEM has been included in the Companys
Distribution and Storage operating segment.
On February 27, 2004, the Companys Coastal
Fabrication joint venture (Coastal Fabrication)
executed an agreement to redeem the joint venture partners
50 percent equity interest of $289 for cash consideration
of $250 and the possibility of additional consideration being
paid based upon the number of direct labor manufacturing hours
performed at the Companys New Iberia, LA facility during
2004 and 2005. The $39 difference between the cash consideration
paid and the value of the 50 percent equity interest was
recorded by Coastal Fabrication as a reduction of certain fixed
assets. As a result of the elimination of the joint venture
partner and the assumption of 100 percent of control by the
Company, the assets, liabilities and operating results of
Coastal Fabrication are included in these consolidated financial
statements subsequent to February 27, 2004.
NOTE F
Income Taxes
Deferred income taxes reflect the net tax effect of temporary
differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts
used for income tax purposes. Significant components of the
Companys deferred tax assets and liabilities are as
follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Accruals and reserves
|
|
$
|
8,871
|
|
|
$
|
7,665
|
|
Pensions
|
|
|
1,197
|
|
|
|
2,699
|
|
Inventory
|
|
|
1,283
|
|
|
|
1,288
|
|
Foreign tax credit carryforward
|
|
|
390
|
|
|
|
|
|
Other net
|
|
|
2,752
|
|
|
|
3,370
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
$
|
14,493
|
|
|
$
|
15,022
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
$
|
6,546
|
|
|
$
|
5,795
|
|
Intangibles
|
|
|
55,996
|
|
|
|
58,836
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
$
|
62,542
|
|
|
$
|
64,631
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax (liabilities)
|
|
$
|
(48,049
|
)
|
|
$
|
(49,609
|
)
|
|
|
|
|
|
|
|
|
|
As of December 31, 2006, the Company has foreign tax credit
carryforwards of $390 which will begin to expire in 2014 through
2016.
The Company has not provided for income taxes on approximately
$27,162 of foreign subsidiaries undistributed earnings as
of December 31, 2006, since the earnings retained have been
reinvested indefinitely by the subsidiaries. It is not
practicable to estimate the additional income taxes and
applicable foreign withholding taxes that would be payable on
the remittance of such undistributed earnings.
Congress passed the American Jobs Creation Act in October 2004.
The Act provided for a special one-time tax deduction of
85 percent of certain foreign earnings that are repatriated
(as defined in the Act) in 2005. During the period
January 1, 2005 to October 17, 2005, the Company
recorded income tax expense of $156 for the repatriation of
$2,970 of foreign earnings under the Act.
F-23
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
Income (loss) before income taxes and minority interest consists
of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
United States
|
|
$
|
22,673
|
|
|
$
|
(1,425
|
)
|
|
|
$
|
10,718
|
|
|
$
|
25,566
|
|
Foreign
|
|
|
17,734
|
|
|
|
530
|
|
|
|
|
5,318
|
|
|
|
7,266
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
40,407
|
|
|
$
|
(895
|
)
|
|
|
$
|
16,036
|
|
|
$
|
32,832
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Significant components of the provision for income taxes are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
13,995
|
|
|
$
|
1,476
|
|
|
|
$
|
6,601
|
|
|
$
|
5,224
|
|
State
|
|
|
1,722
|
|
|
|
199
|
|
|
|
|
1,013
|
|
|
|
928
|
|
Foreign
|
|
|
3,659
|
|
|
|
227
|
|
|
|
|
1,806
|
|
|
|
1,879
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,376
|
|
|
|
1,902
|
|
|
|
|
9,420
|
|
|
|
8,031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(5,838
|
)
|
|
|
(2,055
|
)
|
|
|
|
(1,793
|
)
|
|
|
1,692
|
|
State
|
|
|
(544
|
)
|
|
|
(185
|
)
|
|
|
|
(161
|
)
|
|
|
166
|
|
Foreign
|
|
|
50
|
|
|
|
(103
|
)
|
|
|
|
(307
|
)
|
|
|
245
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,332
|
)
|
|
|
(2,343
|
)
|
|
|
|
(2,261
|
)
|
|
|
2,103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
13,044
|
|
|
$
|
(441
|
)
|
|
|
$
|
7,159
|
|
|
$
|
10,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-24
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
The reconciliation of income taxes computed at the
U.S. federal statutory tax rates to income tax expense is
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Income tax (benefit) expense at
U.S. statutory rates
|
|
$
|
14,142
|
|
|
$
|
(313
|
)
|
|
|
$
|
5,691
|
|
|
$
|
11,491
|
|
State income taxes, net of federal
tax benefit
|
|
|
766
|
|
|
|
9
|
|
|
|
|
554
|
|
|
|
711
|
|
Credit on foreign taxes paid
|
|
|
(544
|
)
|
|
|
(127
|
)
|
|
|
|
(408
|
)
|
|
|
|
|
Effective tax rate differential of
earnings outside of U.S.
|
|
|
(1,967
|
)
|
|
|
(71
|
)
|
|
|
|
(463
|
)
|
|
|
(488
|
)
|
Federal tax benefit of foreign
sales
|
|
|
(676
|
)
|
|
|
(130
|
)
|
|
|
|
(648
|
)
|
|
|
(456
|
)
|
Non-deductible (taxable) items
|
|
|
175
|
|
|
|
191
|
|
|
|
|
1,308
|
|
|
|
(624
|
)
|
In-process research and development
|
|
|
|
|
|
|
|
|
|
|
|
969
|
|
|
|
|
|
Repatriation of foreign earnings
|
|
|
|
|
|
|
|
|
|
|
|
156
|
|
|
|
|
|
Provision (income) for tax
contingencies
|
|
|
1,148
|
|
|
|
|
|
|
|
|
|
|
|
|
(500
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
13,044
|
|
|
$
|
(441
|
)
|
|
|
$
|
7,159
|
|
|
$
|
10,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The taxing rules of the various jurisdictions in which the
Company operates or does business often are complex and subject
to various interpretations and tax authorities may challenge tax
positions that are taken or have historically been taken, and
may assess additional taxes, penalties and interest. A state in
which the Company operates has asserted that the Company may be
liable for substantial state income taxes, penalties and
interest related to the state from 1993 to 2000. As of
December 31, 2006, the Company has not accrued a liability
for this potential contingency as the loss is not probable or
estimatible.
For the period January 1, 2005 to October 16, 2005,
the Company received a tax benefit of $5,818 from the exercise
of stock options as a result of the Acquisition. The Company had
net income tax payments of $10,543 in 2006, $3,113 for the
period October 17, 2005 to December 31, 2005, $11,160
for the period January 1, 2005 to October 16, 2005 and
$8,035 in 2004.
NOTE G
Assets Held for Sale
In June 2004, the Company executed an agreement to sell its
Burnsville, MN BioMedical facility for $4,500. Because the net
sales price, estimated to be $4,175 after selling costs, was
lower than the carrying value, the assets were written down to
the net sales price by recording a $404 loss on sale of assets
in 2004. The net proceeds from this sale were used to pay down
$880 of debt outstanding under an industrial revenue bond and
the remainder was used for working capital purposes.
In June 2004, the Company decided to sell a building, parcel of
land and manufacturing equipment at its Plaistow, NH
Distribution and Storage manufacturing and office facility. The
manufacturing equipment was sold in August 2004 for $1,082
resulting in a gain on sale of assets of $549. In September
2004, the Company entered into an agreement, which expired in
July 2005, to sell the idle Plaistow land and building for
$3,567, net of selling costs. It was determined the net sales
price per the agreement was lower than the carrying value and
the Company recorded a fair value impairment loss of $386 in
2004. During the January 1, 2005 to October 16, 2005
Period, an additional $483 fair value impairment loss was
recognized by the Predecessor Company as the Company entered
into another agreement to sell the land and building that
expired in the first quarter of 2006. In March 2007, the Company
entered into an agreement to sell a portion of the land and all
of the buildings and expects the transaction to close in the
F-25
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
second quarter of 2007. At December 31, 2006, the carrying
value of this property equaled $3,084. The Plaistow facility is
classified as held for sale on its consolidated balance sheet as
of December 31, 2006 and 2005.
NOTE H
Employee Benefit Plans
The Company has four defined benefit pension plans (the
Plans) covering certain U.S. hourly and salary
employees. Effective as of February 28, 2006, all of the
Plans were frozen.
The following table sets forth the components of net periodic
pension (benefit) cost for the year ended December 31,
2006, the period October 17, 2005 to December 31,
2005, the period January 1, 2005 to October 16, 2005
and the year ended December 31, 2004, based on a
December 31st measurement date.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Service cost
|
|
$
|
|
|
|
$
|
53
|
|
|
|
$
|
205
|
|
|
$
|
887
|
|
Interest cost
|
|
|
2,042
|
|
|
|
410
|
|
|
|
|
1,559
|
|
|
|
2,056
|
|
Expected return on plan assets
|
|
|
(2,475
|
)
|
|
|
(474
|
)
|
|
|
|
(1,807
|
)
|
|
|
(2,135
|
)
|
Amortization of net (gain)
|
|
|
|
|
|
|
|
|
|
|
|
(6
|
)
|
|
|
(48
|
)
|
Amortization of prior service cost
|
|
|
|
|
|
|
|
|
|
|
|
(141
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total pension (benefit) cost
|
|
$
|
(433
|
)
|
|
$
|
(11
|
)
|
|
|
$
|
(190
|
)
|
|
$
|
760
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth changes in the projected benefit
obligation and plan assets, the funded status of the plans and
the amounts recognized in the consolidated balance sheet:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Change in projected benefit
obligation:
|
|
|
|
|
|
|
|
|
January 1 projected benefit
obligation
|
|
$
|
37,404
|
|
|
$
|
36,104
|
|
Service cost
|
|
|
|
|
|
|
258
|
|
Interest cost
|
|
|
2,042
|
|
|
|
1,969
|
|
Benefits paid
|
|
|
(1,112
|
)
|
|
|
(990
|
)
|
Actuarial (gains) losses and plan
changes
|
|
|
(934
|
)
|
|
|
63
|
|
|
|
|
|
|
|
|
|
|
December 31 projected benefit
obligation
|
|
$
|
37,400
|
|
|
$
|
37,404
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
Fair value at January 1
|
|
$
|
30,104
|
|
|
$
|
27,789
|
|
Actual return
|
|
|
3,857
|
|
|
|
2,359
|
|
Employer contributions
|
|
|
1,263
|
|
|
|
946
|
|
Benefits paid
|
|
|
(1,112
|
)
|
|
|
(990
|
)
|
|
|
|
|
|
|
|
|
|
Fair value at December 31
|
|
$
|
34,112
|
|
|
$
|
30,104
|
|
|
|
|
|
|
|
|
|
|
Funded status (plan assets less
than projected benefit obligations)
|
|
$
|
(3,288
|
)
|
|
$
|
(7,300
|
)
|
|
|
|
|
|
|
|
|
|
At December 31, 2006 and 2005, the Company recorded an
unrecognized actuarial (gain) loss of ($1,892) and $424 in
accumulated other comprehensive income, respectively.
F-26
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
A minimum pension liability adjustment was required as of
December 31, 2005 as the actuarial present value of a
projected benefit obligations exceeded plan assets and accrued
pension liabilities.
The actuarial assumptions used in determining the funded status
information and subsequent net periodic pension cost are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year Ended
|
|
|
2005 to
|
|
|
|
2005 to
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
United States Plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.75
|
%
|
|
|
5.50
|
%
|
|
|
|
5.75
|
%
|
|
|
5.75
|
%
|
Weighted average rate of increase
in compensation
|
|
|
|
*
|
|
|
|
*
|
|
|
|
3.00
|
%
|
|
|
4.00
|
%
|
Expected long-term weighted
average rate of return on plan assets
|
|
|
8.25
|
%
|
|
|
8.25
|
%
|
|
|
|
8.25
|
%
|
|
|
8.25
|
%
|
|
|
|
* |
|
No longer applicable as Plans were frozen and participants are
no longer accruing benefits. |
The expected long-term weighted average rate of return on plan
assets was established using the Companys target asset
allocation for equity and debt securities and the historical
average rates of return for equity and debt securities. The
Company employs a total return investment approach whereby a mix
of equities and fixed income investments are used to maximize
the long-term return of plan assets for a prudent level of risk.
Risk tolerance is established through careful consideration of
short- and long-term plan liabilities, plan funded status and
corporate financial condition. The investment portfolio contains
a diversified blend of equity and fixed-income investments.
Furthermore, equity investments are diversified across U.S. and
non-U.S. stocks,
as well as growth, value, and small and large capitalizations.
Investment risk is measured and monitored on an ongoing basis
through quarterly investment portfolio reviews, annual liability
measurements and periodic asset/liability studies. The
Companys pension plan weighted-average actual (which is
periodically rebalanced) and target asset allocations by asset
category at December 31 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual
|
|
|
|
Target
|
|
|
2006
|
|
|
2005
|
|
|
Stocks
|
|
|
59
|
%
|
|
|
65
|
%
|
|
|
57
|
%
|
Fixed income funds
|
|
|
39
|
%
|
|
|
33
|
%
|
|
|
41
|
%
|
Cash and cash equivalents
|
|
|
2
|
%
|
|
|
2
|
%
|
|
|
2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-27
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
The Companys funding policy is to contribute at least the
minimum funding amounts required by law. Based upon current
actuarial estimates, the Company expects to contribute $674 to
its defined benefit pension plans in 2007 and expects the
following benefit payments to be paid by the plans:
|
|
|
|
|
2007
|
|
$
|
1,300
|
|
2008
|
|
|
1,378
|
|
2009
|
|
|
1,464
|
|
2010
|
|
|
1,577
|
|
2011
|
|
|
1,711
|
|
In aggregate during five years
thereafter
|
|
|
10,514
|
|
|
|
|
|
|
|
|
$
|
17,944
|
|
|
|
|
|
|
The Company presently makes contributions to one bargaining unit
supported multi-employer pension plan resulting in expense of
$440 for the year ended December 31, 2006, $78 for the
period October 17, 2005 to December 31, 2005, $282 for
the period January 1, 2005 to October 16, 2005, and
$313 for the year ended December 31, 2004. As part of the
closure of Plaistow, NH facility in 2004, the Company withdrew
from the multi-employer plan upon final termination of all
employees at such facility. The Company has recorded a related
estimated withdrawal liability of $170 at December 31,
2006, and 2005. Any additional liability over this accrued
amount is not expected to have a material adverse impact on the
Companys financial position, liquidity, cash flows or
results of operations.
The Company has a defined contribution savings plan that covers
most of its U.S. employees. Company contributions to the
plan are based on employee contributions, and a Company match
and discretionary contributions. Expenses under the plan totaled
$3,685 for the year ended December 31, 2006, $517 for the
period October 17, 2005 to December 31, 2005, $2,188
for the period January 1, 2005 to October 16,
2005, and $1,483 for the year ended December 31, 2004.
NOTE I
Stock Option Plans
In 2005 and 2006, 2,442 New Options were granted to certain
management employees of the Company, under the 2005 Stock
Incentive Plan. The 2005 New Options were granted at an exercise
price of $6.50 per share, and the 2006 New Options were
granted at an exercise price of $12.16 per share. The New
Options are exercisable for a period of ten years and have two
vesting schedules. 861 of the New Options are time-based
(Time-based Options) and vest equally in annual
installments over a five year period and 1,581 of the New
Options are performance-based (Performance-based
Options) and vest based upon specified actual returns on
First Reserves investment in the Company. The New Options
generally may not be sold, transferred, assigned or disposed of.
In addition, the remaining 43 Rollover Options from the 2004
Plan, as described further below, were all vested by April 2006
and stock-based compensation expense recognized there upon. In
April and May 2006, all 610 Rollover Options were exercised. As
of December 31, 2006, there were 2,442 New Options
outstanding of which 153 were vested and 2,289 were unvested.
For the year ended December 31, 2006 and the period
October 17, 2005 to December 31, 2005, $1,906 and
$437, respectively, was recognized for the New Options and the
Rollover Options. As of December 31, 2006, the unrecognized
total share-based compensation expense to be recorded over the
next five years related to the unvested Time-based Options is
$2,378.
As of December 31, 2006, the maximum share-based
compensation expense for the Performance-based Options was
$7,700 which will be recognized if and to the extent it becomes
probable that the specified actual returns on First
Reserves investment will be achieved.
On October 17, 2005, in conjunction with the Acquisition,
all of the unvested 2004 Options under the Predecessor
Companys 2004 Plan were vested upon the change of control,
except for 43 Rollover Options. As a
F-28
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
result of normal vesting and the change in control, $9,508 of
share-based compensation expense was recognized for the period
January 1, 2005 to October 16, 2005. In addition,
certain members of management rolled over 610 Rollover Options
from the 2004 Plan, including the 43 Rollover Options that were
vested in 2006 as described above. These Rollover Options had an
exercise price of $3.50 per share.
On March 19, 2004, the Predecessor Company granted 436 2004
Options to purchase shares of the Companys common stock
with an exercise price of $13.89 per share when the closing
market price of the Companys common stock was
$28.00 per share. These 2004 Options were accounted for
under the intrinsic value method of APB Opinion No. 25,
Accounting for Stock Issued to Employees
(APB 25). These non-qualified stock options
were exercisable for a period of 10 years and have two
different vesting schedules: 320 options were scheduled to vest
in equal annual installments over a four-year period and 116
options were scheduled to vest over a
45-month
period, which commenced April 1, 2004, based upon the
achievement of specific operating performance goals during that
45-month
period as determined by the Compensation Committee of the Board
of Directors. The 320 2004 Options on the time-based vesting
schedule were accounted for as a fixed compensatory plan under
APB 25. For these options, the Company expected to record
$4,313 as compensation expense over the vesting period based on
the $14.11 difference between the closing market price and the
exercise price on the date of grant. The 116 2004 Options on the
performance-based vesting schedule were accounted for as a
variable compensatory plan under APB 25. For these options,
the Company recorded compensation expense over the vesting
period based upon the difference between the closing market
price of the Companys stock and the exercise price at each
balance sheet measurement date, and the Companys estimate
of the number of options that will ultimately vest based upon
actual and estimated performance in comparison to the
performance targets.
During 2004, 14 options on the time-based vesting schedule and
14 options on the performance-based vesting schedule were
cancelled due to the resignation of eligible employees, and 42
additional 2004 Options on the time-based vesting schedule and
30 additional 2004 Options on the performance-based vesting
schedule were issued at the closing market price on the date of
grant to then new eligible employees and non-employee members of
the Companys Board of Directors. The 42 2004 Options with
the time-based vesting schedule were accounted for as a fixed
plan under APB 25. For these options, the Company recorded
no compensation expense, since the exercise price was equal to
the market price at the date of grant. The 30 Options with the
performance-based vesting schedule were accounted for as a
variable compensatory plan under APB 25 and the Company
recorded compensation expense using the same method as the
initial 116 performance-based options. As of December 31,
2004, there were 480 options outstanding. For the year ended
December 31, 2004, the Company recognized $1,998 of
stock-based compensation expense.
The fair value of the New Options was estimated at the date of
grant using a Black-Scholes option pricing model with the
following weighted-average assumptions: risk-free interest rate
of 4.8 percent; dividend yields of 0.0 percent;
volatility factors of the expected market price of the
Companys common shares of 47.0 percent; and a
weighted-average expected life of 7.5 years for the
options. Volatility was calculated using an average of the
Predecessor Companys historical closing stock price on the
OTCBB from October 2, 2003 to October 14, 2005.
Stock-based compensation expense for the Time-based Options is
recorded on an accrual basis over the vesting period.
F-29
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
Certain information for the years ended December 31, 2006
and 2005, relative to the Companys stock option plans is
summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006
|
|
|
|
December 31, 2005
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
Average
|
|
|
|
|
|
|
Average
|
|
|
Average
|
|
|
|
Number
|
|
|
Grant Date
|
|
|
Exercise
|
|
|
|
Number
|
|
|
Grant Date
|
|
|
Exercise
|
|
|
|
of Shares
|
|
|
Fair Value
|
|
|
Price
|
|
|
|
of Shares
|
|
|
Fair Value
|
|
|
Price
|
|
Outstanding balance at beginning
of period
|
|
|
2,785
|
|
|
$
|
2.90
|
|
|
$
|
5.84
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
Rollover
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
610
|
|
|
|
|
|
|
|
3.50
|
|
Granted
|
|
|
267
|
|
|
|
14.05
|
|
|
|
12.16
|
|
|
|
|
2,175
|
|
|
|
3.72
|
|
|
|
6.50
|
|
Exercised
|
|
|
(610
|
)
|
|
|
|
|
|
|
3.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expired or canceled
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period
|
|
|
2,442
|
|
|
$
|
4.85
|
|
|
$
|
7.12
|
|
|
|
|
2,785
|
|
|
$
|
2.90
|
|
|
$
|
5.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at end of year *
|
|
|
135
|
|
|
$
|
3.72
|
|
|
$
|
5.84
|
|
|
|
|
567
|
|
|
$
|
|
|
|
$
|
3.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Participants at end of year
|
|
|
34
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available for future grant at end
of year
|
|
|
963
|
|
|
|
|
|
|
|
|
|
|
|
|
67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Remaining contractual term of 8 years and 11 months. |
In July and August 2006, the Company granted restricted stock
units covering 16 shares of common stock to non-employee
directors. Each of the six grants of restricted stock units had
a fair value of $40 on the date of grant. The restricted stock
units are expected to fully vest on the first anniversary of the
date of grant or earlier in the event of a change of control as
defined in the 2005 Stock Incentive Plan. For the year ended
December 31, 2006, the Company recognized $100 of director
compensation expense related to these restricted stock units.
NOTE J
Lease Commitments
The Company incurred $4,373, $717, $2,665 and $3,478 of rental
expense under operating leases for the year ended
December 31, 2006, the period October 17, 2005
to December 31, 2005, the period January 1, 2005 to
October 16, 2005 and the year ended December 31, 2004.
Certain leases contain rent escalation clauses and lease
concessions that require additional rental payments in the later
years of the term. Rent expense for these types of leases are
recognized on a straight-line basis over the minimum lease term.
In addition, the Company has the right, but no obligation, to
renew certain leases for various renewal terms. At
December 31, 2006, future minimum lease payments for
non-cancelable operating leases for the next five years total
$13,421 and are payable as follows: 2007 $3,905;
2008 $3,324; 2009 $2,558;
2010 $1,960; and 2011 $1,674.
NOTE K
Contingencies
Environmental
The Company is subject to federal, state and local environmental
laws and regulations concerning, among other matters, waste
water effluents, air emissions and handling and disposal of
hazardous materials such as cleaning fluids. The Company is
involved with environmental compliance, investigation,
monitoring and remediation activities at certain of its owned
manufacturing facilities and at one owned facility that is
leased to a third party, and, except for these continuing
remediation efforts, believes it is currently in substantial
compliance with all known environmental regulations. At
December 31, 2006 and 2005, the Company had
F-30
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
undiscounted accrued environmental reserves of $6,658 and
$6,608, respectively, recorded in other long-term liabilities.
The Company accrues for certain environmental
remediation-related activities for which commitments or
remediation plans have been developed and for which costs can be
reasonably estimated. These estimates are determined based upon
currently available facts and circumstances regarding each
facility. Actual costs incurred may vary from these estimates
due to the inherent uncertainties involved. Future expenditures
relating to these environmental remediation efforts are expected
to be made over the next 8 to 14 years as ongoing costs of
remediation programs.
Although the Company believes it has adequately provided for the
cost of all known environmental conditions, the applicable
regulatory agencies could insist upon different and more costly
remediation than those the Company believes are adequate or
required by existing law. The Company believes that any
additional liability in excess of amounts accrued which may
result from the resolution of such matters will not have a
material adverse effect on the Companys financial
position, liquidity, cash flows or results of operations.
Appraisal
Rights
In conjunction with the Acquisition and the Notice of Merger
dated October 25, 2005, certain of the former
shareholders of the Predecessor Company representing
244 shares of common stock, gave notice of their right
under Delaware General Corporation Law to exercise appraisal
rights. In February 2006, before the former shareholders filed
suit in court under Delaware General Corporation Law, the
Company settled this appraisal rights matter by paying
additional proceeds to these former shareholders of
$0.5 million. This settlement amount was accrued at
December 31, 2005 and paid in 2006.
CHEL
In March 2003, the Company completed the closure of its
Wolverhampton, United Kingdom manufacturing facility, operated
by CHEL, and all current heat exchanger manufacturing is being
conducted at the Companys La Crosse, WI facility. On
March 28, 2003, CHEL filed for a voluntary administration
under the United Kingdom (U.K.) Insolvency Act of
1986. CHELs application for voluntary administration was
approved on April 1, 2003 and an administrator was
appointed. Additionally, the Company received information that
indicated that CHELs net pension plan obligations had
increased significantly primarily due to a decline in plan asset
values and interest rates as well as increased plan liabilities,
resulting in an estimated plan deficit of approximately
$12.0 million as of March 2003. Based on the Companys
financial condition in March 2003, it determined not to advance
funds to CHEL in amounts necessary to fund CHELs
obligations. Since CHEL was unable to fund its net pension
deficit, pay remaining severance due to former employees, or pay
other creditors, the trustees of the CHEL pension plan requested
a decision to
wind-up the
plan from a U.K. pension regulatory board. That board approved
the wind-up
as of March 28, 2003.
The Company does not believe that it is legally obligated to
fund the net pension deficit of the CHEL pension plan because
CHEL, which is no longer one of the Companys consolidated
subsidiaries, was the sponsor of the pension plan and the entity
with primary responsibility for the plan. In addition, the
Company considered itself and its consolidated subsidiaries
legally released from being the primary obligor of any CHEL
liabilities. Further, at the time the insolvency administrator
assumed control of CHEL, the Company no longer had control of
the assets or liabilities of CHEL. As a result, in March 2003,
the Company wrote-off its net investment in CHEL. In addition,
any claims of CHEL against the Company were discharged in
bankruptcy as part of the Companys Reorganization Plan.
While no claims presently are pending against the Company
related to CHELs insolvency, persons impacted by the
insolvency or others could bring a claim against the Company
asserting that the Company is directly responsible for pension
and benefit related liabilities of CHEL. Although the Company
would vigorously contest any claim of this kind, it can provide
no assurance that claims will not be asserted against it in the
future. To the
F-31
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
extent the Company has a significant liability related to
CHELs insolvency and pension
wind-up,
satisfaction of that liability could have a material adverse
impact on the Companys liquidity, results of operations
and financial position.
Chapter 11
Reorganization
On July 8, 2003, the Pre-Predecessor Company and all of its
then majority-owned U.S. subsidiaries filed voluntary
petitions for reorganization relief under Chapter 11 of the
U.S. Bankruptcy Code with the United States Bankruptcy
Court for the District of Delaware to implement an agreed upon
senior debt restructuring plan through a pre-packaged plan of
reorganization. None of the Pre-Predecessor Companys
non-U.S. subsidiaries
were included in the filing in the Bankruptcy Court. On
September 15, 2003, the Predecessor Company and all of its
majority-owned U.S. subsidiaries emerged from
Chapter 11 proceedings pursuant to the Amended Joint
Prepackaged Reorganization Plan of Chart Industries, Inc. and
Certain Subsidiaries, dated September 3, 2003. The Company
has resolved all proofs of claim asserted in the bankruptcy
proceedings, including the settlement in July 2005 of a
finders fee claim in the amount of $1.1 million
asserted by a former shareholder of the Company, against which
the Company had filed an objection in the Bankruptcy Court. All
bankruptcy proceedings were closed in May 2006.
Performance
Under Contracts
The Company is occasionally subject to various other legal
proceedings or claims related to performance under contracts,
and other matters, several of which claim substantial damages,
in the ordinary course of its business. Based on the
Companys historical experience in litigating these claims,
as well as the Companys current assessment of the
underlying merits of the actions and applicable insurance, the
Company believes the resolution of these other legal claims will
not have a material adverse effect on the Companys
financial position, liquidity, cash flows or results of
operations. Future developments may, however, result in
resolution of these legal claims in a way that could have a
material adverse effect.
Legal
Proceedings
The Company is a party to product liability and other legal
proceedings incidental to the normal course of its business.
Based on the Companys historical experience in litigating
these actions, as well as the Companys current assessment
of the underlying merits of the actions and applicable
insurance, management believes that the final resolution of
these matters will not have a material adverse affect on the
Companys financial position, liquidity, cash flows or
results of operations. Future developments may, however, result
in resolution of these legal claims in a way that could have a
material adverse effect.
NOTE L
Reporting Segments
The Companys structure of its internal organization is
divided into the following three reportable segments: Energy and
Chemicals, Distribution and Storage, and BioMedical. The
Companys reportable segments are business units that offer
different products. The reportable segments are each managed
separately because they manufacture and distribute distinct
products with different production processes and sales and
marketing approaches. The Energy and Chemicals segment sells
heat exchangers, cold boxes and liquefied natural gas vacuum
insulated pipe to natural gas, petrochemical processing and
industrial gas companies who use them for the liquefaction and
separation of natural and industrial gases. The Distribution and
Storage segment sells cryogenic bulk storage systems, cryogenic
packaged gas systems, cryogenic systems and components, beverage
liquid
CO2
systems and cryogenic services to various companies for the
storage and transportation of both industrial and natural gases.
The BioMedical segment sells medical respiratory products,
biological storage systems and magnetic resonance imaging
cryostat components. Due to the nature of the products that each
operating segment sells, there are no inter-segment sales. The
Company moved the management and reporting of the LNG
alternative fuel systems
F-32
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
product line from the Energy and Chemicals segment to the
Distribution and Storage segment effective December 31,
2004. All segment information for all periods presented has been
restated to conform to this presentation. Corporate headquarters
includes operating expenses for executive management,
accounting, tax, treasury, human resources, information
technology, legal, internal audit, risk management and
stock-based compensation expense that are not allocated to the
reportable segments.
The Company evaluates performance and allocates resources based
on operating income or loss from continuing operations before
net interest expense, financing costs amortization expense,
derivative contracts valuation expense, foreign currency loss,
income taxes, minority interest and cumulative effect of change
in accounting principle. The accounting policies of the
reportable segments are the same as those described in the
summary of significant accounting policies.
Information for the Companys three reportable segments and
its corporate headquarters, and product revenue and geographic
information for the Company, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Reportable Segments
|
|
|
|
Energy and
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Revenues from external customers
|
|
$
|
190,673
|
|
|
$
|
268,303
|
|
|
$
|
78,478
|
|
|
$
|
|
|
|
$
|
537,454
|
|
Employee separation and plant
closure costs
|
|
|
|
|
|
|
396
|
|
|
|
|
|
|
|
|
|
|
|
396
|
|
Depreciation and amortization
expense
|
|
|
8,135
|
|
|
|
10,168
|
|
|
|
2,380
|
|
|
|
230
|
|
|
|
20,913
|
|
Operating income (loss)
|
|
|
18,957
|
|
|
|
54,545
|
|
|
|
15,969
|
|
|
|
(22,600
|
)
|
|
|
66,871
|
|
Total assets(A)(B)
|
|
|
224,277
|
|
|
|
376,168
|
|
|
|
101,785
|
|
|
|
22,645
|
|
|
|
724,875
|
|
Capital expenditures
|
|
|
13,365
|
|
|
|
7,934
|
|
|
|
864
|
|
|
|
90
|
|
|
|
22,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
October 17, 2005 to December 31, 2005
|
|
|
|
Reportable Segments
|
|
|
|
Energy and
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Revenues from external customers
|
|
$
|
34,135
|
|
|
$
|
47,832
|
|
|
$
|
15,685
|
|
|
$
|
|
|
|
$
|
97,652
|
|
Employee separation and plant
closure costs (benefit)
|
|
|
52
|
|
|
|
(18
|
)
|
|
|
19
|
|
|
|
86
|
|
|
|
139
|
|
Depreciation and amortization
expense
|
|
|
1,424
|
|
|
|
2,152
|
|
|
|
458
|
|
|
|
54
|
|
|
|
4,088
|
|
Operating income (loss)
|
|
|
5,092
|
|
|
|
3,947
|
|
|
|
714
|
|
|
|
(4,683
|
)
|
|
|
5,070
|
|
Total assets(A)(C)
|
|
|
177,915
|
|
|
|
339,586
|
|
|
|
93,929
|
|
|
|
24,211
|
|
|
|
635,641
|
|
Capital expenditures
|
|
|
877
|
|
|
|
3,338
|
|
|
|
1,255
|
|
|
|
131
|
|
|
|
5,601
|
|
F-33
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
January 1, 2005 to October 16, 2005
|
|
|
|
Reportable Segments
|
|
|
|
Energy and
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Revenues from external customers
|
|
$
|
86,920
|
|
|
$
|
161,329
|
|
|
$
|
57,248
|
|
|
$
|
|
|
|
$
|
305,497
|
|
Employee separation and plant
closure costs (benefit)
|
|
|
129
|
|
|
|
506
|
|
|
|
540
|
|
|
|
(118
|
)
|
|
|
1,057
|
|
Depreciation and amortization
expense
|
|
|
931
|
|
|
|
3,694
|
|
|
|
1,901
|
|
|
|
282
|
|
|
|
6,808
|
|
Operating income (loss)
|
|
|
13,717
|
|
|
|
27,005
|
|
|
|
8,343
|
|
|
|
(28,206
|
)
|
|
|
20,859
|
|
Total assets(A)(D)
|
|
|
85,203
|
|
|
|
151,404
|
|
|
|
99,001
|
|
|
|
7,499
|
|
|
|
343,107
|
|
Capital expenditures
|
|
|
2,817
|
|
|
|
5,878
|
|
|
|
1,490
|
|
|
|
853
|
|
|
|
11,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
|
Year Ended December 31, 2004
|
|
|
|
Reportable Segments
|
|
|
|
Energy and
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Revenues from external customers
|
|
$
|
69,609
|
|
|
$
|
162,508
|
|
|
$
|
73,459
|
|
|
$
|
|
|
|
$
|
305,576
|
|
Employee separation and plant
closure costs
|
|
|
744
|
|
|
|
1,258
|
|
|
|
787
|
|
|
|
380
|
|
|
|
3,169
|
|
Depreciation and amortization
expense
|
|
|
1,180
|
|
|
|
2,614
|
|
|
|
1,386
|
|
|
|
3,310
|
|
|
|
8,490
|
|
Equity expense in joint venture
|
|
|
(51
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(51
|
)
|
Operating income (loss)
|
|
|
11,545
|
|
|
|
27,951
|
|
|
|
14,208
|
|
|
|
(16,625
|
)
|
|
|
37,079
|
|
Total assets(A)(D)
|
|
|
65,212
|
|
|
|
118,555
|
|
|
|
100,768
|
|
|
|
22,545
|
|
|
|
307,080
|
|
Capital expenditures
|
|
|
1,681
|
|
|
|
4,643
|
|
|
|
2,357
|
|
|
|
698
|
|
|
|
9,379
|
|
|
|
|
(A) |
|
Corporate assets at December 31, 2006, December 31,
2005, October 16, 2005 and December 31, 2004 consist
primarily of cash and cash equivalents and deferred income taxes. |
|
(B) |
|
Total assets at December 31, 2006 include goodwill of
$81,941, $129,751 and $35,452 for the Energy and chemicals,
Distribution and Storage and BioMedical segments, respectively. |
|
(C) |
|
Total assets at December 31, 2005 include goodwill of
$72,833, $128,653 and $35,256 for the Energy and Chemicals,
Distribution and Storage, and BioMedical segments, respectively. |
|
(D) |
|
Total assets at October 16, 2005 and December 31, 2004
include goodwill of $31,648, $2,787 and $40,675 for the Energy
and Chemicals, Distribution and Storage, and BioMedical
segments, respectively. |
F-34
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
A reconciliation of the total of the reportable segments
operating income (loss) to consolidated (loss) income before
income taxes and minority interest is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year
|
|
|
2005
|
|
|
|
2005
|
|
|
Year
|
|
|
|
Ended
|
|
|
to
|
|
|
|
to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Operating income
|
|
$
|
66,871
|
|
|
$
|
5,070
|
|
|
|
$
|
20,859
|
|
|
$
|
37,079
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(25,461
|
)
|
|
|
(5,565
|
)
|
|
|
|
(4,192
|
)
|
|
|
(4,760
|
)
|
Financing costs amortization
|
|
|
(1,536
|
)
|
|
|
(308
|
)
|
|
|
|
|
|
|
|
|
|
Derivative contracts valuation
income (expense)
|
|
|
|
|
|
|
9
|
|
|
|
|
28
|
|
|
|
48
|
|
Foreign currency gain (loss)
|
|
|
533
|
|
|
|
(101
|
)
|
|
|
|
(659
|
)
|
|
|
465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and minority interest
|
|
$
|
40,407
|
|
|
$
|
(895
|
)
|
|
|
$
|
16,036
|
|
|
$
|
32,832
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
October 17,
|
|
|
|
January 1,
|
|
|
|
|
|
|
Year
|
|
|
2005
|
|
|
|
2005
|
|
|
Year
|
|
|
|
Ended
|
|
|
to
|
|
|
|
to
|
|
|
Ended
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
October 16,
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
2005
|
|
|
2004
|
|
Product Revenue
Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy and Chemicals
Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Heat exchangers
|
|
$
|
117,677
|
|
|
$
|
22,218
|
|
|
|
$
|
52,702
|
|
|
$
|
48,091
|
|
Cold boxes and LNG VIP
|
|
|
72,996
|
|
|
|
11,917
|
|
|
|
|
34,218
|
|
|
|
21,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
190,673
|
|
|
|
34,135
|
|
|
|
|
86,920
|
|
|
|
69,609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution and Storage
Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryogenic bulk storage systems
|
|
$
|
141,119
|
|
|
$
|
22,626
|
|
|
|
$
|
70,180
|
|
|
$
|
73,118
|
|
Cryogenic packaged gas systems and
beverage liquid
CO2
systems
|
|
|
93,690
|
|
|
|
18,150
|
|
|
|
|
65,713
|
|
|
|
59,706
|
|
Cryogenic systems and components
|
|
|
12,249
|
|
|
|
2,862
|
|
|
|
|
11,571
|
|
|
|
14,767
|
|
Cryogenic services
|
|
|
21,245
|
|
|
|
4,194
|
|
|
|
|
13,865
|
|
|
|
14,917
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
268,303
|
|
|
$
|
47,832
|
|
|
|
$
|
161,329
|
|
|
$
|
162,508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BioMedical Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical products and biological
storage systems
|
|
|
67,236
|
|
|
|
13,355
|
|
|
|
|
48,488
|
|
|
|
62,873
|
|
MRI components and other
|
|
|
11,242
|
|
|
|
2,330
|
|
|
|
|
8,760
|
|
|
|
10,586
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78,478
|
|
|
|
15,685
|
|
|
|
|
57,248
|
|
|
|
73,459
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sales
|
|
$
|
537,454
|
|
|
$
|
97,652
|
|
|
|
$
|
305,497
|
|
|
$
|
305,576
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-35
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 17, 2005
|
|
|
|
Predecessor Company
|
|
|
|
|
|
|
|
|
|
to
|
|
|
|
January 1, 2005
|
|
|
Year Ended
|
|
|
|
Year Ended
|
|
|
December 31, 2005
|
|
|
|
to
|
|
|
December 31, 2004
|
|
|
|
December 31, 2006
|
|
|
|
|
|
Long-Lived
|
|
|
|
October 16, 2005
|
|
|
|
|
|
Long-Lived
|
|
Geographic Information:
|
|
Revenues
|
|
|
Long-Lived Assets
|
|
|
Revenues
|
|
|
Assets
|
|
|
|
Revenues
|
|
|
Revenues
|
|
|
Assets
|
|
United States
|
|
$
|
403,523
|
|
|
$
|
393,535
|
|
|
$
|
75,692
|
|
|
$
|
398,576
|
|
|
|
$
|
233,669
|
|
|
$
|
233,466
|
|
|
$
|
156,181
|
|
Czech Republic
|
|
|
73,611
|
|
|
|
45,530
|
|
|
|
12,829
|
|
|
|
27,944
|
|
|
|
|
42,645
|
|
|
|
43,163
|
|
|
|
5,494
|
|
Other
Non-U.S. Countries
|
|
|
60,320
|
|
|
|
55,175
|
|
|
|
9,131
|
|
|
|
42,222
|
|
|
|
|
29,183
|
|
|
|
28,947
|
|
|
|
6,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
537,454
|
|
|
$
|
494,240
|
|
|
$
|
97,652
|
|
|
$
|
468,742
|
|
|
|
$
|
305,497
|
|
|
$
|
305,576
|
|
|
$
|
167,691
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note M
Quarterly Data (Unaudited)
Selected quarterly data for the years ended December 31,
2006 and 2005 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Company
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
|
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Total
|
|
|
Sales
|
|
$
|
120,840
|
|
|
$
|
129,367
|
|
|
$
|
142,825
|
|
|
$
|
144,422
|
|
|
$
|
537,454
|
|
Gross Profit
|
|
|
36,987
|
|
|
|
36,113
|
|
|
|
39,440
|
|
|
|
42,379
|
|
|
|
154,919
|
|
Employee separation and plant
closure costs
|
|
|
162
|
|
|
|
69
|
|
|
|
73
|
|
|
|
92
|
|
|
|
396
|
|
Operating Income
|
|
|
15,787
|
|
|
|
14,823
|
|
|
|
16,869
|
|
|
|
19,392
|
|
|
|
66,871
|
|
Net Income
|
|
|
6,046
|
|
|
|
5,308
|
|
|
|
6,932
|
|
|
|
8,609
|
|
|
|
26,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2005
|
|
|
|
Predecessor Company
|
|
|
Company
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
Fourth
|
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter(a)
|
|
|
Quarter(a)
|
|
|
Sales
|
|
$
|
85,170
|
|
|
$
|
99,721
|
|
|
$
|
105,787
|
|
|
$
|
14,819
|
|
|
$
|
97,652
|
|
Gross Profit
|
|
|
24,898
|
|
|
|
29,932
|
|
|
|
30,101
|
|
|
|
3,282
|
|
|
|
21,919
|
|
Employee separation and plant
closure costs
|
|
|
604
|
|
|
|
201
|
|
|
|
200
|
|
|
|
52
|
|
|
|
139
|
|
Operating Income
|
|
|
9,893
|
|
|
|
15,332
|
|
|
|
12,505
|
|
|
|
(16,871
|
)
|
|
|
5,070
|
|
Net Income
|
|
|
5,795
|
|
|
|
8,658
|
|
|
|
7,228
|
|
|
|
(12,823
|
)
|
|
|
(506
|
)
|
|
|
|
(a) |
|
The fourth quarter for the Predecessor Company is the period
October 1, 2005 to October 16, 2005 and the fourth
quarter for the Company is the period October 17, 2005 to
December 31, 2005. |
NOTE N
Subsequent Events
In February 2006, the Company paid $1,498, including fees to
acquire the remaining 4.3% of minority interest in Chart Ferox,
a.s. This transaction was completed in March 2007 and the
Company now owns a 100% interest in Chart Ferox, a.s.
F-36
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
NOTE O
Supplemental Guarantor Financial Information
In connection with the Acquisition, the Company issued $170,000
of senior subordinated notes. The following subsidiaries, all of
which are wholly owned, guaranteed the notes on a full,
unconditional and joint and several basis: Chart Inc., CAIRE
Inc., Chart Energy and Chemicals, Inc., Chart Cooler Service
Company, Inc., Chart International Holdings, Inc., Chart Asia,
Inc. and Chart International, Inc. The following subsidiaries
are not guarantors of the notes:
|
|
|
Non-Guarantor Subsidiaries
|
|
Jurisdiction
|
|
Chart Australia Pty. Ltd.
|
|
Australia
|
Changzhou CEM Cryo Equipment Co.,
Ltd.
|
|
China
|
Chart Biomedical Limited
|
|
United Kingdom
|
Chart Cryogenic Engineering
Systems (Changzhou) Co., Ltd.
|
|
China
|
Chart Cryogenic Equipment
(Changzhou) Co., Ltd.
|
|
China
|
Chart Ferox a.s. (95.7% owned at
December 31, 2006)
|
|
Czech Republic
|
Chart Ferox GmbH
|
|
Germany
|
GTC of Clarksville, LLC
|
|
Delaware
|
Lox Taiwan (16% owned)
|
|
Taiwan
|
Zhangjigang Chart Hailu Cryogenic
Equipment Co., Ltd.
|
|
China
|
F-37
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
The following supplemental condensed consolidating and combining
financial information of the Issuer, Subsidiary Guarantors and
Subsidiary Non-Guarantors presents statements of operations for
the year ended December 31, 2006, the period from
October 17, 2005 to December 31, 2005, the period from
January 1, 2005 to October 16, 2005 and the year ended
December 31, 2004, balance sheets as of December 31,
2006, and December 31, 2005, and statements of cash flows
for the year ended December 31, 2006, the period from
October 17, 2005 to December 31, 2005, the period from
January 1, 2005 to October 16, 2005 and the year ended
December 31, 2004.
CONDENSED
CONSOLIDATING BALANCE SHEET
As of December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
ASSETS
|
Cash and cash equivalents
|
|
$
|
6,084
|
|
|
$
|
114
|
|
|
$
|
12,656
|
|
|
$
|
|
|
|
$
|
18,854
|
|
Accounts receivable, net
|
|
|
|
|
|
|
58,320
|
|
|
|
18,442
|
|
|
|
|
|
|
|
76,762
|
|
Inventory, net
|
|
|
|
|
|
|
43,559
|
|
|
|
29,508
|
|
|
|
(210
|
)
|
|
|
72,857
|
|
Other current assets
|
|
|
8,319
|
|
|
|
39,955
|
|
|
|
13,888
|
|
|
|
|
|
|
|
62,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
14,403
|
|
|
|
141,948
|
|
|
|
74,494
|
|
|
|
(210
|
)
|
|
|
230,635
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
57,469
|
|
|
|
28,254
|
|
|
|
|
|
|
|
85,723
|
|
Goodwill
|
|
|
|
|
|
|
189,671
|
|
|
|
57,473
|
|
|
|
|
|
|
|
247,144
|
|
Intangible assets, net
|
|
|
|
|
|
|
143,998
|
|
|
|
2,625
|
|
|
|
|
|
|
|
146,623
|
|
Investments in affiliates
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
|
|
|
|
(142,435
|
)
|
|
|
|
|
Intercompany receivables
|
|
|
421,549
|
|
|
|
|
|
|
|
|
|
|
|
(421,549
|
)
|
|
|
|
|
Other assets
|
|
|
11,126
|
|
|
|
1,580
|
|
|
|
2,044
|
|
|
|
|
|
|
|
14,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
551,187
|
|
|
$
|
572,992
|
|
|
$
|
164,890
|
|
|
$
|
(564,194
|
)
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Accounts payable and accruals
|
|
$
|
(11,935
|
)
|
|
$
|
122,734
|
|
|
$
|
28,908
|
|
|
$
|
(466
|
)
|
|
$
|
139,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
(11,935
|
)
|
|
|
122,734
|
|
|
|
28,908
|
|
|
|
(466
|
)
|
|
|
139,241
|
|
Long-term debt
|
|
|
290,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290,000
|
|
Intercompany payables
|
|
|
|
|
|
|
332,535
|
|
|
|
88,758
|
|
|
|
(421,293
|
)
|
|
|
|
|
Other long-term liabilities
|
|
|
53,388
|
|
|
|
13,614
|
|
|
|
8,898
|
|
|
|
|
|
|
|
75,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
331,453
|
|
|
|
468,883
|
|
|
|
126,564
|
|
|
|
(421,759
|
)
|
|
|
505,141
|
|
Common Stock
|
|
|
256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
256
|
|
Other stockholders equity
|
|
|
219,478
|
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
(142,435
|
)
|
|
|
219,478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
219,734
|
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
(142,435
|
)
|
|
|
219,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
551,187
|
|
|
$
|
572,992
|
|
|
$
|
164,890
|
|
|
$
|
(564,194
|
)
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-38
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
412,282
|
|
|
$
|
128,980
|
|
|
$
|
(3,808
|
)
|
|
$
|
537,454
|
|
Cost of sales
|
|
|
|
|
|
|
294,657
|
|
|
|
91,661
|
|
|
|
(3,783
|
)
|
|
|
382,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
117,625
|
|
|
|
37,319
|
|
|
|
(25
|
)
|
|
|
154,919
|
|
Selling, general and
administrative expenses
|
|
|
1,370
|
|
|
|
75,574
|
|
|
|
11,095
|
|
|
|
9
|
|
|
|
88,048
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
(1,370
|
)
|
|
|
42,051
|
|
|
|
26,224
|
|
|
|
(34
|
)
|
|
|
66,871
|
|
Interest expense, net
|
|
|
(25,682
|
)
|
|
|
103
|
|
|
|
118
|
|
|
|
|
|
|
|
(25,461
|
)
|
Other income (expense), net
|
|
|
(1,536
|
)
|
|
|
(70
|
)
|
|
|
603
|
|
|
|
|
|
|
|
(1,003
|
)
|
Minority interest, net of tax
|
|
|
|
|
|
|
|
|
|
|
468
|
|
|
|
|
|
|
|
468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and equity in net (income) loss of subsidiaries
|
|
|
(28,588
|
)
|
|
|
42,084
|
|
|
|
26,477
|
|
|
|
(34
|
)
|
|
|
39,939
|
|
Income tax (benefit) provision
|
|
|
(9,242
|
)
|
|
|
18,814
|
|
|
|
3,472
|
|
|
|
|
|
|
|
13,044
|
|
Equity in net (income) loss of
subsidiaries
|
|
|
(46,241
|
)
|
|
|
(22,971
|
)
|
|
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
26,895
|
|
|
$
|
46,241
|
|
|
$
|
23,005
|
|
|
$
|
(69,246
|
)
|
|
$
|
26,895
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-39
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the year Ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities
|
|
$
|
(33,347
|
)
|
|
$
|
51,510
|
|
|
$
|
18,080
|
|
|
$
|
155
|
|
|
$
|
36,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(17,570
|
)
|
|
|
(4,683
|
)
|
|
|
|
|
|
|
(22,253
|
)
|
Acquisition of business, net of
cash acquired
|
|
|
|
|
|
|
(15,927
|
)
|
|
|
|
|
|
|
|
|
|
|
(15,927
|
)
|
Other investing activities
|
|
|
(59
|
)
|
|
|
(425
|
)
|
|
|
|
|
|
|
|
|
|
|
(484
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(59
|
)
|
|
|
(33,922
|
)
|
|
|
(4,683
|
)
|
|
|
|
|
|
|
(38,664
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
(55,000
|
)
|
|
|
750
|
|
|
|
(2,356
|
)
|
|
|
|
|
|
|
(56,606
|
)
|
Initial public offering proceeds,
net
|
|
|
172,496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
172,496
|
|
Dividend payment
|
|
|
(150,313
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(150,313
|
)
|
Warrant and option exercise
proceeds
|
|
|
39,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39,237
|
|
Payment of financing costs
|
|
|
(854
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(854
|
)
|
Tax benefit from exercise of stock
options
|
|
|
5,275
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,275
|
|
Intercompany account changes
|
|
|
21,458
|
|
|
|
(18,515
|
)
|
|
|
(2,788
|
)
|
|
|
(155
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
32,299
|
|
|
|
(17,765
|
)
|
|
|
(5,144
|
)
|
|
|
(155
|
)
|
|
|
9,235
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash
and cash equivalents
|
|
|
(1,107
|
)
|
|
|
(177
|
)
|
|
|
8,253
|
|
|
|
|
|
|
|
6,969
|
|
Effect of exchange rate changes
|
|
|
|
|
|
|
19
|
|
|
|
540
|
|
|
|
|
|
|
|
559
|
|
Cash and cash equivalents,
beginning of period
|
|
|
7,191
|
|
|
|
272
|
|
|
|
3,863
|
|
|
|
|
|
|
|
11,326
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
6,084
|
|
|
$
|
114
|
|
|
$
|
12,656
|
|
|
$
|
|
|
|
$
|
18,854
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-40
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING BALANCE SHEET
As of December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
Cash and cash equivalents
|
|
$
|
7,191
|
|
|
$
|
272
|
|
|
$
|
3,863
|
|
|
$
|
|
|
|
$
|
11,326
|
|
Accounts receivable, net
|
|
|
|
|
|
|
48,979
|
|
|
|
13,484
|
|
|
|
|
|
|
|
62,463
|
|
Inventory, net
|
|
|
|
|
|
|
33,603
|
|
|
|
19,714
|
|
|
|
(185
|
)
|
|
|
53,132
|
|
Other current assets
|
|
|
6,201
|
|
|
|
26,967
|
|
|
|
6,810
|
|
|
|
|
|
|
|
39,978
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
13,392
|
|
|
|
109,821
|
|
|
|
43,871
|
|
|
|
(185
|
)
|
|
|
166,899
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
40,429
|
|
|
|
23,272
|
|
|
|
|
|
|
|
63,701
|
|
Goodwill
|
|
|
|
|
|
|
213,493
|
|
|
|
23,249
|
|
|
|
|
|
|
|
236,742
|
|
Intangible assets, net
|
|
|
|
|
|
|
150,577
|
|
|
|
3,486
|
|
|
|
|
|
|
|
154,063
|
|
Investments in affiliates
|
|
|
56,863
|
|
|
|
5,496
|
|
|
|
|
|
|
|
(62,359
|
)
|
|
|
|
|
Other assets
|
|
|
447,380
|
|
|
|
1,328
|
|
|
|
999
|
|
|
|
(435,471
|
)
|
|
|
14,236
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
517,635
|
|
|
$
|
521,144
|
|
|
$
|
94,877
|
|
|
$
|
(498,015
|
)
|
|
$
|
635,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Accounts payable and accruals
|
|
$
|
1,840
|
|
|
$
|
78,449
|
|
|
$
|
14,866
|
|
|
$
|
857
|
|
|
$
|
96,012
|
|
Short term debt
|
|
|
|
|
|
|
|
|
|
|
2,304
|
|
|
|
|
|
|
|
2,304
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
1,840
|
|
|
|
78,449
|
|
|
|
17,170
|
|
|
|
857
|
|
|
|
98,316
|
|
Long-term debt
|
|
|
345,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
345,000
|
|
Intercompany accounts
|
|
|
|
|
|
|
373,063
|
|
|
|
63,450
|
|
|
|
(436,513
|
)
|
|
|
|
|
Other long-term liabilities
|
|
|
54,465
|
|
|
|
12,769
|
|
|
|
8,761
|
|
|
|
|
|
|
|
75,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
401,305
|
|
|
|
464,281
|
|
|
|
89,381
|
|
|
|
(435,656
|
)
|
|
|
519,311
|
|
Common Stock
|
|
|
80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80
|
|
Other stockholders equity
|
|
|
116,250
|
|
|
|
56,863
|
|
|
|
5,496
|
|
|
|
(62,359
|
)
|
|
|
116,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
116,330
|
|
|
|
56,863
|
|
|
|
5,496
|
|
|
|
(62,359
|
)
|
|
|
116,330
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
517,635
|
|
|
$
|
521,144
|
|
|
$
|
94,877
|
|
|
$
|
(498,015
|
)
|
|
$
|
635,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-41
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Period from October 17, 2005 to December 31,
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
77,591
|
|
|
$
|
20,655
|
|
|
$
|
(594
|
)
|
|
$
|
97,652
|
|
Cost of sales
|
|
|
|
|
|
|
56,495
|
|
|
|
19,883
|
|
|
|
(645
|
)
|
|
|
75,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
21,096
|
|
|
|
772
|
|
|
|
51
|
|
|
|
21,919
|
|
Selling, general and
administrative expenses
|
|
|
423
|
|
|
|
14,300
|
|
|
|
2,126
|
|
|
|
|
|
|
|
16,849
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
(423
|
)
|
|
|
6,796
|
|
|
|
(1,354
|
)
|
|
|
51
|
|
|
|
5,070
|
|
Interest expense, net
|
|
|
(4,473
|
)
|
|
|
(1,084
|
)
|
|
|
(8
|
)
|
|
|
|
|
|
|
(5,565
|
)
|
Other income (expense), net
|
|
|
(300
|
)
|
|
|
(21
|
)
|
|
|
(79
|
)
|
|
|
|
|
|
|
(400
|
)
|
Minority interest, net of tax
|
|
|
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and equity in net (income) loss of subsidiaries
|
|
|
(5,196
|
)
|
|
|
5,691
|
|
|
|
(1,493
|
)
|
|
|
51
|
|
|
|
(947
|
)
|
Income tax (benefit) provision
|
|
|
(2,573
|
)
|
|
|
1,975
|
|
|
|
157
|
|
|
|
|
|
|
|
(441
|
)
|
Equity in net (income) loss of
subsidiaries
|
|
|
(2,117
|
)
|
|
|
1,599
|
|
|
|
|
|
|
|
518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
(506
|
)
|
|
$
|
2,117
|
|
|
$
|
(1,650
|
)
|
|
$
|
(467
|
)
|
|
$
|
(506
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-42
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the Period from October 17, 2005 to December 31,
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
operating activities
|
|
$
|
5,811
|
|
|
$
|
(11,947
|
)
|
|
$
|
1,534
|
|
|
$
|
19,237
|
|
|
$
|
14,635
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(2,569
|
)
|
|
|
(3,032
|
)
|
|
|
|
|
|
|
(5,601
|
)
|
Payments to Reorganized Company
shareholders for transaction
|
|
|
(356,649
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(356,649
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
investing activities
|
|
|
(356,649
|
)
|
|
|
(2,569
|
)
|
|
|
(3,032
|
)
|
|
|
|
|
|
|
(362,250
|
)
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
268,542
|
|
|
|
|
|
|
|
(2,185
|
)
|
|
|
|
|
|
|
266,357
|
|
Intercompany account changes
|
|
|
1,421
|
|
|
|
15,758
|
|
|
|
2,058
|
|
|
|
(19,237
|
)
|
|
|
|
|
Proceeds from equity contribution
|
|
|
111,299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111,299
|
|
Payment of financing costs
|
|
|
(11,558
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,558
|
)
|
Payment of exercised stock options
|
|
|
(15,756
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,756
|
)
|
Payment of Acquisition costs
|
|
|
(1,853
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,853
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
352,095
|
|
|
|
15,758
|
|
|
|
(127
|
)
|
|
|
(19,237
|
)
|
|
|
348,489
|
|
Net increase (decrease) in cash
and cash equivalents
|
|
|
1,257
|
|
|
|
1,242
|
|
|
|
(1,625
|
)
|
|
|
|
|
|
|
874
|
|
Effect of exchange rate changes
|
|
|
|
|
|
|
(1,120
|
)
|
|
|
102
|
|
|
|
|
|
|
|
(1,018
|
)
|
Cash and cash equivalents,
beginning of period
|
|
|
5,934
|
|
|
|
150
|
|
|
|
5,386
|
|
|
|
|
|
|
|
11,470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
7,191
|
|
|
$
|
272
|
|
|
$
|
3,863
|
|
|
$
|
|
|
|
$
|
11,326
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-43
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Period From January 1, 2005 to October 16,
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
238,459
|
|
|
$
|
68,933
|
|
|
$
|
(1,895
|
)
|
|
$
|
305,497
|
|
Cost of sales
|
|
|
|
|
|
|
167,517
|
|
|
|
51,699
|
|
|
|
(1,932
|
)
|
|
|
217,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
70,942
|
|
|
|
17,234
|
|
|
|
37
|
|
|
|
88,213
|
|
Selling, general and
administrative expenses
|
|
|
7,372
|
|
|
|
53,485
|
|
|
|
6,497
|
|
|
|
|
|
|
|
67,354
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
(7,372
|
)
|
|
|
17,457
|
|
|
|
10,737
|
|
|
|
37
|
|
|
|
20,859
|
|
Interest expense
|
|
|
(4,524
|
)
|
|
|
197
|
|
|
|
135
|
|
|
|
|
|
|
|
(4,192
|
)
|
Other income (expense), net
|
|
|
28
|
|
|
|
(123
|
)
|
|
|
(536
|
)
|
|
|
|
|
|
|
(631
|
)
|
Minority interest, net of tax
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and equity in net (income) loss of subsidiaries
|
|
|
(11,868
|
)
|
|
|
17,531
|
|
|
|
10,317
|
|
|
|
37
|
|
|
|
16,017
|
|
Income tax (benefit) provision
|
|
|
(4,528
|
)
|
|
|
10,603
|
|
|
|
1,084
|
|
|
|
|
|
|
|
7,159
|
|
Equity in net (income) loss of
subsidiaries
|
|
|
(16,198
|
)
|
|
|
(9,270
|
)
|
|
|
|
|
|
|
25,468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
8,858
|
|
|
$
|
16,198
|
|
|
$
|
9,233
|
|
|
$
|
(25,431
|
)
|
|
$
|
8,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-44
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the Period from January 1, 2005 to October 16,
2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities
|
|
$
|
(4,781
|
)
|
|
$
|
24,524
|
|
|
$
|
5,820
|
|
|
$
|
(9,922
|
)
|
|
$
|
15,641
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(6,681
|
)
|
|
|
(4,357
|
)
|
|
|
|
|
|
|
(11,038
|
)
|
Proceeds from sale of assets
|
|
|
|
|
|
|
520
|
|
|
|
1,700
|
|
|
|
|
|
|
|
2,220
|
|
Acquisitions, net of cash
|
|
|
|
|
|
|
(12,147
|
)
|
|
|
|
|
|
|
|
|
|
|
(12,147
|
)
|
Other investing activities
|
|
|
|
|
|
|
(96
|
)
|
|
|
262
|
|
|
|
|
|
|
|
166
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing
activities
|
|
|
|
|
|
|
(18,404
|
)
|
|
|
(2,395
|
)
|
|
|
|
|
|
|
(20,799
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
(1,952
|
)
|
|
|
(1,016
|
)
|
|
|
2,985
|
|
|
|
|
|
|
|
17
|
|
Proceeds from sale of stock
|
|
|
1,691
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,691
|
|
Intercompany account changes
|
|
|
657
|
|
|
|
(5,301
|
)
|
|
|
(5,278
|
)
|
|
|
9,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
396
|
|
|
|
(6,317
|
)
|
|
|
(2,293
|
)
|
|
|
9,922
|
|
|
|
1,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
and cash equivalents
|
|
|
(4,385
|
)
|
|
|
(197
|
)
|
|
|
1,132
|
|
|
|
|
|
|
|
(3,450
|
)
|
Effect of exchange rate changes
|
|
|
|
|
|
|
8
|
|
|
|
98
|
|
|
|
|
|
|
|
106
|
|
Cash and cash equivalents,
beginning
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of period
|
|
|
10,319
|
|
|
|
339
|
|
|
|
4,156
|
|
|
|
|
|
|
|
14,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
5,934
|
|
|
$
|
150
|
|
|
$
|
5,386
|
|
|
$
|
|
|
|
$
|
11,470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-45
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Year Ended December 31, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
238,831
|
|
|
$
|
68,763
|
|
|
$
|
(2,018
|
)
|
|
$
|
305,576
|
|
Cost of sales
|
|
|
|
|
|
|
166,606
|
|
|
|
47,257
|
|
|
|
(2,093
|
)
|
|
|
211,770
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
72,225
|
|
|
|
21,506
|
|
|
|
75
|
|
|
|
93,806
|
|
Selling, general and
administrative expenses
|
|
|
1,488
|
|
|
|
49,631
|
|
|
|
5,601
|
|
|
|
7
|
|
|
|
56,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income
|
|
|
(1,488
|
)
|
|
|
22,594
|
|
|
|
15,905
|
|
|
|
68
|
|
|
|
37,079
|
|
Interest expense, net
|
|
|
(4,754
|
)
|
|
|
(38
|
)
|
|
|
32
|
|
|
|
|
|
|
|
(4,760
|
)
|
Other income (expense), net
|
|
|
48
|
|
|
|
596
|
|
|
|
(131
|
)
|
|
|
|
|
|
|
513
|
|
Minority interest, net of tax
|
|
|
|
|
|
|
|
|
|
|
98
|
|
|
|
|
|
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
and equity in net (income) loss of subsidiaries
|
|
|
(6,194
|
)
|
|
|
23,152
|
|
|
|
15,708
|
|
|
|
68
|
|
|
|
32,734
|
|
Income tax (benefit) provision
|
|
|
(2,175
|
)
|
|
|
10,185
|
|
|
|
2,124
|
|
|
|
|
|
|
|
10,134
|
|
Equity in net (income) loss of
subsidiaries
|
|
|
(26,619
|
)
|
|
|
(13,652
|
)
|
|
|
|
|
|
|
40,271
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
22,600
|
|
|
$
|
26,619
|
|
|
$
|
13,584
|
|
|
$
|
(40,203
|
)
|
|
$
|
22,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-46
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Subsidiary
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Non-Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities
|
|
$
|
(14,763
|
)
|
|
$
|
34,925
|
|
|
$
|
12,214
|
|
|
$
|
2,683
|
|
|
$
|
35,059
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(5,834
|
)
|
|
|
(3,545
|
)
|
|
|
|
|
|
|
(9,379
|
)
|
Proceeds from sale of assets
|
|
|
|
|
|
|
6,057
|
|
|
|
|
|
|
|
|
|
|
|
6,057
|
|
Other investing activities
|
|
|
|
|
|
|
(354
|
)
|
|
|
359
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
investing activities
|
|
|
|
|
|
|
(131
|
)
|
|
|
(3,186
|
)
|
|
|
|
|
|
|
(3,317
|
)
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
(31,352
|
)
|
|
|
(1,692
|
)
|
|
|
(104
|
)
|
|
|
|
|
|
|
(33,148
|
)
|
Proceeds from sale of stock
|
|
|
400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
400
|
|
Intercompany account changes
|
|
|
42,420
|
|
|
|
(29,029
|
)
|
|
|
(10,708
|
)
|
|
|
(2,683
|
)
|
|
|
|
|
Other financing activities
|
|
|
(2,679
|
)
|
|
|
(1,179
|
)
|
|
|
862
|
|
|
|
|
|
|
|
(2,996
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
8,789
|
|
|
|
(31,900
|
)
|
|
|
(9,950
|
)
|
|
|
(2,683
|
)
|
|
|
(35,744
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
and cash equivalents
|
|
|
(5,974
|
)
|
|
|
2,894
|
|
|
|
(922
|
)
|
|
|
|
|
|
|
(4,002
|
)
|
Effect of exchange rate changes
|
|
|
|
|
|
|
27
|
|
|
|
189
|
|
|
|
|
|
|
|
216
|
|
Cash and cash equivalents,
beginning of period
|
|
|
16,293
|
|
|
|
(2,582
|
)
|
|
|
4,889
|
|
|
|
|
|
|
|
18,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
10,319
|
|
|
$
|
339
|
|
|
$
|
4,156
|
|
|
$
|
|
|
|
$
|
14,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-47
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
(Dollars in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
|
|
|
ASSETS
|
Current Assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
12,359
|
|
|
$
|
18,854
|
|
Accounts receivable, net
|
|
|
79,897
|
|
|
|
76,762
|
|
Inventories, net
|
|
|
79,629
|
|
|
|
72,857
|
|
Unbilled contract revenue
|
|
|
43,409
|
|
|
|
32,993
|
|
Other current assets
|
|
|
24,082
|
|
|
|
26,085
|
|
Assets held for sale
|
|
|
3,084
|
|
|
|
3,084
|
|
|
|
|
|
|
|
|
|
|
Total Current Assets
|
|
|
242,460
|
|
|
|
230,635
|
|
Property, plant and equipment, net
|
|
|
88,865
|
|
|
|
85,723
|
|
Goodwill
|
|
|
246,832
|
|
|
|
247,144
|
|
Identifiable intangible assets, net
|
|
|
143,593
|
|
|
|
146,623
|
|
Other assets, net
|
|
|
14,566
|
|
|
|
14,750
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$
|
736,316
|
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS EQUITY
|
Current Liabilities
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
49,986
|
|
|
$
|
48,031
|
|
Customer advances and billings in
excess of contract revenue
|
|
|
52,402
|
|
|
|
45,200
|
|
Accrued expenses and other current
liabilities
|
|
|
43,427
|
|
|
|
45,260
|
|
Short-term debt
|
|
|
|
|
|
|
750
|
|
|
|
|
|
|
|
|
|
|
Total Current Liabilities
|
|
|
145,815
|
|
|
|
139,241
|
|
Long-term debt
|
|
|
290,000
|
|
|
|
290,000
|
|
Other long-term liabilities
|
|
|
73,538
|
|
|
|
75,900
|
|
Shareholders Equity
|
|
|
|
|
|
|
|
|
Common stock, par value
$.01 per share 150,000,000 shares
authorized, 25,588,835 and 25,588,043 shares issued and
outstanding at March 31, 2007 and December 31, 2006,
respectively
|
|
|
256
|
|
|
|
256
|
|
Additional paid-in capital
|
|
|
185,933
|
|
|
|
185,567
|
|
Retained earnings
|
|
|
33,567
|
|
|
|
26,389
|
|
Accumulated other comprehensive
income
|
|
|
7,207
|
|
|
|
7,522
|
|
|
|
|
|
|
|
|
|
|
|
|
|
226,963
|
|
|
|
219,734
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND
SHAREHOLDERS EQUITY
|
|
$
|
736,316
|
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
The balance sheet at December 31, 2006 has been derived
from the audited financial statements at that date, but does not
include all of the information and notes required by
U.S. generally accepted accounting principles for complete
financial statements.
See accompanying notes to these unaudited condensed consolidated
financial statements. The accompanying notes are an integral
part of these unaudited condensed consolidated financial
statements.
F-48
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
(Dollars and shares in thousands, except per share
amounts)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Sales
|
|
$
|
152,463
|
|
|
$
|
120,840
|
|
Cost of sales
|
|
|
112,604
|
|
|
|
83,853
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
39,859
|
|
|
|
36,987
|
|
Selling, general and
administrative expenses
|
|
|
19,445
|
|
|
|
17,468
|
|
Amortization expense
|
|
|
3,028
|
|
|
|
3,571
|
|
Employee separation and plant
closure costs
|
|
|
99
|
|
|
|
162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,572
|
|
|
|
21,201
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
17,287
|
|
|
|
15,786
|
|
Other expenses (income):
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
6,346
|
|
|
|
6,545
|
|
Financing costs amortization
|
|
|
404
|
|
|
|
370
|
|
Foreign currency income
|
|
|
(354
|
)
|
|
|
(148
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
6,396
|
|
|
|
6,767
|
|
|
|
|
|
|
|
|
|
|
Income from operations before
income taxes and minority interest
|
|
|
10,891
|
|
|
|
9,019
|
|
Income tax expense
|
|
|
3,713
|
|
|
|
2,980
|
|
|
|
|
|
|
|
|
|
|
Income from operations before
minority interest
|
|
|
7,178
|
|
|
|
6,039
|
|
Minority interest, net of taxes
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
7,178
|
|
|
$
|
6,045
|
|
|
|
|
|
|
|
|
|
|
Net income per common
share basic
|
|
$
|
0.28
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
|
|
|
Net income per common
share diluted
|
|
$
|
0.28
|
|
|
$
|
0.73
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common
shares outstanding basic
|
|
|
25,604
|
|
|
|
7,952
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common
shares outstanding diluted
|
|
|
25,810
|
|
|
|
8,285
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to these unaudited condensed consolidated
financial statements. The accompanying notes are an integral
part of these unaudited condensed consolidated financial
statements.
F-49
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
(Dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
7,178
|
|
|
$
|
6,045
|
|
Adjustments to reconcile net
income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
4,587
|
|
|
|
4,824
|
|
Employee stock and stock option
related compensation expense
|
|
|
361
|
|
|
|
321
|
|
Financing costs amortization
|
|
|
404
|
|
|
|
370
|
|
Other non-cash operating activities
|
|
|
(354
|
)
|
|
|
(159
|
)
|
Increase (decrease) in cash
resulting from changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(2,800
|
)
|
|
|
(3,840
|
)
|
Inventory
|
|
|
(6,812
|
)
|
|
|
30
|
|
Unbilled contract revenues and
other current assets
|
|
|
(10,481
|
)
|
|
|
(4,764
|
)
|
Accounts payable and other current
liabilities
|
|
|
1,740
|
|
|
|
566
|
|
Customer advances and billings in
excess of contract revenue
|
|
|
7,214
|
|
|
|
8,502
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided By Operating
Activities
|
|
|
1,037
|
|
|
|
11,895
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(5,024
|
)
|
|
|
(2,566
|
)
|
Acquisition of minority interest
and other assets
|
|
|
(1,622
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used In Investing
Activities
|
|
|
(6,646
|
)
|
|
|
(2,566
|
)
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Payments on revolving credit
facilities or short-term debt
|
|
|
(750
|
)
|
|
|
(839
|
)
|
Principal payments on long-term
debt
|
|
|
|
|
|
|
(5,000
|
)
|
Payment of financing costs
|
|
|
(183
|
)
|
|
|
|
|
Other financing activities
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used In Financing
Activities
|
|
|
(928
|
)
|
|
|
(5,839
|
)
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash
and cash equivalents
|
|
|
(6,537
|
)
|
|
|
3,490
|
|
Effect of exchange rate changes on
cash
|
|
|
42
|
|
|
|
107
|
|
Cash and cash equivalents at
beginning of period
|
|
|
18,854
|
|
|
|
11,326
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS AT END
OF PERIOD
|
|
$
|
12,359
|
|
|
$
|
14,923
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to these unaudited condensed consolidated
financial statements. The accompanying notes are an integral
part of these unaudited condensed consolidated financial
statements.
F-50
NOTE A
Basis of Preparation
The accompanying unaudited condensed consolidated financial
statements of Chart Industries, Inc. and its subsidiaries (the
Company) have been prepared in accordance with
U.S. generally accepted accounting principles for interim
financial information and with the instructions to
Form 10-Q
and Article 10 of
Regulation S-X.
Accordingly, they do not include all of the information and
footnotes required by U.S. generally accepted accounting
principles for annual financial statements. These financial
statements should be read in conjunction with the audited
financial statements and notes thereto included in the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2006. In the opinion of
management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation have been
included. Operating results for the three months ended
March 31, 2007 are not necessarily indicative of the
results that may be expected for the year ending
December 31, 2007.
Principles of Consolidation: The unaudited
condensed consolidated financial statements include the accounts
of the Company and its subsidiaries. Intercompany accounts and
transactions are eliminated in consolidation. Investments in
affiliates where the Companys ownership is between
20 percent and 50 percent, or where the Company does
not have control, but has the ability to exercise significant
influence over operations or financial policy, are accounted for
under the equity method.
Use of Estimates: The preparation of financial
statements in conformity with U.S. generally accepted
accounting principles requires management to make estimates and
assumptions that affect the amounts reported in the financial
statements and accompanying notes. Actual results could differ
from those estimates.
Nature of Operations: The Company is a leading
global supplier of standard and custom-engineered products and
systems serving a wide variety of low-temperature and cryogenic
applications. The Company has developed an expertise in
cryogenic systems and equipment, which operate at low
temperatures sometimes approaching absolute zero. The majority
of the Companys products, including vacuum-insulated
containment vessels, heat exchangers, cold boxes and other
cryogenic components, are used throughout the liquid-gas supply
chain for the purification, liquefaction, distribution, storage
and end-use of industrial gases and hydrocarbons. The Company
has domestic operations located in eight states, including its
principal executive offices located in Garfield Heights, Ohio
and an international presence in Australia, China, the Czech
Republic, Germany and the United Kingdom.
Basis of Presentation: The consolidated
financial statements have been adjusted for the three months
ended March 31, 2006 to give effect to the 4.6263-for-one
stock split of the Companys common stock that occurred on
July 20, 2006, and related adjustments to its capital
structure and stock options that were effected upon the
completion of the Companys initial public offering
(IPO) on July 31, 2006.
Reclassifications: Certain prior year amounts
have been reclassified to conform to the current year
presentation.
Inventories: Inventories are stated at the
lower of cost or market with cost being determined by the
first-in,
first-out (FIFO) method. The components of inventory
are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Raw materials and supplies
|
|
$
|
34,038
|
|
|
$
|
32,404
|
|
Work in process
|
|
|
27,322
|
|
|
|
20,974
|
|
Finished goods
|
|
|
18,269
|
|
|
|
19,479
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
79,629
|
|
|
$
|
72,857
|
|
|
|
|
|
|
|
|
|
|
F-51
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
Revenue Recognition: For the majority of the
Companys products, revenue is recognized when products are
shipped, title has transferred and collection is reasonably
assured. For these products, there is also persuasive evidence
of an arrangement, and the selling price to the buyer is fixed
or determinable. For brazed aluminum heat exchangers, cold
boxes, vacuum-insulated pipe, liquefied natural gas fueling
stations and engineered tanks, the Company uses the percentage
of completion method of accounting. Earned revenue is based on
the percentage that incurred costs to date bear to total
estimated costs at completion after giving effect to the most
current estimates. The cumulative impact of revisions in total
cost estimates during the progress of work is reflected in the
period in which these changes become known. Earned revenue
reflects the original contract price adjusted for agreed upon
claims and change orders, if any. Losses expected to be incurred
on contracts in process, after consideration of estimated
minimum recoveries from claims and change orders, are charged to
operations as soon as such losses are known. Change orders
resulting in additional revenue and profit are recognized upon
approval by the customer based on the percentage that incurred
costs to date bear to total estimated costs at completion.
Timing of amounts billed on contracts varies from contract to
contract and could cause a significant variation in working
capital requirements.
Product Warranties: The Company provides
product warranties with varying terms and durations for the
majority of its products. The Company records warranty expense
in cost of sales. The changes in the Companys consolidated
warranty reserve during the three months ended March 31,
2007 and 2006 are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Balance as of January 1
|
|
$
|
4,765
|
|
|
$
|
3,598
|
|
Warranty expense
|
|
|
518
|
|
|
|
875
|
|
Warranty usage
|
|
|
(421
|
)
|
|
|
(713
|
)
|
|
|
|
|
|
|
|
|
|
Balance as of March 31
|
|
$
|
4,862
|
|
|
$
|
3,760
|
|
|
|
|
|
|
|
|
|
|
Goodwill and Other Intangible Assets: In
accordance with Financial Accounting Standards Board
(FASB) Statement of Financial Accounting Standards
(SFAS) No. 141, Business
Combinations, and SFAS No. 142, Goodwill
and Other Intangible Assets, the Company does not amortize
goodwill or other indefinite lived intangible assets, but
reviews them at least annually for impairment using a
measurement date of October 1st. The Company amortizes
intangible assets that have finite useful lives.
SFAS No. 142 requires that goodwill and other
indefinite lived intangible assets be tested for impairment at
the reporting unit level on an annual basis. Under
SFAS No. 142, a company determines the fair value of
any indefinite lived intangible assets, compares the fair value
to its carrying value and records an impairment loss if the
carrying value exceeds its fair value. Goodwill is tested
utilizing a two-step approach. After recording any impairment
losses for indefinite lived intangible assets, a company is
required to determine the fair value of each reporting unit and
compare the fair value to its carrying value, including
goodwill, of such reporting unit (step one). If the fair value
exceeds the carrying value, no impairment loss would be
recognized. If the carrying value of the reporting unit exceeds
its fair value, the goodwill of the reporting unit may be
impaired. The amount of the impairment, if any, would then be
measured in step two, which compares the implied fair value of
reporting unit goodwill with the carrying amount of that
goodwill.
F-52
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
The following table displays the gross carrying amount and
accumulated amortization for all intangible assets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
March 31, 2007
|
|
|
2006
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
Estimated
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
|
Useful Life
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amortization
|
|
|
Finite-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unpatented technology
|
|
|
9 years
|
|
|
$
|
9,400
|
|
|
$
|
(1,647
|
)
|
|
$
|
9,400
|
|
|
$
|
(1,364
|
)
|
Patents
|
|
|
10 years
|
|
|
|
8,138
|
|
|
|
(1,539
|
)
|
|
|
8,138
|
|
|
|
(1,287
|
)
|
Product names
|
|
|
14 years
|
|
|
|
2,580
|
|
|
|
(308
|
)
|
|
|
2,580
|
|
|
|
(255
|
)
|
Backlog
|
|
|
14 months
|
|
|
|
6,720
|
|
|
|
(6,720
|
)
|
|
|
6,720
|
|
|
|
(6,336
|
)
|
Non-compete agreements
|
|
|
3 years
|
|
|
|
3,474
|
|
|
|
(1,197
|
)
|
|
|
3,474
|
|
|
|
(977
|
)
|
Customer relations
|
|
|
13 years
|
|
|
|
101,066
|
|
|
|
(10,480
|
)
|
|
|
101,066
|
|
|
|
(8,647
|
)
|
Other
|
|
|
|
|
|
|
60
|
|
|
|
(14
|
)
|
|
|
60
|
|
|
|
(9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
131,438
|
|
|
$
|
(21,905
|
)
|
|
$
|
131,438
|
|
|
$
|
(18,875
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
|
|
|
$
|
246,832
|
|
|
|
|
|
|
|
247,144
|
|
|
|
|
|
Trademarks and trade names
|
|
|
|
|
|
|
34,060
|
|
|
|
|
|
|
|
34,060
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
281,322
|
|
|
|
|
|
|
$
|
281,204
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for finite-lived intangible assets was
$3,028 and $3,571 for the three months ended March 31, 2007
and 2006, respectively, and is estimated to be approximately
$10,900 for 2007 and $9,800 for fiscal years 2008 through 2012.
Employee Stock Options: The Company adopted
SFAS No. 123(R) Share-Based Payments,
using the modified prospective method, which requires all
share-based payments to employees, including grants of employee
stock options, to be recognized in the financial statements
based on their fair values.
As of March 31, 2007 and 2006, there were 846 and 803
time-based options and 1,555 and 1,472 performance-based options
outstanding under the Amended and Restated 2005 Stock Incentive
Plan (Stock Incentive Plan), respectively. For the
three months ended March 31, 2007 and 2006, the Company
recorded $302 and $321, respectively, in compensation expense
related to the time-based options. As of March 31, 2007,
the total share-based compensation expected to be recognized
over the weighted average period of approximately 3.6 years
is $2,546. Further, the Company may also record additional
stock-based compensation expense in future periods related to
the 1,555 performance-based options granted under the Stock
Incentive Plan to certain members of management, if it becomes
probable that any of the future performance criteria will be
achieved. The maximum share-based compensation expense relating
to the performance-based options is approximately $7,500, which
will be recognized if and to the extent it becomes probable that
the specified actual returns on First Reserve Fund X,
L.P.s (First Reserve) investment will be
achieved.
In 2006, the Company granted restricted stock units covering
16 shares of common stock to non-employee directors. Each
of the six grants of restricted stock units had a fair market
value of $40 on the date of grant. Restricted stock units for
3 shares were forfeited in the first quarter of 2007 upon
the resignation of a director. The remaining restricted stock
units are expected to fully vest on the first anniversary of the
date of grant or earlier in the event of a change in
control as such term is defined in the Stock Incentive
Plan. For the three months ended March 31, 2007, the
Company recorded $59 in director compensation expense related to
the restricted stock units.
F-53
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
Recently Issued Accounting Pronouncements: In
September 2006, the FASB issued Statement of Financial
Accounting Standards No. 157, Fair Value
Measurements (SFAS No. 157) which is
effective for fiscal years beginning after November 15,
2007. SFAS No. 157 defines fair value to be applied to
U.S. GAAP guidance requiring use of fair value, establishes
a framework for measuring fair value and expands the disclosure
requirements for fair value measurements. The Company is
currently evaluating the impact of SFAS No. 157 on its
financial position and results of operations.
In September 2006, the FASB issued SFAS No. 158,
Employers Accounting for Defined Pension Benefit
Plans and Other Postretirement Plans. This statement
requires recognition on the balance sheet of the underfunded or
overfunded status of pension and postretirement benefit plans.
SFAS No. 158 also requires the recognition of changes
in the funded status through other comprehensive income in the
year that the changes occur. The amount of net periodic benefit
cost recognized in an entitys results of operation will
not change. SFAS No. 158 is effective for fiscal years
ending after December 15, 2006. The requirement to measure
plan assets and benefit obligations as of the date of the
employers fiscal year end balance sheet is effective for
fiscal years ending after December 15, 2008. The Company
adopted SFAS No. 158 as of December 31, 2006. The
adoption of the statement had no effect on our financial
position, results of operations, liquidity or cash flows.
In February 2007, the FASB issued SFAS No. 159,
The Fair Value Option for Financial Assets and Financial
Liabilities including an amendment of FASB Statement
No. 115. SFAS No. 159 permits entities to
choose to measure many financial instruments and certain other
items at fair value that are not currently required to be
measured at fair value, with unrealized gains and losses related
to these financial instruments reported in earnings at each
subsequent reporting date. This statement is effective for
fiscal years beginning after November 15, 2007. The Company
is currently evaluating the impact of SFAS No. 159 on
its financial position and results of operations.
NOTE B
Debt and Credit Arrangements
The Company has a senior secured credit facility (the
Senior Credit Facility) and $170,000 of
91/8% senior subordinated notes (the Subordinated
Notes) outstanding. The Senior Credit Facility consists of
a $180,000 term loan facility (the Term Loan) and a
$115,000 revolving credit facility (the Revolver),
of which $55,000 may be used for letters of credit extending
beyond one year from their date of issuance. The Term Loan
matures on October 17, 2012 and the Revolver matures on
October 17, 2010. The Term Loan does not require any
principal payments prior to the maturity date. The interest rate
under the Senior Credit Facility is, at the Companys
option, the Alternative Base Rate (ABR) plus 1.0% or
LIBOR plus 2.0% on the Term Loan and ABR plus 1.5% or LIBOR plus
2.5% on the Revolver. The applicable interest margin on the
Revolver could decrease based upon the leverage ratio calculated
at each fiscal quarter end. In addition, the Company is required
to pay an annual administrative fee of $100, a commitment fee of
0.5% on the unused Revolver balance, a letter of credit
participation fee of 2.5% per annum on the letter of credit
exposure and a letter of credit issuance fee of 0.25%. The
obligations under the Senior Credit Facility are secured by
substantially all of the assets of the Company and its
U.S. subsidiaries and 65% of the capital stock of the
Companys
non-U.S. subsidiaries.
The Subordinated Notes are due in 2015 with interest payable
semi-annually on April 15th and October 15th. The
registration rights agreement required the Company to file an
Exchange Offer Registration Statement and complete the exchange
offer for the Subordinated Notes by August 14, 2006. Since
the exchange offer was not completed when required, additional
interest at a rate of 0.50% was incurred for the
90-day
period commencing November 12, 2006 and additional interest
at a rate of 0.75% was incurred for the
90-day
period commencing February 10, 2007. The exchange offer was
completed on April 6, 2007 and this additional interest
ceased accruing as of that date. Any of the Subordinated Notes
may be redeemed solely at the Companys option beginning on
October 15, 2010. The initial redemption price is 104.563%
of the principal amount, plus accrued interest. Also, any of the
notes may be redeemed solely at the Companys option at any
time prior to October 15, 2010, plus accrued
F-54
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
interest and a make-whole premium. In addition,
before October 15, 2008, up to 35% of the Subordinated
Notes may be redeemed solely at the Companys option at a
price of 109.125% of the principal amount, plus accrued
interest, using the proceeds from the sales of certain kinds of
capital stock. The Subordinated Notes are general unsecured
obligations of the Company and are subordinated in right of
payment to all existing and future senior debt of the Company,
including the Senior Credit Facility, pari passu in right of
payment with all future senior subordinated indebtedness of the
Company, and senior in right of payment with any future
indebtedness of the Company that expressly provides for its
subordination to the Subordinated Notes. The Subordinated Notes
are unconditionally guaranteed jointly and severally by
substantially all of the Companys U.S. subsidiaries.
The Senior Credit Facility agreement and provisions of the
indenture governing the Subordinated Notes contain a number of
customary covenants, including but not limited to restrictions
on the Companys ability to incur additional indebtedness,
create liens or other encumbrances, sell assets, enter into sale
and lease-back transactions, make certain payments, investments,
loans, advances or guarantees, make acquisitions, engage in
mergers or consolidations, pay dividends or distributions, and
make capital expenditures. The Senior Credit Facility and
indenture governing the Subordinated Notes also include
financial covenants relating to leverage, interest coverage and
fixed charge coverage ratios. The Company believes that it is in
compliance with all covenants. As of March 31, 2007, there
was $120,000 outstanding under the Term Loan, $170,000
outstanding under the Subordinated Notes and letters of credit
and bank guarantees totaling $22,620 supported by the Revolver.
Chart Ferox a.s. (Ferox), a wholly-owned subsidiary
of the Company, maintains secured revolving credit facilities
with borrowing capacity, including overdraft protection, of up
to $9,600, of which $4,400 is available only for letters of
credit and bank guarantees. Under the revolving credit
facilities, Ferox may make borrowings in Czech Korunas, Euros
and U.S. dollars. Borrowings in Koruna are at PRIBOR,
borrowings in Euros are at EUROBOR and borrowings in
U.S. dollars are at LIBOR, each with a fixed margin of
0.6 percent. Ferox is not required to pay a commitment fee
to the lenders under the revolving credit facilities in respect
to the unutilized commitments thereunder. Ferox must pay letter
of credit and guarantee fees equal to 0.75% on the face amount
of each guarantee. Feroxs land and buildings and accounts
receivable secure $4,600 and $2,500, respectively, of the
revolving credit facilities. As of March 31, 2007, there
were no borrowings outstanding under the Ferox revolving credit
facilities. However, there were $1,429 of bank guarantees
supported by the Ferox revolving credit facilities.
NOTE C
Earnings per Share
The following table presents calculations of net income per
share of common stock for the three months ended March 31,
2007 and 2006:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Net income
|
|
$
|
7,178
|
|
|
$
|
6,045
|
|
Net income per common
share basic
|
|
$
|
0.28
|
|
|
$
|
0.76
|
|
Net income per common
share diluted
|
|
$
|
0.28
|
|
|
$
|
0.73
|
|
Weighted average number of common
shares outstanding basic
|
|
|
25,604
|
|
|
|
7,952
|
|
Incremental shares issuable upon
assumed exercise of stock warrant
|
|
|
|
|
|
|
26
|
|
Incremental shares issuable upon
assumed conversion and exercise of stock options
|
|
|
206
|
|
|
|
307
|
|
|
|
|
|
|
|
|
|
|
Total shares diluted
|
|
|
25,810
|
|
|
|
8,285
|
|
|
|
|
|
|
|
|
|
|
F-55
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
NOTE D
Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss)
are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Foreign currency translation
adjustments
|
|
$
|
6,037
|
|
|
$
|
6,352
|
|
Minimum pension liability
adjustments, net of taxes
|
|
|
1,170
|
|
|
|
1,170
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7,207
|
|
|
$
|
7,522
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the three months ended March 31,
2007 and 2006 was $6,863 and $7,495, respectively.
NOTE E
Employee Separation and Plant Closure Costs
For the three months ended March 31, 2007 and 2006, the
Company recorded employee separation and plant closure costs of
$99 and $162, respectively, primarily related to the closure of
the Distribution and Storage segments idle Plaistow, New
Hampshire facility.
The following table summarizes the Companys employee
separation and plant closure costs activity for the three months
ended March 31, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2007
|
|
|
|
Energy &
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
& Storage
|
|
|
BioMedical
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Other associated costs
|
|
|
|
|
|
|
99
|
|
|
|
|
|
|
|
99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
|
|
|
|
99
|
|
|
|
|
|
|
|
99
|
|
Reserve usage
|
|
|
|
|
|
|
(99
|
)
|
|
|
(39
|
)
|
|
|
(138
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
|
|
|
|
|
|
|
|
(39
|
)
|
|
|
(39
|
)
|
Reserves as of January 1, 2007
|
|
|
1,557
|
|
|
|
190
|
|
|
|
121
|
|
|
|
1,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserves as of March 31, 2007
|
|
$
|
1,557
|
|
|
$
|
190
|
|
|
$
|
82
|
|
|
$
|
1,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2006
|
|
|
|
Energy &
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
Chemicals
|
|
|
& Storage
|
|
|
BioMedical
|
|
|
Total
|
|
|
One-time employee termination costs
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Other associated costs
|
|
|
9
|
|
|
|
153
|
|
|
|
|
|
|
|
162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation and plant
closure costs
|
|
|
9
|
|
|
|
153
|
|
|
|
|
|
|
|
162
|
|
Inventory valuation in cost of
sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
153
|
|
|
|
|
|
|
|
162
|
|
Reserve usage
|
|
|
(9
|
)
|
|
|
(153
|
)
|
|
|
(97
|
)
|
|
|
(259
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserve
|
|
|
|
|
|
|
|
|
|
|
(97
|
)
|
|
|
(97
|
)
|
Reserves as of January 1, 2006
|
|
|
1,557
|
|
|
|
190
|
|
|
|
239
|
|
|
|
1,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserves as of March 31, 2006
|
|
$
|
1,557
|
|
|
$
|
190
|
|
|
$
|
142
|
|
|
$
|
1,889
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-56
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
The employee separation and plant closure costs reserve of
$1,829 and $1,889 at March 31, 2007 and 2006, respectively,
were for one-time employee termination costs.
NOTE F
Acquisitions
On May 26, 2006, the Company acquired the common stock of
Cooler Service Company, Inc. (CSC) based in Tulsa,
Oklahoma. The consideration paid was $15,927, net of cash
acquired, including transaction costs. The acquisition was
funded with cash on hand. The estimated fair value of the net
assets acquired and goodwill at the date of acquisition was
$8,050 and $8,654, respectively. CSC designs and manufactures
air cooled heat exchangers for multiple markets, including
hydrocarbon, petrochemical and industrial gas processing, and
power generation. CSC has been included in the Companys
Energy and Chemical segment.
On March 2, 2007, the Company purchased the remaining
minority interest in Chart Ferox a.s for a purchase price of
$1,612. The purchase price was applied to eliminate the minority
interest in Ferox a.s. of approximately $2,000. The difference
between the purchase price and the value of the minority
interest eliminated was allocated to adjust the fair value of
the assets originally acquired.
NOTE G
Assets Held for Sale
The Company has entered into an agreement to sell the idle
building and a portion of the land at its Plaistow, New
Hampshire facility. The Company expects to complete the sale in
the second or third quarter of 2007. The Plaistow facility is
classified as assets held for sale on the Companys
unaudited condensed consolidated balance sheet as of
March 31, 2007 and the audited consolidated balance sheet
as of December 31, 2006 based on the carrying value of
$3,084.
NOTE H
Income Taxes
The Company adopted the provisions of FASB Interpretation
No. 48, Accounting for Uncertainty in Income Taxes
(FIN 48) on January 1, 2007.
Previously, the Company had accounted for tax contingencies in
accordance with SFAS No. 5, Accounting for
Contingencies. As required by FIN 48, which clarifies
SFAS No. 109, Accounting for Income Taxes, the
Company recognizes the financial statement benefit of a tax
position only after determining that the relevant tax authority
would more likely than not sustain the position following an
audit. For tax positions meeting the more likely than not
threshold, the amount recognized in the financial statements is
the largest benefit that has a greater than 50 percent
likelihood of being realized upon ultimate settlement with the
relevant tax authority. At the adoption date, the Company
applied FIN 48 to all tax positions for which the statute
of limitations remained open. As a result of the implementation
of FIN 48, the Company did not recognize material
adjustments in the liability for unrecognized tax benefits.
The amount of unrecognized tax benefits as of January 1,
2007 was $3,900. This amount includes $1,100 of unrecognized tax
benefits which, if ultimately recognized, will reduce the
Companys annual effective tax rate. There have been no
material changes in unrecognized tax benefits since
January 1, 2007.
The Company is subject to income taxes in the U.S. federal
jurisdiction, and various states and foreign jurisdictions. Tax
regulations within each jurisdiction are subject to the
interpretation of the related tax laws and regulations and
require significant judgment to apply. With few exceptions, the
Company is no longer subject to U.S. federal, state and
local or
non-U.S. income
tax examinations by tax authorities for years prior to 2003.
The Internal Revenue Service (IRS) commenced an
examination of the Companys U.S. income tax returns
for 2004 and 2005 during the three months ended March 31,
2007. The Company expects the examination to be concluded and
settled during 2008. The Company is also currently under
examination by a number of state tax authorities. The Company
also expects those examinations to be concluded and settled
during 2008. It is reasonably
F-57
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
possible that a change in the unrecognized tax benefits may
occur, however, quantification of an estimated range cannot made
at this time.
The Company recognizes interest and penalties related to
uncertain tax positions in income tax expense. The Company had
accrued approximately $302 for the payment of interest and
penalties at March 31, 2007. This amount is included in the
unrecognized tax benefits above.
NOTE I
Employee Benefit Plans
The Company has four defined benefit pension plans covering
certain U.S. hourly and salary employees. All of these
plans were frozen as of February 28, 2006. The defined
benefit plans provide benefits based primarily on the
participants years of service and compensation.
The following table sets forth the components of net periodic
pension benefit for the three months ended March 31, 2007
and 2006.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Service cost
|
|
$
|
|
|
|
$
|
|
|
Interest cost
|
|
|
523
|
|
|
|
510
|
|
Expected return on plan assets
|
|
|
(680
|
)
|
|
|
(618
|
)
|
Recognized actuarial gain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total pension benefit
|
|
$
|
(157
|
)
|
|
$
|
(108
|
)
|
|
|
|
|
|
|
|
|
|
NOTE J
Reporting Segments
The structure of the Companys internal organization is
divided into the following three reportable segments: Energy and
Chemicals (E&C), Distribution and Storage
(D&S) and BioMedical. The Companys
reportable segments are business units that offer different
products and are each managed separately because they
manufacture and distribute distinct products with different
production processes and sales and marketing approaches. The
E&C segment sells heat exchangers, cold boxes and liquefied
natural gas vacuum-insulated pipe to natural gas, petrochemical
processing and industrial gas companies who use them for the
liquefaction and separation of natural and industrial gases. The
D&S segment sells cryogenic bulk storage systems, cryogenic
packaged gas systems, cryogenic systems and components, beverage
liquid
CO2
systems and cryogenic services to various companies for the
storage and transportation of both industrial and natural gases.
The BioMedical segment sells medical respiratory products,
biological storage systems, other oxygen products and magnetic
resonance imaging cryostat components. Due to the nature of the
products that each segment sells, there are no intersegment
sales. Corporate includes operating expenses for executive
management, accounting, tax, treasury, human resources,
information technology, legal, internal audit, risk management
and stock-based compensation expenses that are not allocated to
the reporting segments.
The Company evaluates performance and allocates resources based
on operating income or loss before gain on sale of assets, net
interest expense, financing costs amortization expense, foreign
currency gain or loss, income taxes and minority interest. The
accounting policies of the reportable segments are the same as
those described in the summary of significant accounting
policies.
F-58
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
Information for the Companys three reportable segments and
its corporate headquarters is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2007
|
|
|
|
Energy
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
and Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Sales
|
|
$
|
52,277
|
|
|
$
|
76,779
|
|
|
$
|
23,407
|
|
|
$
|
|
|
|
$
|
152,463
|
|
Operating income (loss)
|
|
|
150
|
|
|
|
18,038
|
|
|
|
4,910
|
|
|
|
(5,811
|
)
|
|
|
17,287
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2006
|
|
|
|
Energy
|
|
|
Distribution
|
|
|
|
|
|
|
|
|
|
|
|
|
and Chemicals
|
|
|
and Storage
|
|
|
BioMedical
|
|
|
Corporate
|
|
|
Total
|
|
|
Sales
|
|
$
|
41,174
|
|
|
$
|
60,318
|
|
|
$
|
19,348
|
|
|
$
|
|
|
|
$
|
120,840
|
|
Operating income (loss)
|
|
|
5,933
|
|
|
|
11,053
|
|
|
|
3,714
|
|
|
|
(4,914
|
)
|
|
|
15,786
|
|
NOTE K
Supplemental Guarantor Financial Information
The Companys Subordinated Notes issued in October 2005 are
guaranteed on a full, unconditional and joint and several basis
by the following wholly owned subsidiaries: Chart Inc., CAIRE
Inc., Chart Energy and Chemicals, Inc., Chart Cooler Service
Company, Inc., Chart International Holdings, Inc., Chart Asia
Inc. and Chart International Inc. The following subsidiaries are
not guarantors of the notes:
|
|
|
Non-Guarantor Subsidiaries
|
|
Jurisdiction
|
|
Chart Australia Pty. Ltd.
|
|
Australia
|
Changzhou CEM Cryo Equipment Co.,
Ltd.
|
|
China
|
Chart Biomedical Limited
|
|
United Kingdom
|
Chart Cryogenic Engineering
Systems (Changzhou) Co., Ltd.
|
|
China
|
Chart Cryogenic Equipment
(Changzhou) Co., Ltd.
|
|
China
|
Chart Ferox a.s
|
|
Czech Republic
|
Chart Ferox GmbH
|
|
Germany
|
GTC of Clarksville, LLC
|
|
Delaware
|
Lox Taiwan (16% owned)
|
|
Taiwan
|
Zhangjigang Chart Hailu Cryogenic
Equipment Co., Ltd.
|
|
China
|
The following supplemental condensed consolidating and combining
financial information of the Issuer, Subsidiary Guarantors and
Subsidiary Non-Guarantors presents statements of operations for
the three months ended March 31, 2007 and 2006, balance
sheets as of March 31, 2007 and December 31, 2006 and
statements of cash flows for the three months ended
March 31, 2007 and 2006.
F-59
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING BALANCE SHEET
As of March 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
ASSETS
|
Cash and cash equivalents
|
|
$
|
(1,080
|
)
|
|
$
|
276
|
|
|
$
|
13,163
|
|
|
$
|
|
|
|
$
|
12,359
|
|
Accounts receivable, net
|
|
|
|
|
|
|
56,390
|
|
|
|
23,507
|
|
|
|
|
|
|
|
79,897
|
|
Inventory, net
|
|
|
|
|
|
|
46,896
|
|
|
|
33,063
|
|
|
|
(330
|
)
|
|
|
79,629
|
|
Other current assets
|
|
|
7,708
|
|
|
|
48,569
|
|
|
|
14,298
|
|
|
|
|
|
|
|
70,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
6,628
|
|
|
|
152,131
|
|
|
|
84,031
|
|
|
|
(330
|
)
|
|
|
242,460
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
59,779
|
|
|
|
29,086
|
|
|
|
|
|
|
|
88,865
|
|
Goodwill
|
|
|
|
|
|
|
189,671
|
|
|
|
57,161
|
|
|
|
|
|
|
|
246,832
|
|
Intangible assets, net
|
|
|
|
|
|
|
141,170
|
|
|
|
2,423
|
|
|
|
|
|
|
|
143,593
|
|
Investments in affiliates
|
|
|
116,153
|
|
|
|
46,009
|
|
|
|
|
|
|
|
(162,162
|
)
|
|
|
|
|
Intercompany receivables
|
|
|
442,863
|
|
|
|
|
|
|
|
|
|
|
|
(442,863
|
)
|
|
|
|
|
Other assets
|
|
|
10,911
|
|
|
|
1,585
|
|
|
|
2,070
|
|
|
|
|
|
|
|
14,566
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
576,555
|
|
|
$
|
590,345
|
|
|
$
|
174,771
|
|
|
$
|
(605,355
|
)
|
|
$
|
736,316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Accounts payable and accruals
|
|
$
|
6,204
|
|
|
$
|
111,470
|
|
|
$
|
27,236
|
|
|
$
|
905
|
|
|
$
|
145,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
6,204
|
|
|
|
111,470
|
|
|
|
27,236
|
|
|
|
905
|
|
|
|
145,815
|
|
Long-term debt
|
|
|
290,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290,000
|
|
Intercompany payables
|
|
|
|
|
|
|
349,102
|
|
|
|
94,996
|
|
|
|
(444,098
|
)
|
|
|
|
|
Other long-term liabilities
|
|
|
53,388
|
|
|
|
13,620
|
|
|
|
6,530
|
|
|
|
|
|
|
|
73,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
349,592
|
|
|
|
474,192
|
|
|
|
128,762
|
|
|
|
(443,193
|
)
|
|
|
509,353
|
|
Common Stock
|
|
|
256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
256
|
|
Other stockholders equity
|
|
|
226,707
|
|
|
|
116,153
|
|
|
|
46,009
|
|
|
|
(162,162
|
)
|
|
|
226,707
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
226,963
|
|
|
|
116,153
|
|
|
|
46,009
|
|
|
|
(162,162
|
)
|
|
|
226,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
576,555
|
|
|
$
|
590,345
|
|
|
$
|
174,771
|
|
|
$
|
(605,355
|
)
|
|
$
|
736,316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-60
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING BALANCE SHEET (AUDITED)
As of December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
ASSETS
|
Cash and cash equivalents
|
|
$
|
6,084
|
|
|
$
|
114
|
|
|
$
|
12,656
|
|
|
$
|
|
|
|
$
|
18,854
|
|
Accounts receivable, net
|
|
|
|
|
|
|
58,320
|
|
|
|
18,442
|
|
|
|
|
|
|
|
76,762
|
|
Inventory, net
|
|
|
|
|
|
|
43,559
|
|
|
|
29,508
|
|
|
|
(210
|
)
|
|
|
72,857
|
|
Other current assets
|
|
|
8,319
|
|
|
|
39,955
|
|
|
|
13,888
|
|
|
|
|
|
|
|
62,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
14,403
|
|
|
|
141,948
|
|
|
|
74,494
|
|
|
|
(210
|
)
|
|
|
230,635
|
|
Property, plant and equipment, net
|
|
|
|
|
|
|
57,469
|
|
|
|
28,254
|
|
|
|
|
|
|
|
85,723
|
|
Goodwill
|
|
|
|
|
|
|
189,671
|
|
|
|
57,473
|
|
|
|
|
|
|
|
247,144
|
|
Intangible assets, net
|
|
|
|
|
|
|
143,998
|
|
|
|
2,625
|
|
|
|
|
|
|
|
146,623
|
|
Investments in affiliates
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
|
|
|
|
(142,435
|
)
|
|
|
|
|
Intercompany receivables
|
|
|
421,549
|
|
|
|
|
|
|
|
|
|
|
|
(421,549
|
)
|
|
|
|
|
Other assets
|
|
|
11,126
|
|
|
|
1,580
|
|
|
|
2,044
|
|
|
|
|
|
|
|
14,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
551,187
|
|
|
$
|
572,992
|
|
|
$
|
164,890
|
|
|
$
|
(564,194
|
)
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Accounts payable and accruals
|
|
$
|
(11,935
|
)
|
|
$
|
122,734
|
|
|
$
|
28,908
|
|
|
$
|
(466
|
)
|
|
$
|
139,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
(11,935
|
)
|
|
|
122,734
|
|
|
|
28,908
|
|
|
|
(466
|
)
|
|
|
139,241
|
|
Long-term debt
|
|
|
290,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290,000
|
|
Intercompany payables
|
|
|
|
|
|
|
332,535
|
|
|
|
88,758
|
|
|
|
(421,293
|
)
|
|
|
|
|
Other long-term liabilities
|
|
|
53,388
|
|
|
|
13,614
|
|
|
|
8,898
|
|
|
|
|
|
|
|
75,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
331,453
|
|
|
|
468,883
|
|
|
|
126,564
|
|
|
|
(421,759
|
)
|
|
|
505,141
|
|
Common Stock
|
|
|
256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
256
|
|
Other stockholders equity
|
|
|
219,478
|
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
(142,435
|
)
|
|
|
219,478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
219,734
|
|
|
|
104,109
|
|
|
|
38,326
|
|
|
|
(142,435
|
)
|
|
|
219,734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
551,187
|
|
|
$
|
572,992
|
|
|
$
|
164,890
|
|
|
$
|
(564,194
|
)
|
|
$
|
724,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-61
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended March 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
111,468
|
|
|
|
42,057
|
|
|
$
|
(1,062
|
)
|
|
$
|
152,463
|
|
Cost of sales
|
|
|
|
|
|
|
81,985
|
|
|
|
31,560
|
|
|
|
(941
|
)
|
|
|
112,604
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
29,483
|
|
|
|
10,497
|
|
|
|
(121
|
)
|
|
|
39,859
|
|
Selling, general and
administrative expenses
|
|
|
651
|
|
|
|
19,779
|
|
|
|
2,142
|
|
|
|
|
|
|
|
22,572
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
(651
|
)
|
|
|
9,704
|
|
|
|
8,355
|
|
|
|
(121
|
)
|
|
|
17,287
|
|
Interest expense
|
|
|
6,329
|
|
|
|
54
|
|
|
|
(37
|
)
|
|
|
|
|
|
|
6,346
|
|
Other expense (income), net
|
|
|
404
|
|
|
|
52
|
|
|
|
(406
|
)
|
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes
and equity in net (income) of subsidiaries
|
|
|
(7,384
|
)
|
|
|
9,598
|
|
|
|
8,798
|
|
|
|
(121
|
)
|
|
|
10,891
|
|
Income tax (benefit) provision
|
|
|
(2,518
|
)
|
|
|
4,506
|
|
|
|
1,725
|
|
|
|
|
|
|
|
3,713
|
|
Equity in net (income) of
subsidiaries
|
|
|
(12,044
|
)
|
|
|
(6,952
|
)
|
|
|
|
|
|
|
18,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
|
|
$
|
7,178
|
|
|
$
|
12,044
|
|
|
$
|
7,073
|
|
|
$
|
(18,996
|
)
|
|
$
|
7,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED
CONSOLIDATING STATEMENT OF OPERATIONS
For the Three Months Ended March 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Net sales
|
|
$
|
|
|
|
$
|
92,677
|
|
|
|
28,994
|
|
|
$
|
(831
|
)
|
|
$
|
120,840
|
|
Cost of sales
|
|
|
|
|
|
|
63,582
|
|
|
|
21,008
|
|
|
|
(737
|
)
|
|
|
83,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
29,095
|
|
|
|
7,986
|
|
|
|
(94
|
)
|
|
|
36,987
|
|
Selling, general and
administrative expenses
|
|
|
391
|
|
|
|
18,325
|
|
|
|
2,476
|
|
|
|
9
|
|
|
|
21,201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
(391
|
)
|
|
|
10,770
|
|
|
|
5,510
|
|
|
|
(103
|
)
|
|
|
15,786
|
|
Interest expense
|
|
|
6,645
|
|
|
|
(17
|
)
|
|
|
(83
|
)
|
|
|
|
|
|
|
6,545
|
|
Other expense (income), net
|
|
|
370
|
|
|
|
29
|
|
|
|
(177
|
)
|
|
|
|
|
|
|
222
|
|
Minority interest, net of tax
|
|
|
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes
and equity in net (income) of subsidiaries
|
|
|
(7,406
|
)
|
|
|
10,758
|
|
|
|
5,776
|
|
|
|
(103
|
)
|
|
|
9,025
|
|
Income tax provision (benefit)
|
|
|
(2,444
|
)
|
|
|
4,778
|
|
|
|
646
|
|
|
|
|
|
|
|
2,980
|
|
Equity in net (income) of
subsidiaries
|
|
|
(11,007
|
)
|
|
|
(5,027
|
)
|
|
|
|
|
|
|
16,034
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
6,045
|
|
|
$
|
11,007
|
|
|
$
|
5,130
|
|
|
$
|
(16,034
|
)
|
|
$
|
6,045
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-62
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
operating activities
|
|
$
|
14,278
|
|
|
$
|
(11,243
|
)
|
|
$
|
(3,153
|
)
|
|
$
|
1,155
|
|
|
$
|
1,037
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(3,318
|
)
|
|
|
(1,706
|
)
|
|
|
|
|
|
|
(5,024
|
)
|
Acquisitions of minority interest
|
|
|
|
|
|
|
(1,622
|
)
|
|
|
|
|
|
|
|
|
|
|
(1,622
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing
activities
|
|
|
|
|
|
|
(4,940
|
)
|
|
|
(1,706
|
)
|
|
|
|
|
|
|
(6,646
|
)
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
|
|
|
|
(750
|
)
|
|
|
|
|
|
|
|
|
|
|
(750
|
)
|
Payment of financing costs
|
|
|
(183
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(183
|
)
|
Other financing activities
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
|
|
Intercompany account changes
|
|
|
(21,264
|
)
|
|
|
17,095
|
|
|
|
5,324
|
|
|
|
(1,155
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
financing activities
|
|
|
(21,442
|
)
|
|
|
16,345
|
|
|
|
5,324
|
|
|
|
(1,155
|
)
|
|
|
(928
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash
and cash equivalents
|
|
|
(7,164
|
)
|
|
|
162
|
|
|
|
465
|
|
|
|
|
|
|
|
(6,537
|
)
|
Effect of exchange rate changes
|
|
|
|
|
|
|
|
|
|
|
42
|
|
|
|
|
|
|
|
42
|
|
Cash and cash equivalents,
beginning of period
|
|
|
6,084
|
|
|
|
114
|
|
|
|
12,656
|
|
|
|
|
|
|
|
18,854
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
(1,080
|
)
|
|
$
|
276
|
|
|
$
|
13,163
|
|
|
$
|
|
|
|
$
|
12,359
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-63
CHART
INDUSTRIES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS March 31, 2007
(Dollars and shares in thousands, except per share
amounts)
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary
|
|
|
Non-
|
|
|
Consolidating
|
|
|
|
|
|
|
Issuer
|
|
|
Guarantors
|
|
|
Guarantors
|
|
|
Adjustments
|
|
|
Total
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
operating activities
|
|
$
|
(1,973
|
)
|
|
$
|
11,681
|
|
|
$
|
2,169
|
|
|
$
|
18
|
|
|
$
|
11,895
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(1,747
|
)
|
|
|
(819
|
)
|
|
|
|
|
|
|
(2,566
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing
activities
|
|
|
|
|
|
|
(1,747
|
)
|
|
|
(819
|
)
|
|
|
|
|
|
|
(2,566
|
)
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
|
(5,000
|
)
|
|
|
|
|
|
|
(839
|
)
|
|
|
|
|
|
|
(5,839
|
)
|
Intercompany account changes
|
|
|
7,898
|
|
|
|
(9,619
|
)
|
|
|
1,739
|
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
2,898
|
|
|
|
(9,619
|
)
|
|
|
900
|
|
|
|
(18
|
)
|
|
|
(5,839
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash
equivalents
|
|
|
925
|
|
|
|
315
|
|
|
|
2,250
|
|
|
|
|
|
|
|
3,490
|
|
Effect of exchange rate changes
|
|
|
|
|
|
|
|
|
|
|
107
|
|
|
|
|
|
|
|
107
|
|
Cash and cash equivalents,
beginning of period
|
|
|
7,191
|
|
|
|
272
|
|
|
|
3,863
|
|
|
|
|
|
|
|
11,326
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of
period
|
|
$
|
8,116
|
|
|
$
|
587
|
|
|
$
|
6,220
|
|
|
$
|
|
|
|
$
|
14,923
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-64